,symbol,name,description__profile,ceo__profile,industry__profile,price__profile,currency__profile,mktCap__profile,image__profile,volAvg__profile,pe__quote,change__quote,volume__quote,ebitda__income_statement,netIncome__income_statement,annual_earnings,quaterly_earnings,eps__income_statement,epsdiluted__income_statement,totalAssets__balance_sheet_statement,totalCurrentAssets__balance_sheet_statement,cashAndShortTermInvestments__balance_sheet_statement,totalLiabilities__balance_sheet_statement,netReceivables__balance_sheet_statement,longTermInvestments__balance_sheet_statement,totalCurrentLiabilities__balance_sheet_statement,cashAndCashEquivalents__balance_sheet_statement,freeCashFlow__cash_flow_statement,growthEBITDA__income_statement_growth,growthNetIncome__income_statement_growth,growthEPS__income_statement_growth,dividend__historical-price-full/stock_dividend,date__historical-price-full/stock_dividend,derived__netIncomeMargin,derived__debtRatio
0,ASTC,Astrotech Corporation (DE) Common Stock,"Astrotech Corporation operates as a science and technology development and commercialization company worldwide. It operates through three segments, Astrotech Technologies, Inc. (ATI), 1st Detect Corporation (1st Detect), and AgLAB Inc (AgLAB). The ATI segment owns and licenses the AMS Technology, the platform mass spectrometry technology. The 1st Detect segment manufactures explosives and narcotics trace detectors for use at airports, secured facilities, and borders. This segment provides TRACER 1000, a mass spectrometer based explosives trace detector to replace the explosives trace detectors used at airports, cargo and secured facilities, and borders. The AgLAB segment develops AgLAB-1000, a mass spectrometer for use in the hemp and cannabis market. It also develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. Astrotech Corporation was incorporated in 1984 is based in Austin, Texas.",Mr. Thomas Boone Pickens III,Aerospace & Defense,5.9639,USD,10102548,https://images.financialmodelingprep.com/symbol/ASTC.png,2772,-0.71,0.1339,1061,-12549000,-11666000,"[{'period': '2024', 'revenue': 1.66, 'unit': 'M', 'net_profit': -11.67}, {'period': '2023', 'revenue': 0.75, 'unit': 'M', 'net_profit': -9.64}, {'period': '2022', 'revenue': 0.869, 'unit': 'M', 'net_profit': -7.56}, {'period': '2021', 'revenue': 0.334, 'unit': 'M', 'net_profit': -7.61}]","[{'period': ""Q3 '25"", 'revenue': 0.534, 'unit': 'M', 'net_profit': -3.63}, {'period': ""Q2 '25"", 'revenue': 0.261, 'unit': 'M', 'net_profit': -4.01}, {'period': ""Q1 '25"", 'revenue': 0.034, 'unit': 'M', 'net_profit': -3.28}, {'period': ""Q4 '24"", 'revenue': 0.074, 'unit': 'M', 'net_profit': -2.96}, {'period': ""Q3 '24"", 'revenue': 0.05, 'unit': 'M', 'net_profit': -3.15}, {'period': ""Q2 '24"", 'revenue': 1.11, 'unit': 'M', 'net_profit': -2.64}]",-7.12,-7.12,37640000,34728000,31916000,2833000,77000,0,2528000,10442000,-10304000,-0.17346175425472227,-0.20991495540344327,-0.19663865546218487,__nan__,__nan__,__nan__,0.07526567481402763
1,ASTE,Astec Industries Inc. Common Stock,"Astec Industries, Inc. designs, engineers, manufactures, and markets equipment and components used primarily in road building and related construction activities in the United States and internationally. The company operates in two segments, Infrastructure Solutions and Materials Solutions. The Infrastructure Solutions segment offers asphalt plants and related components, heaters, concrete dust control systems, asphalt pavers, vaporizers, concrete material handling systems, screeds, heat recovery units, paste back-fill plants, asphalt storage tanks, hot oil heaters, bagging plants, fuel storage tanks, industrial and asphalt burners and systems, custom batch plants, material transfer vehicles, soil stabilizing-reclaiming machinery, blower trucks and trailers, milling machines, soil remediation plants, wood chippers and grinders, pump trailers, concrete batch plants, control systems, liquid terminals, storage equipment and related parts, construction and retrofits, polymer plants, and concrete mixers, as well as engineering and environmental permitting services. This segment provides its products to asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, contractors in the construction and demolition recycling markets, and governmental agencies. The Materials Solutions segment designs and manufactures crushing equipment, mobile plants, bulk material handling solutions, vibrating equipment, screening equipment, electrical control centers, modular plants and systems, conveying equipment, plant automation products, portable plants, and mineral processing equipment, as well as offers consulting and engineering services. Astec Industries, Inc. was incorporated in 1972 and is headquartered in Chattanooga, Tennessee.",Mr. Jaco G. van der Merwe,Agricultural - Machinery,40.09,USD,916738030,https://images.financialmodelingprep.com/symbol/ASTE.png,159491,60.74,-1.45,127446,51400000,4300000,"[{'period': '2024', 'revenue': 1310.0, 'unit': 'M', 'net_profit': 4.3}, {'period': '2023', 'revenue': 1340.0, 'unit': 'M', 'net_profit': 33.5}, {'period': '2022', 'revenue': 1270000.0, 'unit': 'K', 'net_profit': -600.0}, {'period': '2021', 'revenue': 1100.0, 'unit': 'M', 'net_profit': 15.8}]","[{'period': ""Q1 '25"", 'revenue': 329.4, 'unit': 'M', 'net_profit': 14.3}, {'period': ""Q4 '24"", 'revenue': 359.0, 'unit': 'M', 'net_profit': 21.1}, {'period': ""Q3 '24"", 'revenue': 291.4, 'unit': 'M', 'net_profit': -6.2}, {'period': ""Q2 '24"", 'revenue': 345.5, 'unit': 'M', 'net_profit': -14.0}, {'period': ""Q1 '24"", 'revenue': 309.2, 'unit': 'M', 'net_profit': 3.4}, {'period': ""Q4 '23"", 'revenue': 337.2, 'unit': 'M', 'net_profit': 14.9}]",0.19,0.19,1043600000,722800000,91300000,406000000,167200000,18900000,271700000,88300000,2500000,-0.3350582147477361,-0.8716417910447761,-0.870748299319728,"[0.13, 1]","['2025-05-13', '2012-11-16']",__nan__,0.38903794557301646
2,ASTS,AST SpaceMobile Inc. Class A Common Stock,"AST SpaceMobile, Inc. operates space-based cellular broadband network for mobile phones. Its SpaceMobile service provides mobile broadband services for users traveling in and out of areas without terrestrial mobile services on land, at sea, or in flight. The company is headquartered in Midland, Texas.",Mr. Abel  Avellan,Communication Equipment,23.83,USD,7811529476,https://images.financialmodelingprep.com/symbol/ASTS.png,10827142,-12.04,-1.2,10778757,-442981000,-300083000,"[{'period': '2024', 'revenue': 4.42, 'unit': 'M', 'net_profit': -300.08}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -87.56}, {'period': '2022', 'revenue': 13.82, 'unit': 'M', 'net_profit': -31.64}, {'period': '2021', 'revenue': 12.4, 'unit': 'M', 'net_profit': -73.26}]","[{'period': ""Q1 '25"", 'revenue': 0.718, 'unit': 'M', 'net_profit': -45.71}, {'period': ""Q4 '24"", 'revenue': 1.92, 'unit': 'M', 'net_profit': -35.86}, {'period': ""Q3 '24"", 'revenue': 1.1, 'unit': 'M', 'net_profit': -171.95}, {'period': ""Q2 '24"", 'revenue': 0.9, 'unit': 'M', 'net_profit': -72.55}, {'period': ""Q1 '24"", 'revenue': 0.5, 'unit': 'M', 'net_profit': -19.73}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -31.93}]",-1.9423,-1.9423,954561000,600246000,564988000,285415000,0,0,75942000,564988000,-300270000,-1.660115176517922,-2.427130800242117,-0.8150640127090925,__nan__,__nan__,__nan__,0.2990013210261052
3,ASTSW,AST SpaceMobile Inc. Warrant,"AST SpaceMobile, Inc., together with its subsidiaries, operates space-based cellular broadband network for mobile phones in the United States. Its SpaceMobile service provides mobile broadband services to end-users who are out of terrestrial cellular coverage. AST SpaceMobile, Inc. was founded in 2017 and is based in Midland, Texas.",Mr. Abel  Avellan,Telecommunications Services,13.5,USD,1749411756,https://images.financialmodelingprep.com/symbol/ASTSW.png,0,0.0,1.21,375766,-442981000,-300083000,"[{'period': '2024', 'revenue': 4.42, 'unit': 'M', 'net_profit': -300.08}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -87.56}, {'period': '2022', 'revenue': 13.82, 'unit': 'M', 'net_profit': -31.64}, {'period': '2021', 'revenue': 12.4, 'unit': 'M', 'net_profit': -73.26}]","[{'period': ""Q1 '25"", 'revenue': 0.718, 'unit': 'M', 'net_profit': -45.71}, {'period': ""Q4 '24"", 'revenue': 1.92, 'unit': 'M', 'net_profit': -35.86}, {'period': ""Q3 '24"", 'revenue': 1.1, 'unit': 'M', 'net_profit': -171.95}, {'period': ""Q2 '24"", 'revenue': 0.9, 'unit': 'M', 'net_profit': -72.55}, {'period': ""Q1 '24"", 'revenue': 0.5, 'unit': 'M', 'net_profit': -19.73}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -31.93}]",-1.9423,-1.9423,954561000,600246000,564988000,285415000,0,0,75942000,564988000,-300270000,-1.660115176517922,-2.427130800242117,-0.8150640127090925,__nan__,__nan__,__nan__,0.2990013210261052
4,ASUR,Asure Software Inc Common Stock,"Asure Software, Inc. provides cloud-based human capital management solutions the United States. It helps various small and mid-sized businesses to build productive teams to help them stay compliant and allocate resources to grow their business. The company's solutions include Asure Payroll & Tax, an integrated cloud-based solution automates regulations associated with payroll and taxes, including wages, benefits, overtime, garnishments, tips, direct deposits, and fair labor standard act, as well as federal, state, and local payroll taxes; Asure (human resource) HR, a cloud-based functionality that handles HR complexities, such as employee self-service that enable employees to access information, pay history, and company documents; and Asure Time & Attendance that provides cost savings and return on investment gains come in the form of strategic use of labor dollars and the elimination of time theft. It also provides HR services that offers services comprising on-demand HR resource library, phone and email support for any HR issues, and compliance and policy updates; support for strategic HR decision making; and HR outsourcing solution, as well as data integration with related third-party systems, such as 401(k), benefits, and insurance provider systems. Asure Software, Inc. was incorporated in 1985 and is headquartered in Austin, Texas.",Mr. Patrick F. Goepel,Software - Application,9.52,USD,258506080,https://images.financialmodelingprep.com/symbol/ASUR.png,88640,-17.96,-0.22,25248,-10737000,-11773000,"[{'period': '2024', 'revenue': 119.79, 'unit': 'M', 'net_profit': -11.77}, {'period': '2023', 'revenue': 119.08, 'unit': 'M', 'net_profit': -9.21}, {'period': '2022', 'revenue': 95.83, 'unit': 'M', 'net_profit': -14.47}, {'period': '2021', 'revenue': 76.06, 'unit': 'M', 'net_profit': 3.19}]","[{'period': ""Q1 '25"", 'revenue': 34.85, 'unit': 'M', 'net_profit': -2.4}, {'period': ""Q4 '24"", 'revenue': 30.79, 'unit': 'M', 'net_profit': -3.2}, {'period': ""Q3 '24"", 'revenue': 29.3, 'unit': 'M', 'net_profit': -3.9}, {'period': ""Q2 '24"", 'revenue': 28.04, 'unit': 'M', 'net_profit': -4.36}, {'period': ""Q1 '24"", 'revenue': 31650.0, 'unit': 'K', 'net_profit': -308.0}, {'period': ""Q4 '23"", 'revenue': 26.26, 'unit': 'M', 'net_profit': -3.58}]",-0.45,-0.45,436638000,237277000,21425000,247293000,18154000,0,223636000,21425000,-14747000,-1.679213056680162,-0.27772954200130234,-0.0714285714285715,__nan__,__nan__,__nan__,0.5663570280186333
5,ASYS,Amtech Systems Inc. Common Stock,"Amtech Systems, Inc. manufactures and sells capital equipment and related consumables for use in fabricating silicon carbide (SiC), silicon power devices, analog and discrete devices, electronic assemblies, and light-emitting diodes (LEDs) worldwide. The company operates in Semiconductor and Material and Substrate segments. The Semiconductor segment designs, manufactures, sells, and services thermal processing equipment, including solder reflow ovens, diffusion furnaces, and customer high-temp belt furnaces for use by semiconductor manufacturers, as well as in electronics, automotive and other industries; and wafer polishing equipment and related services. Its products include horizontal diffusion furnaces; and belt furnaces. The Material and Substrate segment manufactures and sells consumables and machinery for lapping and polishing of materials, such as silicon wafers for semiconductor products; sapphire substrates for LED lighting and mobile devices; silicon carbide wafers for LED and power device applications; various glass and silica components for 3D image transmission; quartz and ceramic components for telecommunications devices; and medical device components, and optical and photonics applications. This segment also offers substrate process chemicals for use in various manufacturing processes, including semiconductors, silicon and compound semiconductor wafers, and optics. The company sells its products through sales personnel, as well as a network of independent sales representatives and distributors. The company was formerly known as Quartz Engineering & Materials, Inc. and changed its name to Amtech Systems, Inc. in 1987. Amtech Systems, Inc. was incorporated in 1981 and is headquartered in Tempe, Arizona.",Mr. Robert C. Daigle,Semiconductors,3.65,USD,52246100,https://images.financialmodelingprep.com/symbol/ASYS.png,72301,-1.64,-0.15,30570,-3925000,-8486000,"[{'period': '2024', 'revenue': 101.21, 'unit': 'M', 'net_profit': -8.49}, {'period': '2023', 'revenue': 113.31, 'unit': 'M', 'net_profit': -12.58}, {'period': '2022', 'revenue': 106.3, 'unit': 'M', 'net_profit': 17.37}, {'period': '2021', 'revenue': 85.2, 'unit': 'M', 'net_profit': 1.51}]","[{'period': ""Q2 '25"", 'revenue': 15.58, 'unit': 'M', 'net_profit': -31.81}, {'period': ""Q1 '25"", 'revenue': 24390.0, 'unit': 'K', 'net_profit': 312.0}, {'period': ""Q4 '24"", 'revenue': 24110.0, 'unit': 'K', 'net_profit': -536.0}, {'period': ""Q3 '24"", 'revenue': 26750.0, 'unit': 'K', 'net_profit': 438.0}, {'period': ""Q2 '24"", 'revenue': 25430.0, 'unit': 'K', 'net_profit': 970.0}, {'period': ""Q1 '24"", 'revenue': 24.92, 'unit': 'M', 'net_profit': -9.36}]",-0.6,-0.6,118953000,64376000,11086000,36595000,21989000,0,19599000,11086000,4964000,0.5932642487046632,0.3255444285487204,0.3258426966292135,__nan__,__nan__,__nan__,0.30764251427034206
6,ATAX,America First Multifamily Investors L.P. Beneficial Unit Certificates (BUCs) representing Limited Partnership Interests,"America First Multifamily Investors, L.P. acquires, holds, sells, and deals in a portfolio of mortgage revenue bonds (MRBs) that are issued to provide construction and/or permanent financing for multifamily and student housing, and residential and commercial properties. It operates through five segments: Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, Market-Rate Joint Venture Investments, and Public Housing Capital Fund Trusts. As of December 31, 2021, the company owned 74 MRBs issued by state and local housing authorities in order to provide construction or permanent financing for 76 multifamily and seniors housing properties comprising a total of 12,584 rental units located in 17 states; and nine governmental issuer loans related to affordable multifamily properties containing a total of 1,832 rental units located in six states in the United States. America First Capital Associates Limited Partnership Two serves as the general partner of the company. America First Multifamily Investors, L.P. was incorporated in 1998 and is based in Omaha, Nebraska.",Mr. Chad Daffer,Financial - Mortgages,18.6,USD,419223540,https://images.financialmodelingprep.com/symbol/ATAX.png,36184,6.503496503496503,0.0,27807,81411654000,21323333000,"[{'period': '2024', 'revenue': 91.27, 'unit': 'B', 'net_profit': 21.32}, {'period': '2023', 'revenue': 104.9, 'unit': 'B', 'net_profit': 54.01}, {'period': '2022', 'revenue': 81.07, 'unit': 'M', 'net_profit': 65.56}, {'period': '2021', 'revenue': 62.01, 'unit': 'M', 'net_profit': 38.1}]","[{'period': ""Q1 '25"", 'revenue': 25.13, 'unit': 'B', 'net_profit': 3.33}, {'period': ""Q4 '24"", 'revenue': 64.74, 'unit': 'B', 'net_profit': 11.56}, {'period': ""Q3 '24"", 'revenue': 24.35, 'unit': 'B', 'net_profit': -4.64}, {'period': ""Q2 '24"", 'revenue': 21.97, 'unit': 'B', 'net_profit': 5.18}, {'period': ""Q3 '23"", 'revenue': 26.47, 'unit': 'B', 'net_profit': 9.73}, {'period': ""Q2 '23"", 'revenue': 28.3, 'unit': 'M', 'net_profit': 21.29}]",924.24,924.24,1579700160000,22149505000,14703198000,1196267250000,7446307000,0,0,14703198000,17994177000,-0.3467563025161536,-0.6052089717752984,388.9746835443038,"[0.1, 0.142]","['2022-12-29', '1986-04-24']",__nan__,0.7572748805697406
7,ATCOL,Atlas Corp. 7.125% Notes due 2027,"Atlas Corp. operates as an asset manager and operator of containerships. The company, through its subsidiaries, operates as an independent charter owner and manager of containerships. The company charters its containerships under long-term and fixed-rate time charters to various container liner companies. It also provides electricity to oil and gas, mining, and other industries, as well as government backed and private utilities; and power solutions comprising plant design, fast-tracked installation of generating equipment and balance of plant, plant operation, and service and maintenance. As of March 10, 2022, the company operated a fleet of 132 vessels, 30 gas turbines, and 414 diesel generators. Atlas Corp. was incorporated in 2019 and is based in London, the United Kingdom.",Mr. Bing  Chen CPA,Asset Management,25.0775,USD,5124142676,https://images.financialmodelingprep.com/symbol/ATCOL.png,3075,14.45,-0.0025,18267,1708900000,672300000,"[{'period': '2024', 'revenue': 2300.0, 'unit': 'M', 'net_profit': 672.3}, {'period': '2023', 'revenue': 1820.0, 'unit': 'M', 'net_profit': 329.8}, {'period': '2022', 'revenue': 1700.0, 'unit': 'M', 'net_profit': 622.3}, {'period': '2021', 'revenue': 1650.0, 'unit': 'M', 'net_profit': 400.5}]","[{'period': ""Q4 '24"", 'revenue': 552.9, 'unit': 'M', 'net_profit': 240.0}, {'period': ""Q3 '24"", 'revenue': 602.9, 'unit': 'M', 'net_profit': 111.5}, {'period': ""Q2 '24"", 'revenue': 603.2, 'unit': 'M', 'net_profit': 159.9}, {'period': ""Q1 '24"", 'revenue': 541.1, 'unit': 'M', 'net_profit': 148.9}, {'period': ""Q4 '23"", 'revenue': 492.4, 'unit': 'M', 'net_profit': 92.3}, {'period': ""Q3 '23"", 'revenue': 474.0, 'unit': 'M', 'net_profit': 137.5}]",2.74,3.0,17158200000,1736700000,1366300000,11957700000,129700000,0,1593700000,1366300000,-1837200000,0.32134848836310215,1.0385081867798667,0.7018633540372671,"[0.44531, 0.445]","['2025-07-15', '2021-07-14']",__nan__,0.6969087666538448
8,ATCX,Atlas Technical Consultants Inc. Class A Common Stock,"Atlas Technical Consultants, Inc. provides professional testing, inspection, engineering, environmental, and program management and consulting services in the United States. The company provides a range of technical services that helps its clients test, inspect, plan, design, certify, and manage various projects across various end markets. It offers testing, inspection, and certification services, such as construction materials testing; non-destructive testing and evaluations, materials testing and inspection, laboratory, and geophysics; construction quality assurance; owner verification and inspection; forensic and structural investigations; and materials laboratory services. The company also provides environmental services, including environmental permitting, compliance assistance, and auditing and compliance management system implementation; air quality; water, hazardous material permitting, and registration; underground storage tank management; leak detection and repair program management; water resource management; industrial hygiene and building science; and disaster response and recovery. In addition, it offers engineering and design services comprising civil site, transportation, and geotechnical engineering; hydrogeology; water/wastewater; solid waste/landfill; land acquisition; subsurface utility engineering; surveying and mapping; and geographic information system asset inventory and assessments. Further, the company offers program management/construction management/quality management services consisting of programmatic planning and phasing; contract document preparation; bid evaluation and award analysis; alternative/value engineering; project estimating and scheduling; project cost/schedule control; contract administration; project management; community relations/affairs; asset management; construction management; quality management and assurance; and construction engineering and inspection. The company is headquartered in Austin, Texas.",Mr. L. Joseph Boyer,Engineering & Construction,12.25,USD,0,https://images.financialmodelingprep.com/symbol/ATCX.png,233488,-58.333333333333336,0.0,380049,70700000,-8070000,"[{'period': '2022', 'revenue': 604.76, 'unit': 'M', 'net_profit': -8.07}, {'period': '2021', 'revenue': 538.8, 'unit': 'M', 'net_profit': -29.7}, {'period': '2020', 'revenue': 468.22, 'unit': 'M', 'net_profit': -27.06}, {'period': '2019', 'revenue': 471.05, 'unit': 'M', 'net_profit': 8.03}]","[{'period': ""Q4 '22"", 'revenue': 150.96, 'unit': 'M', 'net_profit': -4.22}, {'period': ""Q3 '22"", 'revenue': 162.12, 'unit': 'M', 'net_profit': 1.91}, {'period': ""Q2 '22"", 'revenue': 156.5, 'unit': 'M', 'net_profit': -1.41}, {'period': ""Q1 '22"", 'revenue': 135.19, 'unit': 'M', 'net_profit': -4.42}, {'period': ""Q4 '21"", 'revenue': 145.25, 'unit': 'M', 'net_profit': -7.61}, {'period': ""Q3 '21"", 'revenue': 138.72, 'unit': 'M', 'net_profit': -2.53}]",-0.22,-0.22,487360000,180755000,5799000,613720000,160620000,0,78556000,5799000,-6212000,0.37776478612491476,0.7283285642147787,0.7943925233644861,__nan__,__nan__,__nan__,1.259274458305975
9,ATEC,Alphatec Holdings Inc. Common Stock,"Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.",Mr. Patrick S. Miles,Medical - Devices,12.66,USD,1850550180,https://images.financialmodelingprep.com/symbol/ATEC.png,2349040,-11.11,-0.31,1477121,-53874000,-162123000,"[{'period': '2024', 'revenue': 611.56, 'unit': 'M', 'net_profit': -162.12}, {'period': '2023', 'revenue': 482.26, 'unit': 'M', 'net_profit': -186.64}, {'period': '2022', 'revenue': 350.87, 'unit': 'M', 'net_profit': -152.15}, {'period': '2021', 'revenue': 243.21, 'unit': 'M', 'net_profit': -144.33}]","[{'period': ""Q1 '25"", 'revenue': 169.18, 'unit': 'M', 'net_profit': -51.91}, {'period': ""Q4 '24"", 'revenue': 176.79, 'unit': 'M', 'net_profit': -33.33}, {'period': ""Q3 '24"", 'revenue': 150.72, 'unit': 'M', 'net_profit': -39.62}, {'period': ""Q2 '24"", 'revenue': 145.57, 'unit': 'M', 'net_profit': -40.68}, {'period': ""Q1 '24"", 'revenue': 138.48, 'unit': 'M', 'net_profit': -48.49}, {'period': ""Q4 '23"", 'revenue': 137.97, 'unit': 'M', 'net_profit': -49.08}]",-1.13,-1.13,775710000,417399000,138840000,789879000,82987000,0,153026000,138840000,-137787000,0.5128580729166666,0.13135052883121337,0.2662337662337663,__nan__,__nan__,__nan__,1.0182658467726342
10,ATER,Aterian Inc. Common Stock,"Aterian, Inc., together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. The company provides Artificial Intelligence Marketplace e-Commerce Engine, a software technology platform, which uses machine learning, natural language processing, and data analytics to design, develop, market, and sell products. Its platform offers home and kitchen appliances; kitchenware; heating, cooling, and health and beauty products; and air quality appliances, such as dehumidifiers, humidifiers, and air conditioners under the hOmeLabs, Vremi, Squatty Potty, Xtava, RIF6, Aussie Health, Holonix, Truweo, Mueller, Pursteam, Pohl and Schmitt, Healing Solutions, Photo Paper Direct, and Spiralizer brands. The company also sells essential oils. It primarily serves individual online consumers through Amazon and other e-commerce platforms, as well as through its owned and operated websites and other marketplaces. The company was formerly known as Mohawk Group Holdings, Inc. and changed its name to Aterian, Inc. in April 2021. Aterian, Inc. was founded in 2014 and is headquartered in New York, New York.",Mr. Arturo  Rodriguez,"Furnishings, Fixtures & Appliances",1.63,USD,14263706,https://images.financialmodelingprep.com/symbol/ATER.png,976018,-1.13,-0.03,135963,-9002000,-11862000,"[{'period': '2024', 'revenue': 99.05, 'unit': 'M', 'net_profit': -11.86}, {'period': '2023', 'revenue': 142.57, 'unit': 'M', 'net_profit': -74.56}, {'period': '2022', 'revenue': 221.17, 'unit': 'M', 'net_profit': -196.29}, {'period': '2021', 'revenue': 247.77, 'unit': 'M', 'net_profit': -234.72}]","[{'period': ""Q1 '25"", 'revenue': 15.36, 'unit': 'M', 'net_profit': -3.9}, {'period': ""Q4 '24"", 'revenue': 24.61, 'unit': 'M', 'net_profit': -1.3}, {'period': ""Q3 '24"", 'revenue': 26.24, 'unit': 'M', 'net_profit': -1.77}, {'period': ""Q2 '24"", 'revenue': 27.98, 'unit': 'M', 'net_profit': -3.63}, {'period': ""Q1 '24"", 'revenue': 20.21, 'unit': 'M', 'net_profit': -5.16}, {'period': ""Q4 '23"", 'revenue': 32.75, 'unit': 'M', 'net_profit': -7.71}]",-1.68,-1.68,49542000,38719000,17998000,19525000,3782000,0,19298000,17998000,2123000,0.8703255545952175,0.8409151869534897,0.8532751091703057,__nan__,__nan__,__nan__,0.39411004804004685
11,ATEX,Anterix Inc. Common Stock,"Anterix Inc. operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks, technologies, and solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico. The company was formerly known as pdvWireless, Inc. and changed its name to Anterix Inc. in August 2019. Anterix Inc. was incorporated in 1997 and is headquartered in Woodland Park, New Jersey.",Mr. Scott A. Lang,Telecommunications Services,27.99,USD,520244532,https://images.financialmodelingprep.com/symbol/ATEX.png,148144,-17.28,-0.77,123298,-51622000,-9128000,"[{'period': '2024', 'revenue': 4.19, 'unit': 'M', 'net_profit': -9.13}, {'period': '2023', 'revenue': 1.92, 'unit': 'M', 'net_profit': -16.32}, {'period': '2022', 'revenue': 1.08, 'unit': 'M', 'net_profit': -37.52}, {'period': '2021', 'revenue': 0.921, 'unit': 'M', 'net_profit': -54.43}]","[{'period': ""Q3 '25"", 'revenue': 1.57, 'unit': 'M', 'net_profit': 7.71}, {'period': ""Q2 '25"", 'revenue': 1.55, 'unit': 'M', 'net_profit': -12.77}, {'period': ""Q1 '25"", 'revenue': 1.52, 'unit': 'M', 'net_profit': -15.52}, {'period': ""Q4 '24"", 'revenue': 1.26, 'unit': 'M', 'net_profit': -9.41}, {'period': ""Q3 '24"", 'revenue': 1270.0, 'unit': 'K', 'net_profit': 328.0}, {'period': ""Q2 '24"", 'revenue': 1.05, 'unit': 'M', 'net_profit': 2.07}]",-0.49,-0.49,324894000,73011000,60578000,163862000,8521000,0,17951000,60578000,24655000,0.03383866741530975,0.44058344058344057,0.4367816091954023,__nan__,__nan__,__nan__,0.5043552666408121
12,ATHA,Athira Pharma Inc. Common Stock,"Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical trials for the treatment of Alzheimer's disease, as well as is in Phase 2 clinical trials to treat Parkinson's disease. It also develops product candidates, which are in preclinical stage, including ATH-1019 for peripheral nervous system indications; and ATH-1020 for neuropsychiatric conditions. Athira Pharma, Inc. was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. The company was incorporated in 2011 and is headquartered in Bothell, Washington.","Dr. Mark J. Litton M.B.A., Ph.D.",Biotechnology,0.2685,USD,10482884,https://images.financialmodelingprep.com/symbol/ATHA.png,214750,-0.13,0.0004,59726,-95970000,-96940000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -96.94}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -117.67}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -87.26}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -54.37}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.14}, {'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.0}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -28.74}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -26.86}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -26.34}, {'period': ""Q4 '23"", 'revenue': 1.66, 'unit': 'M', 'net_profit': -27.29}]",-2.52,-2.52,58779000,54841000,51275000,13938000,0,0,13135000,48438000,-97203000,0.1776561013855685,0.17618464885444285,0.18446601941747567,__nan__,__nan__,__nan__,0.23712550400653296
13,ATHE,Alterity Therapeutics Limited American Depositary Shares,"Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase IIa clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.",Dr. David A. Stamler M.D.,Biotechnology,4.01,USD,59361630,https://images.financialmodelingprep.com/symbol/ATHE.png,44450,-2.23,-0.19,5241,-19571603,-19123464,"[{'period': '2024', 'revenue': 4.02, 'unit': 'M', 'net_profit': -19.12}, {'period': '2023', 'revenue': 3.92, 'unit': 'M', 'net_profit': -13.81}, {'period': '2022', 'revenue': 5.12, 'unit': 'M', 'net_profit': -12.85}, {'period': '2021', 'revenue': 4.34, 'unit': 'M', 'net_profit': -15.31}]","[{'period': ""Q2 '25"", 'revenue': 0.80296, 'unit': 'M', 'net_profit': -3.59}, {'period': ""Q1 '25"", 'revenue': 0.80296, 'unit': 'M', 'net_profit': -3.59}, {'period': ""Q4 '24"", 'revenue': 2.12, 'unit': 'M', 'net_profit': -12.62}, {'period': ""Q3 '24"", 'revenue': 1.06, 'unit': 'M', 'net_profit': -6.31}, {'period': ""Q2 '24"", 'revenue': 1.9, 'unit': 'M', 'net_profit': -6.51}, {'period': ""Q1 '24"", 'revenue': 0.95036, 'unit': 'M', 'net_profit': -3.25}]",-3.12,-3.12,19223743,19036860,12638885,5425686,4041675,0,5373772,12638885,-12611546,-0.11748192391216591,-0.3851043510980142,0.08771929824561411,__nan__,__nan__,__nan__,0.28223879189396156
14,ATHX,Athersys Inc. Common Stock,"Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients, including those suffering from serious conditions with unmet medical needs. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. Athersys, Inc. was founded in 1995 and is headquartered in Cleveland, Ohio.",Ms. Z. Kasey Rosado,Biotechnology,0.0135,USD,0,https://images.financialmodelingprep.com/symbol/ATHX.png,1772562,-0.008181818181818182,-0.0068,6462682,-75589000,-68061000,"[{'period': '2022', 'revenue': 5.33, 'unit': 'M', 'net_profit': -68.06}, {'period': '2021', 'revenue': 5.51, 'unit': 'M', 'net_profit': -86.95}, {'period': '2020', 'revenue': 1.43, 'unit': 'M', 'net_profit': -78.77}, {'period': '2019', 'revenue': 5.52, 'unit': 'M', 'net_profit': -44.58}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.77}, {'period': ""Q2 '23"", 'revenue': 0.049, 'unit': 'M', 'net_profit': -12.92}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.29}, {'period': ""Q4 '22"", 'revenue': 0.032, 'unit': 'M', 'net_profit': -12.4}, {'period': ""Q3 '22"", 'revenue': 0.065, 'unit': 'M', 'net_profit': -10.62}, {'period': ""Q2 '22"", 'revenue': 2.32, 'unit': 'M', 'net_profit': -23.04}]",-5.7,-5.7,27731000,13535000,9038000,51582000,716000,0,42363000,9038000,-59347000,0.11727061461386647,0.21728480248404347,0.41176470588235287,__nan__,__nan__,__nan__,1.8600843820994555
15,ATIF,ATIF Holdings Limited Ordinary Shares,"ATIF Holdings Limited operates as a consulting company in Asia and North America. It offers IPO advisory services to small and medium-sized enterprises (SMEs). The company primarily helps clients going public on the OTC markets and exchanges in the United States. It also operates IPOEX.com, an internet-based financial information service platform that provides membership services, including market information, pre-IPO education, and IR media and matchmaking services to SMEs and financing institutions; and chinacnnm.com, a news and financial information platform. In addition, the company offers public consulting, M&A consulting, and financial consulting services. The company was incorporated in 2015 and is headquartered in Shenzhen, China.",Mr. Jun  Liu,Financial - Capital Markets,0.6401,USD,7628392,https://images.financialmodelingprep.com/symbol/ATIF.png,210639,-2.0648387096774194,-0.0939,104175,-1960009,-3184924,"[{'period': '2024', 'revenue': 0.62, 'unit': 'M', 'net_profit': -3.18}, {'period': '2023', 'revenue': 2.45, 'unit': 'M', 'net_profit': -2.88}, {'period': '2022', 'revenue': 1.67, 'unit': 'M', 'net_profit': -4.07}, {'period': '2021', 'revenue': 0.9369299999999999, 'unit': 'M', 'net_profit': -8.82}]","[{'period': ""Q2 '25"", 'revenue': 0.2, 'unit': 'M', 'net_profit': -1.9}, {'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -367.07}, {'period': ""Q4 '24"", 'revenue': 0.27, 'unit': 'M', 'net_profit': -1.35}, {'period': ""Q3 '24"", 'revenue': 200.0, 'unit': 'K', 'net_profit': -807.59}, {'period': ""Q2 '24"", 'revenue': 25.0, 'unit': 'K', 'net_profit': -407.64}, {'period': ""Q1 '24"", 'revenue': 125.0, 'unit': 'K', 'net_profit': -625.46}]",-0.31,-0.31,3012588,2898748,1249376,1258834,200000,0,988417,1249376,-125569,0.13965072613584237,-0.10499431183232552,-0.03333333333333337,__nan__,__nan__,__nan__,0.417858001160464
16,ATLC,Atlanticus Holdings Corporation Common Stock,"Atlanticus Holdings Corporation provides credit and related financial services and products to customers the United States. It operates in two segments, Credit as a Service, and Auto Finance. The Credit as a Service segment originates a range of consumer loan products, such as private label and general purpose credit cards originated by lenders through various channels, including retail and healthcare, direct mail solicitation, digital marketing, and partnerships with third parties; and offers credit to their customers for the purchase of various goods and services, including consumer electronics, furniture, elective medical procedures, healthcare, educational services, and home-improvements by partnering with retailers and service providers. In addition, it offers loan servicing, such as risk management and customer service outsourcing for third parties; and engages in testing and investment activities in consumer finance technology platforms. The Auto Finance segment purchases and/or services loans secured by automobiles from or for a pre-qualified network of independent automotive dealers and automotive finance companies in the buy-here, pay-here, and used car business. This segment also provides floor plan financing and installment lending products. Further, the company invests in and services portfolios of credit card receivables. Atlanticus Holdings Corporation was founded in 1996 and is headquartered in Atlanta, Georgia.",Mr. Jeffrey A. Howard,Financial - Credit Services,49.67,USD,751318354,https://images.financialmodelingprep.com/symbol/ATLC.png,55698,9.61,-1.07,53462,1489000,111296000,"[{'period': '2024', 'revenue': 299.4, 'unit': 'M', 'net_profit': 111.3}, {'period': '2023', 'revenue': 1160.0, 'unit': 'M', 'net_profit': 102.84}, {'period': '2022', 'revenue': 292.56, 'unit': 'M', 'net_profit': 135.6}, {'period': '2021', 'revenue': 399.8, 'unit': 'M', 'net_profit': 177.9}]","[{'period': ""Q1 '25"", 'revenue': 344.87, 'unit': 'M', 'net_profit': 27.95}, {'period': ""Q4 '24"", 'revenue': 133.37, 'unit': 'M', 'net_profit': 31.3}, {'period': ""Q3 '24"", 'revenue': 350.95, 'unit': 'M', 'net_profit': 29.54}, {'period': ""Q2 '24"", 'revenue': 316.02, 'unit': 'M', 'net_profit': 24.28}, {'period': ""Q1 '24"", 'revenue': 290.71, 'unit': 'M', 'net_profit': 19.88}, {'period': ""Q4 '23"", 'revenue': 309.09, 'unit': 'M', 'net_profit': 19.96}]",5.93,4.65,3270707000,499636000,499636000,2781344000,0,0,2337704000,499636000,467616000,-0.9938456578615624,0.08217220088482668,0.07427536231884062,"[0.5, 0.5]","['2009-12-29', '2009-12-29']",__nan__,0.8503800554436701
17,ATLO,Ames National Corporation Common Stock,"Ames National Corporation operates as a multi-bank holding company that provides banking products and services primarily in Boone, Clarke, Hancock, Marshall, Polk, Story, and Union counties in central, north-central, and south-central Iowa. The company accepts a range of deposits, including checking and savings accounts; and time deposits, such as money market accounts and certificates of deposit. It also provides loans, such as short-term and medium-term commercial and agricultural real estate, residential real estate loans, equipment, vehicle, and home improvement loans; personal loans and lines of credit; agricultural and business operating loans and lines of credit; and originates mortgage loans for sale into the secondary market. In addition, the company offers cash management, merchant credit card processing, safe deposit box, wire transfer, direct deposit of payroll and social security check, and automated/video teller machine access services; and automatic drafts for various accounts, as well as wealth management services. Further, it provides farm management, investment, and custodial services for individuals, businesses, and non-profit organizations; and online, mobile, and private banking services. Ames National Corporation was founded in 1903 and is based in Ames, Iowa.",Mr. John P. Nelson,Banks - Regional,17.9,USD,159588524,https://images.financialmodelingprep.com/symbol/ATLO.png,13401,14.09,0.04,13246,0,10218000,"[{'period': '2024', 'revenue': 54.81, 'unit': 'M', 'net_profit': 10.22}, {'period': '2023', 'revenue': 52.28, 'unit': 'M', 'net_profit': 10.82}, {'period': '2022', 'revenue': 62.93, 'unit': 'M', 'net_profit': 19.29}, {'period': '2021', 'revenue': 66.53, 'unit': 'M', 'net_profit': 23.91}]","[{'period': ""Q1 '25"", 'revenue': 23.66, 'unit': 'M', 'net_profit': 3.44}, {'period': ""Q4 '24"", 'revenue': 14.75, 'unit': 'M', 'net_profit': 3.51}, {'period': ""Q3 '24"", 'revenue': 23.12, 'unit': 'M', 'net_profit': 2.22}, {'period': ""Q2 '24"", 'revenue': 23.15, 'unit': 'M', 'net_profit': 2.18}, {'period': ""Q1 '24"", 'revenue': 22.29, 'unit': 'M', 'net_profit': 2.3}, {'period': ""Q4 '23"", 'revenue': 22.14, 'unit': 'M', 'net_profit': 2.14}]",1.14,1.14,2133180000,1971955000,668038000,1958474000,13864000,194787000,1336894000,107393000,14001000,0.0,-0.05537579735601368,-0.050000000000000044,"[0.2, 0.38]","['2025-05-30', '2000-04-04']",__nan__,0.9181006759860865
18,ATNF,180 Life Sciences Corp. Common Stock,"1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.","Mr. Lloyd Blair Jordan L.L.B., M.B.A.",Biotechnology,1.05,USD,5980260,https://images.financialmodelingprep.com/symbol/ATNF.png,147988,-0.07,-0.1,54035,-6324729,-6168177,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.17}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -19.94}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -38.73}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -20.32}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.37}, {'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.27}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -836.72}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 11.78}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.07}, {'period': ""Q4 '23"", 'revenue': 0.16603, 'unit': 'M', 'net_profit': -1.23}]",-6.74,-6.74,12763412,5141371,4585141,3511501,0,0,3504885,4585141,-1480567,0.7142531270970258,0.6905872914082449,0.8718631178707223,__nan__,__nan__,__nan__,0.2751224359129048
19,ATNFW,180 Life Sciences Corp. Warrant,"180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.","Mr. Lloyd Blair Jordan L.L.B., M.B.A.",Medical - Pharmaceuticals,0.0074,USD,6136042,https://images.financialmodelingprep.com/symbol/ATNFW.png,175759.38525,,-0.0006,149728,-6324729,-6168177,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.17}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -19.94}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -38.73}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -20.32}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.37}, {'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.27}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -836.72}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 11.78}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.07}, {'period': ""Q4 '23"", 'revenue': 0.16603, 'unit': 'M', 'net_profit': -1.23}]",-6.74,-6.74,12763412,5141371,4585141,3511501,0,0,3504885,4585141,-1480567,0.7142531270970258,0.6905872914082449,0.8718631178707223,__nan__,__nan__,__nan__,0.2751224359129048
20,ATNI,ATN International Inc. Common Stock,"ATN International, Inc., through its subsidiaries, provides telecommunications services. It operates in three segments: International Telecom, US Telecom, and Renewable Energy. The International Telecom segment provides fixed data and voice; fixed, carrier, managed, and mobility services to customers in Bermuda, the Cayman Islands, Guyana, and the US Virgin Islands, as well as video services in Bermuda, the Cayman Islands, and the US Virgin Islands. This segment also offers mobile, data, and voice services to retail and business customers in Bermuda, Guyana, and US Virgin Islands under the One, GTT+, and Viya brands; roaming services; and handsets and accessories. The US Telecom segment provides carrier services, such as wholesale roaming services; fixed, mobility, carrier, and managed services to business and consumer; private network services to enterprise and consumer customers; and site maintenance services and international long-distance services, as well as leases critical network infrastructure, including towers and transport facilities. The Renewable Energy segment provides distributed generation solar power to commercial and industrial customers in India. As of December 31, 2021, it operated seven retail stores in the US Telecom segment and twenty-one retail stores in the International Telecom segment. The company was formerly known as Atlantic Tele-Network, Inc. and changed its name to ATN International, Inc. in June 2016. ATN International, Inc. was incorporated in 1987 and is headquartered in Beverly, Massachusetts.",Mr. Brad W. Martin,Telecommunications Services,14.23,USD,216530795,https://images.financialmodelingprep.com/symbol/ATNI.png,70168,-6.21,-0.38,60917,151424000,-26429000,"[{'period': '2024', 'revenue': 729.08, 'unit': 'M', 'net_profit': -26.43}, {'period': '2023', 'revenue': 762.22, 'unit': 'M', 'net_profit': -14.54}, {'period': '2022', 'revenue': 725.75, 'unit': 'M', 'net_profit': -5.64}, {'period': '2021', 'revenue': 602.71, 'unit': 'M', 'net_profit': -22.11}]","[{'period': ""Q1 '25"", 'revenue': 179.29, 'unit': 'M', 'net_profit': -8.93}, {'period': ""Q4 '24"", 'revenue': 180.55, 'unit': 'M', 'net_profit': 3.57}, {'period': ""Q3 '24"", 'revenue': 178.45, 'unit': 'M', 'net_profit': -32.69}, {'period': ""Q2 '24"", 'revenue': 183.28, 'unit': 'M', 'net_profit': 9.0}, {'period': ""Q1 '24"", 'revenue': 186.79, 'unit': 'M', 'net_profit': -6.32}, {'period': ""Q4 '23"", 'revenue': 198.97, 'unit': 'M', 'net_profit': -5.84}]",-1.74,-1.74,1727103000,309161000,73693000,1055349000,142216000,0,267314000,73393000,16968000,-0.1061684670326427,-0.817925436786353,-0.392,"[0.24, 0.08]","['2025-03-31', '1992-03-04']",__nan__,0.6110515701727112
21,ATNX,Athenex Inc. Common Stock,"Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar, an oral dosage form, which is in Phase III trial for metastatic breast cancer, as well as various clinical studies in cutaneous angiosarcoma, advanced gastric cancer, and advanced solid malignancies. It also offers Src Kinase product candidates comprising Tirbanibulin ointments for actinic keratosis, skin cancers, and psoriasis. In addition, the company is developing KUR-501, an autologous product that is in a phase I clinical trial for treating children with relapsed-refractory (R/R) high risk neuroblastoma; KUR-502, an allogeneic product, which is in a phase I clinical trial for treating adults with R/R CD19 positive malignancies, including B cell lymphoma, acute lymphoblastic leukemia, and chronic lymphocytic leukemia; and KUR-503, an allogeneic product that is in preclinical development for advanced hepatocellular carcinomas, as well as TCRT-ESO-A2, an autologous T cell receptor (TCR)-T cell therapy that is in phase 1 clinical trial for solid tumors. Further, it is developing dual absorption enhancers to inhibit the P-gp transporter and the cytochrome p450 3A enzymes within the gastrointestinal tract; and has a portfolio of TCRs that recognize hotspot mutations in p53, KRAS, and EGFR genes for multiple tumors. The company was formerly known as Kinex Pharmaceuticals LLC and changed its name to Athenex, Inc. in August 2015. Athenex, Inc. was incorporated in 2003 and is headquartered in Buffalo, New York.","Dr. Yiu-Nam  Lau F.R.C.P., M.B.B.S., M.D., Ph.D.",Drug Manufacturers - Specialty & Generic,0.2031,USD,2333680,https://images.financialmodelingprep.com/symbol/ATNX.png,263314,-0.019435406698564594,0.0,1754889,-69572000,-98975000,"[{'period': '2022', 'revenue': 102.82, 'unit': 'M', 'net_profit': -98.97}, {'period': '2021', 'revenue': 120.18, 'unit': 'M', 'net_profit': -194.31}, {'period': '2020', 'revenue': 144.39, 'unit': 'M', 'net_profit': -148.43}, {'period': '2019', 'revenue': 101.23, 'unit': 'M', 'net_profit': -125.53}]","[{'period': ""Q4 '22"", 'revenue': 25.06, 'unit': 'M', 'net_profit': -28.77}, {'period': ""Q3 '22"", 'revenue': 33.53, 'unit': 'M', 'net_profit': -19.62}, {'period': ""Q2 '22"", 'revenue': 31.52, 'unit': 'M', 'net_profit': -24.03}, {'period': ""Q1 '22"", 'revenue': 29.72, 'unit': 'M', 'net_profit': -30.47}, {'period': ""Q4 '21"", 'revenue': 24.94, 'unit': 'M', 'net_profit': -97.35}, {'period': ""Q3 '21"", 'revenue': 32.3, 'unit': 'M', 'net_profit': -36.06}]",-15.13,-15.13,204055000,124929000,36691000,204055000,27865000,0,114879000,35620000,-77074000,0.39369749363823336,0.4906204163557294,0.5953463492912543,__nan__,__nan__,__nan__,1.0
22,ATOM,Atomera Incorporated Common Stock,"Atomera Incorporated develops, commercializes, and licenses proprietary materials, processes, and technologies for the semiconductor industry in North America and the Asia Pacific. The company's lead technology is the Mears Silicon Technology, a thin film of reengineered silicon that can be applied as a transistor channel enhancement to CMOS-type transistors. Its customers include foundries, integrated device manufacturers, fabless semiconductor manufacturers, original equipment manufacturers, and electronic design automation companies. The company was formerly known as Mears Technologies, Inc. and changed its name to Atomera Incorporated in January 2016. Atomera Incorporated was incorporated in 2001 and is headquartered in Los Gatos, California.",Mr. Scott A. Bibaud,Semiconductors,6.665,USD,204642827,https://images.financialmodelingprep.com/symbol/ATOM.png,489962,-10.1,-0.525,574820,-16941000,-18435000,"[{'period': '2024', 'revenue': 0.135, 'unit': 'M', 'net_profit': -18.43}, {'period': '2023', 'revenue': 0.55, 'unit': 'M', 'net_profit': -19.79}, {'period': '2022', 'revenue': 0.382, 'unit': 'M', 'net_profit': -17.36}, {'period': '2021', 'revenue': 0.4, 'unit': 'M', 'net_profit': -15.71}]","[{'period': ""Q1 '25"", 'revenue': 0.004, 'unit': 'M', 'net_profit': -5.21}, {'period': ""Q4 '24"", 'revenue': 0.023, 'unit': 'M', 'net_profit': -4.66}, {'period': ""Q3 '24"", 'revenue': 0.022, 'unit': 'M', 'net_profit': -4.59}, {'period': ""Q2 '24"", 'revenue': 0.07200000000000001, 'unit': 'M', 'net_profit': -4.36}, {'period': ""Q1 '24"", 'revenue': 0.018000000000000002, 'unit': 'M', 'net_profit': -4.82}, {'period': ""Q4 '23"", 'revenue': 0.55, 'unit': 'M', 'net_profit': -4.58}]",-0.68,-0.68,29124000,27092000,26773000,4047000,79000,0,3576000,25778000,-13250000,0.06697141598281654,0.0684689236988378,0.15,__nan__,__nan__,__nan__,0.13895756077461888
23,ATOS,Atossa Therapeutics Inc. Common Stock,"Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patients; AT-301, a proprietary drug candidate for nasal administration in patients diagnosed with COVID-19; and immunotherapy/chimeric antigen receptor therapy programs for the treatment of breast cancer. It has a research agreement with Dana-Farber Cancer Institute, Inc. to support research of cytokine-coated nanoparticles for the treatment of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.","Dr. Steven C. Quay FCAP, M.D., Ph.D.",Biotechnology,0.8707,USD,112468318,https://images.financialmodelingprep.com/symbol/ATOS.png,648814,-4.35,-0.0714,941406,-25487000,-25504000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -25.5}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -30.09}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -26.23}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -20.61}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.72}, {'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.35}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.23}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.05}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.88}, {'period': ""Q4 '23"", 'revenue': 0.018000000000000002, 'unit': 'M', 'net_profit': -7.75}]",-0.2,-0.2,76444000,74457000,71084000,4967000,0,0,4967000,71084000,-21049000,0.18712126044523825,0.15252209742805875,0.1666666666666666,__nan__,__nan__,__nan__,0.06497566846318874
24,ATRA,Atara Biotherapeutics Inc. Common Stock,"Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company is also developing next-generation CAR T immunotherapies for patients with hematologic malignancies and solid tumors, including ATA2271 and ATA3271 for mesothelin; and ATA2431 and ATA3219 for B-cell malignancies, as well as ATA188 for the treatment of multiple sclerosis. In addition, it develops ATA368 program for patients with human papillomavirus associated cancers. Atara Biotherapeutics, Inc. has a license agreement with Memorial Sloan Kettering Cancer Center; license, and research and development collaboration agreement with QIMR Berghofer Medical Research Institute; and strategic collaboration with H. Lee Moffitt Cancer Center, as well as Bayer AG for mesothelin-targeted CAR T-cell therapies for solid tumors. The company was incorporated in 2012 and is headquartered in South San Francisco, California.",Dr. Anhco  Nguyen Ph.D.,Biotechnology,6.9,USD,46889847,https://images.financialmodelingprep.com/symbol/ATRA.png,59365,-3.05,-0.1,67320,-75749000,-85403000,"[{'period': '2024', 'revenue': 128.94, 'unit': 'M', 'net_profit': -85.4}, {'period': '2023', 'revenue': 8.57, 'unit': 'M', 'net_profit': -276.13}, {'period': '2022', 'revenue': 0.06357, 'unit': 'B', 'net_profit': -2.28}, {'period': '2021', 'revenue': 0.02034, 'unit': 'B', 'net_profit': -3.4}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 38.01}, {'period': ""Q4 '24"", 'revenue': 32.75, 'unit': 'M', 'net_profit': -12.69}, {'period': ""Q3 '24"", 'revenue': 40.19, 'unit': 'M', 'net_profit': -21.91}, {'period': ""Q2 '24"", 'revenue': 28.64, 'unit': 'M', 'net_profit': -19.05}, {'period': ""Q1 '24"", 'revenue': 27.36, 'unit': 'M', 'net_profit': -317.52}, {'period': ""Q4 '23"", 'revenue': 4.25, 'unit': 'M', 'net_profit': -604.5}]",-11.41,-11.41,109098000,64894000,42496000,206381000,1482000,0,134574000,25030000,-68963000,0.7152261115726869,0.6907100381709799,0.8249463025467936,__nan__,__nan__,__nan__,1.8917028726466114
25,ATRC,AtriCure Inc. Common Stock,"AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.",Mr. Michael H. Carrel,Medical - Instruments & Supplies,33.26,USD,1646532974,https://images.financialmodelingprep.com/symbol/ATRC.png,639072,-41.06,-0.79,457327,-18534000,-44698000,"[{'period': '2024', 'revenue': 465.31, 'unit': 'M', 'net_profit': -44.7}, {'period': '2023', 'revenue': 399.25, 'unit': 'M', 'net_profit': -30.44}, {'period': '2022', 'revenue': 330.38, 'unit': 'M', 'net_profit': -46.47}, {'period': '2021', 'revenue': 274.33, 'unit': 'M', 'net_profit': 50.2}]","[{'period': ""Q1 '25"", 'revenue': 123.62, 'unit': 'M', 'net_profit': -6.75}, {'period': ""Q4 '24"", 'revenue': 124.28, 'unit': 'M', 'net_profit': -15.57}, {'period': ""Q3 '24"", 'revenue': 115.91, 'unit': 'M', 'net_profit': -7.85}, {'period': ""Q2 '24"", 'revenue': 116.27, 'unit': 'M', 'net_profit': -8.01}, {'period': ""Q1 '24"", 'revenue': 108.85, 'unit': 'M', 'net_profit': -13.27}, {'period': ""Q4 '23"", 'revenue': 106.54, 'unit': 'M', 'net_profit': -9.79}]",-0.95,-0.95,609328000,267826000,122721000,148359000,60339000,0,73424000,122721000,-11255000,-1.285608583055864,-0.46849333070503973,-0.4393939393939393,__nan__,__nan__,__nan__,0.24347970222934118
26,ATRI,Atrion Corporation Common Stock,"Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.",Mr. David A. Battat,Medical - Instruments & Supplies,459.92,USD,809436204,https://images.financialmodelingprep.com/symbol/ATRI.png,27595,64.50490883590463,0.26,29517,37677000,19411000,"[{'period': '2023', 'revenue': 169.33, 'unit': 'M', 'net_profit': 19.41}, {'period': '2022', 'revenue': 183.51, 'unit': 'M', 'net_profit': 35.01}, {'period': '2021', 'revenue': 165.01, 'unit': 'M', 'net_profit': 33.05}, {'period': '2020', 'revenue': 147.59, 'unit': 'M', 'net_profit': 32.12}]","[{'period': ""Q2 '24"", 'revenue': 48770.0, 'unit': 'K', 'net_profit': 402.0}, {'period': ""Q1 '24"", 'revenue': 47.33, 'unit': 'M', 'net_profit': 2.79}, {'period': ""Q4 '23"", 'revenue': 43.58, 'unit': 'M', 'net_profit': 6.42}, {'period': ""Q3 '23"", 'revenue': 41.91, 'unit': 'M', 'net_profit': 2.94}, {'period': ""Q2 '23"", 'revenue': 43.84, 'unit': 'M', 'net_profit': 6.56}, {'period': ""Q1 '23"", 'revenue': 39.99, 'unit': 'M', 'net_profit': 3.48}]",11.02,11.02,260825000,114765000,6256000,17936000,23029000,8165000,12621000,3565000,-2313000,-0.3077771041172904,-0.44552673674588666,-0.4374680959673303,"[2.2, 0.55035]","['2024-06-14', '1985-02-08']",__nan__,0.0687664142624365
27,ATRO,Astronics Corporation Common Stock,"Astronics Corporation, through its subsidiaries, designs and manufactures products for the aerospace, defense, and electronics industries in the United States, rest of North America, Asia, Europe, South America, and internationally. It operates in two segments, Aerospace and Test Systems. The Aerospace segment offers lighting and safety systems, electrical power generation systems, distribution and seat motions systems, aircraft structures, avionics products, system certification, and other products. This segment serves airframe manufacturers (OEM) that build aircraft for the commercial, military, and general aviation markets; suppliers to OEMs; and aircraft operators, such as airlines; suppliers to the aircraft operators; and branches of the U.S. Department of Defense. The Test Systems segment designs, develops, manufactures, and maintains automated test systems that support the aerospace and defense, and communications and mass transit industries; and provides wireless communication testing for the civil land mobile radio market, as well as training and simulation devices for commercial and military applications. It serves OEMs and prime government contractors for electronics and military products. The company was incorporated in 1968 and is headquartered in East Aurora, New York.",Mr. Peter J. Gundermann,Aerospace & Defense,30.59,USD,1078211603,https://images.financialmodelingprep.com/symbol/ATRO.png,578791,-278.09,-0.46,391660,50932000,-16215000,"[{'period': '2024', 'revenue': 795.43, 'unit': 'M', 'net_profit': -16.21}, {'period': '2023', 'revenue': 689.21, 'unit': 'M', 'net_profit': -26.42}, {'period': '2022', 'revenue': 534.89, 'unit': 'M', 'net_profit': -35.75}, {'period': '2021', 'revenue': 444.91, 'unit': 'M', 'net_profit': -25.58}]","[{'period': ""Q1 '25"", 'revenue': 205.94, 'unit': 'M', 'net_profit': 9.53}, {'period': ""Q4 '24"", 'revenue': 208.54, 'unit': 'M', 'net_profit': -2.83}, {'period': ""Q3 '24"", 'revenue': 203.7, 'unit': 'M', 'net_profit': -11.74}, {'period': ""Q2 '24"", 'revenue': 198.11, 'unit': 'M', 'net_profit': 1.53}, {'period': ""Q1 '24"", 'revenue': 185.07, 'unit': 'M', 'net_profit': -3.18}, {'period': ""Q4 '23"", 'revenue': 195.29, 'unit': 'M', 'net_profit': 6.98}]",-0.46,-0.46,648764000,426172000,9285000,392667000,191446000,0,156152000,9285000,22138000,1.6209025883805896,0.38628363801521515,0.425,"[4.516, 0.0022]","['2012-10-25', '1994-01-25']",__nan__,0.6052539906653267
28,ATRS,Antares Pharma Inc. Common Stock,"Antares Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of pharmaceutical products and technologies that address patient needs in targeted therapeutic areas. It develops, manufactures, and commercializes novel therapeutic products using its drug delivery systems. The company's injection products include XYOSTED for subcutaneous administration of testosterone replacement therapy in adult males; OTREXUP a subcutaneous methotrexate injection indicated for adults with severe active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis, and adults with severe recalcitrant psoriasis; and NOCDURNA sublingual tablets indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least two times per night to urinate. Its injection products also comprise generic Epinephrine Injection USP products indicated for emergency treatment of severe allergic reactions, including anaphylaxis in adults and certain pediatric patients; Sumatriptan Injection USP indicated for the acute treatment of migraine headaches and cluster headache in adults; and Makena subcutaneous auto-injector drug-device combination product indicated to reduce the risk of preterm birth in women, as well as Teriparatide injection used for the treatment of osteoporosis in postmenopausal women and men at increased risk of fracture, and glucocorticoid induced osteoporosis in men and women. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; QuickShot auto-injectors; TLANDO to treat deficiency or absence of endogenous testosterone in adult males; and drug/device products for urologic oncology, immunology, and endocrinology. The company has strategic alliances and partnerships with Pfizer Inc., Idorsia Pharmaceuticals Ltd, Teva Pharmaceutical Industries, Ltd, and AMAG. Antares Pharma, Inc. was incorporated in 1979 and is headquartered in Ewing, New Jersey. As of May 23, 2022, Antares Pharma, Inc. operates as a subsidiary of Halozyme Therapeutics, Inc.",Mr. Robert Apple,Medical - Instruments & Supplies,5.59,USD,0,https://images.financialmodelingprep.com/symbol/ATRS.png,5230217,14.946524064171124,0.01000023,1763417,66172000,46289000,"[{'period': '2021', 'revenue': 183.98, 'unit': 'M', 'net_profit': 46.29}, {'period': '2020', 'revenue': 149.6, 'unit': 'M', 'net_profit': 56.2}, {'period': '2019', 'revenue': 123.86, 'unit': 'M', 'net_profit': -2.03}, {'period': '2018', 'revenue': 63.55, 'unit': 'M', 'net_profit': -6.51}]","[{'period': ""Q1 '22"", 'revenue': 41.56, 'unit': 'M', 'net_profit': -2.32}, {'period': ""Q4 '21"", 'revenue': 48.73, 'unit': 'M', 'net_profit': 32.68}, {'period': ""Q3 '21"", 'revenue': 48.19, 'unit': 'M', 'net_profit': 5.39}, {'period': ""Q2 '21"", 'revenue': 44.98, 'unit': 'M', 'net_profit': 6.71}, {'period': ""Q1 '21"", 'revenue': 42.08, 'unit': 'M', 'net_profit': 3.79}, {'period': ""Q4 '20"", 'revenue': 44.13, 'unit': 'M', 'net_profit': 51.39}]",0.27,0.27,257505000,161710000,67158000,81747000,83008000,0,58930000,65913000,30002000,3.0509335782063056,-0.1763669685592783,-0.1818181818181818,__nan__,__nan__,__nan__,0.317457913438574
29,ATSG,Air Transport Services Group Inc,"Air Transport Services Group, Inc., together with its subsidiaries, provides aircraft leasing and air cargo transportation and related services in the United States and internationally. The company offers aircraft, flight crews, aircraft maintenance, aircraft hull and liability insurance, and aviation fuel services; and aircraft maintenance and modification services, including airframe modification and heavy maintenance, component repairs, engineering services, and aircraft line maintenance. It also provides equipment maintenance services; cargo load transfer and package sorting services; crew training services; and airline express operation, line and heavy maintenance, and ground handling services. The company's ground support services include labor and management for cargo load transfer and sorting; design, installation, and maintenance of material handling equipment; leasing and maintenance of ground support equipment; and general facilities maintenance. In addition, it offers equipment installation and maintenance, vehicle maintenance and repair, jet fuel, and deicing services. Further, the company operates cargo and passenger transportation business; resells and brokers aircraft parts; and performs passenger-to-freighter and passenger-to-combi conversions of aircrafts. It provides its services to delivery companies, freight forwarders, airlines, air transportation, e-commerce, package delivery, and logistics industries, as well as government customers. As of December 31, 2021, the company's in-service aircraft fleet consisted of 107 owned aircraft and ten leased aircraft. The company was formerly known as ABX Holdings, Inc. Air Transport Services Group, Inc. was founded in 1980 and is based in Wilmington, Ohio.",Mr. Michael L. Berger,"Airlines, Airports & Air Services",22.48,USD,1481218440,https://images.financialmodelingprep.com/symbol/ATSG.png,1202479,56.2,-0.01,4627099,540665000,27434000,"[{'period': '2024', 'revenue': 1960.0, 'unit': 'M', 'net_profit': 27.43}, {'period': '2023', 'revenue': 2070.0, 'unit': 'M', 'net_profit': 60.33}, {'period': '2022', 'revenue': 2050.0, 'unit': 'M', 'net_profit': 198.58}, {'period': '2021', 'revenue': 1730.0, 'unit': 'M', 'net_profit': 231.42}]","[{'period': ""Q4 '24"", 'revenue': 516.79, 'unit': 'M', 'net_profit': 14.71}, {'period': ""Q3 '24"", 'revenue': 471.25, 'unit': 'M', 'net_profit': -7.05}, {'period': ""Q2 '24"", 'revenue': 488.41, 'unit': 'M', 'net_profit': 7.43}, {'period': ""Q1 '24"", 'revenue': 485.52, 'unit': 'M', 'net_profit': 8.62}, {'period': ""Q4 '23"", 'revenue': 517.04, 'unit': 'M', 'net_profit': -15.01}, {'period': ""Q3 '23"", 'revenue': 523.14, 'unit': 'M', 'net_profit': 17.17}]",0.42,0.4,3893711000,351582000,60576000,2409699000,208269000,0,359220000,60576000,654081000,0.06502657321719124,-0.545245080975351,-0.5333333333333333,__nan__,__nan__,__nan__,0.6188695052098114
30,ATSPT,Archimedes Tech SPAC Partners Co. Subunit,"Archimedes Tech SPAC Partners Co. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses. It intends to focus on the artificial intelligence, cloud services, and automotive technology sectors. The company was incorporated in 2020 and is based in Claymont, Delaware.",Mr. Stephen N. Cannon,Shell Companies,8.18,USD,0,https://images.financialmodelingprep.com/symbol/ATSPT.png,52693,0,-1.4299994,108356,-981884,-948508,"[{'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -948.51}]","[{'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -280.85}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -70.54}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -84.03}]",0.0,0.0,0.333361,0.33336099999999996,0.23529499999999998,0.497198,0,133.01058300000003,0.249684,0.23529499999999998,-864358,0.0,0.0,0.0,__nan__,__nan__,__nan__,1.491470207972738
31,ATSPU,Archimedes Tech SPAC Partners Co. Unit,"Archimedes Tech SPAC Partners Co. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses. It intends to focus on the artificial intelligence, cloud services, and automotive technology sectors. The company was incorporated in 2020 and is based in Claymont, Delaware.",Mr. Stephen N. Cannon,Shell Companies,8.1,USD,0,https://images.financialmodelingprep.com/symbol/ATSPU.png,3313,0,-1.7999992,21081,-981884,-948508,"[{'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -948.51}]","[{'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -280.85}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -70.54}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -84.03}]",0.0,0.0,0.333361,0.33336099999999996,0.23529499999999998,0.497198,0,133.01058300000003,0.249684,0.23529499999999998,-864358,0.0,0.0,0.0,__nan__,__nan__,__nan__,1.491470207972738
32,ATSPW,Archimedes Tech SPAC Partners Co. Warrant,"Archimedes Tech SPAC Partners Co. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on the technology industry. The company was founded in 2020 and is based in Claymont, Delaware.",Mr. Stephen N. Cannon,Shell Companies,0.6893,USD,0,https://images.financialmodelingprep.com/symbol/ATSPW.png,0,0,-0.01069999,89693,-981884,-948508,"[{'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -948.51}]","[{'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -280.85}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -70.54}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -84.03}]",0.0,0.0,0.333361,0.33336099999999996,0.23529499999999998,0.497198,0,133.01058300000003,0.249684,0.23529499999999998,-864358,0.0,0.0,0.0,__nan__,__nan__,__nan__,1.491470207972738
33,ATVCU,Tribe Capital Growth Corp I Units,"Tribe Capital Growth Corp I does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in San Francisco, California.",Mr. Arjun  Sethi,Shell Companies,9.83,USD,321109238,https://images.financialmodelingprep.com/symbol/ATVCU.png,2119,33.435374149659864,0.0,5940,4369659000,11273590000,"[{'period': '2021', 'revenue': 0.0, 'unit': 'B', 'net_profit': 11.27}]","[{'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'B', 'net_profit': 8.22}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'B', 'net_profit': 11.28}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -161.06}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.96}]",326.77,326.77,276438,421.922,336.228,21569,0,276016,1380.389,336.228,-1215879000,0.0,0.0,0.0,__nan__,__nan__,__nan__,0.07802472887229686
34,ATVCW,Tribe Capital Growth Corp I Warrant,"Tribe Capital Growth Corp I focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in San Francisco, California.",Mr. Arjun  Sethi,Shell Companies,0.1242,USD,4057148,https://images.financialmodelingprep.com/symbol/ATVCW.png,0,0,0.0141,46446,4369659000,11273590000,"[{'period': '2021', 'revenue': 0.0, 'unit': 'B', 'net_profit': 11.27}]","[{'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'B', 'net_profit': 8.22}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'B', 'net_profit': 11.28}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -161.06}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.96}]",326.77,326.77,276438,421.922,336.228,21569,0,276016,1380.389,336.228,-1215879000,0.0,0.0,0.0,__nan__,__nan__,__nan__,0.07802472887229686
35,ATVI,Activision Blizzard Inc. Common Stock,"Activision Blizzard, Inc., together with its subsidiaries, develops and publishes interactive entertainment content and services in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through three segments: Activision, Blizzard, and King. It develops and distributes content and services on video game consoles, personal computers, and mobile devices, including subscription, full-game, and in-game sales, as well as by licensing software to third-party or related-party companies that distribute Activision and Blizzard products. The company also maintains a proprietary online gaming service, Battle.net that facilitates digital distribution of content, online social connectivity, and the creation of user-generated content. In addition, it operates esports leagues and offer digital advertising content; and provides warehousing, logistics, and sales distribution services to third-party publishers of interactive entertainment software, as well as manufacturers of interactive entertainment hardware products. The company's key product franchises include Call of Duty, World of Warcraft, Diablo, Hearthstone, Overwatch, Overwatch League, and Candy Crush. It serves retailers and distributors, including mass-market retailers, consumer electronics stores, discount warehouses, and game specialty stores through third-party distribution and licensing arrangements. The company is headquartered in Santa Monica, California.",Mr. Robert A. Kotick,Electronic Gaming & Multimedia,94.42,USD,74289468671,https://images.financialmodelingprep.com/symbol/ATVI.png,9578042,34.586080586080584,-0.05,7127746,2248000000,1513000000,"[{'period': '2022', 'revenue': 7.53, 'unit': 'B', 'net_profit': 1.51}, {'period': '2021', 'revenue': 8.8, 'unit': 'B', 'net_profit': 2.7}, {'period': '2020', 'revenue': 8.09, 'unit': 'B', 'net_profit': 2.2}, {'period': '2019', 'revenue': 6.49, 'unit': 'B', 'net_profit': 1.5}]","[{'period': ""Q2 '23"", 'revenue': 2210.0, 'unit': 'M', 'net_profit': 587.0}, {'period': ""Q1 '23"", 'revenue': 2380.0, 'unit': 'M', 'net_profit': 740.0}, {'period': ""Q4 '22"", 'revenue': 2330.0, 'unit': 'M', 'net_profit': 403.0}, {'period': ""Q3 '22"", 'revenue': 1780.0, 'unit': 'M', 'net_profit': 435.0}, {'period': ""Q2 '22"", 'revenue': 1640.0, 'unit': 'M', 'net_profit': 280.0}, {'period': ""Q1 '22"", 'revenue': 1770.0, 'unit': 'M', 'net_profit': 395.0}]",1.92,1.92,27383000000,14469000000,11992000000,8140000000,1204000000,0,3555000000,7060000000,2129000000,-0.4048186391315859,-0.4394220081511671,-0.4466858789625361,"[0.99, 0.15]","['2023-08-01', '2010-02-18']",__nan__,0.297264726290034
36,ATXI,Avenue Therapeutics Inc. Common Stock,"Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.",Dr. Alexandra  MacLean M.D.,Biotechnology,0.2201,USD,693249,https://images.financialmodelingprep.com/symbol/ATXI.png,51298,-0.22,0.0,351,-11283000,-11652000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.65}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.38}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.55}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.72}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.85}, {'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.54}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.08}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.19}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.34}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 640.0}]",-0.9,-0.9,2672000,2672000,2594000,816000,0,0,816000,2594000,-9026000,-3.7845508390918066,-0.12286788089043076,0.9877717391304347,__nan__,__nan__,__nan__,0.30538922155688625
37,AUB,Atlantic Union Bankshares Corporation Common Stock,"Atlantic Union Bankshares Corporation operates as the holding company for Atlantic Union Bank that provides banking and related financial services to consumers and businesses. The company accepts various deposit products, including checking, savings, NOW, time deposit, and money market accounts; certificates of deposit; and other depository services. It also provides loans for commercial, industrial, residential mortgage, and consumer purposes. In addition, the company offers credit cards, automated teller machine (ATM) services, mobile and internet banking services, and online bill payment services, as well as financial planning, trust, and wealth management services. Further, it provides securities, brokerage, and investment advisory products and services; and originates and sells residential loan products in the secondary market. As of February 25, 2022, it operated 130 branches and approximately 150 ATMs in Virginia, Maryland, and North Carolina. The company was formerly known as Union Bankshares Corporation and changed its name to Atlantic Union Bankshares Corporation in May 2019. Atlantic Union Bankshares Corporation was founded in 1902 and is headquartered in Richmond, Virginia.",Mr. John C. Asbury,Banks - Regional,29.45,USD,4195682600,https://images.financialmodelingprep.com/symbol/AUB.png,1801518,13.76,-0.92,756655,295106000,209131000,"[{'period': '2024', 'revenue': 1350.0, 'unit': 'M', 'net_profit': 209.13}, {'period': '2023', 'revenue': 696.27, 'unit': 'M', 'net_profit': 201.82}, {'period': '2022', 'revenue': 696.21, 'unit': 'M', 'net_profit': 234.51}, {'period': '2021', 'revenue': 677.07, 'unit': 'M', 'net_profit': 263.92}]","[{'period': ""Q1 '25"", 'revenue': 305.84, 'unit': 'M', 'net_profit': 49.82}, {'period': ""Q4 '24"", 'revenue': 358.48, 'unit': 'M', 'net_profit': 57.78}, {'period': ""Q3 '24"", 'revenue': 215.77, 'unit': 'M', 'net_profit': 76.42}, {'period': ""Q2 '24"", 'revenue': 343.43, 'unit': 'M', 'net_profit': 25.16}, {'period': ""Q1 '24"", 'revenue': 172.05, 'unit': 'M', 'net_profit': 49.77}, {'period': ""Q4 '23"", 'revenue': -515.45, 'unit': 'M', 'net_profit': 56.91}]",2.29,2.24,24585323000,2796240000,2638601000,21442444000,0,3246017000,20513894000,350130000,301063000,0.12810260134941417,0.0362356182302867,-0.0948616600790513,"[0.34, 0.25]","['2025-05-23', '1994-05-27']",__nan__,0.8721644210246903
38,AUBAP,Atlantic Union Bankshares Corporation Depositary Shares each representing a 1/400th ownership interest in a share of 6.875% Perpetual Non-Cumulative Preferred Stock Series A,"Atlantic Union Bankshares Corporation operates as the holding company for Atlantic Union Bank that provides banking and related financial services to consumers and businesses. The company accepts various deposit products, including checking, savings, NOW, time deposit, and money market accounts; certificates of deposit; and other depository services. It also provides loans for commercial, industrial, residential mortgage, and consumer purposes. In addition, the company offers credit cards, automated teller machine (ATM) services, mobile and internet banking services, and online bill payment services, as well as financial planning, trust, and wealth management services. Further, it provides securities, brokerage, and investment advisory products and services; and originates and sells residential loan products in the secondary market. As of February 25, 2022, it operated 130 branches and approximately 150 ATMs in Virginia, Maryland, and North Carolina. The company was formerly known as Union Bankshares Corporation and changed its name to Atlantic Union Bankshares Corporation in May 2019. Atlantic Union Bankshares Corporation was founded in 1902 and is headquartered in Richmond, Virginia.",Mr. John C. Asbury,Banks - Regional,25.27,USD,4414370966,https://images.financialmodelingprep.com/symbol/AUBAP.png,12060,8.076062639821028,0.27,10394,295106000,209131000,"[{'period': '2024', 'revenue': 1350.0, 'unit': 'M', 'net_profit': 209.13}, {'period': '2023', 'revenue': 696.27, 'unit': 'M', 'net_profit': 201.82}, {'period': '2022', 'revenue': 696.21, 'unit': 'M', 'net_profit': 234.51}, {'period': '2021', 'revenue': 677.07, 'unit': 'M', 'net_profit': 263.92}]","[{'period': ""Q1 '25"", 'revenue': 305.84, 'unit': 'M', 'net_profit': 49.82}, {'period': ""Q4 '24"", 'revenue': 358.48, 'unit': 'M', 'net_profit': 57.78}, {'period': ""Q3 '24"", 'revenue': 215.77, 'unit': 'M', 'net_profit': 76.42}, {'period': ""Q2 '24"", 'revenue': 343.43, 'unit': 'M', 'net_profit': 25.16}, {'period': ""Q1 '24"", 'revenue': 172.05, 'unit': 'M', 'net_profit': 49.77}, {'period': ""Q4 '23"", 'revenue': -515.45, 'unit': 'M', 'net_profit': 56.91}]",2.29,2.24,24585323000,2796240000,2638601000,21442444000,0,3246017000,20513894000,350130000,301063000,0.12810260134941417,0.0362356182302867,-0.0948616600790513,"[0.43, 0.39]","['2025-02-14', '2020-08-13']",__nan__,0.8721644210246903
39,AUBN,Auburn National Bancorporation Inc. Common Stock,"Auburn National Bancorporation, Inc. operates as the bank holding company for AuburnBank that provides various banking products and services in East Alabama. The company's deposit products include checking, savings, and transaction deposit accounts, as well as certificates of deposit. It also provides commercial, financial, agricultural, real estate construction, and consumer loan products; and other financial services. In addition, the company offers automated teller services; debit cards; online banking, bill payment, and other electronic services; and safe deposit boxes. It operates through seven full-service branches in Auburn, Opelika, Notasulga, and Valley, Alabama; as well as loan production offices in Auburn and Phenix City, Alabama. Auburn National Bancorporation, Inc. was founded in 1907 and is headquartered in Auburn, Alabama.",Mr. William James Walker IV,Banks - Regional,20.5,USD,71620850,https://images.financialmodelingprep.com/symbol/AUBN.png,1659,10.9,0.0,238,10330000,6397000,"[{'period': '2024', 'revenue': 30.6, 'unit': 'M', 'net_profit': 6.4}, {'period': '2023', 'revenue': 23.35, 'unit': 'M', 'net_profit': 1.4}, {'period': '2022', 'revenue': 3.23, 'unit': 'M', 'net_profit': 10.35}, {'period': '2021', 'revenue': 28.28, 'unit': 'M', 'net_profit': 8.04}]","[{'period': ""Q1 '25"", 'revenue': 7.79, 'unit': 'M', 'net_profit': 1.53}, {'period': ""Q4 '24"", 'revenue': 7.81, 'unit': 'M', 'net_profit': 1.56}, {'period': ""Q3 '24"", 'revenue': 7.64, 'unit': 'M', 'net_profit': 1.73}, {'period': ""Q2 '24"", 'revenue': 10.48, 'unit': 'M', 'net_profit': 1.73}, {'period': ""Q1 '24"", 'revenue': 10.12, 'unit': 'M', 'net_profit': 1.37}, {'period': ""Q4 '23"", 'revenue': 0.63, 'unit': 'M', 'net_profit': -3.98}]",1.83,1.83,977324000,56164000,56164000,899032000,0,243012000,789281000,56154000,8720000,3.456427955133736,3.585663082437276,3.575,"[0.27, 0.27]","['2025-06-10', '1995-12-20']",__nan__,0.9198914587178868
40,AUDC,AudioCodes Ltd. Common Stock,"AudioCodes Ltd. provides advanced communications software, products, and productivity solutions for the digital workplace. The company offers solutions, products, and services for unified communications, contact centers, VoiceAI business line, and service provider business. Its products include session border controllers, life cycle management solutions, VoIP network routing solutions, media gateways and servers, multi-service business routers, IP phones solutions, and value-added applications, as well as professional services. The company also offers One Voice Operations Center, a voice network management solution; Device Manager for administering business phones and meeting room solutions; AudioCodes Routing Manager for handling call routing in VoIP networks; and User Management Pack 365 simplifies user lifecycle and identity management across Microsoft Teams and Skype for Business deployments. In addition, it provides AudioCodes Live for Microsoft Teams, a portfolio of managed services for simplifying Teams adoption; appliances for Microsoft Skype/Teams for Business such as survivable branch appliances, CCE, and CloudBond 365; and a range of value-added voice applications comprising SmartTAP, Voca, VoiceAI Connect, and Meeting Insights. Further, the company offers managed services; and AudioCodes Live Cloud, a Microsoft Teams software as a service solution that enables service providers to offer their business customers a seamless migration to Microsoft Teams. It primarily markets and sells its products through a direct sales force and sales representatives to original equipment manufacturers, network equipment providers, and systems integrators and distributors in the telecommunications and networking industries. The company primarily operates in the Americas, Europe, the Far East, and Israel. AudioCodes Ltd. was incorporated in 1992 and is headquartered in Lod, Israel.",Mr. Shabtai  Adlersberg,Communication Equipment,8.96,USD,265931008,https://images.financialmodelingprep.com/symbol/AUDC.png,85026,16,0.1,94393,21074000,15311000,"[{'period': '2024', 'revenue': 242.18, 'unit': 'M', 'net_profit': 15.31}, {'period': '2023', 'revenue': 244.38, 'unit': 'M', 'net_profit': 8.78}, {'period': '2022', 'revenue': 275.09, 'unit': 'M', 'net_profit': 28.47}, {'period': '2021', 'revenue': 248.92, 'unit': 'M', 'net_profit': 33.75}]","[{'period': ""Q1 '25"", 'revenue': 60.37, 'unit': 'M', 'net_profit': 4.02}, {'period': ""Q4 '24"", 'revenue': 61.55, 'unit': 'M', 'net_profit': 6.78}, {'period': ""Q3 '24"", 'revenue': 60.24, 'unit': 'M', 'net_profit': 2.68}, {'period': ""Q2 '24"", 'revenue': 60.3, 'unit': 'M', 'net_profit': 3.77}, {'period': ""Q1 '24"", 'revenue': 60.08, 'unit': 'M', 'net_profit': 2.08}, {'period': ""Q4 '23"", 'revenue': 63.56, 'unit': 'M', 'net_profit': 3.65}]",0.5,0.5,335901000,162876000,62385000,144087000,56016000,31526000,77758000,58749000,10973000,0.13710678249608807,0.7438496583143508,0.7857142857142856,"[0.18, 0.18]","['2025-02-20', '2025-02-20']",__nan__,0.42895674618414353
41,AUPH,Aurinia Pharmaceuticals Inc Ordinary Shares,"Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.",Mr. Peter S. Greenleaf M.B.A.,Biotechnology,8.34,USD,1126767360,https://images.financialmodelingprep.com/symbol/AUPH.png,1454624,30.89,0.04,1111110,31728000,5752000,"[{'period': '2024', 'revenue': 235.13, 'unit': 'M', 'net_profit': 5.75}, {'period': '2023', 'revenue': 175.51, 'unit': 'M', 'net_profit': -78.02}, {'period': '2022', 'revenue': 134.03, 'unit': 'M', 'net_profit': -108.18}, {'period': '2021', 'revenue': 45.6, 'unit': 'M', 'net_profit': -180.97}]","[{'period': ""Q1 '25"", 'revenue': 62.47, 'unit': 'M', 'net_profit': 23.34}, {'period': ""Q4 '24"", 'revenue': 59.87, 'unit': 'M', 'net_profit': 1.43}, {'period': ""Q3 '24"", 'revenue': 67.77, 'unit': 'M', 'net_profit': 14.35}, {'period': ""Q2 '24"", 'revenue': 57190.0, 'unit': 'K', 'net_profit': 722.0}, {'period': ""Q1 '24"", 'revenue': 50.3, 'unit': 'M', 'net_profit': -10.75}, {'period': ""Q4 '23"", 'revenue': 45.09, 'unit': 'M', 'net_profit': -26.88}]",0.04,0.0393,550645000,446596000,358476000,173167000,36544000,0,97763000,83433000,44107000,1.5032436119085761,1.0737246859779543,1.0740740740740742,__nan__,__nan__,__nan__,0.31448029129475435
42,AURC,Aurora Acquisition Corp. Class A Ordinary Shares,"Aurora Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in London, the United Kingdom.",Mr. Arnaud  Massenet,Shell Companies,17.4425,USD,140531938,https://images.financialmodelingprep.com/symbol/AURC.png,332406,-134.17307692307693,-6.9075,113455,-193701000,-206290000,"[{'period': '2024', 'revenue': 108.49, 'unit': 'M', 'net_profit': -206.29}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 26.05}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.32}]","[{'period': ""Q1 '25"", 'revenue': 32.55, 'unit': 'M', 'net_profit': -50.56}, {'period': ""Q4 '24"", 'revenue': 108.49, 'unit': 'M', 'net_profit': -222.29}, {'period': ""Q3 '24"", 'revenue': 28.99, 'unit': 'M', 'net_profit': -54.21}, {'period': ""Q2 '24"", 'revenue': 32.26, 'unit': 'M', 'net_profit': -41.37}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -831.13}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.57}]",-13.65,-13.65,913057000,282424000,264875000,971227000,17549000,0,138211000,211101000,-383359000,0.0,0.0,0.0,__nan__,__nan__,__nan__,1.0637090564992109
43,AURCU,Aurora Acquisition Corp. Unit,"Aurora Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in London, the United Kingdom.",Mr. Arnaud  Massenet,Shell Companies,16.6,USD,148896788,https://images.financialmodelingprep.com/symbol/AURCU.png,588,-286.2068965517241,-9.21,1037,-193701000,-206290000,"[{'period': '2024', 'revenue': 108.49, 'unit': 'M', 'net_profit': -206.29}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 26.05}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.32}]","[{'period': ""Q1 '25"", 'revenue': 32.55, 'unit': 'M', 'net_profit': -50.56}, {'period': ""Q4 '24"", 'revenue': 108.49, 'unit': 'M', 'net_profit': -222.29}, {'period': ""Q3 '24"", 'revenue': 28.99, 'unit': 'M', 'net_profit': -54.21}, {'period': ""Q2 '24"", 'revenue': 32.26, 'unit': 'M', 'net_profit': -41.37}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -831.13}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.57}]",-13.65,-13.65,913057000,282424000,264875000,971227000,17549000,0,138211000,211101000,-383359000,0.0,0.0,0.0,__nan__,__nan__,__nan__,1.0637090564992109
44,AURCW,Aurora Acquisition Corp. Warrant,"Aurora Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the technology and media companies in Europe, the Middle East, and Africa. The company was incorporated in 2020 and is based in London, the United Kingdom.",Mr. Arnaud  Massenet,Shell Companies,0.3,USD,4485395,https://images.financialmodelingprep.com/symbol/AURCW.png,0,0,0.0474,26069,-193701000,-206290000,"[{'period': '2024', 'revenue': 108.49, 'unit': 'M', 'net_profit': -206.29}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 26.05}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.32}]","[{'period': ""Q1 '25"", 'revenue': 32.55, 'unit': 'M', 'net_profit': -50.56}, {'period': ""Q4 '24"", 'revenue': 108.49, 'unit': 'M', 'net_profit': -222.29}, {'period': ""Q3 '24"", 'revenue': 28.99, 'unit': 'M', 'net_profit': -54.21}, {'period': ""Q2 '24"", 'revenue': 32.26, 'unit': 'M', 'net_profit': -41.37}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -831.13}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.57}]",-13.65,-13.65,913057000,282424000,264875000,971227000,17549000,0,138211000,211101000,-383359000,0.0,0.0,0.0,__nan__,__nan__,__nan__,1.0637090564992109
45,AUTL,Autolus Therapeutics plc American Depositary Share,"Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a programmed T cell investigational therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1; AUTO6NG, a programmed T cell investigational therapy, which is in preclinical trail targeting GD2 in development for the treatment of neuroblastoma; and AUTO8, a product candidate that is in a Phase I clinical trial for multiple myeloma. It also focuses on developing AUTO5, a hematological product candidate, which is in preclinical development. The company was incorporated in 2014 and is headquartered in London, the United Kingdom.",Dr. Christian Martin Itin Ph.D.,Biotechnology,1.47,USD,391227252,https://images.financialmodelingprep.com/symbol/AUTL.png,1971524,-1.67,-0.06,1979248,-182424000,-220662000,"[{'period': '2024', 'revenue': 10.12, 'unit': 'M', 'net_profit': -220.66}, {'period': '2023', 'revenue': 1.7, 'unit': 'M', 'net_profit': -208.38}, {'period': '2022', 'revenue': 6.19, 'unit': 'M', 'net_profit': -148.84}, {'period': '2021', 'revenue': 2.33, 'unit': 'M', 'net_profit': -142.1}]","[{'period': ""Q1 '25"", 'revenue': 8.98, 'unit': 'M', 'net_profit': -70.16}, {'period': ""Q4 '24"", 'revenue': 0.029, 'unit': 'M', 'net_profit': -27.61}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -82.09}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -58.27}, {'period': ""Q1 '24"", 'revenue': 10.09, 'unit': 'M', 'net_profit': -52.69}, {'period': ""Q4 '23"", 'revenue': 1.77, 'unit': 'M', 'net_profit': -77.17}]",-0.86,-0.86,782725000,660929000,588023000,355400000,48240000,0,60743000,227380000,-241090000,-0.16364100274287172,-0.0589251522437051,0.2833333333333333,__nan__,__nan__,__nan__,0.4540547446421157
46,AUTO,AutoWeb Inc. Common Stock,"AutoWeb, Inc. operates as a digital marketing company for the automotive industry in the United States. It assists automotive retail dealers and manufacturers to market and sell new and used vehicles to consumers through its programs. The company's products include new vehicle lead program, which allows consumers to submit requests for pricing and availability of specific makes and models; and used vehicle lead program, which allows consumers to search for used vehicles according to specific search parameters, such as price, make, model, mileage, year, and location of the vehicle. Its products and services also comprise WebLeads+ that offers various coupon options, which display marketing messages to consumers visiting the dealer's website; and Payment Pro, a dealer website conversion tool that offers consumers real-time online monthly payment information, as well as sells fixed placement advertising across its Website to automotive advertisers. It owns and operates automotive websites that offers consumers with the information and tools to aid them with their automotive purchase decisions; direct marketing platform that enables manufacturers to selectively target in-market consumers during the often-extended vehicle shopping process; and click traffic referral program, a pay-per-click advertising program that offer targeted offers to consumers based on make, model, and geographic location. The company was formerly known as Autobytel Inc. and changed its name to AutoWeb, Inc. in October 2017. AutoWeb, Inc. was founded in 1995 and is headquartered in Tampa, Florida.",Mr. Jared Rowe,Internet Content & Information,0.388,USD,0,https://images.financialmodelingprep.com/symbol/AUTO.png,0,-0.503242542153048,0.003,97457,-2164000,-6670000,"[{'period': '2021', 'revenue': 71.58, 'unit': 'M', 'net_profit': -6.67}, {'period': '2020', 'revenue': 76.57, 'unit': 'M', 'net_profit': -6.82}, {'period': '2019', 'revenue': 113.98, 'unit': 'M', 'net_profit': -15.23}, {'period': '2018', 'revenue': 125.59, 'unit': 'M', 'net_profit': -38.82}]","[{'period': ""Q2 '22"", 'revenue': 17.2, 'unit': 'M', 'net_profit': -4.68}, {'period': ""Q1 '22"", 'revenue': 19.06, 'unit': 'M', 'net_profit': -4.31}, {'period': ""Q4 '21"", 'revenue': 17.81, 'unit': 'M', 'net_profit': -2.87}, {'period': ""Q3 '21"", 'revenue': 17.16, 'unit': 'M', 'net_profit': -3.06}, {'period': ""Q2 '21"", 'revenue': 18740.0, 'unit': 'K', 'net_profit': -304.0}, {'period': ""Q1 '21"", 'revenue': 17880.0, 'unit': 'K', 'net_profit': 310.0}]",-0.51,-0.51,35132000,25136000,7315000,22375000,11433000,0,20943000,7315000,-3460000,0.32077840552416825,0.021994134897360705,0.019230769230769246,__nan__,__nan__,__nan__,0.6368837527040875
47,AUUD,Auddia Inc. Common Stock,"Auddia Inc., a technology company, develops software products for the audio and podcast markets. The company's flagship product is Faidr, a subscription based mobile application that enables users to listen to various streaming AM/FM radio stations without commercials. It also provides Vodacast, an interactive podcasting platform and application; and Vodcast Hub, a content management system. The company was formerly known as Clip Interactive, LLC and changed its name to Auddia Inc. in November 2019. Auddia Inc. was founded in 2012 and is headquartered in Boulder, Colorado.",Mr. Michael Thomas Lawless,Software - Application,4.1,USD,2543784,https://images.financialmodelingprep.com/symbol/AUUD.png,99546,-0.15,-0.2,17373,-6478074,-8722039,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.72}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.81}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.07}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.93}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.75}, {'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.26}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.95}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.3}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.21}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.21}]",-3.39,-3.39,5298328,2762378,2706319,604008,353,0,550920,2706319,-5105341,0.1305739998158631,0.009702757741814472,0.7377946909225914,__nan__,__nan__,__nan__,0.11399973727560846
48,AUUDW,Auddia Inc. Warrants,"Auddia Inc. develops software technologies for audio media companies and consumers of audio media. The company's flagship product is Auddia App, a subscription based commercial free AM/FM software application. It also provides Vodacast, an interactive podcasting platform and application. The company was founded in 2012 and is headquartered in Boulder, Colorado.",Mr. Michael Thomas Lawless,Software - Application,0.0299,USD,2683716,https://images.financialmodelingprep.com/symbol/AUUDW.png,12726.11888,,-0.0001,5610,-6478074,-8722039,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.72}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.81}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.07}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.93}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.75}, {'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.26}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.95}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.3}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.21}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.21}]",-3.39,-3.39,5298328,2762378,2706319,604008,353,0,550920,2706319,-5105341,0.1305739998158631,0.009702757741814472,0.7377946909225914,__nan__,__nan__,__nan__,0.11399973727560846
49,AUVI,Applied UV Inc. Common Stock,"Applied UV, Inc., through its subsidiaries, develops, acquires, and commercializes technology that addresses air purification and infection control in the healthcare, hospitality, commercial, municipal, and residential markets in the United States, Canada, and Europe. It operates through Disinfection and Hospitality segments. The company offers science-based solutions and products in air purification under the Airocide brand; and disinfection of hard surfaces under the Lumicide brand. It also manufactures and supplies fine decorative framed mirrors, framed arts, and bathroom vanities. The company was incorporated in 2019 and is headquartered in Mount Vernon, New York.",Mr. Max  Munn,"Furnishings, Fixtures & Appliances",0.2926,USD,1367759,https://images.financialmodelingprep.com/symbol/AUVI.png,347986,-0.007315,0.0001,5561130,-9054290,-13203852,"[{'period': '2023', 'revenue': 40.72, 'unit': 'M', 'net_profit': -13.2}, {'period': '2022', 'revenue': 20.14, 'unit': 'M', 'net_profit': -22.05}, {'period': '2021', 'revenue': 11.67, 'unit': 'M', 'net_profit': -7.39}, {'period': '2020', 'revenue': 5.73, 'unit': 'M', 'net_profit': -3.37}]","[{'period': ""Q4 '23"", 'revenue': 7.77, 'unit': 'M', 'net_profit': -3.1}, {'period': ""Q3 '23"", 'revenue': 11.45, 'unit': 'M', 'net_profit': -2.57}, {'period': ""Q2 '23"", 'revenue': 10.84, 'unit': 'M', 'net_profit': -2.99}, {'period': ""Q1 '23"", 'revenue': 10.65, 'unit': 'M', 'net_profit': -5.95}, {'period': ""Q4 '22"", 'revenue': 5.0, 'unit': 'M', 'net_profit': -15.18}, {'period': ""Q3 '22"", 'revenue': 5.88, 'unit': 'M', 'net_profit': -3.06}]",-35.63,-35.63,58386231,17023926,1130947,33502612,7187052,0,27871423,1130947,-8777006,-0.02083431986019505,0.40118900054766155,0.8351149983803046,__nan__,__nan__,__nan__,0.5738101505473097
50,AVAH,Aveanna Healthcare Holdings Inc. Common Stock,"Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.",Mr. Jeffrey S. Shaner,Medical - Care Facilities,5.49,USD,1071066060,https://images.financialmodelingprep.com/symbol/AVAH.png,415891,183,-0.26,418909,192837000,-10929000,"[{'period': '2024', 'revenue': 2020.0, 'unit': 'M', 'net_profit': -10.93}, {'period': '2023', 'revenue': 1900.0, 'unit': 'M', 'net_profit': -134.52}, {'period': '2022', 'revenue': 1790.0, 'unit': 'M', 'net_profit': -662.03}, {'period': '2021', 'revenue': 1680.0, 'unit': 'M', 'net_profit': -117.04}]","[{'period': ""Q1 '25"", 'revenue': 559.22, 'unit': 'M', 'net_profit': 15.1}, {'period': ""Q4 '24"", 'revenue': 519.87, 'unit': 'M', 'net_profit': 29.18}, {'period': ""Q3 '24"", 'revenue': 509.02, 'unit': 'M', 'net_profit': -42.84}, {'period': ""Q2 '24"", 'revenue': 504.96, 'unit': 'M', 'net_profit': 13.91}, {'period': ""Q1 '24"", 'revenue': 490.65, 'unit': 'M', 'net_profit': -11.17}, {'period': ""Q4 '23"", 'revenue': 478.84, 'unit': 'M', 'net_profit': -25.74}]",-0.0567,-0.0567,1663394000,392670000,84288000,1785484000,277658000,0,402167000,84288000,26318000,3.348268242085325,0.9187579911391276,0.9201408450704226,__nan__,__nan__,__nan__,1.073398124557381
51,AVAV,AeroVironment Inc. Common Stock,"AeroVironment, Inc. designs, develops, produces, delivers, and supports a portfolio of robotic systems and related services for government agencies and businesses in the United States and internationally. It operates through four segments: Unmanned Aircraft Systems (UAS), Tactical Missile System (TMS), Medium Unmanned Aircraft Systems (MUAS), and High Altitude Pseudo-Satellite Systems (HAPS). The company supplies UAS, TMS, unmanned ground vehicle, and related services primarily to organizations within the U.S. Department of Defense and to international allied governments. It also designs, engineers, tools, and manufactures unmanned aerial and aircraft systems, including airborne platforms, payloads and payload integration, ground control systems, and ground support equipment and other items and services related to unmanned aircraft systems. In addition, the company offers small UAS products, including spare equipment, alternative payload modules, batteries, chargers, repair services, and customer support, as well as multiple aircraft, hand-held ground control system, and spare parts and accessories. Further, it develops high-altitude pseudo-satellite UAS systems. The company was incorporated in 1971 and is headquartered in Arlington, Virginia.",Mr. Wahid  Nawabi,Aerospace & Defense,166.73,USD,7610340831,https://images.financialmodelingprep.com/symbol/AVAV.png,481980,142.5,-2.56,516585,102503000,59666000,"[{'period': '2024', 'revenue': 716.72, 'unit': 'M', 'net_profit': 59.67}, {'period': '2023', 'revenue': 540.54, 'unit': 'M', 'net_profit': -173.71}, {'period': '2022', 'revenue': 445.73, 'unit': 'M', 'net_profit': -8.77}, {'period': '2021', 'revenue': 394.91, 'unit': 'M', 'net_profit': 33.83}]","[{'period': ""Q3 '25"", 'revenue': 167.64, 'unit': 'M', 'net_profit': -1.75}, {'period': ""Q2 '25"", 'revenue': 188.46, 'unit': 'M', 'net_profit': 7.54}, {'period': ""Q1 '25"", 'revenue': 189.48, 'unit': 'M', 'net_profit': 21.17}, {'period': ""Q4 '24"", 'revenue': 196.98, 'unit': 'M', 'net_profit': 6.05}, {'period': ""Q3 '24"", 'revenue': 186.58, 'unit': 'M', 'net_profit': 13.88}, {'period': ""Q2 '24"", 'revenue': 180.82, 'unit': 'M', 'net_profit': 17.84}]",2.19,2.18,1015860000,515581000,73301000,193115000,269779000,21112000,144879000,73301000,-9191000,2.2961117784662073,1.343472604395731,1.3155619596541788,__nan__,__nan__,__nan__,0.19010001378142657
52,AVCO,Avalon GloboCare Corp. Common Stock,"Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells. It is also developing RNA-based FASH-CARTM cell therapy platform. In addition, the company develops avalon clinical-grade tissue-specific exosome (ACTEX); offers therapeutic and diagnostic targets utilizing QTY-code protein design technology with Massachusetts Institute of Technology (MIT), including using the QTY code protein design technology for development of a hemofiltration device to treat Cytokine Storm; and provides co-development of next generation, transposon-based, multi-target CAR-T, CAR-NK, and other immune effector cell therapeutic modalities with Arbele Limited. Further, it has strategic partnership with the University of Natural Resources and Life Sciences in Vienna and Austria to develop an S-layer vaccine that could be administered by an intranasal or oral route against SARS-CoV-2 and coronavirus that causes COVID-19 disease; and develops Avalon Cell and Avalon Rehab, as well as promotes standardization related to exosome industry. The company is headquartered in Freehold, New Jersey.",Dr. David K. Jin,Real Estate - Services,0.5259,USD,5258180,https://images.financialmodelingprep.com/symbol/AVCO.png,189950,-5.155882352941177,-0.1041,432165,-5165951,-7903394,"[{'period': '2024', 'revenue': 1.33, 'unit': 'M', 'net_profit': -7.9}, {'period': '2023', 'revenue': 1.26, 'unit': 'M', 'net_profit': -16.71}, {'period': '2022', 'revenue': 1.2, 'unit': 'M', 'net_profit': -12.68}, {'period': '2021', 'revenue': 1.39, 'unit': 'M', 'net_profit': -9.23}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.48}, {'period': ""Q4 '24"", 'revenue': 0.34576999999999997, 'unit': 'M', 'net_profit': -2.72}, {'period': ""Q3 '24"", 'revenue': 0.34516, 'unit': 'M', 'net_profit': -1.68}, {'period': ""Q2 '24"", 'revenue': 0.32789, 'unit': 'M', 'net_profit': -2.13}, {'period': ""Q1 '24"", 'revenue': 0.31459, 'unit': 'M', 'net_profit': -1.37}, {'period': ""Q4 '23"", 'revenue': 0.32132, 'unit': 'M', 'net_profit': -9.56}]",-8.44,-8.44,20985178,3236498,2856309,13882555,122959,10636544,13882555,2856309,-4969205,0.6561890746420199,0.5269414455369333,-4.3081761006289305,__nan__,__nan__,__nan__,0.6615409695357362
53,AVCT,American Virtual Cloud Technologies Inc. Common Stock ,"American Virtual Cloud Technologies, Inc., a pure-play cloud communications and collaboration company, provides cloud-based enterprise services worldwide. The company's Kandy cloud communications platform is a cloud-based, real-time communications platform, which offers proprietary unified communications as a service, communications platform as a service, contact center as a service, Microsoft Teams Direct Routing as a Service, and SIP Trunking as a Service capabilities. Its cloud-based, real-time communications platform enables service providers, enterprises, software vendors, systems integrators, partners, and developers to enrich their applications and services with real-time contextual communications empowering the application programming interface economy. American Virtual Cloud Technologies, Inc. also has strategic partnerships with AT&T, IBM, and Etisalat to sell various solutions. The company was founded in 1987 and is based in Atlanta, Georgia.",Mr. Darrell J. Mays,Information Technology Services,0.598,USD,0,https://images.financialmodelingprep.com/symbol/AVCT.png,2857270,0,0.0,5956527,-57166000,-39427000,"[{'period': '2022', 'revenue': 16.81, 'unit': 'M', 'net_profit': -39.43}, {'period': '2021', 'revenue': 20.05, 'unit': 'M', 'net_profit': -162.56}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.02}, {'period': '2019', 'revenue': 0.0, 'unit': 'K', 'net_profit': 989.8}]","[{'period': ""Q1 '23"", 'revenue': 4.06, 'unit': 'M', 'net_profit': -9.88}, {'period': ""Q4 '22"", 'revenue': 4.25, 'unit': 'M', 'net_profit': -7.6}, {'period': ""Q3 '22"", 'revenue': 4.74, 'unit': 'M', 'net_profit': -25.55}, {'period': ""Q2 '22"", 'revenue': 3.72, 'unit': 'M', 'net_profit': 8.35}, {'period': ""Q1 '22"", 'revenue': 4.09, 'unit': 'M', 'net_profit': -14.63}, {'period': ""Q4 '21"", 'revenue': -62.19, 'unit': 'M', 'net_profit': -55.0}]",-0.0029,-0.0029,31909000,26402000,12627000,13418000,7390000,0,11104000,12627000,-64359000,0.5450522864373597,0.757460368235533,0.9999576147325344,__nan__,__nan__,__nan__,0.42050832053652576
54,AVCTW,American Virtual Cloud Technologies Inc. Warrant expiring 4/7/2025,,None,,0.0161,USD,0,https://images.financialmodelingprep.com/symbol/AVCTW.png,0,0,0.0,574251,-57166000,-39427000,"[{'period': '2022', 'revenue': 16.81, 'unit': 'M', 'net_profit': -39.43}, {'period': '2021', 'revenue': 20.05, 'unit': 'M', 'net_profit': -162.56}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.02}, {'period': '2019', 'revenue': 0.0, 'unit': 'K', 'net_profit': 989.8}]","[{'period': ""Q1 '23"", 'revenue': 4.06, 'unit': 'M', 'net_profit': -9.88}, {'period': ""Q4 '22"", 'revenue': 4.25, 'unit': 'M', 'net_profit': -7.6}, {'period': ""Q3 '22"", 'revenue': 4.74, 'unit': 'M', 'net_profit': -25.55}, {'period': ""Q2 '22"", 'revenue': 3.72, 'unit': 'M', 'net_profit': 8.35}, {'period': ""Q1 '22"", 'revenue': 4.09, 'unit': 'M', 'net_profit': -14.63}, {'period': ""Q4 '21"", 'revenue': -62.19, 'unit': 'M', 'net_profit': -55.0}]",-0.0029,-0.0029,31909000,26402000,12627000,13418000,7390000,0,11104000,12627000,-64359000,0.5450522864373597,0.757460368235533,0.9999576147325344,__nan__,__nan__,__nan__,0.42050832053652576
55,AVDL,Avadel Pharmaceuticals plc American Depositary Shares,"Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.",Mr. Gregory J. Divis Jr.,Drug Manufacturers - Specialty & Generic,9.15,USD,885160898,https://images.financialmodelingprep.com/symbol/AVDL.png,1191262,-35.19,-0.22,806270,-35568000,-48832000,"[{'period': '2024', 'revenue': 169.12, 'unit': 'M', 'net_profit': -48.83}, {'period': '2023', 'revenue': 27.96, 'unit': 'M', 'net_profit': -160.28}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -137.46}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -77.33}]","[{'period': ""Q1 '25"", 'revenue': 52.51, 'unit': 'M', 'net_profit': -4.92}, {'period': ""Q4 '24"", 'revenue': 50.41, 'unit': 'M', 'net_profit': -5.04}, {'period': ""Q3 '24"", 'revenue': 50.02, 'unit': 'M', 'net_profit': -2.62}, {'period': ""Q2 '24"", 'revenue': 41.5, 'unit': 'M', 'net_profit': -13.82}, {'period': ""Q1 '24"", 'revenue': 27.18, 'unit': 'M', 'net_profit': -27.34}, {'period': ""Q4 '23"", 'revenue': 19.45, 'unit': 'M', 'net_profit': -28.79}]",-0.51,-0.51,164236000,134208000,73777000,90388000,34097000,0,48834000,51371000,-46907000,0.7614886839899413,0.6953255634031296,0.745,__nan__,__nan__,__nan__,0.550354368104435
56,AVEO,AVEO Pharmaceuticals Inc. Common Stock,"AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the treatment of RCC, HCC, immunologically cold tumors, and CCA. The company has also completed a Phase II clinical trial of tivozanib in combination with Opdivo (nivolumab) for the treatment of RCC. In addition, it is developing Ficlatuzumab, a potent humanized immunoglobulin G1 (IgG1) monoclonal antibody that targets hepatocyte growth factor that is in a Phase II clinical trial for the treatment of squamous cell carcinoma of the head and neck, pancreatic cancer, and acute myeloid leukemia; AV-203, a potent humanized IgG1 monoclonal antibody, which completed Phase I clinical trial for treating human ErbB3; and AV-380, a potent humanized IgG1 inhibitory monoclonal antibody that is in a Phase I clinical trial for the treatment or prevention of cachexia. The company's preclinical stage product includes AV-353 that targets the Notch 3 pathway. AVEO Pharmaceuticals, Inc. has collaboration agreements with CANbridge Life Sciences Ltd.; EUSA Pharma (UK) Limited; Novartis International Pharmaceutical Ltd.; Biodesix, Inc.; St. Vincent's Hospital Sydney Limited; Biogen Idec International GmbH; Kyowa Kirin Co., Ltd.; and AstraZeneca PLC. The company was formerly known as GenPath Pharmaceuticals, Inc. and changed its name to AVEO Pharmaceuticals, Inc. in March 2005. AVEO Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Boston, Massachusetts.",Mr. Michael P. Bailey,Biotechnology,15.0,USD,0,https://images.financialmodelingprep.com/symbol/AVEO.png,564056,0,0.0,245298,-57387000,-61175000,"[{'period': '2021', 'revenue': 38.87, 'unit': 'M', 'net_profit': -61.17}, {'period': '2020', 'revenue': 6.02, 'unit': 'M', 'net_profit': -35.58}, {'period': '2019', 'revenue': 28.8, 'unit': 'M', 'net_profit': 9.39}, {'period': '2018', 'revenue': 5.41, 'unit': 'M', 'net_profit': -5.33}]","[{'period': ""Q3 '22"", 'revenue': 30.45, 'unit': 'M', 'net_profit': -4.36}, {'period': ""Q2 '22"", 'revenue': 25.3, 'unit': 'M', 'net_profit': -9.48}, {'period': ""Q1 '22"", 'revenue': 20.92, 'unit': 'M', 'net_profit': -11.39}, {'period': ""Q4 '21"", 'revenue': 14.22, 'unit': 'M', 'net_profit': -15.29}, {'period': ""Q3 '21"", 'revenue': 15.17, 'unit': 'M', 'net_profit': -10.37}, {'period': ""Q2 '21"", 'revenue': 7.56, 'unit': 'M', 'net_profit': -13.6}]",-2.86,-2.86,105341000,104736000,70542000,59471000,9811000,16784000,18731000,70542000,-57257000,-0.689940514753519,-0.7191715377697842,-0.7228915662650602,__nan__,__nan__,__nan__,0.5645570100910376
57,AVGO,Broadcom Inc. Common Stock,"Broadcom Inc. designs, develops, and supplies various semiconductor devices with a focus on complex digital and mixed signal complementary metal oxide semiconductor based devices and analog III-V based products worldwide. The company operates in two segments, Semiconductor Solutions and Infrastructure Software. It provides set-top box system-on-chips (SoCs); cable, digital subscriber line, and passive optical networking central office/consumer premise equipment SoCs; wireless local area network access point SoCs; Ethernet switching and routing merchant silicon products; embedded processors and controllers; serializer/deserializer application specific integrated circuits; optical and copper, and physical layers; and fiber optic transmitter and receiver components. The company also offers RF front end modules, filters, and power amplifiers; Wi-Fi, Bluetooth, and global positioning system/global navigation satellite system SoCs; custom touch controllers; serial attached small computer system interface, and redundant array of independent disks controllers and adapters; peripheral component interconnect express switches; fiber channel host bus adapters; read channel based SoCs; custom flash controllers; preamplifiers; and optocouplers, industrial fiber optics, and motion control encoders and subsystems. Its products are used in various applications, including enterprise and data center networking, home connectivity, set-top boxes, broadband access, telecommunication equipment, smartphones and base stations, data center servers and storage systems, factory automation, power generation and alternative energy systems, and electronic displays. Broadcom Inc. was incorporated in 2018 and is headquartered in San Jose, California.",Mr. Hock E. Tan,Semiconductors,229.73,USD,1080178973500,https://images.financialmodelingprep.com/symbol/AVGO.png,30916075,106.85,-1.95,16780348,23879000000,5895000000,"[{'period': '2024', 'revenue': 51.57, 'unit': 'B', 'net_profit': 5.89}, {'period': '2023', 'revenue': 35.82, 'unit': 'B', 'net_profit': 14.08}, {'period': '2022', 'revenue': 33.2, 'unit': 'B', 'net_profit': 11.49}, {'period': '2021', 'revenue': 27.45, 'unit': 'B', 'net_profit': 6.74}]","[{'period': ""Q1 '25"", 'revenue': 14.92, 'unit': 'B', 'net_profit': 5.5}, {'period': ""Q4 '24"", 'revenue': 14.05, 'unit': 'B', 'net_profit': 4.32}, {'period': ""Q3 '24"", 'revenue': 13.07, 'unit': 'B', 'net_profit': -1.88}, {'period': ""Q2 '24"", 'revenue': 12.49, 'unit': 'B', 'net_profit': 2.12}, {'period': ""Q1 '24"", 'revenue': 11.96, 'unit': 'B', 'net_profit': 1.32}, {'period': ""Q4 '23"", 'revenue': 9.29, 'unit': 'B', 'net_profit': 3.52}]",1.27,1.23,165645000000,19595000000,9348000000,97967000000,4416000000,0,16697000000,9348000000,19414000000,0.16176899873503942,-0.5813804857264593,-0.6253687315634219,"[0.59, 0.07]","['2025-03-20', '2010-12-13']",__nan__,0.5914274502701561
58,AVGOP,Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock Series A,"Broadcom Inc. designs, develops, and supplies various semiconductor devices with a focus on complex digital and mixed signal complementary metal oxide semiconductor based devices and analog III-V based products worldwide. The company operates in two segments, Semiconductor Solutions and Infrastructure Software. It provides set-top box system-on-chips (SoCs); cable, digital subscriber line, and passive optical networking central office/consumer premise equipment SoCs; wireless local area network access point SoCs; Ethernet switching and routing merchant silicon products; embedded processors and controllers; serializer/deserializer application specific integrated circuits; optical and copper, and physical layers; and fiber optic transmitter and receiver components. The company also offers RF front end modules, filters, and power amplifiers; Wi-Fi, Bluetooth, and global positioning system/global navigation satellite system SoCs; custom touch controllers; serial attached small computer system interface, and redundant array of independent disks controllers and adapters; peripheral component interconnect express switches; fiber channel host bus adapters; read channel based SoCs; custom flash controllers; preamplifiers; and optocouplers, industrial fiber optics, and motion control encoders and subsystems. Its products are used in various applications, including enterprise and data center networking, home connectivity, set-top boxes, broadband access, telecommunication equipment, smartphones and base stations, data center servers and storage systems, factory automation, power generation and alternative energy systems, and electronic displays. Broadcom Inc. was incorporated in 2018 and is headquartered in San Jose, California.",Mr. Hock E. Tan,Semiconductors,1406.7,USD,0,https://images.financialmodelingprep.com/symbol/AVGOP.png,0,0,-37.3201,36980,23879000000,5895000000,"[{'period': '2024', 'revenue': 51.57, 'unit': 'B', 'net_profit': 5.89}, {'period': '2023', 'revenue': 35.82, 'unit': 'B', 'net_profit': 14.08}, {'period': '2022', 'revenue': 33.2, 'unit': 'B', 'net_profit': 11.49}, {'period': '2021', 'revenue': 27.45, 'unit': 'B', 'net_profit': 6.74}]","[{'period': ""Q1 '25"", 'revenue': 14.92, 'unit': 'B', 'net_profit': 5.5}, {'period': ""Q4 '24"", 'revenue': 14.05, 'unit': 'B', 'net_profit': 4.32}, {'period': ""Q3 '24"", 'revenue': 13.07, 'unit': 'B', 'net_profit': -1.88}, {'period': ""Q2 '24"", 'revenue': 12.49, 'unit': 'B', 'net_profit': 2.12}, {'period': ""Q1 '24"", 'revenue': 11.96, 'unit': 'B', 'net_profit': 1.32}, {'period': ""Q4 '23"", 'revenue': 9.29, 'unit': 'B', 'net_profit': 3.52}]",1.27,1.23,165645000000,19595000000,9348000000,97967000000,4416000000,0,16697000000,9348000000,19414000000,0.16176899873503942,-0.5813804857264593,-0.6253687315634219,"[20, 20]","['2022-09-14', '2019-12-12']",__nan__,0.5914274502701561
59,AVGR,Avinger Inc. Common Stock,"Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was incorporated in 2007 and is headquartered in Redwood City, California.",Mr. Nabeel P. Subainati CPA,Medical - Instruments & Supplies,0.474,USD,1515364,https://images.financialmodelingprep.com/symbol/AVGR.png,3195863,-0.05410958904109589,-0.124,2592021,-16346000,-18320000,"[{'period': '2023', 'revenue': 7.65, 'unit': 'M', 'net_profit': -18.32}, {'period': '2022', 'revenue': 8.27, 'unit': 'M', 'net_profit': -17.43}, {'period': '2021', 'revenue': 10.13, 'unit': 'M', 'net_profit': -20.71}, {'period': '2020', 'revenue': 8.76, 'unit': 'M', 'net_profit': -19.82}]","[{'period': ""Q3 '24"", 'revenue': 1.65, 'unit': 'M', 'net_profit': -3.71}, {'period': ""Q2 '24"", 'revenue': 1.85, 'unit': 'M', 'net_profit': -4.36}, {'period': ""Q1 '24"", 'revenue': 1.86, 'unit': 'M', 'net_profit': -5.52}, {'period': ""Q4 '23"", 'revenue': 1.91, 'unit': 'M', 'net_profit': -5.02}, {'period': ""Q3 '23"", 'revenue': 1.82, 'unit': 'M', 'net_profit': -2.04}, {'period': ""Q2 '23"", 'revenue': 2.04, 'unit': 'M', 'net_profit': -4.18}]",-23.31,-23.31,13770000,12162000,5275000,19972000,1014000,0,19300000,5275000,-14440000,-0.03711693420468244,-0.051242325127675445,0.4427444417881903,__nan__,__nan__,__nan__,1.45039941902687
60,AVID,Avid Technology Inc. Common Stock,"Avid Technology, Inc., together with its subsidiaries, develops, markets, sells, and supports software and integrated solutions for video and audio content creation, management, and distribution worldwide. The company's video products and solutions include the Media Composer, a cloud-enabled solution used to edit video content; Avid NEXIS shared storage systems; Maestro solutions for the integration of virtual sets, augmented reality, and video wall control into existing workflows; AirSpeed 5000 and AirSpeed 5500 on-air server solutions; and MediaCentral, a media production suite. Its audio products and solutions comprise Pro Tools digital audio software solutions to facilitate the audio production process; Sibelius solution to create, edit, and publish musical scores; S6 line of complementary control surfaces and consoles; S1 and S4 audio control surfaces; and VENUE | S6L live sound system for mixing audio for live sound reinforcement. The company also provides Avid Link, a mobile application to connect with other artists, producers, mixers, composers, editors, videographers, movie makers, and graphic designers; FastServe video server that assists broadcasters in making the move to UHD and IP based workflows with a new and modular architecture; and hardware products, such as I/O devices, interfaces, and audio and video processing equipment. In addition, it offers various maintenance contracts and support services; professional services, such as workflow design and consulting, program and project management, system installation and commissioning, and custom development and role-based product level training; and public and private training to customers and alliance partners, as well as develops and licenses curriculum content for use by third party Avid Learning partners to deliver training to customers, users, and alliance partners. The company was incorporated in 1987 and is headquartered in Burlington, Massachusetts.",Mr. Jeffrey  Rosica,Electronic Gaming & Multimedia,27.045,USD,1191107777,https://images.financialmodelingprep.com/symbol/AVID.png,676342,37.5625,0.005,412361,63524000,55241000,"[{'period': '2022', 'revenue': 417.41, 'unit': 'M', 'net_profit': 55.24}, {'period': '2021', 'revenue': 409.94, 'unit': 'M', 'net_profit': 41.39}, {'period': '2020', 'revenue': 360.47, 'unit': 'M', 'net_profit': 11.06}, {'period': '2019', 'revenue': 411.79, 'unit': 'M', 'net_profit': 7.6}]","[{'period': ""Q3 '23"", 'revenue': 91.01, 'unit': 'M', 'net_profit': -7.33}, {'period': ""Q2 '23"", 'revenue': 108.54, 'unit': 'M', 'net_profit': -4.6}, {'period': ""Q1 '23"", 'revenue': 97810.0, 'unit': 'K', 'net_profit': -381.0}, {'period': ""Q4 '22"", 'revenue': 116.1, 'unit': 'M', 'net_profit': 25.26}, {'period': ""Q3 '22"", 'revenue': 102.98, 'unit': 'M', 'net_profit': 12.02}, {'period': ""Q2 '22"", 'revenue': 97.68, 'unit': 'M', 'net_profit': 7.37}]",1.24,1.23,287453000,178971000,35247000,406235000,109144000,0,190617000,35247000,32768000,0.05043489764196184,0.3347105441190683,0.3478260869565217,__nan__,__nan__,__nan__,1.413222335477452
61,AVIR,Atea Pharmaceuticals Inc. Common Stock,"Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The company also develops AT-752, an oral purine nucleoside prodrug product candidate, which has completed Phase Ia clinical trial for the treatment of dengue; AT-777, an NS5A inhibitor; AT-787, a co-formulated, oral, pan-genotypic fixed dose combination of AT-527 and AT-777 for the treatment of hepatitis C virous (HCV); and AT-281, a pharmaceutically acceptable salt for the treatment or prevention of an RNA viral infection, including dengue fever, yellow fever, Zika virus, and coronaviridae viral infection, as well as Ruzasvir, an investigational oral, pan genotypic NS5A inhibitor for the treatment of chronic HCV infection. It has a license agreement with Merck & Co, Inc. for development and commercialization of ruzasvir for the treatment of HCV. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.",Dr. Jean-Pierre  Sommadossi Ph.D.,Biotechnology,2.81,USD,240478395,https://images.financialmodelingprep.com/symbol/AVIR.png,381054,-1.7,-0.09,276504,-167044000,-168385000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -168.38}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -135.96}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -115.91}, {'period': '2021', 'revenue': 351.37, 'unit': 'M', 'net_profit': 121.19}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -34.27}, {'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -33.54}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -31.15}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -40.52}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -63.17}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -39.16}]",-2.0,-2.0,464668000,462355000,454721000,25801000,0,0,18603000,64696000,-135499000,-0.3967707140050003,-0.2385256994910118,-0.22699386503067492,__nan__,__nan__,__nan__,0.055525665636540496
62,AVNW,Aviat Networks Inc. Common Stock,"Aviat Networks, Inc. provides wireless transport solutions worldwide. It offers a comprehensive suite of products and localized professional and support services enabling customers to simplify their networks and lives. The company's products and solutions include wireless transmission systems for microwave and millimeter wave networking applications. It serves communications service providers and private network operators, including state/local government, utility, federal government, and defense organizations. The company markets its products through a direct sales, service, and support organization; indirect sales channels comprising dealers, resellers, and sales representatives; and through online. Aviat Networks, Inc. was incorporated in 2006 and is headquartered in Austin, Texas.",Mr. Peter A. Smith Ph.D.,Communication Equipment,20.54,USD,260701896,https://images.financialmodelingprep.com/symbol/AVNW.png,105932,-108.11,0.26,115421,28261000,10760000,"[{'period': '2024', 'revenue': 408.08, 'unit': 'M', 'net_profit': 10.76}, {'period': '2023', 'revenue': 346.59, 'unit': 'M', 'net_profit': 11.53}, {'period': '2022', 'revenue': 302.96, 'unit': 'M', 'net_profit': 21.16}, {'period': '2021', 'revenue': 274.91, 'unit': 'M', 'net_profit': 110.14}]","[{'period': ""Q3 '25"", 'revenue': 112.64, 'unit': 'M', 'net_profit': 3.53}, {'period': ""Q2 '25"", 'revenue': 118.2, 'unit': 'M', 'net_profit': 4.5}, {'period': ""Q1 '25"", 'revenue': 88.43, 'unit': 'M', 'net_profit': -11.88}, {'period': ""Q4 '24"", 'revenue': 113870.0, 'unit': 'K', 'net_profit': 447.0}, {'period': ""Q3 '24"", 'revenue': 111.61, 'unit': 'M', 'net_profit': 3.42}, {'period': ""Q2 '24"", 'revenue': 95.04, 'unit': 'M', 'net_profit': 2.89}]",0.88,0.86,535223000,405223000,64622000,279338000,248538000,0,218857000,64622000,27865000,-0.16414776256247968,-0.06662040249826509,-0.12871287128712872,__nan__,__nan__,__nan__,0.521909559193084
63,AVO,Mission Produce Inc. Common Stock,"Mission Produce, Inc. engages in sourcing, producing, packaging, and distributing avocados in the United States and internationally. The company operates through two segments, Marketing and Distribution, and International Farming. It also provides value-added services, including ripening, bagging, custom packing, and logistical management. The company serves retail, wholesale, and foodservice customers. The company was founded in 1983 and is headquartered in Oxnard, California.",Mr. Stephen J. Barnard,Food Distribution,10.44,USD,741989592,https://images.financialmodelingprep.com/symbol/AVO.png,304886,18.32,-0.33,172105,110700000,36700000,"[{'period': '2024', 'revenue': 1230.0, 'unit': 'M', 'net_profit': 36.7}, {'period': '2023', 'revenue': 953.9, 'unit': 'M', 'net_profit': -2.8}, {'period': '2022', 'revenue': 1050.0, 'unit': 'M', 'net_profit': -34.9}, {'period': '2021', 'revenue': 891.7, 'unit': 'M', 'net_profit': 44.9}]","[{'period': ""Q1 '25"", 'revenue': 334.2, 'unit': 'M', 'net_profit': 3.9}, {'period': ""Q4 '24"", 'revenue': 354.4, 'unit': 'M', 'net_profit': 17.3}, {'period': ""Q3 '24"", 'revenue': 324.0, 'unit': 'M', 'net_profit': 12.4}, {'period': ""Q2 '24"", 'revenue': 297.6, 'unit': 'M', 'net_profit': 7.0}, {'period': ""Q1 '24"", 'revenue': 258.7, 'unit': 'M', 'net_profit': 2.0}, {'period': ""Q4 '23"", 'revenue': 257.9, 'unit': 'M', 'net_profit': 3.7}]",0.52,0.52,971500000,279000000,58000000,394400000,119100000,33000000,149100000,58000000,61200000,1.5448275862068965,14.107142857142858,14.13131313131313,__nan__,__nan__,__nan__,0.4059701492537313
64,AVRO,AVROBIO Inc. Common Stock,"AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, for the treatment of Pompe disease; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-06 that is in preclinical stage for the treatment of Gaucher disease type 3. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.",Mr. Erik John Ostrowski M.B.A.,Biotechnology,1.4,USD,5237596,https://images.financialmodelingprep.com/symbol/AVRO.png,19048,0.16908212560386474,-0.02,204382,-58015000,-57982000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -57.98}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': 12.16}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -106.05}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -117.73}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.91}, {'period': ""Q4 '24"", 'revenue': -3.6, 'unit': 'M', 'net_profit': -20.81}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.72}, {'period': ""Q2 '24"", 'revenue': 3.6, 'unit': 'M', 'net_profit': -12.64}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.81}, {'period': ""Q4 '23"", 'revenue': 3.6, 'unit': 'M', 'net_profit': -8.79}]",-6.83,-6.83,152905000,146857000,141239000,12129000,0,0,11610000,141239000,-59236000,0.18346235045742434,-5.769433248334293,-26.296296296296294,__nan__,__nan__,__nan__,0.07932376312089205
65,AVT,Avnet Inc. Common Stock,"Avnet, Inc., a technology solutions company, markets, sells, and distributes electronic components. The company operates through two segments, Electronic Components and Farnell. The Electronic Components segment markets, sells, and distributes semiconductors; interconnect, passive, and electromechanical devices; and other integrated components from electronic component manufacturers. It also offers design chain support that provides engineers with technical design solutions; engineering and technical resources to support product design, bill of materials development, and technical education and training; and supply chain solutions that provide support and logistical services to original equipment manufacturers, electronic manufacturing service providers, and electronic component manufacturers. In addition, this segment provides integrated solutions, such as technical design, integration, and assembly of embedded products, and systems and solutions primarily for industrial applications, as well as for intelligent and innovative embedded display solutions comprising touch and passive displays. Further, it develops and manufactures standard board and industrial subsystems, and application-specific devices that enable it to produce systems tailored to specific customer requirements. This segment serves various markets, such as automotive, medical, defense, aerospace, telecommunications, industrial, and digital editing. The Farnell segment distributes kits, tools, and electronic and industrial automation components, as well as test and measurement products to engineers and entrepreneurs. It has operations in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Avnet, Inc. was founded in 1921 and is headquartered in Phoenix, Arizona.",Mr. Philip R. Gallagher,Technology Distributors,50.04,USD,4196219292,https://images.financialmodelingprep.com/symbol/AVT.png,1040401,14.06,-0.87,458136,1060170000,498699000,"[{'period': '2024', 'revenue': 23760.0, 'unit': 'M', 'net_profit': 498.7}, {'period': '2023', 'revenue': 26540.0, 'unit': 'M', 'net_profit': 770.83}, {'period': '2022', 'revenue': 24310.0, 'unit': 'M', 'net_profit': 692.38}, {'period': '2021', 'revenue': 19530.0, 'unit': 'M', 'net_profit': 193.11}]","[{'period': ""Q3 '25"", 'revenue': 5320.0, 'unit': 'M', 'net_profit': 87.92}, {'period': ""Q2 '25"", 'revenue': 5660.0, 'unit': 'M', 'net_profit': 87.25}, {'period': ""Q1 '25"", 'revenue': 5600.0, 'unit': 'M', 'net_profit': 58.96}, {'period': ""Q4 '24"", 'revenue': 5560.0, 'unit': 'M', 'net_profit': 82.67}, {'period': ""Q3 '24"", 'revenue': 5650.0, 'unit': 'M', 'net_profit': 88.83}, {'period': ""Q2 '24"", 'revenue': 6200.0, 'unit': 'M', 'net_profit': 117.93}]",5.51,5.43,12209147000,10370552000,310941000,7283643000,4391187000,0,4465269000,310941000,463506000,-0.22994733974940984,-0.3530346588343963,-0.34169653524492233,"[0.33, 0.25]","['2025-06-04', '1982-03-01']",__nan__,0.596572635254535
66,AVXL,Anavex Life Sciences Corp. Common Stock,"Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinical clinical trials to treat epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. The company's drug candidate also comprises ANAVEX 3-71, which is in Phase I clinical trial for the treatment of frontotemporal dementia and other dementia indications; and preclinical clinical trials for the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. Its preclinical drug candidates include ANAVEX 1-41, a sigma-1 receptor agonist for the treatment of depression, stroke, Parkinson's, and Alzheimer's diseases; ANAVEX 1066, a mixed sigma-1/sigma-2 ligand for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.","Dr. Christopher U. Missling M.B.A., M.S., Ph.D.",Biotechnology,7.78,USD,664192604,https://images.financialmodelingprep.com/symbol/AVXL.png,1028313,-13.89,0.25,1027043,-45293000,-43002000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -43.0}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -47.51}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -47.98}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -37.91}]","[{'period': ""Q2 '25"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.11}, {'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.62}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.21}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.55}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.62}]",-0.52,-0.52,135567000,135567000,132187000,15304000,2449000,0,15304000,132187000,-30812000,0.18765693378291126,0.09479002210293654,0.13333333333333328,__nan__,__nan__,__nan__,0.11288882987747756
67,AWH,Aspira Women's Health Inc. Common Stock,"Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service for decentralized access of protein biomarker and hereditary genetic testing; and owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, its pipeline products include OVAWatch, EndoCheck, and OVAInherit. The company serves physicians, physician office laboratories, and national and regional laboratories. It has a collaborative research agreement with Baylor Genetics; an agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas.",Ms. Nicolette  Possemato,Medical - Diagnostics & Research,0.082,USD,2888393,https://images.financialmodelingprep.com/symbol/AWH.png,4780901,-0.08817204301075268,0.0,2869147,-16186000,-13094000,"[{'period': '2024', 'revenue': 9.18, 'unit': 'M', 'net_profit': -13.09}, {'period': '2023', 'revenue': 9.15, 'unit': 'M', 'net_profit': -16.69}, {'period': '2022', 'revenue': 8.18, 'unit': 'M', 'net_profit': -21.57}, {'period': '2021', 'revenue': 6.81, 'unit': 'M', 'net_profit': -31.71}]","[{'period': ""Q1 '25"", 'revenue': 2.28, 'unit': 'M', 'net_profit': -1.85}, {'period': ""Q4 '24"", 'revenue': 2.35, 'unit': 'M', 'net_profit': -1.39}, {'period': ""Q3 '24"", 'revenue': 2.26, 'unit': 'M', 'net_profit': -3.55}, {'period': ""Q2 '24"", 'revenue': 2.42, 'unit': 'M', 'net_profit': -3.53}, {'period': ""Q1 '24"", 'revenue': 2.15, 'unit': 'M', 'net_profit': -4.63}, {'period': ""Q4 '23"", 'revenue': 2.13, 'unit': 'M', 'net_profit': -3.09}]",-0.93,-0.93,5491000,4183000,1769000,8054000,990000,0,5468000,1769000,-12150000,0.13225754570310405,0.21545835829838225,0.4861878453038674,"[0.0173, 0.012]","['2016-12-16', '2009-05-21']",__nan__,1.4667637953014023
68,AWRE,Aware Inc. Common Stock,"Aware, Inc. provides biometrics software products and solutions in the United States, Brazil, the United Kingdom, and internationally. It offers biometrics software products, including biometric search and matching software development kits (SDKs); biometric enrollment SDKs and application programming interfaces (APIs); and imaging products for medical and advanced imaging applications, such as JPEG2000 product to compress, store, and display images, as well as software maintenance services. The company also provides Knomi mobile biometric authentication framework; AwareABIS, an automated biometric identification system; AFIX suite of products for small-scale law enforcement focused biometric identification; BioSP, a biometric services platform; WebEnroll, a browser-based biometric enrollment and data management solution; AwareID, a software-as-a-service that provides biometric face and voice analysis for liveness-verification, and document validation; and Fortress Identity Biometric Authenticator and Onboarding Authentication Platform, which offers multi-factor authentication through passive and active biometrics for multiple modalities, including voice, fingerprint, face, and behavior to enable online onboarding and identity proofing. In addition, it offers program management and software engineering services, including project planning and management; system and architecture design; software design, development, customization, configuration, and testing; and software integration and installation. The company's software portfolio enables government agencies and commercial entities to enroll, identify, authenticate, and enable using biometrics, such as fingerprints, faces, irises, and voices. The company sells its products through systems integrators, original equipment manufacturers, value added resellers, and partners, as well as directly to end user customers. Aware, Inc. was incorporated in 1986 and is headquartered in Bedford, Massachusetts.",Mr. Ajay K. Amlani,Software - Application,1.63,USD,34379145,https://images.financialmodelingprep.com/symbol/AWRE.png,31534,-6.79,-0.02,25487,-4983000,-4431000,"[{'period': '2024', 'revenue': 17.39, 'unit': 'M', 'net_profit': -4.43}, {'period': '2023', 'revenue': 18.24, 'unit': 'M', 'net_profit': -7.31}, {'period': '2022', 'revenue': 16.01, 'unit': 'M', 'net_profit': -1.73}, {'period': '2021', 'revenue': 16.85, 'unit': 'M', 'net_profit': -5.82}]","[{'period': ""Q1 '25"", 'revenue': 3.61, 'unit': 'M', 'net_profit': -1.6}, {'period': ""Q4 '24"", 'revenue': 4.8, 'unit': 'M', 'net_profit': -1.19}, {'period': ""Q3 '24"", 'revenue': 3.85, 'unit': 'M', 'net_profit': -1.17}, {'period': ""Q2 '24"", 'revenue': 4.32, 'unit': 'M', 'net_profit': -1.09}, {'period': ""Q1 '24"", 'revenue': 4420.0, 'unit': 'K', 'net_profit': -982.0}, {'period': ""Q4 '23"", 'revenue': 4.37, 'unit': 'M', 'net_profit': -4.24}]",-0.21,-0.21,42644000,32985000,27814000,11748000,4002000,0,7864000,12972000,-3206000,0.18029281131765093,0.3941755537325677,0.39999999999999997,"[1.75, 1.15]","['2014-07-25', '2012-05-09']",__nan__,0.2754901041178126
69,AXAS,Abraxas Petroleum Corporation Common Stock,"Abraxas Petroleum Corporation, an independent energy company, engages in the acquisition, exploration, exploitation, development, and production of oil and gas properties in the United States. The company operates oil and gas assets in the Permian/Delaware Basin and the Rocky Mountain regions. As of December 31, 2021, its estimated net proved reserves were 14.8 million barrels of oil equivalent. The company was founded in 1977 and is based in San Antonio, Texas.",Mr. Stephen T. Wendel,Oil & Gas Exploration & Production,0.0347,USD,10271546,https://images.financialmodelingprep.com/symbol/AXAS.png,10824,0.07081632653061225,-0.0673,683,21455000,59653000,"[{'period': '2022', 'revenue': 49.74, 'unit': 'M', 'net_profit': 59.65}, {'period': '2021', 'revenue': 78.86, 'unit': 'M', 'net_profit': -80.34}, {'period': '2020', 'revenue': 43.04, 'unit': 'M', 'net_profit': -205.73}, {'period': '2019', 'revenue': 129.15, 'unit': 'M', 'net_profit': -77.73}]","[{'period': ""Q4 '22"", 'revenue': 9.76, 'unit': 'M', 'net_profit': -24.99}, {'period': ""Q3 '22"", 'revenue': 13.25, 'unit': 'M', 'net_profit': 2.43}, {'period': ""Q2 '22"", 'revenue': 14.54, 'unit': 'M', 'net_profit': 6.75}, {'period': ""Q1 '22"", 'revenue': 12.19, 'unit': 'M', 'net_profit': 40.06}, {'period': ""Q4 '21"", 'revenue': 22.88, 'unit': 'M', 'net_profit': -19.66}, {'period': ""Q3 '21"", 'revenue': 20.86, 'unit': 'M', 'net_profit': -1.25}]",2.31,2.31,70547000,11213000,2876000,9410000,4878000,15091000,6369000,2876000,18768000,-0.4169044707161299,1.7425068459049042,1.24163179916318,__nan__,__nan__,__nan__,0.13338625313620706
70,AXDX,Accelerate Diagnostics Inc. Common Stock,"Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.",Mr. Jack  Phillips,Medical - Devices,0.034,USD,859918,https://images.financialmodelingprep.com/symbol/AXDX.png,1856939,-0.02,0.0,13824707,-33573000,-50045000,"[{'period': '2024', 'revenue': 11.7, 'unit': 'M', 'net_profit': -50.05}, {'period': '2023', 'revenue': 12.06, 'unit': 'M', 'net_profit': -61.62}, {'period': '2022', 'revenue': 12.75, 'unit': 'M', 'net_profit': -62.49}, {'period': '2021', 'revenue': 11.78, 'unit': 'M', 'net_profit': -77.7}]","[{'period': ""Q4 '24"", 'revenue': 2.82, 'unit': 'M', 'net_profit': -9.59}, {'period': ""Q3 '24"", 'revenue': 2.98, 'unit': 'M', 'net_profit': -14.64}, {'period': ""Q2 '24"", 'revenue': 2.99, 'unit': 'M', 'net_profit': -11.59}, {'period': ""Q1 '24"", 'revenue': 2.92, 'unit': 'M', 'net_profit': -14.23}, {'period': ""Q4 '23"", 'revenue': 3.0, 'unit': 'M', 'net_profit': -13.0}, {'period': ""Q3 '23"", 'revenue': 3300.0, 'unit': 'K', 'net_profit': 910.0}]",-2.15,-2.15,28556000,22238000,16297000,84596000,2037000,0,31201000,15098000,-24703000,0.3254505635812019,0.18781849459573502,0.5647773279352227,__nan__,__nan__,__nan__,2.9624597282532568
71,AXGN,Axogen Inc. Common Stock,"AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.",Mr. Michael D. Dale,Medical - Devices,11.395,USD,518973880,https://images.financialmodelingprep.com/symbol/AXGN.png,626260,-71.22,-0.175,482588,6078999,-9964000,"[{'period': '2024', 'revenue': 187.34, 'unit': 'M', 'net_profit': -9.96}, {'period': '2023', 'revenue': 159.01, 'unit': 'M', 'net_profit': -21.72}, {'period': '2022', 'revenue': 138.58, 'unit': 'M', 'net_profit': -27.34}, {'period': '2021', 'revenue': 127.36, 'unit': 'M', 'net_profit': -28.06}]","[{'period': ""Q1 '25"", 'revenue': 48.56, 'unit': 'M', 'net_profit': -3.83}, {'period': ""Q4 '24"", 'revenue': 49410.0, 'unit': 'K', 'net_profit': 450.0}, {'period': ""Q3 '24"", 'revenue': 48.64, 'unit': 'M', 'net_profit': -1.86}, {'period': ""Q2 '24"", 'revenue': 47.91, 'unit': 'M', 'net_profit': -1.92}, {'period': ""Q1 '24"", 'revenue': 41.38, 'unit': 'M', 'net_profit': -6.63}, {'period': ""Q4 '23"", 'revenue': 42.92, 'unit': 'M', 'net_profit': -3.89}]",-0.23,-0.23,203728000,99217000,33482000,99821000,24105000,0,30610000,27554000,11000,1.4561073679471788,0.5411678025419046,0.5490196078431373,"[1, 0.04172]","['2010-01-27', '1992-07-10']",__nan__,0.48997192334877876
72,AXLA,Axcella Health Inc. Common Stock,"Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.",Mr. Craig R. Jalbert CIRA,Biotechnology,4.58,USD,12503400,https://images.financialmodelingprep.com/symbol/AXLA.png,0,-0.25095890410958904,0.0,6782,-67009000,-81186000,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -81.19}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -67.12}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -58.81}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -59.97}]","[{'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.41}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.77}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -24.26}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -18.59}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.99}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -19.75}]",-37.25,-37.25,18927000,17147000,17147000,14763000,0,0,14148000,17147000,-70014000,-0.08348155094913172,-0.2096010012217289,-20.164772727272727,__nan__,__nan__,__nan__,0.7799968299255032
73,AXNX,Axonics Inc. Common Stock,"Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.",Mr. Raymond W. Cohen,Medical - Devices,70.98,USD,3627731016,https://images.financialmodelingprep.com/symbol/AXNX.png,0,-709.8,,0,7775000,-6088000,"[{'period': '2023', 'revenue': 366.38, 'unit': 'M', 'net_profit': -6.09}, {'period': '2022', 'revenue': 273.7, 'unit': 'M', 'net_profit': -59.7}, {'period': '2021', 'revenue': 180.29, 'unit': 'M', 'net_profit': -80.07}, {'period': '2020', 'revenue': 111.53, 'unit': 'M', 'net_profit': -54.91}]","[{'period': ""Q3 '24"", 'revenue': 116190.0, 'unit': 'K', 'net_profit': -21.0}, {'period': ""Q2 '24"", 'revenue': 114.56, 'unit': 'M', 'net_profit': 6.9}, {'period': ""Q1 '24"", 'revenue': 91.41, 'unit': 'M', 'net_profit': -19.11}, {'period': ""Q4 '23"", 'revenue': 109.73, 'unit': 'M', 'net_profit': 6.57}, {'period': ""Q3 '23"", 'revenue': 93.1, 'unit': 'M', 'net_profit': 3.93}, {'period': ""Q2 '23"", 'revenue': 22.7, 'unit': 'M', 'net_profit': -7.34}]",-0.12,-0.12,719923000,491422000,344960000,82359000,57243000,0,45816000,104811000,-5566000,1.1648607959966921,0.898020034171999,0.9062500000000001,__nan__,__nan__,__nan__,0.11439973441604172
74,AXON,Axon Enterprise Inc. Common Stock,"Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. Its products include TASER 7, TASER X26P, TASER X2, TASER Consumer devices, and related cartridges; on-officer body cameras, Axon Fleet in-car systems, and other devices; Axon Evidence digital evidence management software; Axon Signal enabled devices, as well as hardware extended warranties; and Axon docks, cartridges, and batteries. It sells its products through its direct sales force, distribution partners, online store, and third-party resellers. Axon Enterprise, Inc. has a strategic partnership with Fusus, Inc. to expand the capabilities of Axon Respond and the Fusus Real Time Crime Center in the Cloud solution to provide agencies real-time operations situational awareness, including streamlined investigative workflows. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.",Mr. Patrick W. Smith,Aerospace & Defense,735.38,USD,57249921304,https://images.financialmodelingprep.com/symbol/AXON.png,769596,176.77,-7.37,519814,437027000,377034000,"[{'period': '2024', 'revenue': 2080.0, 'unit': 'M', 'net_profit': 377.03}, {'period': '2023', 'revenue': 1560.0, 'unit': 'M', 'net_profit': 174.23}, {'period': '2022', 'revenue': 1190.0, 'unit': 'M', 'net_profit': 147.14}, {'period': '2021', 'revenue': 863.38, 'unit': 'M', 'net_profit': -60.02}]","[{'period': ""Q1 '25"", 'revenue': 603.63, 'unit': 'M', 'net_profit': 87.98}, {'period': ""Q4 '24"", 'revenue': 575.14, 'unit': 'M', 'net_profit': 135.18}, {'period': ""Q3 '24"", 'revenue': 544.27, 'unit': 'M', 'net_profit': 67.03}, {'period': ""Q2 '24"", 'revenue': 504.1, 'unit': 'M', 'net_profit': 40.8}, {'period': ""Q1 '24"", 'revenue': 460.74, 'unit': 'M', 'net_profit': 133.22}, {'period': ""Q4 '23"", 'revenue': 432.14, 'unit': 'M', 'net_profit': 57.27}]",4.98,4.8,4474588000,2297481000,986349000,2146923000,915501000,332550000,997586000,454844000,329527000,1.2453900417709227,1.1640388688320409,1.119148936170213,__nan__,__nan__,__nan__,0.4798035036968767
75,AXSM,Axsome Therapeutics Inc. Common Stock,"Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. It is also developing AXS-07, a novel, oral, rapidly absorbed, multi-mechanistic, and investigational medicine that has completed two Phase III trials for the acute treatment of migraine; AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is in Phase III trial to treat narcolepsy; and AXS-14, a novel, oral, and investigational medicine that is in Phase III trial for the treatment of fibromyalgia. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.",Dr. Herriot  Tabuteau M.D.,Biotechnology,105.76,USD,5207241664,https://images.financialmodelingprep.com/symbol/AXSM.png,740496,-18.3,-2.59,371789,-272604000,-287216000,"[{'period': '2024', 'revenue': 385.69, 'unit': 'M', 'net_profit': -287.22}, {'period': '2023', 'revenue': 270.6, 'unit': 'M', 'net_profit': -239.24}, {'period': '2022', 'revenue': 50.04, 'unit': 'M', 'net_profit': -197.77}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -134.94}]","[{'period': ""Q1 '25"", 'revenue': 121.46, 'unit': 'M', 'net_profit': -59.41}, {'period': ""Q4 '24"", 'revenue': 118.77, 'unit': 'M', 'net_profit': -74.91}, {'period': ""Q3 '24"", 'revenue': 104.76, 'unit': 'M', 'net_profit': -64.6}, {'period': ""Q2 '24"", 'revenue': 87.17, 'unit': 'M', 'net_profit': -79.34}, {'period': ""Q1 '24"", 'revenue': 75.0, 'unit': 'M', 'net_profit': -68.36}, {'period': ""Q4 '23"", 'revenue': 71.53, 'unit': 'M', 'net_profit': -98.65}]",-5.99,-5.99,568498000,485064000,315353000,511483000,142001000,0,230104000,315353000,-128680000,-0.21162179820526156,-0.20054506391125157,-0.13662239089184075,__nan__,__nan__,__nan__,0.8997094097076859
76,AXTI,AXT Inc Common Stock,"AXT, Inc. designs, develops, manufactures, and distributes compound and single element semiconductor substrates. It produces semiconductor substrates using its proprietary vertical gradient freeze technology. The company offers indium phosphide for use in data center connectivity using light/lasers, 5G communications, fiber optic lasers and detectors, passive optical networks, silicon photonics, photonic integrated circuits, terrestrial solar cells, RF amplifier and switching, infrared light-emitting diode (LEDS) motion control, lidar for robotics and autonomous vehicles, and infrared thermal imaging. It also provides semi-insulating gallium arsenide (GaAs) substrates for use in Wi-Fi and IoT devices, transistors, direct broadcast television, power amplifiers, satellite communications, and solar cells; and semi-conducting GaAs substrates that are used in LED, screen displays, printer head lasers and LEDs, 3-D sensing using VCSELs, data center communication using VCSELs, sensors for industrial robotics/near-infrared sensors, optical couplers, solar cells, night vision goggles, lidar for robotics and autonomous vehicles, and other lasers, as well as laser machining, cutting, and drilling. In addition, the company offers germanium substrates for use in multi-junction solar cells for satellites, optical sensors and detectors, terrestrial concentrated photo voltaic cells, infrared detectors, and carrier wafer for LED. Further, it provides 6N+ and 7N+ purified gallium, boron trioxide, gallium-magnesium alloy, pyrolytic boron nitride (pBN) crucibles, and pBN insulating parts. AXT, Inc. sells its products through direct salesforce in the United States, China, and Europe, as well as through independent sales representatives and distributors in Japan, Taiwan, Korea, and internationally. The company was formerly known as American Xtal Technology, Inc. and changed its name to AXT, Inc. in July 2000. AXT, Inc. was incorporated in 1986 and is headquartered in Fremont, California.",Dr. Morris S. Young Ph.D.,Semiconductors,1.41,USD,64301217,https://images.financialmodelingprep.com/symbol/AXTI.png,509267,-3.36,-0.01,256267,-338000,-11624000,"[{'period': '2024', 'revenue': 99.36, 'unit': 'M', 'net_profit': -11.62}, {'period': '2023', 'revenue': 75.8, 'unit': 'M', 'net_profit': -17.88}, {'period': '2022', 'revenue': 141.12, 'unit': 'M', 'net_profit': 15.81}, {'period': '2021', 'revenue': 137.39, 'unit': 'M', 'net_profit': 14.57}]","[{'period': ""Q1 '25"", 'revenue': 19.36, 'unit': 'M', 'net_profit': -8.8}, {'period': ""Q4 '24"", 'revenue': 25.11, 'unit': 'M', 'net_profit': -5.09}, {'period': ""Q3 '24"", 'revenue': 23.64, 'unit': 'M', 'net_profit': -2.94}, {'period': ""Q2 '24"", 'revenue': 27.92, 'unit': 'M', 'net_profit': -1.52}, {'period': ""Q1 '24"", 'revenue': 22.69, 'unit': 'M', 'net_profit': -2.08}, {'period': ""Q4 '23"", 'revenue': 20.43, 'unit': 'M', 'net_profit': -3.62}]",-0.27,-0.27,339314000,158272000,22833000,84406000,25640000,14066000,74176000,22833000,-17883000,0.9615209471766849,0.3499245008668419,0.3571428571428571,__nan__,__nan__,__nan__,0.2487548406490743
77,AY,Atlantica Sustainable Infrastructure plc Ordinary Shares,"Atlantica Sustainable Infrastructure plc owns, manages, and invests in renewable energy, storage, natural gas and heat, electric transmission lines, and water assets in the United States, Canada, Mexico, Peru, Chile, Colombia, Uruguay, Spain, Italy, Algeria, and South Africa. It owns 39 assets comprising 2,044 megawatts (MW) of aggregate renewable energy installed generation capacity; 343 MW of natural gas-fired power generation capacity; 55 thermal megawatts of district heating capacity; 1,229 miles of electric transmission lines; and 17.5 million cubic feet per day of water desalination assets. The company was formerly known as Atlantica Yield plc and changed its name to Atlantica Sustainable Infrastructure plc in May 2020. Atlantica Sustainable Infrastructure plc was incorporated in 2013 and is based in Brentford, the United Kingdom.",Mr. Santiago  Seage Medela,Renewable Utilities,21.99,USD,2554578300,https://images.financialmodelingprep.com/symbol/AY.png,924829,87.96,0,2164429,828502000,43380000,"[{'period': '2023', 'revenue': 1100.0, 'unit': 'M', 'net_profit': 43.38}, {'period': '2022', 'revenue': 1100.0, 'unit': 'M', 'net_profit': -2.09}, {'period': '2021', 'revenue': 1210.0, 'unit': 'M', 'net_profit': -10.92}, {'period': '2020', 'revenue': 1010.0, 'unit': 'M', 'net_profit': 16.87}]","[{'period': ""Q3 '24"", 'revenue': 347.55, 'unit': 'M', 'net_profit': 16.64}, {'period': ""Q2 '24"", 'revenue': 328.26, 'unit': 'M', 'net_profit': 21.43}, {'period': ""Q1 '24"", 'revenue': 242.93, 'unit': 'M', 'net_profit': -5.39}, {'period': ""Q4 '23"", 'revenue': 241.31, 'unit': 'M', 'net_profit': -2.67}, {'period': ""Q3 '23"", 'revenue': 303.96, 'unit': 'M', 'net_profit': 21.39}, {'period': ""Q2 '23"", 'revenue': 312.11, 'unit': 'M', 'net_profit': 35.65}]",0.37,0.37,8714333000,982182000,460215000,7125524000,273766000,230307000,607782000,448301000,303839000,0.12241851139350259,21.785816962146622,21.32967032967033,"[0.2225, 0.2962]","['2024-11-29', '2014-11-25']",__nan__,0.8176786450552211
78,AYLA,Ayala Pharmaceuticals Inc. Common Stock,"Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinical trial for the treatment of recurrent/metastatic adenoid cystic carcinoma for patients bearing Notch-activating mutations. It is also involved in developing AL102, a potent, selective, and oral small molecule GSI that is in Phase II/III pivotal study for the treatment of desmoid tumors. Ayala Pharmaceuticals, Inc. has a collaboration agreement with Novartis International Pharmaceutical Limited to develop AL102 for the treatment of multiple myeloma. The company was incorporated in 2017 and is headquartered in Rehovot, Israel.","Dr. Roni  Mamluk M.D., Ph.D.",Biotechnology,0.5339,USD,0,https://images.financialmodelingprep.com/symbol/AYLA.png,50544,0,0,137793,-37503000,-38013000,"[{'period': '2022', 'revenue': 0.6920000000000001, 'unit': 'M', 'net_profit': -38.01}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -38.7}, {'period': '2020', 'revenue': 3.71, 'unit': 'M', 'net_profit': -30.15}, {'period': '2019', 'revenue': 2.33, 'unit': 'M', 'net_profit': -17.79}]","[{'period': ""Q4 '22"", 'revenue': 0.105, 'unit': 'M', 'net_profit': -9.59}, {'period': ""Q3 '22"", 'revenue': 0.091, 'unit': 'M', 'net_profit': -10.19}, {'period': ""Q2 '22"", 'revenue': 0.038, 'unit': 'M', 'net_profit': -8.21}, {'period': ""Q1 '22"", 'revenue': 0.458, 'unit': 'M', 'net_profit': -10.03}, {'period': ""Q4 '21"", 'revenue': -2.36, 'unit': 'M', 'net_profit': -8.5}, {'period': ""Q3 '21"", 'revenue': 0.625, 'unit': 'M', 'net_profit': -9.8}]",-2.46,-2.46,4581000,3188000,2408000,5680000,0,0,7536000,2408000,-34512000,0.08220351426753462,0.01780269753501111,0.37244897959183676,__nan__,__nan__,__nan__,1.2399039511023795
79,AYRO,AYRO Inc. Common Stock,"Ayro, Inc. designs and manufactures electric vehicles for closed campus mobility, urban and community transport, local on-demand and last mile delivery, and government use. The company provides four-wheeled purpose-built electric vehicles for universities, business and medical campuses, last mile delivery services, and food service providers. It also offers AYRO vehicles to internal combustion engine vehicles for light duty uses, including low-speed logistics, maintenance, and cargo services; and Club Car 411 for low-speed logistics and cargo services for campus. The company was formerly known as AEV Technologies, Inc. Ayro, Inc. was founded in 2017 and is headquartered in Round Rock, Texas.",Mr. Joshua N. Silverman,Auto - Manufacturers,0.4237,USD,3619021,https://images.financialmodelingprep.com/symbol/AYRO.png,158031,-0.56,0.0051,52893,-19377011,-1755479,"[{'period': '2024', 'revenue': 0.06378, 'unit': 'M', 'net_profit': -1.76}, {'period': '2023', 'revenue': 0.49892000000000003, 'unit': 'M', 'net_profit': -34.16}, {'period': '2022', 'revenue': 2.99, 'unit': 'M', 'net_profit': -45.87}, {'period': '2021', 'revenue': 2.68, 'unit': 'M', 'net_profit': -33.13}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.68}, {'period': ""Q4 '24"", 'revenue': 5.02, 'unit': 'M', 'net_profit': -5.58}, {'period': ""Q3 '24"", 'revenue': 5.43, 'unit': 'K', 'net_profit': 550.56}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.91}, {'period': ""Q1 '24"", 'revenue': 0.058350000000000006, 'unit': 'M', 'net_profit': -3.64}, {'period': ""Q4 '23"", 'revenue': 0.15789, 'unit': 'M', 'net_profit': -10.09}]",-2.02,-2.02,21738718,21262234,20125307,9469271,0,0,4161629,16035475,-13514725,0.2800782108736922,0.9486107840191239,0.7533577533577533,__nan__,__nan__,__nan__,0.43559473010321953
80,AYTU,Aytu BioPharma Inc.  Common Stock,"Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.",Mr. Joshua R. Disbrow,Drug Manufacturers - Specialty & Generic,2.02,USD,12463905,https://images.financialmodelingprep.com/symbol/AYTU.png,1217552,-1.36,-0.01,374602,-1012000,-15844000,"[{'period': '2024', 'revenue': 81.0, 'unit': 'M', 'net_profit': -15.84}, {'period': '2023', 'revenue': 107.4, 'unit': 'M', 'net_profit': -17.05}, {'period': '2022', 'revenue': 96.67, 'unit': 'M', 'net_profit': -108.78}, {'period': '2021', 'revenue': 65.63, 'unit': 'M', 'net_profit': -58.29}]","[{'period': ""Q3 '25"", 'revenue': 18.45, 'unit': 'M', 'net_profit': 3.99}, {'period': ""Q2 '25"", 'revenue': 16219.999999999998, 'unit': 'K', 'net_profit': 788.0}, {'period': ""Q1 '25"", 'revenue': 16.57, 'unit': 'M', 'net_profit': 1.47}, {'period': ""Q4 '24"", 'revenue': 17.98, 'unit': 'M', 'net_profit': -4.62}, {'period': ""Q3 '24"", 'revenue': 17.99, 'unit': 'M', 'net_profit': -2.89}, {'period': ""Q2 '24"", 'revenue': 22930.0, 'unit': 'K', 'net_profit': -220.0}]",-2.86,-2.86,118095000,61891000,20006000,90379000,23617000,0,62228000,20006000,-1388000,0.6908035441490987,0.0707876370887338,0.44031311154598834,__nan__,__nan__,__nan__,0.7653075913459503
81,AZN,AstraZeneca PLC American Depositary Shares,"AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.","Mr. Pascal Claude Roland Soriot D.V.M., M.B.A.",Drug Manufacturers - General,69.68,USD,432070332632,https://images.financialmodelingprep.com/symbol/AZN.png,6121498,27.98,-0.24,4305541,15438000000,7035000000,"[{'period': '2024', 'revenue': 54.07, 'unit': 'B', 'net_profit': 7.04}, {'period': '2023', 'revenue': 45.81, 'unit': 'B', 'net_profit': 5.96}, {'period': '2022', 'revenue': 44.35, 'unit': 'B', 'net_profit': 3.29}, {'period': '2021', 'revenue': 37420.0, 'unit': 'M', 'net_profit': 112.0}]","[{'period': ""Q1 '25"", 'revenue': 13.59, 'unit': 'B', 'net_profit': 2.92}, {'period': ""Q4 '24"", 'revenue': 14.89, 'unit': 'B', 'net_profit': 1.5}, {'period': ""Q3 '24"", 'revenue': 13.56, 'unit': 'B', 'net_profit': 1.43}, {'period': ""Q2 '24"", 'revenue': 12.94, 'unit': 'B', 'net_profit': 1.93}, {'period': ""Q1 '24"", 'revenue': 12.68, 'unit': 'B', 'net_profit': 2.18}, {'period': ""Q4 '23"", 'revenue': 12020.0, 'unit': 'M', 'net_profit': 960.0}]",1.14,1.13,104035000000,25827000000,5654000000,63164000000,11235000000,1734000000,27866000000,5488000000,7275000000,0.10968947671075331,0.181360201511335,-0.4041994750656168,"[1.05, 0.579]","['2025-02-21', '1993-09-24']",__nan__,0.6071418272696688
82,AZPN,Aspen Technology Inc. Common Stock,"Aspen Technology, Inc. provides enterprise asset performance management, asset performance monitoring, and asset optimization solutions worldwide. The company's solutions address complex environments where it is critical to optimize the asset design, operation, and maintenance lifecycle. It serves bulk chemicals, consumer packaged goods, downstream, food and beverage, metals and mining, midstream and LNG, pharmaceuticals, polymers, pulp and paper, specialty chemicals, transportation, upstream, and water and wastewater industries; power generation, transmission, and distribution industries; and engineering, procurement, and construction industries. The company was incorporated in 2021 and is headquartered in Bedford, Massachusetts.",Mr. Antonio J. Pietri,Software - Application,264.33,USD,16734309372,https://images.financialmodelingprep.com/symbol/AZPN.png,711599,2403,0,4048661,403469000,-9771000,"[{'period': '2024', 'revenue': 1130.0, 'unit': 'M', 'net_profit': -9.77}, {'period': '2023', 'revenue': 1040.0, 'unit': 'M', 'net_profit': -107.76}, {'period': '2022', 'revenue': 482.31, 'unit': 'M', 'net_profit': 41.94}, {'period': '2021', 'revenue': 709.38, 'unit': 'M', 'net_profit': 319.8}]","[{'period': ""Q2 '25"", 'revenue': 303.56, 'unit': 'M', 'net_profit': 20.34}, {'period': ""Q1 '25"", 'revenue': 215.88, 'unit': 'M', 'net_profit': -60.46}, {'period': ""Q4 '24"", 'revenue': 342.9, 'unit': 'M', 'net_profit': 44.7}, {'period': ""Q3 '24"", 'revenue': 278.11, 'unit': 'M', 'net_profit': 1.56}, {'period': ""Q2 '24"", 'revenue': 257.16, 'unit': 'M', 'net_profit': -21.5}, {'period': ""Q1 '24"", 'revenue': 249.31, 'unit': 'M', 'net_profit': -34.52}]",-0.15,-0.15,14071707000,876066000,236970000,1258852000,603193000,0,337401000,236970000,335271000,0.30846040589711826,0.909326280623608,0.9101796407185629,"[0.525, 0.525]","['2024-02-15', '2024-02-15']",__nan__,0.08945979332855637
83,AZRX,AzurRx BioPharma Inc. Common Stock,"AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. The company is headquartered in Brooklyn, New York and currently employs 12 full-time employees. The firm is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal (GI) disorders. The firm's product pipeline consists of two therapeutic proteins, such as MS1819 and AZX1101. MS1819 is an acid-resistant secreted lipase produced by Yarrowia lipolytica, known as LIP2, that the Company is developing through recombinant deoxyribonucleic acid (DNA) technology for the treatment of exocrine pancreatic insufficiency (EPI), associated with chronic pancreatitis (CP) and cystic fibrosis (CF). AZX1101 is a recombinant-lactamase combination of bacterial origin under development for the prevention of hospital-acquired infections by resistant bacterial strains induced by parenteral administration of b-lactam antibiotics (known as nosocomial infections), as well as the prevention of antibiotic-associated diarrhea (AAD).",Mr. James Sapirstein,Biotechnology,3.45,USD,3432760,https://images.financialmodelingprep.com/symbol/AZRX.png,713030,-1.8449197860962567,0.06999993,629030,-26830851.962203,-32671466,"[{'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -32.67}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.18}, {'period': '2018', 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.53}, {'period': '2017', 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.1}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.28}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.69}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -5.31}, {'period': ""Q2 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.7}, {'period': ""Q1 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.26}, {'period': ""Q4 '19"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.28}]",-5.902903309999999,-5.902903309999999,9942.161,7869.784,6062.141,15564,0,0,15545,6062.141,-11225705,-1955073.0694658824,-2152597.62405903,-871919.7252584934,__nan__,__nan__,__nan__,1.5654544318886006
84,AZYO,Aziyo Biologics Inc. Class A Common Stock,"Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device. The company also provides cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. In addition, it offers Fiber VBM, ViBone, and OsteGro V that are human tissue-derived bone allografts designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. Further, the company provides contract manufacturing services for various products to corporate customers. It sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. The company was incorporated in 2015 and is headquartered in Silver Spring, Maryland.",Dr. C. Randal Mills Ph.D.,Medical - Devices,1.49,USD,24212202,https://images.financialmodelingprep.com/symbol/AZYO.png,432734,-0.6834862385321101,0.03,8103,-35651000,-53949000,"[{'period': '2024', 'revenue': 24.38, 'unit': 'M', 'net_profit': -53.95}, {'period': '2022', 'revenue': 49.19, 'unit': 'M', 'net_profit': -32.9}, {'period': '2021', 'revenue': 47.39, 'unit': 'M', 'net_profit': -24.83}, {'period': '2020', 'revenue': 42.68, 'unit': 'M', 'net_profit': -21.82}]","[{'period': ""Q1 '25"", 'revenue': 6.03, 'unit': 'M', 'net_profit': -3.93}, {'period': ""Q4 '24"", 'revenue': -5.1, 'unit': 'M', 'net_profit': -25.61}, {'period': ""Q3 '24"", 'revenue': 5.92, 'unit': 'M', 'net_profit': 1.07}, {'period': ""Q2 '24"", 'revenue': 6.29, 'unit': 'M', 'net_profit': -28.18}, {'period': ""Q3 '23"", 'revenue': 6.13, 'unit': 'M', 'net_profit': -9.75}, {'period': ""Q2 '23"", 'revenue': 10.3, 'unit': 'M', 'net_profit': -10.62}]",-1.86,-1.86,36127000,26172000,13239000,82387000,2276000,0,37795000,13239000,-22657000,0.0,0.0,0.0,__nan__,__nan__,__nan__,2.2804827414399202
85,BAND,Bandwidth Inc. Class A Common Stock,"Bandwidth Inc. operates as a cloud-based software-powered communications platform-as-a-service (CPaaS) provider in the United States. The company operates in two segments, CPaaS and Other. Its platform enables enterprises to create, scale, and operate voice or messaging communications services across various mobile applications or connected devices. The company also provides SIP trunking, data resale, and hosted voice over Internet protocol services. It serves large enterprises, communications service providers, conferencing providers, contact centers, small and medium-sized businesses, emerging technology companies, and many other businesses. Bandwidth Inc. was founded in 2000 and is headquartered in Raleigh, North Carolina.",Mr. David Andrew Morken J.D.,Software - Infrastructure,13.71,USD,408049524,https://images.financialmodelingprep.com/symbol/BAND.png,297772,-685.5,-0.51,208926,42150000,-6524000,"[{'period': '2024', 'revenue': 748.49, 'unit': 'M', 'net_profit': -6.52}, {'period': '2023', 'revenue': 601.12, 'unit': 'M', 'net_profit': -16.34}, {'period': '2022', 'revenue': 573.15, 'unit': 'M', 'net_profit': 19.57}, {'period': '2021', 'revenue': 490.91, 'unit': 'M', 'net_profit': -27.36}]","[{'period': ""Q1 '25"", 'revenue': 174.24, 'unit': 'M', 'net_profit': -3.74}, {'period': ""Q4 '24"", 'revenue': 209.97, 'unit': 'M', 'net_profit': -1.76}, {'period': ""Q3 '24"", 'revenue': 193880.0, 'unit': 'K', 'net_profit': 413.0}, {'period': ""Q2 '24"", 'revenue': 173.6, 'unit': 'M', 'net_profit': 4.05}, {'period': ""Q1 '24"", 'revenue': 171.03, 'unit': 'M', 'net_profit': -9.23}, {'period': ""Q4 '23"", 'revenue': 165.39, 'unit': 'M', 'net_profit': -10.93}]",-0.24,-0.24,989166000,187812000,83787000,676633000,86455000,0,140323000,81812000,69897000,0.2951298202488862,0.6008076852475066,0.625,__nan__,__nan__,__nan__,0.684043931958842
86,BANF,BancFirst Corporation Common Stock,"BancFirst Corporation operates as the bank holding company for BancFirst that provides a range of commercial banking services to retail customers, and small to medium-sized businesses. It operates through Metropolitan Banks, Community Banks, Pegasus Bank, and Other Financial Services segments. The company offers checking accounts, negotiable order of withdrawal accounts, savings accounts, money market accounts, sweep accounts, club accounts, individual retirement accounts, and certificates of deposit, as well as overdraft protection and auto draft services. It also provides commercial, financial, and other loans for working capital, facilities acquisition or expansion, purchase of equipment, and other needs; lending services that include private banking, energy, commercial and residential real estate, and commercial and industrial loans; and loans to finance purchases of consumer goods, such as automobiles, boats, household goods, vacations, and education. In addition, the company engages in the investment management and administration of trusts for individuals, corporations, and employee benefit plans, as well as bond trustee and paying agent business for various Oklahoma municipalities and governmental entities; and provision of item processing, research, and other correspondent banking services. Further, it is involved in real estate investment and insurance agency services; and providing funds transfer, collection, safe deposit box, cash management, and other services. The company serves customers in non-metropolitan trade centers and cities in the metropolitan statistical areas of Oklahoma. It operates through 108 banking locations in Oklahoma and 3 banking locations in Dallas, Texas. The company was formerly known as United Community Corporation and changed its name to BancFirst Corporation in November 1988. BancFirst Corporation was incorporated in 1984 and is headquartered in Oklahoma City, Oklahoma.",Mr. David R. Harlow,Banks - Regional,125.91,USD,4185600948,https://images.financialmodelingprep.com/symbol/BANF.png,106836,19.11,-3.63,98904,0,216354000,"[{'period': '2024', 'revenue': 724.14, 'unit': 'M', 'net_profit': 216.35}, {'period': '2023', 'revenue': 623.94, 'unit': 'M', 'net_profit': 212.47}, {'period': '2022', 'revenue': 557.42, 'unit': 'M', 'net_profit': 193.1}, {'period': '2021', 'revenue': 485.69, 'unit': 'M', 'net_profit': 167.63}]","[{'period': ""Q1 '25"", 'revenue': 156.4, 'unit': 'M', 'net_profit': 56.11}, {'period': ""Q4 '24"", 'revenue': 162.94, 'unit': 'M', 'net_profit': 56.48}, {'period': ""Q3 '24"", 'revenue': 187.65, 'unit': 'M', 'net_profit': 58.9}, {'period': ""Q2 '24"", 'revenue': 220.66, 'unit': 'M', 'net_profit': 50.64}, {'period': ""Q1 '24"", 'revenue': 148.8, 'unit': 'M', 'net_profit': 50.33}, {'period': ""Q4 '23"", 'revenue': 142.35, 'unit': 'M', 'net_profit': 48.93}]",6.55,6.44,13554314000,1448757000,1448757000,11933127000,0,330752000,5209379000,237840000,224548000,-1.0,0.018304191278563527,0.015503875968992192,"[0.46, 0.15]","['2025-03-31', '1991-02-22']",__nan__,0.8803932829060918
87,BANFP,BancFirst Corporation - BFC Capital Trust II Cumulative Trust Preferred Securities,"BFC Capital Trust II provides a full range of commercial banking services to retail customers and small to medium-sized businesses in both the non-metropolitan trade centers and cities in the metropolitan statistical areas of Oklahoma. BancFirst operates as a “super community bank”, managing its community banking offices on a decentralized basis, which permits them to be responsive to local customer needs. Underwriting, funding, customer service, and pricing decisions are made by presidents in each market within BancFirst’s strategic parameters.",None,Banks,25.5874,USD,4199173469,https://images.financialmodelingprep.com/symbol/BANFP.png,680,,-0.0226,681,0,216354000,"[{'period': '2024', 'revenue': 724.14, 'unit': 'M', 'net_profit': 216.35}, {'period': '2023', 'revenue': 623.94, 'unit': 'M', 'net_profit': 212.47}, {'period': '2022', 'revenue': 557.42, 'unit': 'M', 'net_profit': 193.1}, {'period': '2021', 'revenue': 485.69, 'unit': 'M', 'net_profit': 167.63}]","[{'period': ""Q1 '25"", 'revenue': 156.4, 'unit': 'M', 'net_profit': 56.11}, {'period': ""Q4 '24"", 'revenue': 162.94, 'unit': 'M', 'net_profit': 56.48}, {'period': ""Q3 '24"", 'revenue': 187.65, 'unit': 'M', 'net_profit': 58.9}, {'period': ""Q2 '24"", 'revenue': 220.66, 'unit': 'M', 'net_profit': 50.64}, {'period': ""Q1 '24"", 'revenue': 148.8, 'unit': 'M', 'net_profit': 50.33}, {'period': ""Q4 '23"", 'revenue': 142.35, 'unit': 'M', 'net_profit': 48.93}]",6.55,6.44,13554314000,1448757000,1448757000,11933127000,0,330752000,5209379000,237840000,224548000,-1.0,0.018304191278563527,0.015503875968992192,"[0.45, 0.45]","['2025-03-31', '2004-03-29']",__nan__,0.8803932829060918
88,BANR,Banner Corporation Common Stock,"Banner Corporation operates as the bank holding company for Banner Bank that provide commercial banking and financial products and services to individuals, businesses, and public sector entities in the United States. It accepts various deposit instruments, including interest-bearing and non-interest-bearing checking accounts, money market deposit accounts, regular savings accounts, and certificates of deposit, as well as treasury management services and retirement savings plans. The company also provides commercial real estate loans, including owner-occupied, investment properties, and multifamily residential real estate loans; construction, land, and land development loans; residential mortgage loans; commercial business loans; agricultural loans; and consumer and other loans, such as home equity lines of credit, automobile, and boat and recreational vehicle loans, as well as loans secured by deposit accounts. In addition, it engages in the mortgage banking operations through the origination and sale of one-to four-family and multi-family residential loans, as well as small business administration loans. Further, the company provides electronic and digital banking services. As of December 31, 2021, it operated 150 branch offices and 18 loan production offices located in Washington, Oregon, California, Idaho, and Utah. Banner Corporation was founded in 1890 and is headquartered in Walla Walla, Washington.",Mr. Mark J. Grescovich,Banks - Regional,62.66,USD,2166782800,https://images.financialmodelingprep.com/symbol/BANR.png,236380,12.31,-1.72,164056,0,168898000,"[{'period': '2024', 'revenue': 602.94, 'unit': 'M', 'net_profit': 168.9}, {'period': '2023', 'revenue': 620.41, 'unit': 'M', 'net_profit': 183.62}, {'period': '2022', 'revenue': 623.75, 'unit': 'M', 'net_profit': 195.38}, {'period': '2021', 'revenue': 630.77, 'unit': 'M', 'net_profit': 201.05}]","[{'period': ""Q1 '25"", 'revenue': 210.56, 'unit': 'M', 'net_profit': 45.13}, {'period': ""Q4 '24"", 'revenue': 158.99, 'unit': 'M', 'net_profit': 46.39}, {'period': ""Q3 '24"", 'revenue': 152.75, 'unit': 'M', 'net_profit': 45.15}, {'period': ""Q2 '24"", 'revenue': 205.28, 'unit': 'M', 'net_profit': 39.8}, {'period': ""Q1 '24"", 'revenue': 184.69, 'unit': 'M', 'net_profit': 37.56}, {'period': ""Q4 '23"", 'revenue': 150.24, 'unit': 'M', 'net_profit': 42.62}]",4.9,4.88,16200037000,586029000,501858000,14425711000,60885000,0,258070000,501858000,279440000,-1.0,-0.08019648847645187,-0.08411214953271015,"[0.48, 0.0087]","['2025-04-29', '1995-12-27']",__nan__,0.8904739538557844
89,BANX,StoneCastle Financial Corp Common Stock,"StoneCastle Financial Corp. is a closed ended balanced mutual fund launched and managed by StoneCastle Asset Management LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across the banking sector. It invests in dividend paying growth and value stocks of companies. For its fixed income portion, the fund invests in subordinated debt securities which are rated BBB- or better by Kroll Ratings. The fund employs fundamental analysis with bottom-up security picking approach by focusing on factors such as review of historical and prospective financial information, interviews with management and key employees of the prospective bank, financial models and projections, changes in interest rates, changes in unemployment rates, changes in home prices, changes in economic activity to create its portfolio. It employs proprietary research to create its portfolio. StoneCastle Financial Corp. was formed on February 7, 2013 and is domiciled in the United States.",Mr. Sanjai Suryaji Bhonsle,Asset Management,20.61,USD,146883554,https://images.financialmodelingprep.com/symbol/BANX.png,22350,8.77,0.29,16201,21198171,16744994,"[{'period': '2024', 'revenue': 19.65, 'unit': 'M', 'net_profit': 16.74}, {'period': '2023', 'revenue': 23.25, 'unit': 'M', 'net_profit': 20.25}, {'period': '2022', 'revenue': 7.86, 'unit': 'M', 'net_profit': 5.37}, {'period': '2021', 'revenue': 14.24, 'unit': 'M', 'net_profit': 12.63}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q3 '22"", 'revenue': 1.9, 'unit': 'M', 'net_profit': 1.41}, {'period': ""Q2 '22"", 'revenue': -231.5, 'unit': 'K', 'net_profit': -845.57}]",2.35,2.35,208214504,2661187,2661187,53114711,3537456,201662989,0,2661187,13781839,-0.043567844864147845,-0.17300201511996835,-0.17253521126760557,"[0.55, 0.28]","['2025-03-20', '2013-12-19']",__nan__,0.2550961147259943
90,BAOS,Baosheng Media Group Holdings Limited Ordinary shares,"Baosheng Media Group Holdings Limited operates as an online marketing solution provider in the People's Republic of China. The company connects advertisers, online media, and helping advertisers to manage their online marketing activities in various ways, including advising on advertising strategies, budget, and choice of advertising channels; procures ad inventory; offers ad optimization services; and administrates and fine-tunes the ad placement process. It also serves media businesses in various ways, including identifying advertisers to buy their ad inventory; facilitating payment arrangements with advertisers; assisting advertisers in handling ad deployment logistics with media; and engaging in other marketing and promotion activities aimed at educating and inducing advertisers to use online advertising. The company's advertising services comprise search engine marketing (SEM) services, such as the deployment of ranked search ads and other display search ads offered by search engine operators; and non-SEM services consisting of social media marketing, in-feed advertising, and mobile app advertising through deploying ads on media, such as social media platforms, short-video platforms, news portals, and mobile apps. Baosheng Media Group Holdings Limited was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China.",Ms. Lina  Jiang,Advertising Agencies,2.26,USD,3467947,https://images.financialmodelingprep.com/symbol/BAOS.png,826191,-0.13,-0.07,29902,-26390705,-26871234,"[{'period': '2024', 'revenue': 0.62409, 'unit': 'M', 'net_profit': -26.87}, {'period': '2023', 'revenue': 0.92183, 'unit': 'M', 'net_profit': -1.85}, {'period': '2022', 'revenue': 2.42, 'unit': 'M', 'net_profit': -23.41}, {'period': '2021', 'revenue': 3.91, 'unit': 'M', 'net_profit': -6.6}]","[{'period': ""Q2 '24"", 'revenue': 23.09, 'unit': 'K', 'net_profit': -870.21}, {'period': ""Q1 '24"", 'revenue': 23.09, 'unit': 'K', 'net_profit': -870.21}, {'period': ""Q4 '23"", 'revenue': -274.3, 'unit': 'K', 'net_profit': -920.54}, {'period': ""Q3 '23"", 'revenue': -274.3, 'unit': 'K', 'net_profit': -920.54}, {'period': ""Q2 '23"", 'revenue': 1470.0, 'unit': 'K', 'net_profit': -4.08}, {'period': ""Q1 '23"", 'revenue': 735.22, 'unit': 'K', 'net_profit': -2.04}]",-17.512,-17.512,21247962,12712574,2806769,6424204,5857141,6576688,6424204,1480528,-2005988,-12.555000552149918,-13.563012622143217,1.0,__nan__,__nan__,__nan__,0.30234447896697103
91,BATRA,Liberty Media Corporation Series A Liberty Braves Common Stock,"Atlanta Braves Holdings, through its wholly-owned subsidiary Braves Holdings, LLC, indirectly owns the Atlanta Braves Major League Baseball club and the associated mixed-use development project, The Battery Atlanta.",Mr. Terence Foster McGuirk,Entertainment,43.8,USD,2521655921,https://images.financialmodelingprep.com/symbol/BATRA.png,54872,-132.73,-0.74,45201,-137559000,-31268000,"[{'period': '2024', 'revenue': 662.75, 'unit': 'M', 'net_profit': -31.27}, {'period': '2023', 'revenue': 640.67, 'unit': 'M', 'net_profit': -125.29}, {'period': '2022', 'revenue': 588.0, 'unit': 'M', 'net_profit': -35.0}, {'period': '2021', 'revenue': 568.0, 'unit': 'M', 'net_profit': -11.0}]","[{'period': ""Q1 '25"", 'revenue': 447.0, 'unit': 'M', 'net_profit': -53.0}, {'period': ""Q4 '24"", 'revenue': -2660.0, 'unit': 'M', 'net_profit': -273.4}, {'period': ""Q3 '24"", 'revenue': 290.67, 'unit': 'M', 'net_profit': 10.02}, {'period': ""Q2 '24"", 'revenue': 282.88, 'unit': 'M', 'net_profit': 29.11}, {'period': ""Q1 '24"", 'revenue': 2750.0, 'unit': 'M', 'net_profit': 203.0}, {'period': ""Q4 '23"", 'revenue': 67.75, 'unit': 'M', 'net_profit': -32.36}]",-0.5,-0.5,1582990000,179146000,112599000,987622000,49991000,108786000,286660000,110144000,-69382000,-5.708558888076079,0.750442958162402,0.7536945812807881,"[0.25, 0.25]","['2022-02-10', '2022-02-10']",__nan__,0.6238965501993063
92,BATRK,Liberty Media Corporation Series C Liberty Braves Common Stock,"Atlanta Braves Holdings, through its wholly-owned subsidiary Braves Holdings, LLC, indirectly owns the Atlanta Braves Major League Baseball club and the associated mixed-use development project, The Battery Atlanta.",Mr. Terence Foster McGuirk,Entertainment,40.76,USD,2545433957,https://images.financialmodelingprep.com/symbol/BATRK.png,297275,-123.52,-0.55,202617,-137559000,-31268000,"[{'period': '2024', 'revenue': 662.75, 'unit': 'M', 'net_profit': -31.27}, {'period': '2023', 'revenue': 640.67, 'unit': 'M', 'net_profit': -125.29}, {'period': '2022', 'revenue': 588.0, 'unit': 'M', 'net_profit': -35.0}, {'period': '2021', 'revenue': 568.0, 'unit': 'M', 'net_profit': -11.0}]","[{'period': ""Q1 '25"", 'revenue': 447.0, 'unit': 'M', 'net_profit': -53.0}, {'period': ""Q4 '24"", 'revenue': -2660.0, 'unit': 'M', 'net_profit': -273.4}, {'period': ""Q3 '24"", 'revenue': 290.67, 'unit': 'M', 'net_profit': 10.02}, {'period': ""Q2 '24"", 'revenue': 282.88, 'unit': 'M', 'net_profit': 29.11}, {'period': ""Q1 '24"", 'revenue': 2750.0, 'unit': 'M', 'net_profit': 203.0}, {'period': ""Q4 '23"", 'revenue': 67.75, 'unit': 'M', 'net_profit': -32.36}]",-0.5,-0.5,1582990000,179146000,112599000,987622000,49991000,108786000,286660000,110144000,-69382000,-5.708558888076079,0.750442958162402,0.7536945812807881,__nan__,__nan__,__nan__,0.6238965501993063
93,BBBY,Bed Bath & Beyond Inc. Common Stock,"Bed Bath & Beyond Inc., together with its subsidiaries, operates a chain of retail stores. It sells a range of domestics merchandise, including bed linens and related items, bath items, and kitchen textiles; and home furnishings, such as kitchen and tabletop items, fine tabletop, basic housewares, general home furnishings, consumables, and various juvenile products. As of February 26, 2022, the company had 953 stores, which included 771 Bed Bath & Beyond stores in 50 states, the District of Columbia, Puerto Rico, and Canada; 130 buybuy BABY stores in 37 states and Canada; and 52 stores in 6 states under the names Harmon, Harmon Face Values or Face Values. It also offers products through various Websites and applications comprising bedbathandbeyond.com, bedbathandbeyond.ca, harmondiscount.com, facevalues.com, buybuybaby.com, buybuybaby.ca, and decorist.com. In addition, the company operates Decorist, an online interior design platform that provides personalized home design services. Bed Bath & Beyond Inc. was incorporated in 1971 and is headquartered in Union, New Jersey.",Ms. Sue Ellen Gove,Specialty Retail,0.0751,USD,41961072,https://images.financialmodelingprep.com/symbol/BBBY.png,121625124,-0.0051615120274914085,0,192179915,-2992286000,-3498801000,"[{'period': '2022', 'revenue': 5.34, 'unit': 'B', 'net_profit': -3.5}, {'period': '2021', 'revenue': 7870.0, 'unit': 'M', 'net_profit': -559.62}, {'period': '2020', 'revenue': 9230.0, 'unit': 'M', 'net_profit': -150.77}, {'period': '2019', 'revenue': 11160.0, 'unit': 'M', 'net_profit': -613.82}]","[{'period': ""Q2 '23"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q4 '22"", 'revenue': 1.19, 'unit': 'B', 'net_profit': -2.38}, {'period': ""Q3 '22"", 'revenue': 1260.0, 'unit': 'M', 'net_profit': -392.97}, {'period': ""Q2 '22"", 'revenue': 1440.0, 'unit': 'M', 'net_profit': -366.16}, {'period': ""Q1 '22"", 'revenue': 1460.0, 'unit': 'M', 'net_profit': -357.67}]",-36.03,-36.03,2225217000,1096909000,65853000,5025225000,16100000,0,2495884000,65853000,-1323865000,-25.17281878606132,-5.252067910003699,-5.388297872340426,"[0.17, 0.125]","['2020-03-12', '2016-06-15']",__nan__,2.2583078414374866
94,BBCP,Concrete Pumping Holdings Inc. Common Stock,"Concrete Pumping Holdings, Inc. provides concrete pumping and waste management services in the United States and the United Kingdom. The company offers concrete pumping services to general contractors and concrete finishing companies in the commercial, infrastructure, and residential sectors under the Brundage-Bone and Camfaud brands; and industrial cleanup and containment services primarily to customers in the construction industry under the Eco-Pan brand. It also leases and rents concrete pumping equipment, pans, and containers. As of October 31, 2021, the company owned a fleet of approximately 820 boom pumps, 70 placing booms, 20 telebelts, 250 stationary pumps, and 90 waste management trucks. Concrete Pumping Holdings, Inc. was founded in 1983 and is headquartered in Thornton, Colorado.",Mr. Bruce F. Young,Engineering & Construction,7.14,USD,378783426,https://images.financialmodelingprep.com/symbol/BBCP.png,166649,25.5,0.01,88454,107301000,16207000,"[{'period': '2024', 'revenue': 425.87, 'unit': 'M', 'net_profit': 16.21}, {'period': '2023', 'revenue': 442.24, 'unit': 'M', 'net_profit': 31.79}, {'period': '2022', 'revenue': 401.29, 'unit': 'M', 'net_profit': 28.68}, {'period': '2021', 'revenue': 315.81, 'unit': 'M', 'net_profit': -15.07}]","[{'period': ""Q1 '25"", 'revenue': 86.45, 'unit': 'M', 'net_profit': -2.64}, {'period': ""Q4 '24"", 'revenue': 111.48, 'unit': 'M', 'net_profit': 9.43}, {'period': ""Q3 '24"", 'revenue': 109.62, 'unit': 'M', 'net_profit': 7.56}, {'period': ""Q2 '24"", 'revenue': 107.06, 'unit': 'M', 'net_profit': 3.05}, {'period': ""Q1 '24"", 'revenue': 97.71, 'unit': 'M', 'net_profit': -3.83}, {'period': ""Q4 '23"", 'revenue': 120.2, 'unit': 'M', 'net_profit': 9.39}]",0.27,0.26,897990000,112360000,43041000,576275000,56441000,0,56331000,43041000,43090000,-0.1923328791973083,-0.490185592953759,-0.5090909090909091,"[1, 1]","['2025-01-24', '2025-01-24']",__nan__,0.6417387721466832
95,BBGI,Beasley Broadcast Group Inc. Class A Common Stock,"Beasley Broadcast Group, Inc., a multi-platform media company, owns and operates radio stations in the United States. It also operates Houston Outlaws, an esports team that competes in the Overwatch League. The company was founded in 1961 and is headquartered in Naples, Florida.",Ms. Barbara Caroline Beasley,Broadcasting,5.6453,USD,10130045,https://images.financialmodelingprep.com/symbol/BBGI.png,4236,-1.08,0.07,1460,21172074,-5887258,"[{'period': '2024', 'revenue': 240.29, 'unit': 'M', 'net_profit': -5.89}, {'period': '2023', 'revenue': 247.11, 'unit': 'M', 'net_profit': -75.12}, {'period': '2022', 'revenue': 256.38, 'unit': 'M', 'net_profit': -43.38}, {'period': '2021', 'revenue': 241.43, 'unit': 'M', 'net_profit': -1.4}]","[{'period': ""Q1 '25"", 'revenue': 48.91, 'unit': 'M', 'net_profit': -2.69}, {'period': ""Q4 '24"", 'revenue': 67.29, 'unit': 'M', 'net_profit': -2.06}, {'period': ""Q3 '24"", 'revenue': 58.19, 'unit': 'M', 'net_profit': -3.56}, {'period': ""Q2 '24"", 'revenue': 60440.0, 'unit': 'K', 'net_profit': -276.02}, {'period': ""Q1 '24"", 'revenue': 54380.0, 'unit': 'K', 'net_profit': 7.97}, {'period': ""Q4 '23"", 'revenue': 65.75, 'unit': 'M', 'net_profit': 6.38}]",-0.19,-0.19,549206825,69290137,13772720,401987118,51551945,0,52987167,13772720,-6725453,1.3316338593290273,0.9216287648459858,0.9243027888446216,"[0.05, 0.0625]","['2020-03-30', '2005-12-29']",__nan__,0.7319412281520719
96,BBI,Brickell Biotech Inc. Common Stock,"Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. The company was founded in 2009 and is headquartered in Boulder, Colorado.",Mr. Robert Brown,Biotechnology,2.35,USD,7080973,https://images.financialmodelingprep.com/symbol/BBI.png,0,-5.595238095238095,0.049999952,31317,-40244000,-39543000,"[{'period': '2021', 'revenue': 0.404, 'unit': 'M', 'net_profit': -39.54}, {'period': '2020', 'revenue': 1.82, 'unit': 'M', 'net_profit': -20.91}, {'period': '2019', 'revenue': 7.92, 'unit': 'M', 'net_profit': -23.88}, {'period': '2018', 'revenue': 1.62, 'unit': 'M', 'net_profit': -16.25}]","[{'period': ""Q2 '22"", 'revenue': 4.32, 'unit': 'M', 'net_profit': -1.15}, {'period': ""Q1 '22"", 'revenue': 0.092, 'unit': 'M', 'net_profit': -9.41}, {'period': ""Q4 '21"", 'revenue': 0.10400000000000001, 'unit': 'M', 'net_profit': -6.07}, {'period': ""Q3 '21"", 'revenue': 0.132, 'unit': 'M', 'net_profit': -13.25}, {'period': ""Q2 '21"", 'revenue': 0.151, 'unit': 'M', 'net_profit': -11.15}, {'period': ""Q1 '21"", 'revenue': 0.017, 'unit': 'M', 'net_profit': -9.01}]",-22.16,-22.16,29717000,29600000,26884000,4810000,0,0,4810000,26884000,-36184000,-0.9185736079328757,-0.8908334528762014,0.42276634540244856,__nan__,__nan__,__nan__,0.16186021469192718
97,BBIG,Vinco Ventures Inc. Common Stock,"Vinco Ventures, Inc. develops and commercializes end-to-end consumer products in North America. It offers kitchenware, small appliances, toys, pet care, baby products, health and beauty aids, entertainment venue merchandise, and housewares to retailers, mass-market retailers, and e-commerce sites; and personal protective equipment to governmental agencies, hospitals, and distributors. The company also offers Lomotif app that allows its users to create their own music videos; Cortex, a real-time analytics for marketing spend and revenue optimization; and delivers ad-campaign creation, optimalization, and monetization at scale. In addition, it provides Non-Fungible Token, a platform for artists and content owners to distribute their intellectual property, and digital marketing services for brands and influencers. The company was formerly known as Edison Nation, Inc. and changed its name to Vinco Ventures, Inc. in November 2020. Vinco Ventures, Inc. was incorporated in 2017 and is based in Fairport, New York.",Mr. James  Robertson,Leisure,0.0001,USD,1245,https://images.financialmodelingprep.com/symbol/BBIG.png,2414,,0,158,-639202096,-713172942,"[{'period': '2021', 'revenue': 9.79, 'unit': 'M', 'net_profit': -713.17}, {'period': '2020', 'revenue': 15.78, 'unit': 'M', 'net_profit': -5.07}, {'period': '2019', 'revenue': 19.63, 'unit': 'M', 'net_profit': -14.2}, {'period': '2018', 'revenue': 16.5, 'unit': 'M', 'net_profit': -5.34}]","[{'period': ""Q3 '22"", 'revenue': 5.56, 'unit': 'M', 'net_profit': -241.63}, {'period': ""Q2 '22"", 'revenue': 10.37, 'unit': 'M', 'net_profit': 145.93}, {'period': ""Q1 '22"", 'revenue': 11.53, 'unit': 'M', 'net_profit': -372.95}, {'period': ""Q4 '21"", 'revenue': 2.3, 'unit': 'M', 'net_profit': 75.43}, {'period': ""Q3 '21"", 'revenue': 2.23, 'unit': 'M', 'net_profit': -542.46}, {'period': ""Q2 '21"", 'revenue': 2.69, 'unit': 'M', 'net_profit': -183.67}]",-224.72,-224.8,405142729,219741467,87790176,271455687,21072224,1000000,70089546,87612176,-47897324,-114.7477431799234,-139.79896414465333,-22.31120331950207,__nan__,__nan__,__nan__,0.6700248272257652
98,BBIO,BridgeBio Pharma Inc. Common Stock,"BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabilizer of transthyretin, or TTR that is in Phase 3 clinical trial for the treatment of TTR amyloidosis-cardiomyopathy, or ATTR-CM; BBP-831, a small molecule selective FGFR1-3 inhibitor, which is Phase 2 clinical trial to treat achondroplasia in pediatric patients; and BBP-631, an AAV5 gene transfer product candidate that is in Phase 2 clinical trial for the treatment of congenital adrenal hyperplasia, or CAH, driven by 21-hydroxylase deficiency, or 21OHD. The company also develops Encaleret, a small molecule antagonist of the calcium sensing receptor, or CaSR, which is in phase 2 proof-of-concept clinical trial for Autosomal Dominant Hypocalcemia Type 1, or ADH1; and BBP-711 for the treatment of hyperoxaluria, as well as patients suffering from recurrent kidney stones. In addition, it engages in developing products for Mendelian, oncology, and gene therapy diseases. BridgeBio Pharma, Inc. has license and collaboration agreements with the Leland Stanford Junior University; and The Regents of the University of California; Leidos Biomedical Research, Inc. The company was founded in 2015 and is headquartered in Palo Alto, California.",Dr. Neil  Kumar Ph.D.,Biotechnology,32.84,USD,6235692040,https://images.financialmodelingprep.com/symbol/BBIO.png,3219500,-9.22,-0.87,1672464,-436829000,-535762000,"[{'period': '2024', 'revenue': 221.9, 'unit': 'M', 'net_profit': -535.76}, {'period': '2023', 'revenue': 9.3, 'unit': 'M', 'net_profit': -643.2}, {'period': '2022', 'revenue': 77.65, 'unit': 'M', 'net_profit': -493.96}, {'period': '2021', 'revenue': 69.72, 'unit': 'M', 'net_profit': -639.3}]","[{'period': ""Q1 '25"", 'revenue': 116.63, 'unit': 'M', 'net_profit': -167.42}, {'period': ""Q4 '24"", 'revenue': 5.88, 'unit': 'M', 'net_profit': -265.05}, {'period': ""Q3 '24"", 'revenue': 2.73, 'unit': 'M', 'net_profit': -162.04}, {'period': ""Q2 '24"", 'revenue': 2.17, 'unit': 'M', 'net_profit': -73.46}, {'period': ""Q1 '24"", 'revenue': 211.12, 'unit': 'M', 'net_profit': -35.22}, {'period': ""Q4 '23"", 'revenue': 1.75, 'unit': 'M', 'net_profit': -168.15}]",-2.88,-2.88,919338000,720692000,681101000,2376950000,4722000,143747000,154400000,681101000,-521659000,0.2274912108200641,0.16703928159427364,0.27088607594936714,__nan__,__nan__,__nan__,2.585501741470493
99,BBQ,BBQ Holdings Inc. Common Stock,"BBQ Holdings, Inc. develops, owns, operates, and franchises casual and fast dining restaurants under the Famous Dave's, Village Inn, Clark Crew BBQ, Granite City, Tahoe Joe's Steakhouse, Bakers Square, and Real Urban Barbecue names in the United States, Canada, and the United Arab Emirates. It offers smoked, barbequed, and grilled meats, as well as entrée items, and side dishes and appetizers. The company operates full-service and counter-service restaurants. As of March 14, 2022, it had 100 company owned locations and approximately 200 franchised locations, including ghost kitchens operating out of the kitchen of another restaurant location or shared kitchen space. BBQ Holdings, Inc. was incorporated in 1994 and is based in Minnetonka, Minnesota.",Mr. Jeffery Crivello,Restaurants,17.24,USD,185504124,https://images.financialmodelingprep.com/symbol/BBQ.png,0,15.531531531531531,0,14040,23554000,24021000,"[{'period': '2021', 'revenue': 206.44, 'unit': 'M', 'net_profit': 24.02}, {'period': '2020', 'revenue': 121.44, 'unit': 'M', 'net_profit': 4.95}, {'period': '2019', 'revenue': 82.27, 'unit': 'M', 'net_profit': -1.25}, {'period': '2018', 'revenue': 54.89, 'unit': 'M', 'net_profit': 4.86}]","[{'period': ""Q2 '22"", 'revenue': 79.94, 'unit': 'M', 'net_profit': 4.18}, {'period': ""Q1 '22"", 'revenue': 64180.00000000001, 'unit': 'K', 'net_profit': 767.0}, {'period': ""Q4 '21"", 'revenue': 68.39, 'unit': 'M', 'net_profit': 2.6}, {'period': ""Q3 '21"", 'revenue': 55.38, 'unit': 'M', 'net_profit': 4.83}, {'period': ""Q2 '21"", 'revenue': 45.52, 'unit': 'M', 'net_profit': 15.79}, {'period': ""Q1 '21"", 'revenue': 37320.0, 'unit': 'K', 'net_profit': 799.0}]",2.44,2.42,204423000,54172000,40309000,140076000,5476000,0,48074000,40309000,21032000,12.677739216658404,3.8556701030927836,3.518518518518518,__nan__,__nan__,__nan__,0.6852262220982962
100,BBSI,Barrett Business Services Inc. Common Stock,"Barrett Business Services, Inc. provides business management solutions for small and mid-sized companies in the United States. The company develops a management platform that integrates a knowledge-based approach from the management consulting industry with tools from the human resource outsourcing industry. It offers professional employer services under which it enters into a client services agreement to establish a co-employment relationship with each client company, assuming responsibility for payroll, payroll taxes, workers' compensation coverage, and other administration functions for the client's existing workforce. The company also provides staffing and recruiting services, such as on-demand or short-term staffing assignment, contract staffing, direct placement, and long-term or indefinite-term on-site management services. It serves electronics manufacturers, light-manufacturing industries, agriculture-based companies, transportation and shipping enterprises, food processors, telecommunications companies, public utilities, general contractors in various construction-related fields, and professional services firms. The company was incorporated in 1965 and is headquartered in Vancouver, Washington.",Mr. Gary Edward Kramer,Staffing & Employment Services,41.6,USD,1068296320,https://images.financialmodelingprep.com/symbol/BBSI.png,161654,21.33,-0.84,94484,78245000,52993000,"[{'period': '2024', 'revenue': 1140.0, 'unit': 'M', 'net_profit': 52.99}, {'period': '2023', 'revenue': 1070.0, 'unit': 'M', 'net_profit': 50.61}, {'period': '2022', 'revenue': 1050.0, 'unit': 'M', 'net_profit': 47.27}, {'period': '2021', 'revenue': 955.17, 'unit': 'M', 'net_profit': 38.08}]","[{'period': ""Q1 '25"", 'revenue': 292.57, 'unit': 'M', 'net_profit': -1.02}, {'period': ""Q4 '24"", 'revenue': 304.82, 'unit': 'M', 'net_profit': 16.8}, {'period': ""Q3 '24"", 'revenue': 294.28, 'unit': 'M', 'net_profit': 19.63}, {'period': ""Q2 '24"", 'revenue': 279.65, 'unit': 'M', 'net_profit': 16.7}, {'period': ""Q1 '24"", 'revenue': 265780.0, 'unit': 'K', 'net_profit': -136.0}, {'period': ""Q4 '23"", 'revenue': 276.68, 'unit': 'M', 'net_profit': 14.56}]",2.03,1.98,745508000,475442000,153057000,524104000,237195000,0,358896000,55367000,-4073000,0.025975558585964544,0.04704417924602861,0.07978723404255315,"[0.08, 0.035]","['2025-05-23', '2006-11-28']",__nan__,0.7030159300772091
101,BCAB,BioAtla Inc. Common Stock,"BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, melanoma, and ovarian cancer; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California.",Dr. Jay M. Short Ph.D.,Biotechnology,0.3822,USD,22327398,https://images.financialmodelingprep.com/symbol/BCAB.png,632837,-0.31,-0.0094,376312,-73943000,-69776000,"[{'period': '2024', 'revenue': 11.0, 'unit': 'M', 'net_profit': -69.78}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -123.46}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -105.28}, {'period': '2021', 'revenue': 0.25, 'unit': 'M', 'net_profit': -95.41}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.33}, {'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.88}, {'period': ""Q3 '24"", 'revenue': 11.0, 'unit': 'M', 'net_profit': -10.59}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.07}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -23.23}, {'period': ""Q4 '23"", 'revenue': 1.71, 'unit': 'M', 'net_profit': -26.93}]",-1.44,-1.44,52422000,51232000,49046000,38157000,0,0,14540000,49046000,-71936000,0.39510475208808826,0.43483824982585734,0.44186046511627913,__nan__,__nan__,__nan__,0.7278814238296898
102,BCAC,Brookline Capital Acquisition Corp. Common Stock,"Brookline Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to acquire companies in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.",James Jiayuan Tong,Shell Companies,22.71,USD,559613007,https://images.financialmodelingprep.com/symbol/BCAC.png,0,-61.04838709677419,12.719999,586499,-484062,-364939,"[{'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -364.94}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.57}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.46}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -280.95}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 316.75}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -399.63}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -170.0}]",-0.0491,-0.0491,58316,230.826,217.409,236.363,0,58085,186.703,217.409,-451526,0.0,0.0,0.0,__nan__,__nan__,__nan__,0.004053141504904314
103,BCACU,Brookline Capital Acquisition Corp. Units,"Brookline Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to acquire companies in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.",James Jiayuan Tong,Shell Companies,23.2,USD,0,https://images.financialmodelingprep.com/symbol/BCACU.png,0,-62.365591397849464,13.910001,9932,-484062,-364939,"[{'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -364.94}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.57}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.46}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -280.95}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 316.75}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -399.63}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -170.0}]",-0.0491,-0.0491,58316,230.826,217.409,236.363,0,58085,186.703,217.409,-451526,0.0,0.0,0.0,__nan__,__nan__,__nan__,0.004053141504904314
104,BCACW,Brookline Capital Acquisition Corp. Warrant,,,Shell Companies,0.55,USD,0,https://images.financialmodelingprep.com/symbol/BCACW.png,0,0,0.31,901118,-484062,-364939,"[{'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -364.94}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.57}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.46}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -280.95}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 316.75}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -399.63}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -170.0}]",-0.0491,-0.0491,58316,230.826,217.409,236.363,0,58085,186.703,217.409,-451526,0.0,0.0,0.0,__nan__,__nan__,__nan__,0.004053141504904314
105,BCBP,BCB Bancorp Inc. (NJ) Common Stock,"BCB Bancorp, Inc. operates as a bank holding company for BCB Community Bank that provides banking products and services to businesses and individuals in the United States. The company offers deposit products, including savings and club accounts, interest and non-interest-bearing demand accounts, money market accounts, certificates of deposit, and individual retirement accounts. It also provides loans, such as commercial and multi-family real estate, one-to-four family mortgage, commercial business, small business administration, construction, home equity and lines of credit, and consumer loans, as well as residential loans secured by one-to-four family dwellings, condominiums, and cooperative units. In addition, the company offers retail and commercial banking services comprising wire transfers, money orders, safe deposit boxes, night depository services, debit cards, online and mobile banking services, fraud detection services, and automated teller services. As of December 31, 2021, it operated 29 branch offices in Bayonne, Carteret, Edison, Hoboken, Fairfield, Holmdel, Jersey City, Lyndhurst, Maplewood, Monroe Township, Newark, Parsippany, Plainsboro, River Edge, Rutherford, South Orange, Union, and Woodbridge, New Jersey, as well as three branches in Staten Island and Hicksville, New York. The company was founded in 2000 and is headquartered in Bayonne, New Jersey.",Mr. Michael A. Shriner,Banks - Regional,8.14,USD,139703564,https://images.financialmodelingprep.com/symbol/BCBP.png,63378,50.88,-0.25,60929,0,18623000,"[{'period': '2024', 'revenue': 194.01, 'unit': 'M', 'net_profit': 18.62}, {'period': '2023', 'revenue': 102.05, 'unit': 'M', 'net_profit': 29.48}, {'period': '2022', 'revenue': 115.54, 'unit': 'M', 'net_profit': 45.58}, {'period': '2021', 'revenue': 105.72, 'unit': 'M', 'net_profit': 34.24}]","[{'period': ""Q1 '25"", 'revenue': 45.98, 'unit': 'M', 'net_profit': -8.32}, {'period': ""Q4 '24"", 'revenue': 23.13, 'unit': 'M', 'net_profit': 3.27}, {'period': ""Q3 '24"", 'revenue': 26.17, 'unit': 'M', 'net_profit': 6.67}, {'period': ""Q2 '24"", 'revenue': 46.21, 'unit': 'M', 'net_profit': 2.82}, {'period': ""Q1 '24"", 'revenue': 51.39, 'unit': 'M', 'net_profit': 5.87}, {'period': ""Q4 '23"", 'revenue': 52.93, 'unit': 'M', 'net_profit': 6.06}]",0.99,0.99,3599118000,130968000,115792000,3275193000,15176000,9472000,13139000,318017000,66502000,0.0,-0.36834786147949666,-0.42105263157894735,"[0.16, 0.3]","['2025-05-07', '2006-08-30']",__nan__,0.909998783035177
106,BCDA,BioCardia Inc. Common Stock,"BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.",Dr. Peter A. Altman Ph.D.,Biotechnology,1.88,USD,9734433,https://images.financialmodelingprep.com/symbol/BCDA.png,84544,-0.88,-0.08,42286,-7934000,-7946000,"[{'period': '2024', 'revenue': 0.058, 'unit': 'M', 'net_profit': -7.95}, {'period': '2023', 'revenue': 0.47700000000000004, 'unit': 'M', 'net_profit': -11.57}, {'period': '2022', 'revenue': 1.35, 'unit': 'M', 'net_profit': -11.91}, {'period': '2021', 'revenue': 1.01, 'unit': 'M', 'net_profit': -12.62}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.71}, {'period': ""Q4 '24"", 'revenue': -0.058, 'unit': 'M', 'net_profit': -2.3}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.74}, {'period': ""Q2 '24"", 'revenue': 0.003, 'unit': 'M', 'net_profit': -1.65}, {'period': ""Q1 '24"", 'revenue': 0.055, 'unit': 'M', 'net_profit': -2.27}, {'period': ""Q4 '23"", 'revenue': 0.013000000000000001, 'unit': 'M', 'net_profit': -2.07}]",-2.9,-0.0029,3724000,2622000,2371000,2887000,0,0,2321000,2371000,-8032000,0.31366782006920413,0.3132832080200501,0.6459096459096458,__nan__,__nan__,__nan__,0.7752416756176155
107,BCDAW,BioCardia Inc. Warrant,"BioCardia, Inc., a clinical-stage regenerative medicine company, engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP, an autologous mononuclear cell therapy system for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.",Dr. Peter A. Altman Ph.D.,Biotechnology,0.0061,USD,10116,https://images.financialmodelingprep.com/symbol/BCDAW.png,0,-0.00190625,-0.0002,18712,-7934000,-7946000,"[{'period': '2024', 'revenue': 0.058, 'unit': 'M', 'net_profit': -7.95}, {'period': '2023', 'revenue': 0.47700000000000004, 'unit': 'M', 'net_profit': -11.57}, {'period': '2022', 'revenue': 1.35, 'unit': 'M', 'net_profit': -11.91}, {'period': '2021', 'revenue': 1.01, 'unit': 'M', 'net_profit': -12.62}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.71}, {'period': ""Q4 '24"", 'revenue': -0.058, 'unit': 'M', 'net_profit': -2.3}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.74}, {'period': ""Q2 '24"", 'revenue': 0.003, 'unit': 'M', 'net_profit': -1.65}, {'period': ""Q1 '24"", 'revenue': 0.055, 'unit': 'M', 'net_profit': -2.27}, {'period': ""Q4 '23"", 'revenue': 0.013000000000000001, 'unit': 'M', 'net_profit': -2.07}]",-2.9,-0.0029,3724000,2622000,2371000,2887000,0,0,2321000,2371000,-8032000,0.31366782006920413,0.3132832080200501,0.6459096459096458,__nan__,__nan__,__nan__,0.7752416756176155
108,BCEL,Atreca Inc. Class A Common Stock,"Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal, and breast cancer samples from multiple patients. It also developing APN-122597, a receptor tyrosine kinase that target tumor tissues; and ATRC-501/MAM01, that targets the circumsporozoite protein of Plasmodium falciparum for the treatment of malaria. It has a collaboration and license agreement with Xencor, Inc. for research, development, and commercialization of novel CD3 bispecific antibodies in oncology; licensing agreement with the Bill & Melinda Gates Medical Research Institute for the development and commercialization of MAM01/ATRC-501 for the prevention of malaria. Atreca, Inc. was incorporated in 2010 and is based in San Carlos, California.",Mr. John A. Orwin M.B.A.,Biotechnology,0.09,USD,3568788,https://images.financialmodelingprep.com/symbol/BCEL.png,267000,-0.036,-0.0012,122115,-90444000,-90525000,"[{'period': '2022', 'revenue': 0.77, 'unit': 'M', 'net_profit': -90.53}, {'period': '2021', 'revenue': 0.851, 'unit': 'M', 'net_profit': -109.33}, {'period': '2020', 'revenue': 1.35, 'unit': 'M', 'net_profit': -86.33}, {'period': '2019', 'revenue': 2.13, 'unit': 'M', 'net_profit': -67.48}]","[{'period': ""Q3 '23"", 'revenue': 0.08, 'unit': 'M', 'net_profit': -36.22}, {'period': ""Q2 '23"", 'revenue': 0.07100000000000001, 'unit': 'M', 'net_profit': -19.19}, {'period': ""Q1 '23"", 'revenue': 0.092, 'unit': 'M', 'net_profit': -18.76}, {'period': ""Q4 '22"", 'revenue': 0.02, 'unit': 'M', 'net_profit': -20.91}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -23.29}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -28.03}]",-2.35,-2.35,155030000,78026000,70495000,76624000,3985000,1115000,16293000,30819000,-81606000,0.1361192034003534,0.17197190055430547,0.2033898305084746,__nan__,__nan__,__nan__,0.4942527252789783
109,BCLI,Brainstorm Cell Therapeutics Inc. Common Stock,"Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; and Phase II clinical trial for the treatment of progressive multiple sclerosis and alzheimer's disease, as well as for other neurodegenerative diseases. The company has a partnership with Catalent for manufacturing NurOwn. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.",Mr. Chaim  Lebovits,Biotechnology,1.18,USD,9367878,https://images.financialmodelingprep.com/symbol/BCLI.png,1179893,-0.59,-0.06,1010931,0,11623000,"[{'period': '2024', 'revenue': 0.849, 'unit': 'M', 'net_profit': 11.62}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.19}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -24.28}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -24.46}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.97}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.71}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.54}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.4}, {'period': ""Q4 '23"", 'revenue': 0.343, 'unit': 'M', 'net_profit': -5.58}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.23}]",2.19,2.19,1832000,385000,187000,9596000,63000,0,8978000,187000,-9093000,1.0,1.6760702652396464,6.475,__nan__,__nan__,__nan__,5.237991266375546
110,BCML,BayCom Corp Common Stock,"BayCom Corp operates as the bank holding company for United Business Bank that provides various financial services to small and mid-sized businesses, service professionals, and individuals. The company offers demand, savings, money market, and time deposit accounts. It also provides commercial and multifamily real estate loans, including owner-occupied and investor real estate loans; commercial and industrial loans, such as equipment loans and working capital lines of credit; small business administration loans; construction and land loans; agriculture-related loans; and consumer loans comprising installment loans, unsecured and secured personal lines of credit, and overdraft protection. In addition, the company offers online and mobile banking, automated teller machine, remote deposit capture, night depository, courier, direct deposit, treasury management, wire transfer, automated clearing house services, debit cards, cashier's and travelers checks, letters of credit, lockbox, positive pay, reverse positive pay, and account reconciliation services, as well as zero balance accounts and sweep accounts, including loan sweep. As of December 31, 2021, it operated through a network of 33 full-service banking branches in Northern and Southern California; Denver, Colorado; Custer, Delta, and Grand counties, Colorado; and Seattle, Washington and Central New Mexico. The company was formerly known as Bay Commercial Bank and changed its name to BayCom Corp in January 2017. BayCom Corp was incorporated in 2004 and is headquartered in Walnut Creek, California.",Mr. George J. Guarini,Banks - Regional,26.52,USD,291902988,https://images.financialmodelingprep.com/symbol/BCML.png,24995,12.63,-0.4,27155,35387000,23614000,"[{'period': '2024', 'revenue': 97.14, 'unit': 'M', 'net_profit': 23.61}, {'period': '2023', 'revenue': 102.84, 'unit': 'M', 'net_profit': 27.43}, {'period': '2022', 'revenue': 105.31, 'unit': 'M', 'net_profit': 23.73}, {'period': '2021', 'revenue': 84.06, 'unit': 'M', 'net_profit': 20.69}]","[{'period': ""Q1 '25"", 'revenue': 32.65, 'unit': 'M', 'net_profit': 5.7}, {'period': ""Q4 '24"", 'revenue': 23.57, 'unit': 'M', 'net_profit': 6.12}, {'period': ""Q3 '24"", 'revenue': 24.36, 'unit': 'M', 'net_profit': 6.02}, {'period': ""Q2 '24"", 'revenue': 23.61, 'unit': 'M', 'net_profit': 5.6}, {'period': ""Q1 '24"", 'revenue': 24.22, 'unit': 'M', 'net_profit': 5.88}, {'period': ""Q4 '23"", 'revenue': 23.88, 'unit': 'M', 'net_profit': 6.4}]",2.1,2.1,2664508000,396794000,366274000,2340142000,28578000,24921000,1828260000,23387000,28656000,-0.13944213418934365,-0.13896080218778487,-0.07488986784140966,"[0.15, 0.05]","['2025-03-13', '2022-03-10']",__nan__,0.8782642048738454
111,BCOR,Blucora Inc. Common Stock,"Blucora, Inc. provides technology-enabled financial solutions to consumers, small business owners, tax professionals, financial advisors, and certified public accounting firms in the United States. The company operates through two segments, Wealth Management and Tax Preparation. The Wealth Management segment offers an integrated platform of brokerage, investment advisory, and insurance services to financial advisors. The Tax Preparation segment provides digital do-it-yourself tax preparation solutions through TaxAct.com; and ancillary services, including refund payment transfer, audit defense, stored value cards, retirement plan services, and e-filing services. This segment also offers professional tax preparer software that allows professional tax preparers to prepare and file individual and business returns. The company was formerly known as InfoSpace, Inc. and changed its name to Blucora, Inc. in June 2012. Blucora, Inc. was founded in 1996 and is headquartered in Dallas, Texas.",Mr. Christopher W. Walters,Asset Management,27.19,USD,1002604,https://images.financialmodelingprep.com/symbol/BCOR.png,395637,15.911443657747714,-0.08,254725,-11338000,3121000,"[{'period': '2022', 'revenue': 666.5, 'unit': 'M', 'net_profit': 3.12}, {'period': '2021', 'revenue': 885.2, 'unit': 'M', 'net_profit': 7.76}, {'period': '2020', 'revenue': 754.95, 'unit': 'M', 'net_profit': -342.75}, {'period': '2019', 'revenue': 717.95, 'unit': 'M', 'net_profit': 48.15}]","[{'period': ""Q3 '23"", 'revenue': 192.34, 'unit': 'M', 'net_profit': -3.63}, {'period': ""Q2 '23"", 'revenue': 186.93, 'unit': 'M', 'net_profit': 7.73}, {'period': ""Q1 '23"", 'revenue': 177980.0, 'unit': 'K', 'net_profit': -111.0}, {'period': ""Q4 '22"", 'revenue': 172.39, 'unit': 'M', 'net_profit': -1.6}, {'period': ""Q3 '22"", 'revenue': 171.7, 'unit': 'M', 'net_profit': -21.84}, {'period': ""Q2 '22"", 'revenue': 256.88, 'unit': 'M', 'net_profit': 39.42}]",0.0635,0.0635,963515000,323751000,263928000,220317000,24117000,0,142294000,263928000,91730000,-1.1576517700714704,-0.5976537321129303,-0.603125,"[9, 6.3]","['2008-01-09', '2007-05-16']",__nan__,0.22865964722915574
112,BCOV,Brightcove Inc. Common Stock,"Brightcove Inc. provides cloud-based services for video. Its flagship product includes Video Cloud, an online video platform that enables its customers to publish and distribute video to Internet-connected devices. The company also offers Brightcove Live, a solution for live streaming; Brightcove Beacon, an application that enables companies to launch over-the-top video experiences on multiple monetization models; Brightcove Player, a video player technology with a cloud-based service for creating and managing experiences; and Zencoder, a cloud-based video encoding technology. In addition, it provides video solutions, such as Brightcove CorpTV, an application that enables marketing videos, product announcements, training programs, and other live and on-demand content; Video Marketing Suite, a suite of video technologies to drive awareness, engagement, and conversion; Enterprise Video Suite, an enterprise-class platform for internal communications, employee training, live streaming, marketing, and e-commerce videos; and Virtual Events Experience, a platform to create customized, live, and virtual experiences. The company serves media, broadcasters, publishers, sports and entertainment companies, fashion, faith-based institutions, retail and e-commerce platforms, and hi-tech organizations, governments, educational institutions, and hospitality brands. It also sells its products in the America, Europe, Asia Pacific, Japan, and the Middle East. Brightcove Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.",Mr. Marc  DeBevoise,Software - Application,4.45,USD,202097640,https://images.financialmodelingprep.com/symbol/BCOV.png,623023,-21.19047619047619,0,301250,-5159000,-22886000,"[{'period': '2023', 'revenue': 201.19, 'unit': 'M', 'net_profit': -22.89}, {'period': '2022', 'revenue': 211.01, 'unit': 'M', 'net_profit': -9.02}, {'period': '2021', 'revenue': 211.09, 'unit': 'M', 'net_profit': 5.4}, {'period': '2020', 'revenue': 197.35, 'unit': 'M', 'net_profit': -5.81}]","[{'period': ""Q3 '24"", 'revenue': 49.95, 'unit': 'M', 'net_profit': -2.96}, {'period': ""Q2 '24"", 'revenue': 49.25, 'unit': 'M', 'net_profit': -5.25}, {'period': ""Q1 '24"", 'revenue': 50.48, 'unit': 'M', 'net_profit': 1.57}, {'period': ""Q4 '23"", 'revenue': 50.16, 'unit': 'M', 'net_profit': -2.51}, {'period': ""Q3 '23"", 'revenue': 50.98, 'unit': 'M', 'net_profit': -2.42}, {'period': ""Q2 '23"", 'revenue': 50.99, 'unit': 'M', 'net_profit': -6.24}]",-0.53,-0.53,216107000,70399000,18615000,122194000,33451000,0,104629000,18615000,-11145000,-4.122880750605327,-1.5386577925679423,-1.4090909090909094,__nan__,__nan__,__nan__,0.5654328642755672
113,BCOW,1895 Bancorp of Wisconsin Inc. Common Stock,"1895 Bancorp of Wisconsin, Inc. operates as a holding company for PyraMax Bank, FSB that provides a range of financial services. The company offers checking, savings, and certificate of deposits accounts. Its loan products include one- to four-family residential real estate, residential real estate construction, commercial real estate, and land development loans; commercial loans and lines of credit secured by non-real estate business assets; and consumer loans, such as home equity lines of credit, new and used automobile loans, boat loans, recreational vehicle loans, and loans secured by certificates of deposit. It also provides insurance and risk products for personal and business needs. The company operates through a network of three full-service banking offices in Milwaukee County, two full-service banking offices in Waukesha County, and one full service banking office in Ozaukee County, Wisconsin. 1895 Bancorp of Wisconsin, Inc. was founded in 1895 and is headquartered in Greenfield, Wisconsin.",Mr. David R. Ball,Banks - Regional,10.0,USD,51783500,https://images.financialmodelingprep.com/symbol/BCOW.png,24610,-16.67,-0.05,6813,-5912000,-6792000,"[{'period': '2023', 'revenue': 9.98, 'unit': 'M', 'net_profit': -6.79}, {'period': '2022', 'revenue': 16180.0, 'unit': 'K', 'net_profit': -148.0}, {'period': '2021', 'revenue': 16970.0, 'unit': 'K', 'net_profit': 85.0}, {'period': '2020', 'revenue': 19.23, 'unit': 'M', 'net_profit': 1.32}]","[{'period': ""Q3 '24"", 'revenue': 3660.0, 'unit': 'K', 'net_profit': -159.0}, {'period': ""Q2 '24"", 'revenue': 6880.0, 'unit': 'K', 'net_profit': -516.0}, {'period': ""Q1 '24"", 'revenue': 6600.0, 'unit': 'K', 'net_profit': -306.0}, {'period': ""Q4 '23"", 'revenue': 3.7, 'unit': 'M', 'net_profit': -2.28}, {'period': ""Q3 '23"", 'revenue': 5.37, 'unit': 'M', 'net_profit': -3.64}, {'period': ""Q2 '23"", 'revenue': 3990.0, 'unit': 'K', 'net_profit': -508.0}]",-1.23,-1.23,557607000,14804000,13250000,484846000,0,2838000,311244000,11220000,-1521000,0.0,-44.891891891891895,-47.04687499999999,__nan__,__nan__,__nan__,0.8695120398416806
114,BCPC,Balchem Corporation Common Stock,"Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.",Mr. Theodore Lee Harris,Chemicals - Specialty,168.3,USD,5489491590,https://images.financialmodelingprep.com/symbol/BCPC.png,190937,40.26,-2.15,96894,230954000,128475000,"[{'period': '2024', 'revenue': 953.68, 'unit': 'M', 'net_profit': 128.47}, {'period': '2023', 'revenue': 922.44, 'unit': 'M', 'net_profit': 108.54}, {'period': '2022', 'revenue': 942.36, 'unit': 'M', 'net_profit': 105.37}, {'period': '2021', 'revenue': 799.02, 'unit': 'M', 'net_profit': 96.1}]","[{'period': ""Q1 '25"", 'revenue': 250.52, 'unit': 'M', 'net_profit': 37.05}, {'period': ""Q4 '24"", 'revenue': 240.0, 'unit': 'M', 'net_profit': 33.58}, {'period': ""Q3 '24"", 'revenue': 239.94, 'unit': 'M', 'net_profit': 33.84}, {'period': ""Q2 '24"", 'revenue': 234.08, 'unit': 'M', 'net_profit': 32.07}, {'period': ""Q1 '24"", 'revenue': 239.66, 'unit': 'M', 'net_profit': 28.99}, {'period': ""Q4 '23"", 'revenue': 228.7, 'unit': 'M', 'net_profit': 26.65}]",3.97,3.93,1575371000,313770000,49515000,425458000,119662000,0,157685000,49515000,146338000,0.07515979311853786,0.18363229319255964,0.17455621301775157,"[0.87, 0.03]","['2024-12-26', '1988-11-17']",__nan__,0.2700684473689055
115,BCRX,BioCryst Pharmaceuticals Inc. Common Stock,"BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II clinical trial for complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitor that is in Phase I clinical trial to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trial to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.",Mr. Jon P. Stonehouse,Biotechnology,10.07,USD,2107147500,https://images.financialmodelingprep.com/symbol/BCRX.png,4673957,-38.73,-0.26,4199335,12808000,-88881000,"[{'period': '2024', 'revenue': 450.71, 'unit': 'M', 'net_profit': -88.88}, {'period': '2023', 'revenue': 331.41, 'unit': 'M', 'net_profit': -226.54}, {'period': '2022', 'revenue': 270.83, 'unit': 'M', 'net_profit': -247.12}, {'period': '2021', 'revenue': 157.17, 'unit': 'M', 'net_profit': -184.06}]","[{'period': ""Q1 '25"", 'revenue': 145530.0, 'unit': 'K', 'net_profit': 32.0}, {'period': ""Q4 '24"", 'revenue': 131.53, 'unit': 'M', 'net_profit': -26.8}, {'period': ""Q3 '24"", 'revenue': 117.08, 'unit': 'M', 'net_profit': -14.03}, {'period': ""Q2 '24"", 'revenue': 109.33, 'unit': 'M', 'net_profit': -12.67}, {'period': ""Q1 '24"", 'revenue': 92.76, 'unit': 'M', 'net_profit': -35.38}, {'period': ""Q4 '23"", 'revenue': 93.4, 'unit': 'M', 'net_profit': -61.73}]",-0.43,-0.43,490420000,421968000,320850000,966354000,79069000,20323000,160384000,104713000,-53144000,1.1100958438990844,0.6076569597287884,0.6355932203389831,__nan__,__nan__,__nan__,1.9704620529342196
116,BCTG,BCTG Acquisition Corp. Common Stock,"BCTG Acquisition Corp. intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses primarily located in North America and Europe in the biotechnology industry. The company was founded in 2020 and is based in San Diego, California.","Mr. Aaron I. Davis B.A., M.A.",Shell Companies,10.2,USD,899409480,https://images.financialmodelingprep.com/symbol/BCTG.png,25308,-204,0,151857,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
117,BCTX,BriaCell Therapeutics Corp. Common Shares,"BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.","Dr. William V. Williams FCPA, M.D.",Biotechnology,3.55,USD,20289706,https://images.financialmodelingprep.com/symbol/BCTX.png,1256267,-0.75,-0.01,191898,-4771736,-4716430,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.72}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -20.3}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.58}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.89}]","[{'period': ""Q2 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.29}, {'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.8}, {'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.21}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.72}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.29}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.0}]",-0.29,-0.29,5872261,3653854,862089,8557193,1369016,418490,7461157,862089,-24582929,0.8247061350957146,0.7676909432454123,0.8333333333333333,__nan__,__nan__,__nan__,1.4572228652643335
118,BCTXW,BriaCell Therapeutics Corp. Warrant,"BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.","Dr. William V. Williams FCPA, M.D.",Biotechnology,0.1,USD,370832,https://images.financialmodelingprep.com/symbol/BCTXW.png,112611.05217,,-0.02,53009,-27221352,-20302394,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -20.3}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.58}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.89}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.38}]","[{'period': ""Q2 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.29}, {'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.8}, {'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.21}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.72}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.29}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.0}]",-1.74,-1.74,5872261,3653854,862089,8557193,1369016,418490,7461157,862089,-24582929,0.2004714927906788,-0.7531244246889565,-1.32,__nan__,__nan__,__nan__,1.4572228652643335
119,BCYC,Bicycle Therapeutics plc American Depositary Shares,"Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The company's oncology product candidates also comprise BT5528, a BTC that is in a Phase I/II clinical trial targeting EphA2; and BT8009, which is in Phase I/II clinical trial targeting Nectin-4. In addition, it is developing THR-149, a plasma kallikrein inhibitor that completed Phase II clinical trials for the treatment of diabetic macular edema; BT7480, a Bicycle tumor-targeted immune cell agonist (TICA) targeting Nectin-4 and agonizing; BT7455, an EphA2/CD137 Bicycle TICA, which is in preclinical studies; and BT1718, a BTC that target tumors, that is in Phase I/IIa clinical trial that express Membrane Type 1 matrix metalloproteinase. Further, the company collaborates with biopharmaceutical companies and organizations to develop programs in therapeutic areas, such as anti-infective, cardiovascular, ophthalmology, and respiratory indications. It has a clinical trial and license agreement with the Cancer Research Technology Limited and Cancer Research UK; research collaboration agreements with AstraZeneca, Sanofi, Oxurion, and the Dementia Discovery Fund; and discovery collaboration and license agreement with Genentech for the discovery and development of Bicycle peptides for multiple immuno-oncology targets. Bicycle Therapeutics plc was incorporated in 2009 and is headquartered in Cambridge, the United Kingdom.","Dr. Kevin  Lee M.B.A., Ph.D.",Biotechnology,8.05,USD,557078958,https://images.financialmodelingprep.com/symbol/BCYC.png,373555,-2.55,-0.46,275353,-164892000,-169031000,"[{'period': '2024', 'revenue': 35.27, 'unit': 'M', 'net_profit': -169.03}, {'period': '2023', 'revenue': 26.98, 'unit': 'M', 'net_profit': -180.66}, {'period': '2022', 'revenue': 14.46, 'unit': 'M', 'net_profit': -112.72}, {'period': '2021', 'revenue': 11.7, 'unit': 'M', 'net_profit': -66.82}]","[{'period': ""Q1 '25"", 'revenue': 9.98, 'unit': 'M', 'net_profit': -60.75}, {'period': ""Q4 '24"", 'revenue': 3.71, 'unit': 'M', 'net_profit': -51.85}, {'period': ""Q3 '24"", 'revenue': 2.68, 'unit': 'M', 'net_profit': -50.8}, {'period': ""Q2 '24"", 'revenue': 9.37, 'unit': 'M', 'net_profit': -39.86}, {'period': ""Q1 '24"", 'revenue': 19.52, 'unit': 'M', 'net_profit': -26.55}, {'period': ""Q4 '23"", 'revenue': 5.33, 'unit': 'M', 'net_profit': -49.1}]",-0.29,-2.9,956868000,928605000,879520000,163808000,35653000,0,67230000,879520000,-165959000,0.10091603053435115,0.06439024930257273,0.9429133858267716,__nan__,__nan__,__nan__,0.17119184673330073
120,BCYP,Big Cypress Acquisition Corp. Common stock,"Big Cypress Acquisition Corp. intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or similar business combination. It intends to focus on life science companies in the United States and Israel. The company was founded in 2020 and is based in Miami Beach, Florida.",Mr. Samuel J. Reich,Biotechnology,8.44,USD,425357432,https://images.financialmodelingprep.com/symbol/BCYP.png,2267566,0,-2.0100002,15335164,0,0,"[{'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': '2019', 'revenue': 3.44, 'unit': 'M', 'net_profit': -8.99}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.2}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",0,0,322205,87094,84836,306201,0,0,306201,84836,-2726907,1,1,1,__nan__,__nan__,__nan__,0.9503297590043606
121,BCYPU,Big Cypress Acquisition Corp. Unit,,,Biotechnology,8.57,USD,0,https://images.financialmodelingprep.com/symbol/BCYPU.png,1730,0,-2.28,32880,0,0,"[{'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': '2019', 'revenue': 3.44, 'unit': 'M', 'net_profit': -8.99}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.2}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",0,0,322205,87094,84836,306201,0,0,306201,84836,-2726907,1,1,1,__nan__,__nan__,__nan__,0.9503297590043606
122,BCYPW,Big Cypress Acquisition Corp. Warrant,"Big Cypress Acquisition Corp. intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or similar business combination. It intends to focus on life science companies in the United States and Israel. The company was founded in 2020 and is based in Miami Beach, Florida.",Mr. Samuel J. Reich,Shell Companies,1.1001,USD,0,https://images.financialmodelingprep.com/symbol/BCYPW.png,0,0,-0.14989996,3600913,0,0,"[{'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': '2019', 'revenue': 3.44, 'unit': 'M', 'net_profit': -8.99}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.2}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",0,0,322205,87094,84836,306201,0,0,306201,84836,-2726907,1,1,1,__nan__,__nan__,__nan__,0.9503297590043606
123,BDSI,BioDelivery Sciences International Inc. Common Stock,"BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; and Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. The company also provides ELYXYB, a celecoxib oral solution for the treatment of migraine with or without aura in adults; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina. As of March 18, 2022, BioDelivery Sciences International, Inc. operates as a subsidiary of Collegium Pharmaceutical, Inc.",Mr. Herm Cukier,Drug Manufacturers - Specialty & Generic,5.59,USD,577050110,https://images.financialmodelingprep.com/symbol/BDSI.png,3352473,6.817073170731708,-0.005,2107479,44542000,84860000,"[{'period': '2021', 'revenue': 166.7, 'unit': 'M', 'net_profit': 84.86}, {'period': '2020', 'revenue': 156.47, 'unit': 'M', 'net_profit': 25.71}, {'period': '2019', 'revenue': 111.39, 'unit': 'M', 'net_profit': -15.3}, {'period': '2018', 'revenue': 55.64, 'unit': 'M', 'net_profit': -33.87}]","[{'period': ""Q4 '21"", 'revenue': 43.15, 'unit': 'M', 'net_profit': 63.89}, {'period': ""Q3 '21"", 'revenue': 41.09, 'unit': 'M', 'net_profit': 6.67}, {'period': ""Q2 '21"", 'revenue': 41.44, 'unit': 'M', 'net_profit': 9.06}, {'period': ""Q1 '21"", 'revenue': 41.02, 'unit': 'M', 'net_profit': 5.24}, {'period': ""Q4 '20"", 'revenue': 42.17, 'unit': 'M', 'net_profit': 10.2}, {'period': ""Q3 '20"", 'revenue': 39.44, 'unit': 'M', 'net_profit': 9.38}]",0.82,0.82,324596000,202065000,114309000,136774000,56867000,0,82378000,114309000,40622000,0.0999382639832078,2.3005328458636383,2.1538461538461537,__nan__,__nan__,__nan__,0.4213668683532761
124,BDSX,Biodesix Inc. Common Stock,"Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also offers GeneStrat ddPCR and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions; and GeneStrat NGS (NGS) test, a 72-hour blood-based NGS test. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. Biodesix, Inc. was incorporated in 2005 and is headquartered in Boulder, Colorado.",Mr. Scott  Hutton,Medical - Diagnostics & Research,0.3951,USD,57907041,https://images.financialmodelingprep.com/symbol/BDSX.png,2035395,-1.46,0.1243,351926888,-34498000,-42931000,"[{'period': '2024', 'revenue': 71.32, 'unit': 'M', 'net_profit': -42.93}, {'period': '2023', 'revenue': 49.09, 'unit': 'M', 'net_profit': -52.15}, {'period': '2022', 'revenue': 38.21, 'unit': 'M', 'net_profit': -80.39}, {'period': '2021', 'revenue': 54.51, 'unit': 'M', 'net_profit': -44.48}]","[{'period': ""Q1 '25"", 'revenue': 17.96, 'unit': 'M', 'net_profit': -11.1}, {'period': ""Q4 '24"", 'revenue': 20.43, 'unit': 'M', 'net_profit': -8.25}, {'period': ""Q3 '24"", 'revenue': 18.15, 'unit': 'M', 'net_profit': -10.26}, {'period': ""Q2 '24"", 'revenue': 17.93, 'unit': 'M', 'net_profit': -10.81}, {'period': ""Q1 '24"", 'revenue': 14.82, 'unit': 'M', 'net_profit': -13.61}, {'period': ""Q4 '23"", 'revenue': 14.67, 'unit': 'M', 'net_profit': -9.14}]",-0.33,-0.33,97244000,39484000,26245000,76368000,8603000,0,14317000,26245000,-51879000,0.07020995606824246,0.17671537605952517,0.484375,__nan__,__nan__,__nan__,0.7853235161038213
125,BDTX,Black Diamond Therapeutics Inc. Common Stock,"Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 driver mutations. The company is also developing BDTX-1535, a brain-penetrant inhibitor of EGFR mutations, including canonical, intrinsic resistance, and acquired resistance mutations; and BDTX-4933, a brain-penetrant inhibitor of oncogenic BRAF class I, II and III alterations. It has a strategic partnership with OpenEye Scientific Software, Inc. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.","Dr. Mark A. Velleca M.D., Ph.D.",Biotechnology,2.03,USD,115431078,https://images.financialmodelingprep.com/symbol/BDTX.png,3434067,33.83,-0.14,1008998,-69333000,-69676000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -69.68}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -82.44}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -84.52}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -123.2}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 56.54}, {'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.98}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.56}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -19.91}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -18.23}, {'period': ""Q4 '23"", 'revenue': 4.89, 'unit': 'M', 'net_profit': -19.41}]",-1.27,-1.27,122640000,101176000,98575000,39355000,0,0,20573000,36437000,-62303000,0.19401787893935343,0.15484825695640572,0.3244680851063829,__nan__,__nan__,__nan__,0.32089856490541424
126,BEAM,Beam Therapeutics Inc. Common Stock,"Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-301, a liver-targeted development candidate for the treatment of patients with Glycogen Storage Disease Type Ia. It also develops therapies for alpha-1 antitrypsin deficiency; ocular diseases; and other liver, muscle, and central nervous system disorders. The company has an alliance with Boston Children's Hospital; a research and clinical trial collaboration agreement with Magenta Therapeutics, Inc.; license agreement with Sana Biotechnology, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration agreement with Pfizer Inc. and Apellis Pharmaceuticals, Inc.; and collaboration and license agreement with Verve Therapeutics, Inc. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.",Mr. John M. Evans M.B.A.,Biotechnology,17.22,USD,1731591540,https://images.financialmodelingprep.com/symbol/BEAM.png,2407295,-3.74,-0.53,1856297,-383975000,-376742000,"[{'period': '2024', 'revenue': 63.52, 'unit': 'M', 'net_profit': -376.74}, {'period': '2023', 'revenue': 377.71, 'unit': 'M', 'net_profit': -132.53}, {'period': '2022', 'revenue': 60.92, 'unit': 'M', 'net_profit': -263.59}, {'period': '2021', 'revenue': 51.84, 'unit': 'M', 'net_profit': -341.36}]","[{'period': ""Q1 '25"", 'revenue': 7.47, 'unit': 'M', 'net_profit': -109.27}, {'period': ""Q4 '24"", 'revenue': 30.07, 'unit': 'M', 'net_profit': -90.35}, {'period': ""Q3 '24"", 'revenue': 14.27, 'unit': 'M', 'net_profit': -96.67}, {'period': ""Q2 '24"", 'revenue': 11.77, 'unit': 'M', 'net_profit': -91.05}, {'period': ""Q1 '24"", 'revenue': 7.41, 'unit': 'M', 'net_profit': -98.67}, {'period': ""Q4 '23"", 'revenue': 316.19, 'unit': 'M', 'net_profit': 142.8}]",-4.58,-4.58,1103824000,878149000,850740000,370279000,0,0,182066000,281967000,-356192000,-1.45393774005739,-1.8427565703592474,-1.662790697674419,"[0.225, 0.19]","['2014-02-04', '2011-11-07']",__nan__,0.33545112264274013
127,BECN,Beacon Roofing Supply Inc. Common Stock,"Beacon Roofing Supply, Inc., together with its subsidiaries, distributes residential and non-residential roofing materials, and complementary building products to contractors, home builders, building owners, lumberyards, and retailers. It offers pitched roofing and low slope roof products; gutters and sidings; building materials, such as lumber and composite, skylights and window, plywood and OSB, decking and railing, and HVAC products; and foam board, spray foam, roll, batt, mineral wool, fiberglass, and commercial insulation products, as well as radiant barriers and blown-in insulation and equipment. The company also provides above grade and below grade membranes and coatings, deck and floor coatings, plaza deck waterproofing products, damp proofing coatings, and air and vapor barriers; tools and equipment, including power and hand tools, ladders and scaffolding, air tools and compressors, nails, screws and fasteners, generators, work wear and safety gear, job site supplies, tool bags and belts, welding and soldering, cleaning supplies, drill bits, and saw blades; and solar panels, mounting hardware, inverters, and storage and batteries. As of September 30, 2021, it operated approximately 446 branches in 50 states of the United States and 6 provinces in Canada. Beacon Roofing Supply, Inc. was founded in 1928 and is headquartered in Herndon, Virginia.",Mr. Julian G. Francis,Construction,124.17,USD,7718630706,https://images.financialmodelingprep.com/symbol/BECN.png,2333543,21.86,-0.1,2403993,858700000,361700000,"[{'period': '2024', 'revenue': 9760.0, 'unit': 'M', 'net_profit': 361.7}, {'period': '2023', 'revenue': 9120.0, 'unit': 'M', 'net_profit': 435.0}, {'period': '2022', 'revenue': 8430.0, 'unit': 'M', 'net_profit': 458.4}, {'period': '2021', 'revenue': 6820.0, 'unit': 'M', 'net_profit': 243.0}]","[{'period': ""Q4 '24"", 'revenue': 2400.0, 'unit': 'M', 'net_profit': 83.6}, {'period': ""Q3 '24"", 'revenue': 2770.0, 'unit': 'M', 'net_profit': 145.3}, {'period': ""Q2 '24"", 'revenue': 2670.0, 'unit': 'M', 'net_profit': 127.2}, {'period': ""Q1 '24"", 'revenue': 1910.0, 'unit': 'M', 'net_profit': 5.6}, {'period': ""Q4 '23"", 'revenue': 2300.0, 'unit': 'M', 'net_profit': 95.3}, {'period': ""Q3 '23"", 'revenue': 2580.0, 'unit': 'M', 'net_profit': -262.8}]",5.79,5.68,6953600000,3179800000,74300000,4961100000,1196100000,0,1613300000,74300000,292800000,-0.041415494530029025,-0.1685057471264368,-0.15226939970717424,__nan__,__nan__,__nan__,0.7134577772664519
128,BEEM,Beam Global Common Stock,"Beam Global, a cleantech company, designs, develops, engineers, manufactures, and sells renewably energized products for electric vehicle (EV) charging infrastructure, outdoor media and branding, and energy security products. The company's product portfolio include EV ARC (electric vehicle autonomous renewable charger), an infrastructure product that uses integrated solar power and battery storage to provide a source of power for factory installed electric vehicle charging stations; Solar Tree DCFC, an off-grid, renewably energized, and single-column mounted smart generation and energy storage system to provide a 50kW DC fast charge to one or more electric vehicles or larger vehicles; and EV ARC DCFC, a DC fast charging system for charging EVs. It is also developing EV-Standard, a lamp standard, EV charging, and emergency power product that uses an existing streetlamp's foundation and a combination of solar, wind, grid connection, and onboard energy storage to provide curbside charging; and UAV ARC, an off-grid and renewably energized product and network used to charge aerial drone (UAV) fleets. The company was formerly known as Envision Solar International, Inc. and changed its name to Beam Global in September 2020. Beam Global was incorporated in 2006 and is headquartered in San Diego, California.",Mr. Desmond  Wheatley,Solar,1.66,USD,25607492,https://images.financialmodelingprep.com/symbol/BEEM.png,144677,-1.04,0.01,116821,-6925000,-11282000,"[{'period': '2024', 'revenue': 49.34, 'unit': 'M', 'net_profit': -11.28}, {'period': '2023', 'revenue': 67.35, 'unit': 'M', 'net_profit': -16.06}, {'period': '2022', 'revenue': 22.0, 'unit': 'M', 'net_profit': -19.68}, {'period': '2021', 'revenue': 9.0, 'unit': 'M', 'net_profit': -6.6}]","[{'period': ""Q1 '25"", 'revenue': 6.32, 'unit': 'M', 'net_profit': -15.52}, {'period': ""Q4 '24"", 'revenue': 8.48, 'unit': 'M', 'net_profit': -4.63}, {'period': ""Q3 '24"", 'revenue': 11.48, 'unit': 'M', 'net_profit': 1.3}, {'period': ""Q2 '24"", 'revenue': 14.81, 'unit': 'M', 'net_profit': -4.92}, {'period': ""Q1 '24"", 'revenue': 14.56, 'unit': 'M', 'net_profit': -3.04}, {'period': ""Q4 '23"", 'revenue': 20.03, 'unit': 'M', 'net_profit': -5.07}]",-0.77,-0.77,61459000,27126000,4572000,20171000,8027000,0,13315000,4572000,-3021000,0.511429377733879,0.2975093399750934,0.4076923076923077,__nan__,__nan__,__nan__,0.3282025415317529
129,BEEMW,Beam Global Warrant,"Beam Global, a cleantech company, designs, develops, engineers, manufactures, and sells renewably energized infrastructure products for electric vehicle (EV) charging infrastructure, energy storage, energy security, disaster preparedness, and outdoor media advertising. The company's product portfolio includes EV ARC (electric vehicle autonomous renewable charger), an infrastructure product that uses integrated solar power and battery storage to provide a source of power for factory installed electric vehicle charging stations; Solar Tree DCFC, an off-grid, renewably energized, and single-column mounted smart generation and energy storage system to provide a 50kW DC fast charge to one or more electric vehicles or larger vehicles; and EV ARC DCFC, a DC fast charging system for charging EVs. It is also developing EV-Standard, a lamp standard, EV charging, and emergency power product that uses an existing streetlamp's foundation and a combination of solar, wind, grid connection, and onboard energy storage to provide curbside charging; and UAV ARC, an off-grid and renewably energized product and network used to charge aerial drone (UAV) fleets. The company was formerly known as Envision Solar International, Inc. and changed its name to Beam Global in September 2020. Beam Global was incorporated in 2006 and is headquartered in San Diego, California.",Mr. Desmond  Wheatley,Solar,0.0997,USD,1334957,https://images.financialmodelingprep.com/symbol/BEEMW.png,0,0,-0.0502,32367,-6925000,-11282000,"[{'period': '2024', 'revenue': 49.34, 'unit': 'M', 'net_profit': -11.28}, {'period': '2023', 'revenue': 67.35, 'unit': 'M', 'net_profit': -16.06}, {'period': '2022', 'revenue': 22.0, 'unit': 'M', 'net_profit': -19.68}, {'period': '2021', 'revenue': 9.0, 'unit': 'M', 'net_profit': -6.6}]","[{'period': ""Q1 '25"", 'revenue': 6.32, 'unit': 'M', 'net_profit': -15.52}, {'period': ""Q4 '24"", 'revenue': 8.48, 'unit': 'M', 'net_profit': -4.63}, {'period': ""Q3 '24"", 'revenue': 11.48, 'unit': 'M', 'net_profit': 1.3}, {'period': ""Q2 '24"", 'revenue': 14.81, 'unit': 'M', 'net_profit': -4.92}, {'period': ""Q1 '24"", 'revenue': 14.56, 'unit': 'M', 'net_profit': -3.04}, {'period': ""Q4 '23"", 'revenue': 20.03, 'unit': 'M', 'net_profit': -5.07}]",-0.77,-0.77,61459000,27126000,4572000,20171000,8027000,0,13315000,4572000,-3021000,0.511429377733879,0.2975093399750934,0.4076923076923077,__nan__,__nan__,__nan__,0.3282025415317529
130,BELFA,Bel Fuse Inc. Class A Common Stock,"Bel Fuse Inc. designs, manufactures, markets, and sells products that are used in the networking, telecommunication, high-speed data transmission, commercial aerospace, military, broadcasting, transportation, e-Mobility and broadcasting, and consumer electronic industries in the United States, Macao, the United Kingdom, Slovakia, Germany, Switzerland, and internationally. It offers magnetic products, such as integrated connector modules; power transformers; SMD power inductors and SMPS transformers; and ethernet discrete components. The company also provides power solutions and protection products comprising front-end power supplies; board-mount power; industrial power; external power; and circuit protection products. In addition, it offers connectivity solutions, which includes expanded beam fiber optic connectors, cable assemblies, and active optical devices; copper-based connectors/cable assemblies; radio frequency connectors, cable assemblies, microwave devices, and low loss cables; and ethernet, I/O, and industrial and power connectivity. The company sells its products under the Bel, TRP Connector, MagJack, Signal, Bel Power Solutions, Melcher, CUI, Stratos, Fibreco, Cinch, Johnson, Trompeter, Midwest Microwave, Semflex, and Stewart Connector brands through direct strategic account managers, regional sales managers working with independent sales representative organizations, and authorized distributors. Bel Fuse Inc. was incorporated in 1949 and is headquartered in Jersey City, New Jersey.",Mr. Daniel  Bernstein,"Hardware, Equipment & Parts",65.48,USD,906051867,https://images.financialmodelingprep.com/symbol/BELFA.png,5177,20.02,-2,5587,82343000,40960000,"[{'period': '2024', 'revenue': 534.79, 'unit': 'M', 'net_profit': 40.96}, {'period': '2023', 'revenue': 639.81, 'unit': 'M', 'net_profit': 73.83}, {'period': '2022', 'revenue': 654.23, 'unit': 'M', 'net_profit': 52.69}, {'period': '2021', 'revenue': 543.49, 'unit': 'M', 'net_profit': 24.82}]","[{'period': ""Q1 '25"", 'revenue': 152.24, 'unit': 'M', 'net_profit': 17.87}, {'period': ""Q4 '24"", 'revenue': 149.86, 'unit': 'M', 'net_profit': -1.8}, {'period': ""Q3 '24"", 'revenue': 123.64, 'unit': 'M', 'net_profit': 8.08}, {'period': ""Q2 '24"", 'revenue': 133.21, 'unit': 'M', 'net_profit': 18.81}, {'period': ""Q1 '24"", 'revenue': 128.09, 'unit': 'M', 'net_profit': 15.87}, {'period': ""Q4 '23"", 'revenue': 140.01, 'unit': 'M', 'net_profit': 12.04}]",3.26,3.26,949789000,373530000,69203000,508627000,116370000,9265000,128069000,68253000,59956000,-0.1721159839938871,-0.4452194877490485,-0.43598615916955025,"[0.06, 0.05]","['2025-07-15', '2000-07-12']",__nan__,0.5355157829791669
131,BELFB,Bel Fuse Inc. Class B Common Stock,"Bel Fuse Inc. designs, manufactures, markets, and sells products that are used in the networking, telecommunication, high-speed data transmission, commercial aerospace, military, broadcasting, transportation, e-Mobility and broadcasting, and consumer electronic industries in the United States, Macao, the United Kingdom, Slovakia, Germany, Switzerland, and internationally. It offers magnetic products, such as integrated connector modules; power transformers; SMD power inductors and SMPS transformers; and ethernet discrete components. The company also provides power solutions and protection products comprising front-end power supplies; board-mount power; industrial power; external power; and circuit protection products. In addition, it offers connectivity solutions, which includes expanded beam fiber optic connectors, cable assemblies, and active optical devices; copper-based connectors/cable assemblies; radio frequency connectors, cable assemblies, microwave devices, and low loss cables; and ethernet, I/O, and industrial and power connectivity. The company sells its products under the Bel, TRP Connector, MagJack, Signal, Bel Power Solutions, Melcher, CUI, Stratos, Fibreco, Cinch, Johnson, Trompeter, Midwest Microwave, Semflex, and Stewart Connector brands through direct strategic account managers, regional sales managers working with independent sales representative organizations, and authorized distributors. Bel Fuse Inc. was incorporated in 1949 and is headquartered in Jersey City, New Jersey.",Mr. Daniel  Bernstein,"Hardware, Equipment & Parts",73.33,USD,913422239,https://images.financialmodelingprep.com/symbol/BELFB.png,92209,22.43,-1.63,41484,82343000,40960000,"[{'period': '2024', 'revenue': 534.79, 'unit': 'M', 'net_profit': 40.96}, {'period': '2023', 'revenue': 639.81, 'unit': 'M', 'net_profit': 73.83}, {'period': '2022', 'revenue': 654.23, 'unit': 'M', 'net_profit': 52.69}, {'period': '2021', 'revenue': 543.49, 'unit': 'M', 'net_profit': 24.82}]","[{'period': ""Q1 '25"", 'revenue': 152.24, 'unit': 'M', 'net_profit': 17.87}, {'period': ""Q4 '24"", 'revenue': 149.86, 'unit': 'M', 'net_profit': -1.8}, {'period': ""Q3 '24"", 'revenue': 123.64, 'unit': 'M', 'net_profit': 8.08}, {'period': ""Q2 '24"", 'revenue': 133.21, 'unit': 'M', 'net_profit': 18.81}, {'period': ""Q1 '24"", 'revenue': 128.09, 'unit': 'M', 'net_profit': 15.87}, {'period': ""Q4 '23"", 'revenue': 140.01, 'unit': 'M', 'net_profit': 12.04}]",3.26,3.26,949789000,373530000,69203000,508627000,116370000,9265000,128069000,68253000,59956000,-0.1721159839938871,-0.4452194877490485,-0.43598615916955025,"[0.07, 0.1]","['2025-07-15', '1999-01-07']",__nan__,0.5355157829791669
132,BENE,Benessere Capital Acquisition Corp. Class A Common Stock,"Benessere Capital Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the technology-focused companies in the North, Central, and South America. The company was incorporated in 2020 and is based in Miami, Florida.",,Shell Companies,10.44,USD,0,https://images.financialmodelingprep.com/symbol/BENE.png,30136,-62.142857142857146,0,20259,2057947,5787234,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.79}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -38.77}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.45}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.2}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.63}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 839.92}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -941.35}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.16}]",0.39,0.39,220.02000000000044,160.457,117.191,11352,0,116784,876.128,117.191,-997685,54.08091307712149,150.2709311323188,151,__nan__,__nan__,__nan__,51.59530951731651
133,BENER,Benessere Capital Acquisition Corp. Right,,,,0.0028,USD,0,https://images.financialmodelingprep.com/symbol/BENER.png,74426,0,-0.0012,328803,2057947,5787234,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.79}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -38.77}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.45}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.2}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.63}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 839.92}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -941.35}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.16}]",0.39,0.39,220.02000000000044,160.457,117.191,11352,0,116784,876.128,117.191,-997685,54.08091307712149,150.2709311323188,151,__nan__,__nan__,__nan__,51.59530951731651
134,BENEU,Benessere Capital Acquisition Corp. Unit,"Benessere Capital Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the technology-focused companies in the North, Central, and South America. The company was incorporated in 2020 and is based in Miami, Florida.",Mr. Patrick F.  Orlando,Shell Companies,10.4201,USD,0,https://images.financialmodelingprep.com/symbol/BENEU.png,58,-62.02440476190476,-0.5249,1078,2057947,5787234,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.79}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -38.77}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.45}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.2}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.63}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 839.92}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -941.35}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.16}]",0.39,0.39,220.02000000000044,160.457,117.191,11352,0,116784,876.128,117.191,-997685,54.08091307712149,150.2709311323188,151,__nan__,__nan__,__nan__,51.59530951731651
135,BENEW,Benessere Capital Acquisition Corp. Warrant,,,Shell Companies,0.0025,USD,0,https://images.financialmodelingprep.com/symbol/BENEW.png,100921,0,0,419955,2057947,5787234,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.79}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -38.77}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.45}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.2}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.63}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 839.92}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -941.35}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.16}]",0.39,0.39,220.02000000000044,160.457,117.191,11352,0,116784,876.128,117.191,-997685,54.08091307712149,150.2709311323188,151,__nan__,__nan__,__nan__,51.59530951731651
136,BFC,Bank First Corporation Common Stock,"Bank First Corporation operates as a holding company for Bank First N.A. that provides consumer and commercial financial services to businesses, professionals, consumers, associations, individuals, and governmental authorities in Wisconsin. The company offers checking, savings, money market, cash management, retirement, and health savings accounts; other time deposits; certificates of deposit; and residential mortgage products. It also provides credit cards; ATM processing; insurance; data processing and other information technology; investment and safekeeping; treasury management; and online, telephone, and mobile banking services. The company's loan products include real estate loans, including commercial real estate, residential mortgage, and home equity loans; commercial and industrial loans for working capital, accounts receivable, inventory financing, and other business purposes; construction and development loans; residential 1-4 family loans; and consumer loans for personal and household purposes, including secured and unsecured installment loans, and revolving lines of credit. It operates through 21 offices in Manitowoc, Outagamie, Brown, Winnebago, Sheboygan, Waupaca, Ozaukee, Monroe, and Jefferson counties in Wisconsin. The company was formerly known as Bank First National Corporation and changed its name to Bank First Corporation in June 2019. Bank First Corporation was founded in 1894 and is headquartered in Manitowoc, Wisconsin.",Mr. Michael B. Molepske,Banks - Regional,115.7,USD,1147480204,https://images.financialmodelingprep.com/symbol/BFC.png,26695,16.99,-1.27,23107,0,65563000,"[{'period': '2024', 'revenue': 206.41, 'unit': 'M', 'net_profit': 65.56}, {'period': '2023', 'revenue': 179.01, 'unit': 'M', 'net_profit': 74.51}, {'period': '2022', 'revenue': 118.32, 'unit': 'M', 'net_profit': 45.21}, {'period': '2021', 'revenue': 108.48, 'unit': 'M', 'net_profit': 45.44}]","[{'period': ""Q1 '25"", 'revenue': 60.45, 'unit': 'M', 'net_profit': 18.24}, {'period': ""Q4 '24"", 'revenue': 40.18, 'unit': 'M', 'net_profit': 17.54}, {'period': ""Q3 '24"", 'revenue': 39.71, 'unit': 'M', 'net_profit': 16.55}, {'period': ""Q2 '24"", 'revenue': 54.31, 'unit': 'M', 'net_profit': 16.06}, {'period': ""Q1 '24"", 'revenue': 52.7, 'unit': 'M', 'net_profit': 15.41}, {'period': ""Q4 '23"", 'revenue': 42.87, 'unit': 'M', 'net_profit': 34.9}]",6.62,6.58,4495060000,282225000,282225000,3855377000,0,22643000,1778806000,59164000,58622000,-1,-0.12012507716670692,-0.09065934065934067,"[0.45, 0.105]","['2025-06-25', '2010-11-24']",__nan__,0.8576919996618511
137,BFI,BurgerFi International Inc. Common Stock ,"BurgerFi International, Inc., together with its subsidiaries, owns and franchises fast-casual and premium-casual dining restaurants. Its restaurants offer burgers, hot dogs, crispy chicken, frozen custard, hand-cut fries, shakes, beer, wine, pizza, coal fired chicken wings, homemade meatballs, and a variety of handcrafted sandwiches and salads. As of March 31, 2022, the company has 185 franchised and corporate-owned restaurants. The company was formerly known as Opes Acquisition Corp. and changed its name to BurgerFi International, Inc. in December 2020. BurgerFi International, Inc. was founded in 2011 and is headquartered in Fort Lauderdale, Florida.",Mr. Carl J. Bachmann,Restaurants,0.083,USD,2274491,https://images.financialmodelingprep.com/symbol/BFI.png,12823115,-0.07904761904761905,0,15054439,-9002000,-30708000,"[{'period': '2023', 'revenue': 170.1, 'unit': 'M', 'net_profit': -30.71}, {'period': '2022', 'revenue': 178.72, 'unit': 'M', 'net_profit': -103.43}, {'period': '2021', 'revenue': 68.87, 'unit': 'M', 'net_profit': -121.49}, {'period': '2020', 'revenue': 32299.999999999996, 'unit': 'K', 'net_profit': 488.0}]","[{'period': ""Q1 '24"", 'revenue': 42.88, 'unit': 'M', 'net_profit': -6.54}, {'period': ""Q4 '23"", 'revenue': 41.47, 'unit': 'M', 'net_profit': -10.6}, {'period': ""Q3 '23"", 'revenue': 39.48, 'unit': 'M', 'net_profit': -4.96}, {'period': ""Q2 '23"", 'revenue': 43.43, 'unit': 'M', 'net_profit': -6.0}, {'period': ""Q1 '23"", 'revenue': 45.73, 'unit': 'M', 'net_profit': -13.38}, {'period': ""Q4 '22"", 'revenue': 45.23, 'unit': 'M', 'net_profit': -26.16}]",-1.2,-1.2,258476000,12500000,7556000,201226000,1368000,0,82692000,7556000,-7886000,0.9051002551181766,0.7031092891948333,0.7424892703862661,__nan__,__nan__,__nan__,0.7785094167350161
138,BFIIW,BurgerFi International Inc. Warrant ,"BurgerFi International, Inc., together with its subsidiaries, owns and franchises fast-casual and premium-casual dining restaurants. Its restaurants offer burgers, hot dogs, crispy chicken, frozen custard, hand-cut fries, shakes, beer, wine, pizza, coal fired chicken wings, homemade meatballs, and a variety of handcrafted sandwiches and salads. The company was formerly known as Opes Acquisition Corp. and changed its name to BurgerFi International, Inc. in December 2020. The company was founded in 2011 and is headquartered in Fort Lauderdale, Florida.",Mr. Carl J. Bachmann,Restaurants,0.009,USD,242318,https://images.financialmodelingprep.com/symbol/BFIIW.png,0,0,0.0014,121426,-913000,-30708000,"[{'period': '2023', 'revenue': 170.1, 'unit': 'M', 'net_profit': -30.71}, {'period': '2022', 'revenue': 178.72, 'unit': 'M', 'net_profit': -103.43}, {'period': '2021', 'revenue': 68.87, 'unit': 'M', 'net_profit': -121.49}, {'period': '2020', 'revenue': 32299.999999999996, 'unit': 'K', 'net_profit': 488.0}]","[{'period': ""Q1 '24"", 'revenue': 42.88, 'unit': 'M', 'net_profit': -6.54}, {'period': ""Q4 '23"", 'revenue': 41.47, 'unit': 'M', 'net_profit': -10.6}, {'period': ""Q3 '23"", 'revenue': 39.48, 'unit': 'M', 'net_profit': -4.96}, {'period': ""Q2 '23"", 'revenue': 43.43, 'unit': 'M', 'net_profit': -6.0}, {'period': ""Q1 '23"", 'revenue': 45.73, 'unit': 'M', 'net_profit': -13.38}, {'period': ""Q4 '22"", 'revenue': 45.23, 'unit': 'M', 'net_profit': -26.16}]",-1.2,-1.2,258476000,12500000,7556000,145597000,1368000,149633000,82692000,7556000,-7886000,0.9903750869721056,0.7031092891948333,0.7424892703862661,__nan__,__nan__,__nan__,0.5632902087621288
139,BFIN,BankFinancial Corporation Common Stock,"BankFinancial Corporation operates as the bank holding company for BankFinancial, National Association that provides various commercial, family, and personal banking products and services. The company accepts various deposit products, including savings, NOW, checking, money market, IRA, and other retirement accounts, as well as certificates of deposit. Its loan products include multi-family and nonresidential real estate, construction and land, and commercial loans and leases; one-to-four family residential mortgage loans, including home equity loans and lines of credit; and consumer loans. The company also provides cash management, funds transfer, bill payment, other online and mobile banking transactions, automated teller machines, safe deposit boxes, trust, wealth management, and general insurance agency services. In addition, it offers financial planning services; and sells property and casualty, and other insurance products on an agency basis. The company operates 19 full-service banking offices located in Cook, DuPage, Lake, and Will Counties, Illinois. BankFinancial Corporation was founded in 1924 and is headquartered in Burr Ridge, Illinois.",Mr. F. Morgan Gasior,Banks - Regional,12.21,USD,152145147,https://images.financialmodelingprep.com/symbol/BFIN.png,18144,33.92,0.17,10476,0,4073000,"[{'period': '2024', 'revenue': 49.2, 'unit': 'M', 'net_profit': 4.07}, {'period': '2023', 'revenue': 55.93, 'unit': 'M', 'net_profit': 9.39}, {'period': '2022', 'revenue': 56.79, 'unit': 'M', 'net_profit': 10.49}, {'period': '2021', 'revenue': 49.46, 'unit': 'M', 'net_profit': 7.41}]","[{'period': ""Q1 '25"", 'revenue': 16.31, 'unit': 'M', 'net_profit': 2.08}, {'period': ""Q4 '24"", 'revenue': 8.6, 'unit': 'M', 'net_profit': -1.76}, {'period': ""Q3 '24"", 'revenue': 18.39, 'unit': 'M', 'net_profit': 1.99}, {'period': ""Q2 '24"", 'revenue': 18.94, 'unit': 'M', 'net_profit': 2.13}, {'period': ""Q1 '24"", 'revenue': 18.77, 'unit': 'M', 'net_profit': 1.71}, {'period': ""Q4 '23"", 'revenue': 18.57, 'unit': 'M', 'net_profit': 2.08}]",0.33,0.33,1434814000,20647000,20647000,1278437000,0,0,0,20647000,5469000,0,-0.566379218567018,-0.5540540540540541,"[0.1, 0.06]","['2025-05-09', '2006-05-01']",__nan__,0.8910123542145533
140,BFRA,Biofrontera AG American Depositary Shares,"Biofrontera AG, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin. Its principal product is Ameluz, a prescription drug for the treatment of lesion-directed and field-directed actinic keratosis. The company also offers BF-RhodoLED lamp, a photodynamic therapy for lesion-directed and field-directed treatment of actinic keratosis; and Belixos, an over-the-counter line of skin care cosmetic products. In addition, it is developing Ameluz for the treatment of field cancerization and nodular basal cell carcinoma. Further, the company's product portfolio includes Xepi, a prescription antibiotic cream for the treatment of impetigo; and Aktipak, a generic drug for the treatment of acne. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.",Dr. Hermann Lbbert,Biotechnology,2.67,USD,0,https://images.financialmodelingprep.com/symbol/BFRA.png,30523,-4.348534201954397,-0.07999992,4951,-4284000,-13023000,"[{'period': '2020', 'revenue': 30.35, 'unit': 'M', 'net_profit': -13.02}, {'period': '2019', 'revenue': 31.27, 'unit': 'M', 'net_profit': -7.64}, {'period': '2018', 'revenue': 21.11, 'unit': 'M', 'net_profit': -8.88}, {'period': '2017', 'revenue': 12.03, 'unit': 'M', 'net_profit': -16.1}]","[{'period': ""Q3 '21"", 'revenue': 5.38, 'unit': 'M', 'net_profit': -5.73}, {'period': ""Q2 '21"", 'revenue': 7.62, 'unit': 'M', 'net_profit': -4.0}, {'period': ""Q1 '21"", 'revenue': 5.48, 'unit': 'M', 'net_profit': -4.88}, {'period': ""Q4 '20"", 'revenue': 9.52, 'unit': 'M', 'net_profit': -2.12}, {'period': ""Q3 '20"", 'revenue': 4.71, 'unit': 'M', 'net_profit': -5.5}, {'period': ""Q2 '20"", 'revenue': 9640.0, 'unit': 'K', 'net_profit': 93.0}]",-0.47,-0.47,56390000,26126000,17077000,49016000,3506000,0,8286000,16546000,-3623000,-6.3283582089552235,-0.7036891679748822,-0.4242424242424241,"[0.1039, 0.0221]","['2021-02-24', '2020-03-18']",__nan__,0.8692321333569782
141,BFST,Business First Bancshares Inc. Common Stock,"Business First Bancshares, Inc. operates as the bank holding company for b1BANK that provides various banking products and services. It offers various deposit products and services, including checking, demand, money market, time, and savings accounts; and certificates of deposits, remote deposit capture, and direct deposit services. The company also provides commercial and industrial loans, such as commercial lines of credit, letters of credit, working capital, term, equipment financing, asset acquisition, expansion and development, borrowing base, and other loan products; construction and development loans; commercial real estate loans; residential real estate loans comprising first and second lien 1-4 family mortgage loans, and home equity lines of credit; and consumer loans, including secured and unsecured installment and term loans. In addition, it offers wealth management products, including mutual funds, annuities, individual retirement accounts, and other financial products, as well as other fiduciary services and private banking products and services. Further, the company provides a range of other financial services comprising debit and credit cards, treasury and cash management, merchant, automated clearing house, lock-box, receivables factoring, correspondent banking, and other treasury services, as well as employee and payroll benefits solutions; and drive-through banking facilities, automated teller machines, night depository, personalized checks, electronic funds transfer, domestic and foreign wire transfer, traveler's checks, vault, loan and deposit sweep accounts, online and mobile banking, e-statements, and bank-by-mail services. As of March 01, 2022, it operates approximately 48 full-service banking centers and three loan production offices across Louisiana, and in the Dallas and Houston markets. Business First Bancshares, Inc. was incorporated in 2006 and is headquartered in Baton Rouge, Louisiana.",Mr. David R. Melville III,Banks - Regional,23.73,USD,704662350,https://images.financialmodelingprep.com/symbol/BFST.png,102973,9.77,-0.68,52123,0,65107000,"[{'period': '2024', 'revenue': 270.37, 'unit': 'M', 'net_profit': 65.11}, {'period': '2023', 'revenue': 247.42, 'unit': 'M', 'net_profit': 71.04}, {'period': '2022', 'revenue': 227.54, 'unit': 'M', 'net_profit': 54.26}, {'period': '2021', 'revenue': 186.56, 'unit': 'M', 'net_profit': 52.14}]","[{'period': ""Q1 '25"", 'revenue': 77.83, 'unit': 'M', 'net_profit': 20.54}, {'period': ""Q4 '24"", 'revenue': 77.4, 'unit': 'M', 'net_profit': 16.49}, {'period': ""Q3 '24"", 'revenue': 66.55, 'unit': 'M', 'net_profit': 17.84}, {'period': ""Q2 '24"", 'revenue': 111.65, 'unit': 'M', 'net_profit': 17.21}, {'period': ""Q1 '24"", 'revenue': 105.1, 'unit': 'M', 'net_profit': 13.57}, {'period': ""Q4 '23"", 'revenue': 100.56, 'unit': 'M', 'net_profit': 15.82}]",2.27,2.26,7857090000,7175078000,1212647000,7057624000,5962431000,69758000,5988949000,319098000,59840000,0,-0.0835550300522219,-0.133587786259542,"[0.14, 0.08]","['2025-05-15', '2018-05-14']",__nan__,0.8982490973121092
142,BGCP,BGC Partners Inc Class A Common Stock,"BGC Partners, Inc. operates as a financial brokerage and technology company in the United States, France, other Europe, the United Kingdom, other Americas, Asia, Australia, Africa, and the Middle East. It offers various brokerage products, such as fixed income, such as government bonds, corporate bonds, and other debt instruments, as well as related interest rate derivatives and credit derivatives; and fixed income, equity derivatives and cash equities, energy and commodities, shipping, insurance, and futures and options. The company also provides trade execution, brokerage, clearing, trade compression, post-trade, information, consulting, and other back office services to financial and non-financial institutions. In addition, it offers electronic and hybrid brokerage, other financial technology solutions, market data and related information services, and analytics related to financial instrument and markets under the Fenics, FMX, BGC Trader, CreditMatch, Fenics Market Data, Fenics GO, BGC Market Data, kACE2, Capitalab, Swaptioniser, CBID, Lucera, and LumeAlfa brand names. Further, the company provides screen-based market solutions, which enable its clients to develop a marketplace, trade with their customers, issue debt, trade odd lots, access program trading interfaces, and access its network and intellectual property; option pricing and analysis tools; and software and technology infrastructure for the transactional and technology related elements. It primarily serves banks, broker-dealers, investment banks, trading firms, hedge funds, governments, and corporations, as well as investment firms. BGC Partners, Inc. was founded in 1945 and is headquartered in New York, New York.",Mr. Howard W. Lutnick,Financial - Capital Markets,4.43,USD,1734216446,https://images.financialmodelingprep.com/symbol/BGCP.png,2433100,40.27272727272727,0.06,3475885,0,121215000,"[{'period': '2024', 'revenue': 2260.0, 'unit': 'M', 'net_profit': 121.22}, {'period': '2023', 'revenue': 2029.9999999999998, 'unit': 'M', 'net_profit': 34.07}, {'period': '2022', 'revenue': 1800.0, 'unit': 'M', 'net_profit': 48.71}, {'period': '2021', 'revenue': 2020.0, 'unit': 'M', 'net_profit': 124.01}]","[{'period': ""Q1 '25"", 'revenue': 664.24, 'unit': 'M', 'net_profit': 52.78}, {'period': ""Q4 '24"", 'revenue': 754.18, 'unit': 'M', 'net_profit': 105.97}, {'period': ""Q3 '24"", 'revenue': 561.11, 'unit': 'M', 'net_profit': 14.19}, {'period': ""Q2 '24"", 'revenue': 550.76, 'unit': 'M', 'net_profit': 36.05}, {'period': ""Q3 '23"", 'revenue': 482.69, 'unit': 'M', 'net_profit': 15.97}, {'period': ""Q2 '23"", 'revenue': 493.08, 'unit': 'M', 'net_profit': -19.7}]",0.26,0.25,3591967000,1077074000,711584000,2512728000,365490000,0,0,711584000,66948000,-1,2.557822130906956,2.741007194244604,"[0.01, 0.2021]","['2023-05-16', '2008-09-11']",__nan__,0.6995409478984634
143,BGFV,Big 5 Sporting Goods Corporation Common Stock,"Big 5 Sporting Goods Corporation operates as a sporting goods retailer in the western United States. The company's products include athletic shoes, apparel, and accessories. It also offers a selection of outdoor and athletic equipment for team sports, fitness, camping, hunting, fishing, tennis, golf, and winter and summer recreation, as well as home recreation. The company also provides private label items, such as shoes, apparel, camping equipment, fishing supplies, and snow sport equipment. It sells private label merchandise under its own trademarks comprising Golden Bear, Harsh, Pacifica, and Rugged Exposure. As of May 03, 2022, the company operated 431 stores. It also operates an e-commerce platform under the Big 5 Sporting Goods name. The company was founded in 1955 and is headquartered in El Segundo, California.",Mr. Steven G. Miller,Specialty Retail,1.17,USD,26740467,https://images.financialmodelingprep.com/symbol/BGFV.png,290759,-0.33,-0.04,163069,-36443000,-69072000,"[{'period': '2024', 'revenue': 795.47, 'unit': 'M', 'net_profit': -69.07}, {'period': '2023', 'revenue': 884.75, 'unit': 'M', 'net_profit': -7.08}, {'period': '2022', 'revenue': 995.54, 'unit': 'M', 'net_profit': 26.13}, {'period': '2021', 'revenue': 1160.0, 'unit': 'M', 'net_profit': 102.39}]","[{'period': ""Q1 '25"", 'revenue': 175.65, 'unit': 'M', 'net_profit': -17.25}, {'period': ""Q4 '24"", 'revenue': 181.62, 'unit': 'M', 'net_profit': -20.88}, {'period': ""Q3 '24"", 'revenue': 220.6, 'unit': 'M', 'net_profit': -29.9}, {'period': ""Q2 '24"", 'revenue': 199.82, 'unit': 'M', 'net_profit': -10.0}, {'period': ""Q1 '24"", 'revenue': 193.43, 'unit': 'M', 'net_profit': -8.29}, {'period': ""Q4 '23"", 'revenue': 196.35, 'unit': 'M', 'net_profit': -8.85}]",-3.15,-3.15,609366000,286169000,5418000,433755000,10252000,0,202604000,5418000,-22320000,-5.45731409001957,-8.751800084709869,-8.545454545454545,"[0.05, 0.07]","['2024-05-31', '2004-11-29']",__nan__,0.7118135898622503
144,BGNE,BeiGene Ltd. American Depositary Shares,"BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; XGEVA to treat giant cell tumor of bone; BLINCYTO to treat acute lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; SYLVANT to treat idiopathic multicentric castleman disease; QARZIBA to treat neuroblastoma; Pamiparib for the treatment of various solid tumors; and Pobevcy to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC). The company's clinical stage drug candidates comprise Zanubrutinib, a BTK inhibitor to treat lymphomas; Tislelizumab, an anti-PD-1 antibody to treat solid and hematological cancers; Lifirafenib and BGB-3245 to treat melanoma, NSCLC, and endometrial cancer; and Sitravatinib, a multi-kinase inhibitor to treat NSCLC, melanoma, and other solid tumors. Its clinical stage drug candidates also include BGB-A333, a PD-L1 inhibitor to treat various solid tumors; Ociperlimab, a TIGIT inhibitor to treat various solid tumors; BGB-11417, a small molecule Bcl-2 inhibitor to treat mature B-cell malignancies; BGB-A445, an OX40 agonist antibody to treat solid tumors; Zanidatamab, a bispecific HER2 inhibitor to treat breast and gastric cancer; BGB-A425, a T-cell immunoglobulin and mucin-domain containing-3 inhibitor to treat various solid tumors; and BGB-15025, a small molecule inhibitor of HPK1. The company has strategic collaborations with Shoreline Biosciences, Inc., Amgen Inc., Novartis AG, and Bristol Myers Squibb company. BeiGene, Ltd. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.",Mr. John V. Oyler,Biotechnology,184.71,USD,20209121100,https://images.financialmodelingprep.com/symbol/BGNE.png,357765,-22.553113553113555,0.9,329397,-396437000,-644786000,"[{'period': '2024', 'revenue': 3810.0, 'unit': 'M', 'net_profit': -644.79}, {'period': '2023', 'revenue': 2460.0, 'unit': 'M', 'net_profit': -881.71}, {'period': '2022', 'revenue': 1.42, 'unit': 'B', 'net_profit': -2.0}, {'period': '2021', 'revenue': 1.18, 'unit': 'B', 'net_profit': -1.41}]","[{'period': ""Q1 '25"", 'revenue': 1120.0, 'unit': 'M', 'net_profit': 1.27}, {'period': ""Q4 '24"", 'revenue': 1130.0, 'unit': 'M', 'net_profit': -151.88}, {'period': ""Q3 '24"", 'revenue': 1000.0, 'unit': 'M', 'net_profit': -121.35}, {'period': ""Q2 '24"", 'revenue': 929.17, 'unit': 'M', 'net_profit': -120.41}, {'period': ""Q1 '24"", 'revenue': 751.65, 'unit': 'M', 'net_profit': -251.15}, {'period': ""Q4 '23"", 'revenue': 0.63441, 'unit': 'B', 'net_profit': -2.66}]",-79.43,-6.11,5920910000,3991593000,2627410000,2588688000,709106000,128933000,2214899000,2627410000,-669768000,0.6460576700733264,0.26870800763971747,-8.4,__nan__,__nan__,__nan__,0.4372111719313416
145,BHAT,Blue Hat Interactive Entertainment Technology Ordinary Shares,"Fujian Blue Hat Interactive Entertainment Technology Ltd. engages in the designing, producing, promoting, and selling animated toys with mobile games features, intellectual property, and peripheral derivatives features worldwide. It offers AR Racer, a car-racing mobile game; AR Crazy Bug, a combat game played using a ladybug-shaped electronic toy; AR 3D Magic Box, which uses AR recognition technology to allow children to draw shapes or objects onto a physical card while the mobile game captures the drawings and animates them onto a set background; AR Dinosaur, an educational toy; 'Talking Tom and Friends' Bouncing Bubble, which enables children to bounce and play with bubbles; and AR Shake Bouncing Bubble, which helps children to improve concentration and reaction. The company also holds license to sell products with WUHUANGWANSHUI brand images. Its distribution channels include domestic distributors, e-commerce platforms, supermarkets, and export distributors. Fujian Blue Hat Interactive Entertainment Technology Ltd. was incorporated in 2010 and is based in Xiamen, China.",Mr. Xiaodong  Chen,Electronic Gaming & Multimedia,1.82,USD,8987542,https://images.financialmodelingprep.com/symbol/BHAT.png,741614,,-0.04,52346,-9132157,-9524783,"[{'period': '2024', 'revenue': 18.72, 'unit': 'M', 'net_profit': -9.52}, {'period': '2023', 'revenue': 73.69, 'unit': 'M', 'net_profit': -19.3}, {'period': '2022', 'revenue': 2.2, 'unit': 'M', 'net_profit': -9.37}, {'period': '2021', 'revenue': 12.14, 'unit': 'M', 'net_profit': -58.63}]","[{'period': ""Q2 '22"", 'revenue': 1.69, 'unit': 'M', 'net_profit': -3.44}, {'period': ""Q4 '21"", 'revenue': -16.1, 'unit': 'M', 'net_profit': -63.45}, {'period': ""Q3 '21"", 'revenue': 13.32, 'unit': 'M', 'net_profit': 2.02}, {'period': ""Q2 '21"", 'revenue': 8000.0, 'unit': 'K', 'net_profit': 150.62}, {'period': ""Q1 '21"", 'revenue': 9.94, 'unit': 'M', 'net_profit': 1.23}, {'period': ""Q4 '20"", 'revenue': 21.37, 'unit': 'M', 'net_profit': 5.36}]",-16290,-16290,75232436,70064559,14300,43089618,5469522,0,40648112,14300,-884952,0.6784123039055717,0.5064372413788815,-4666.6217765042975,__nan__,__nan__,__nan__,0.5727531938484619
146,BHF,Brighthouse Financial Inc. Common Stock,"Brighthouse Financial, Inc. provides annuity and life insurance products in the United States. It operates through three segments: Annuities, Life, and Run-off. The Annuities segment offers variable, fixed, index-linked, and income annuities for contract holders' needs for protected wealth accumulation on a tax-deferred basis, wealth transfer, and income security. The Life segment provides term, universal, whole, and variable life policies for policyholders' needs for financial security and protected wealth transfer. The Run-off segment manages structured settlements, pension risk transfer contracts, certain company-owned life insurance policies, funding agreements, and universal life with secondary guarantees. The company was incorporated in 2016 and is based in Charlotte, North Carolina.",Mr. Eric Thomas Steigerwalt,Insurance - Life,58.33,USD,3348666970,https://images.financialmodelingprep.com/symbol/BHF.png,933096,7.46,-2.82,767295,574000000,388000000,"[{'period': '2024', 'revenue': 4370.0, 'unit': 'M', 'net_profit': 388.0}, {'period': '2023', 'revenue': 4.12, 'unit': 'B', 'net_profit': -1.11}, {'period': '2022', 'revenue': 8470.0, 'unit': 'M', 'net_profit': 10.0}, {'period': '2021', 'revenue': 7140.0, 'unit': 'M', 'net_profit': -103.0}]","[{'period': ""Q1 '25"", 'revenue': 2390.0, 'unit': 'M', 'net_profit': -268.0}, {'period': ""Q4 '24"", 'revenue': 1080.0, 'unit': 'M', 'net_profit': 671.0}, {'period': ""Q3 '24"", 'revenue': 2020.0, 'unit': 'M', 'net_profit': 176.0}, {'period': ""Q2 '24"", 'revenue': 1430.0, 'unit': 'M', 'net_profit': 34.0}, {'period': ""Q1 '24"", 'revenue': 74.0, 'unit': 'M', 'net_profit': -493.0}, {'period': ""Q4 '23"", 'revenue': 737.0, 'unit': 'M', 'net_profit': -917.0}]",6.88,4.64,238537000000,108113000000,86968000000,234244000000,0,115519000000,3891000000,5045000000,-290000000,0,1.3489208633093526,1.3929183323814962,__nan__,__nan__,__nan__,0.9820027920196867
147,BHFAL,Brighthouse Financial Inc. 6.25% Junior Subordinated Debentures due 2058,"Brighthouse Financial, Inc. operates as a holding company, which engages in the provision of life insurance and annuities through independent distribution channels and marketing arrangements with a diverse network of distribution partners. It operates through the following segments: Annuities, Life, Run-Off, and Corporate & Others. The Annuities segment product offerings include fixed, structured, income and variable annuities. The Life segment manufactures products to serve its target segments through a broad independent distribution network. The Run-Off segment includes structured settlements, pension risk transfer contracts, certain company-owned life insurance policies, funding agreements and universal life with secondary guarantees. The Corporate & Other segment refers to the general account investments and the separate account assets of the company. The company was founded in June 1863 and is headquartered in Charlotte, NC.",None,Insurance - Life,20.0,USD,3434708820,https://images.financialmodelingprep.com/symbol/BHFAL.png,24724,-4.12,-0.44,23544,574000000,388000000,"[{'period': '2024', 'revenue': 4370.0, 'unit': 'M', 'net_profit': 388.0}, {'period': '2023', 'revenue': 4.12, 'unit': 'B', 'net_profit': -1.11}, {'period': '2022', 'revenue': 8470.0, 'unit': 'M', 'net_profit': 10.0}, {'period': '2021', 'revenue': 7140.0, 'unit': 'M', 'net_profit': -103.0}]","[{'period': ""Q1 '25"", 'revenue': 2390.0, 'unit': 'M', 'net_profit': -268.0}, {'period': ""Q4 '24"", 'revenue': 1080.0, 'unit': 'M', 'net_profit': 671.0}, {'period': ""Q3 '24"", 'revenue': 2020.0, 'unit': 'M', 'net_profit': 176.0}, {'period': ""Q2 '24"", 'revenue': 1430.0, 'unit': 'M', 'net_profit': 34.0}, {'period': ""Q1 '24"", 'revenue': 74.0, 'unit': 'M', 'net_profit': -493.0}, {'period': ""Q4 '23"", 'revenue': 737.0, 'unit': 'M', 'net_profit': -917.0}]",6.88,4.64,238537000000,108113000000,86968000000,234244000000,0,115519000000,3891000000,5045000000,-290000000,0,1.3489208633093526,1.3929183323814962,"[0.39063, 0.391]","['2025-02-28', '2019-02-28']",__nan__,0.9820027920196867
148,BHFAN,Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C,"Brighthouse Financial, Inc. provides annuity and life insurance products in the United States. It operates through three segments: Annuities, Life, and Run-off. The Annuities segment offers variable, fixed, index-linked, and income annuities for contract holders' needs for protected wealth accumulation on a tax-deferred basis, wealth transfer, and income security. The Life segment provides term, universal, whole, and variable life policies for policyholders' needs for financial security and protected wealth transfer. The Run-off segment manages structured settlements, pension risk transfer contracts, certain company-owned life insurance policies, funding agreements, and universal life with secondary guarantees. The company was incorporated in 2016 and is based in Charlotte, North Carolina.",Mr. Eric Thomas Steigerwalt,Insurance - Life,16.24,USD,932322160,https://images.financialmodelingprep.com/symbol/BHFAN.png,73531,1.29,-0.23,47913,574000000,388000000,"[{'period': '2024', 'revenue': 4370.0, 'unit': 'M', 'net_profit': 388.0}, {'period': '2023', 'revenue': 4.12, 'unit': 'B', 'net_profit': -1.11}, {'period': '2022', 'revenue': 8470.0, 'unit': 'M', 'net_profit': 10.0}, {'period': '2021', 'revenue': 7140.0, 'unit': 'M', 'net_profit': -103.0}]","[{'period': ""Q1 '25"", 'revenue': 2390.0, 'unit': 'M', 'net_profit': -268.0}, {'period': ""Q4 '24"", 'revenue': 1080.0, 'unit': 'M', 'net_profit': 671.0}, {'period': ""Q3 '24"", 'revenue': 2020.0, 'unit': 'M', 'net_profit': 176.0}, {'period': ""Q2 '24"", 'revenue': 1430.0, 'unit': 'M', 'net_profit': 34.0}, {'period': ""Q1 '24"", 'revenue': 74.0, 'unit': 'M', 'net_profit': -493.0}, {'period': ""Q4 '23"", 'revenue': 737.0, 'unit': 'M', 'net_profit': -917.0}]",6.88,4.64,238537000000,108113000000,86968000000,234244000000,0,115519000000,3891000000,5045000000,-290000000,0,1.3489208633093526,1.3929183323814962,"[0.33594, 0.467]","['2025-03-10', '2021-03-09']",__nan__,0.9820027920196867
149,BHFAO,Brighthouse Financial Inc. Depositary Shares 6.75% Non-Cumulative Preferred Stock Series B,"Brighthouse Financial, Inc. provides annuity and life insurance products in the United States. It operates through three segments: Annuities, Life, and Run-off. The Annuities segment offers variable, fixed, index-linked, and income annuities for contract holders' needs for protected wealth accumulation on a tax-deferred basis, wealth transfer, and income security. The Life segment provides term, universal, whole, and variable life policies for policyholders' needs for financial security and protected wealth transfer. The Run-off segment manages structured settlements, pension risk transfer contracts, certain company-owned life insurance policies, funding agreements, and universal life with secondary guarantees. The company was incorporated in 2016 and is based in Charlotte, North Carolina.",Mr. Eric Thomas Steigerwalt,Insurance - Life,20.06,USD,1151624540,https://images.financialmodelingprep.com/symbol/BHFAO.png,43331,1.59,-0.31,31426,574000000,388000000,"[{'period': '2024', 'revenue': 4370.0, 'unit': 'M', 'net_profit': 388.0}, {'period': '2023', 'revenue': 4.12, 'unit': 'B', 'net_profit': -1.11}, {'period': '2022', 'revenue': 8470.0, 'unit': 'M', 'net_profit': 10.0}, {'period': '2021', 'revenue': 7140.0, 'unit': 'M', 'net_profit': -103.0}]","[{'period': ""Q1 '25"", 'revenue': 2390.0, 'unit': 'M', 'net_profit': -268.0}, {'period': ""Q4 '24"", 'revenue': 1080.0, 'unit': 'M', 'net_profit': 671.0}, {'period': ""Q3 '24"", 'revenue': 2020.0, 'unit': 'M', 'net_profit': 176.0}, {'period': ""Q2 '24"", 'revenue': 1430.0, 'unit': 'M', 'net_profit': 34.0}, {'period': ""Q1 '24"", 'revenue': 74.0, 'unit': 'M', 'net_profit': -493.0}, {'period': ""Q4 '23"", 'revenue': 737.0, 'unit': 'M', 'net_profit': -917.0}]",6.88,4.64,238537000000,108113000000,86968000000,234244000000,0,115519000000,3891000000,5045000000,-290000000,0,1.3489208633093526,1.3929183323814962,"[0.42188, 0.595]","['2025-03-10', '2020-09-09']",__nan__,0.9820027920196867
150,BHFAP,Brighthouse Financial Inc. Depositary Shares 6.6% Non-Cumulative Preferred Stock Series A,"Brighthouse Financial, Inc. provides annuity and life insurance products in the United States. It operates through three segments: Annuities, Life, and Run-off. The Annuities segment offers variable, fixed, index-linked, and income annuities for contract holders' needs for protected wealth accumulation on a tax-deferred basis, wealth transfer, and income security. The Life segment provides term, universal, whole, and variable life policies for policyholders' needs for financial security and protected wealth transfer. The Run-off segment manages structured settlements, pension risk transfer contracts, certain company-owned life insurance policies, funding agreements, and universal life with secondary guarantees. The company was incorporated in 2016 and is based in Charlotte, North Carolina.",Mr. Eric Thomas Steigerwalt,Insurance - Life,19.5,USD,3464084618,https://images.financialmodelingprep.com/symbol/BHFAP.png,38596,1.55,-0.3,58064,574000000,388000000,"[{'period': '2024', 'revenue': 4370.0, 'unit': 'M', 'net_profit': 388.0}, {'period': '2023', 'revenue': 4.12, 'unit': 'B', 'net_profit': -1.11}, {'period': '2022', 'revenue': 8470.0, 'unit': 'M', 'net_profit': 10.0}, {'period': '2021', 'revenue': 7140.0, 'unit': 'M', 'net_profit': -103.0}]","[{'period': ""Q1 '25"", 'revenue': 2390.0, 'unit': 'M', 'net_profit': -268.0}, {'period': ""Q4 '24"", 'revenue': 1080.0, 'unit': 'M', 'net_profit': 671.0}, {'period': ""Q3 '24"", 'revenue': 2020.0, 'unit': 'M', 'net_profit': 176.0}, {'period': ""Q2 '24"", 'revenue': 1430.0, 'unit': 'M', 'net_profit': 34.0}, {'period': ""Q1 '24"", 'revenue': 74.0, 'unit': 'M', 'net_profit': -493.0}, {'period': ""Q4 '23"", 'revenue': 737.0, 'unit': 'M', 'net_profit': -917.0}]",6.88,4.64,238537000000,108113000000,86968000000,234244000000,0,115519000000,3891000000,5045000000,-290000000,0,1.3489208633093526,1.3929183323814962,"[0.4125, 0.413]","['2025-03-10', '2019-06-07']",__nan__,0.9820027920196867
151,BHSE,Bull Horn Holdings Corp. Ordinary Shares,"Bull Horn Holdings Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the sports, entertainment, and brand sectors. The company was incorporated in 2018 and is based in Miami Beach, Florida.",,Shell Companies,11.95,USD,234718303,https://images.financialmodelingprep.com/symbol/BHSE.png,27407,11.95,3.69,1176367,-10054488,-9813602,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.81}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.27}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -40.97}, {'period': '2021', 'revenue': 0.075, 'unit': 'M', 'net_profit': -14.42}]","[{'period': ""Q1 '25"", 'revenue': 0.06287, 'unit': 'M', 'net_profit': -3.06}, {'period': ""Q4 '24"", 'revenue': 1.86, 'unit': 'M', 'net_profit': -1.95}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.83}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.04}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.0}, {'period': ""Q4 '23"", 'revenue': 1.5, 'unit': 'M', 'net_profit': -3.76}]",-5.1,-5.1,8908660,1051292,532885,5041434,0,5691084,4513309,532885,-6649281,0.5012065413681319,0.5385425469130212,-5.144578313253012,__nan__,__nan__,__nan__,0.5659026161061259
152,BHSEU,Bull Horn Holdings Corp. Unit,"Bull Horn Holdings Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the sports, entertainment, and brand sectors. The company was incorporated in 2018 and is based in Miami Beach, Florida.",Mr. Robert  Striar,Shell Companies,12.96,USD,0,https://images.financialmodelingprep.com/symbol/BHSEU.png,743,27.99136069114471,3.36,5787,-10054488,-9813602,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.81}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.27}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -40.97}, {'period': '2021', 'revenue': 0.075, 'unit': 'M', 'net_profit': -14.42}]","[{'period': ""Q1 '25"", 'revenue': 0.06287, 'unit': 'M', 'net_profit': -3.06}, {'period': ""Q4 '24"", 'revenue': 1.86, 'unit': 'M', 'net_profit': -1.95}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.83}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.04}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.0}, {'period': ""Q4 '23"", 'revenue': 1.5, 'unit': 'M', 'net_profit': -3.76}]",-5.1,-5.1,8908660,1051292,532885,5041434,0,5691084,4513309,532885,-6649281,0.5012065413681319,0.5385425469130212,-5.144578313253012,__nan__,__nan__,__nan__,0.5659026161061259
153,BHSEW,Bull Horn Holdings Corp. Warrants,"Bull Horn Holdings Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the sports, entertainment, and brands sectors. The company was founded in 2018 and is based in Miami Beach, Florida.",Mr. Robert  Striar,Shell Companies,0.12,USD,0,https://images.financialmodelingprep.com/symbol/BHSEW.png,0,0,0.0497,1777079,-10054488,-9813602,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.81}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.27}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -40.97}, {'period': '2021', 'revenue': 0.075, 'unit': 'M', 'net_profit': -14.42}]","[{'period': ""Q1 '25"", 'revenue': 0.06287, 'unit': 'M', 'net_profit': -3.06}, {'period': ""Q4 '24"", 'revenue': 1.86, 'unit': 'M', 'net_profit': -1.95}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.83}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.04}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.0}, {'period': ""Q4 '23"", 'revenue': 1.5, 'unit': 'M', 'net_profit': -3.76}]",-5.1,-5.1,8908660,1051292,532885,5041434,0,5691084,4513309,532885,-6649281,0.5012065413681319,0.5385425469130212,-5.144578313253012,__nan__,__nan__,__nan__,0.5659026161061259
154,BHTG,BioHiTech Global Inc. Common Stock,"BioHiTech Global, Inc. engages in the provision of waste management services. The company is headquartered in Chestnut Ridge, New York and currently employs 27 full-time employees. The Company, through its subsidiaries, BioHiTech America, LLC and BioHiTech Europe Limited, offers its customers various technologies integrating technological, biological and mechanical engineering solutions for the control, reduction and/or reuse of organic waste. The company has a distribution license to sell, lease, use, distribute and manufacture the Eco-Safe Digester product. The Eco-Safe Digester is a data-driven, network-based mechanical/biological technology, which transforms food waste into nutrient-neutral water that can be disposed of via conventional sanitary sewer systems. The Eco-Safe Digester may be used by businesses in food service, hospitality, healthcare, government, conference centers, education centers or stadiums. Its Internet enabled system, the BioHiTech Cloud, streams data from the digesters, collects information from system users and integrates business application data.",Mr. Frank E. Celli,Industrial - Pollution & Treatment Controls,0.837,USD,29461982,https://images.financialmodelingprep.com/symbol/BHTG.png,447030,-2.551829268292683,-0.01309997,164762,-17517852,-15741839,"[{'period': '2020', 'revenue': 5.88, 'unit': 'M', 'net_profit': -15.74}, {'period': '2019', 'revenue': 4.22, 'unit': 'M', 'net_profit': -7.62}, {'period': '2018', 'revenue': 3.36, 'unit': 'M', 'net_profit': -14.67}, {'period': '2017', 'revenue': 2.42, 'unit': 'M', 'net_profit': -8.35}]","[{'period': ""Q3 '21"", 'revenue': 3940.0, 'unit': 'K', 'net_profit': 25.79}, {'period': ""Q2 '21"", 'revenue': 3.45, 'unit': 'M', 'net_profit': -2.38}, {'period': ""Q1 '21"", 'revenue': 3.04, 'unit': 'M', 'net_profit': -1.63}, {'period': ""Q4 '20"", 'revenue': 2500.0, 'unit': 'K', 'net_profit': -7.21}, {'period': ""Q3 '20"", 'revenue': 0.74288, 'unit': 'M', 'net_profit': -3.29}, {'period': ""Q2 '20"", 'revenue': 1.27, 'unit': 'M', 'net_profit': -2.66}]",-0.65,-0.65,56686425,6741981,3115161,52605248,1574047,711302,18349491,2403859,-8758207,-5.96236997610565,-1.0650592133122252,-0.32653061224489804,__nan__,__nan__,__nan__,0.9280043326069689
155,BIDU,Baidu Inc. ADS,"Baidu, Inc. provides online marketing and cloud services through an internet platform in the People's Republic of China. It operates in two segments, Baidu Core and iQIYI. The Baidu Core segment offers search-based, feed-based, and other online marketing services; cloud services; and products and other services from AI initiatives. This segment also operates Haokan, a user generated and professionally produced short videos platform. The iQIYI segment operates an online entertainment video platform that offers original, professionally produced, and partner-generated content. The company was incorporated in 2000 and is headquartered in Beijing, the People's Republic of China.",Mr. Yanhong  Li,Internet Content & Information,85.48,USD,29537529204,https://images.financialmodelingprep.com/symbol/BIDU.png,4592026,9.35,-3.86,16540924,35949000000,23760000000,"[{'period': '2024', 'revenue': 133.12, 'unit': 'B', 'net_profit': 23.76}, {'period': '2023', 'revenue': 134.6, 'unit': 'B', 'net_profit': 20.32}, {'period': '2022', 'revenue': 123.67, 'unit': 'B', 'net_profit': 7.56}, {'period': '2021', 'revenue': 124.49, 'unit': 'B', 'net_profit': 7.59}]","[{'period': ""Q4 '24"", 'revenue': 34.12, 'unit': 'B', 'net_profit': 5.19}, {'period': ""Q3 '24"", 'revenue': 33.56, 'unit': 'B', 'net_profit': 7.63}, {'period': ""Q2 '24"", 'revenue': 33.93, 'unit': 'B', 'net_profit': 5.49}, {'period': ""Q1 '24"", 'revenue': 34.95, 'unit': 'B', 'net_profit': 2.6}, {'period': ""Q4 '23"", 'revenue': 34.95, 'unit': 'B', 'net_profit': 2.6}, {'period': ""Q3 '23"", 'revenue': 34.45, 'unit': 'B', 'net_profit': 6.68}]",66.48,65.92,427780000000,168849000000,127440000000,144168000000,14280000000,140256000000,80953000000,24832000000,13100000000,-0.016039414260298344,0.16957912872261877,-0.14418125643666327,__nan__,__nan__,__nan__,0.3370143531721913
156,BIGC,BigCommerce Holdings Inc. Series 1 Common Stock,"BigCommerce Holdings, Inc. operates a software-as-a-service platform for small businesses, mid-markets, and large enterprises in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company's platform provides various services for launching and scaling e-commerce operation, including store design, catalog management, hosting, checkout, order management, reporting, and pre-integrations. As of December 31, 2021, it served approximately 60,000 online stores across industries. BigCommerce Holdings, Inc. was founded in 2009 and is headquartered in Austin, Texas.",Mr. Christopher Travis Hess,Software - Application,4.89,USD,391680687,https://images.financialmodelingprep.com/symbol/BIGC.png,817329,-18.11,-0.17,849821,-6153000,-27030000,"[{'period': '2024', 'revenue': 332.93, 'unit': 'M', 'net_profit': -27.03}, {'period': '2023', 'revenue': 309.39, 'unit': 'M', 'net_profit': -64.67}, {'period': '2022', 'revenue': 279.07, 'unit': 'M', 'net_profit': -139.92}, {'period': '2021', 'revenue': 219.85, 'unit': 'M', 'net_profit': -76.68}]","[{'period': ""Q1 '25"", 'revenue': 82370.0, 'unit': 'K', 'net_profit': -353.0}, {'period': ""Q4 '24"", 'revenue': 87.03, 'unit': 'M', 'net_profit': -2.39}, {'period': ""Q3 '24"", 'revenue': 83.71, 'unit': 'M', 'net_profit': -6.99}, {'period': ""Q2 '24"", 'revenue': 81.83, 'unit': 'M', 'net_profit': -11.26}, {'period': ""Q1 '24"", 'revenue': 80.36, 'unit': 'M', 'net_profit': -6.39}, {'period': ""Q4 '23"", 'revenue': 84.15, 'unit': 'M', 'net_profit': -3.18}]",-0.35,-0.35,340289000,251219000,178160000,306920000,48117000,0,88006000,88877000,22533000,0.8752078854500467,0.5820383170199935,0.5930232558139535,__nan__,__nan__,__nan__,0.9019392340040377
157,BIIB,Biogen Inc. Common Stock,"Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for treating relapsing MS and primary progressive MS; and other anti-CD20 therapies. Further, it develops BIIB135, BIIB061, BIIB091, and BIIB107 for MS and neuroimmunology; Aducanumab, Lecanemab, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB067, BIIB078, BIIB105, BIIB100, and BIIB110 to treat neuromuscular disorders; BIIB124, BIIB094, BIIB118, BIIB101, and BIIB122 for treating Parkinson's disease and movement disorders; BIIB125 and BIIB104 for treating neuropsychiatry; Dapirolizumab pegol and BIIB059 to treat immunology related diseases; BIIB093 and BIIB131 to treat acute neurology; BIIB074 for neuropathic pain; and BYOOVIZ, BIIB800, and SB15 biosimilars, which are under various stages of development. The company has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis Co., Ltd.; Sangamo Therapeutics, Inc.; and Sage Therapeutics, Inc. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts.",Mr. Christopher A. Viehbacher,Drug Manufacturers - General,126.82,USD,18582680960,https://images.financialmodelingprep.com/symbol/BIIB.png,1769231,12.53,-3.73,1510186,0,1632200000,"[{'period': '2024', 'revenue': 9.68, 'unit': 'B', 'net_profit': 1.63}, {'period': '2023', 'revenue': 9.84, 'unit': 'B', 'net_profit': 1.16}, {'period': '2022', 'revenue': 10.17, 'unit': 'B', 'net_profit': 3.05}, {'period': '2021', 'revenue': 10.98, 'unit': 'B', 'net_profit': 1.56}]","[{'period': ""Q1 '25"", 'revenue': 2430.0, 'unit': 'M', 'net_profit': 240.5}, {'period': ""Q4 '24"", 'revenue': 2450.0, 'unit': 'M', 'net_profit': 266.7}, {'period': ""Q3 '24"", 'revenue': 2470.0, 'unit': 'M', 'net_profit': 388.5}, {'period': ""Q2 '24"", 'revenue': 2350.0, 'unit': 'M', 'net_profit': 583.6}, {'period': ""Q1 '24"", 'revenue': 2200.0, 'unit': 'M', 'net_profit': 393.4}, {'period': ""Q4 '23"", 'revenue': 2390.0, 'unit': 'M', 'net_profit': 249.7}]",11.2,11.19,28049300000,7456800000,2375000000,11333300000,1868800000,226700000,5528800000,2375000000,2515700000,-1,0.40573594005684266,0.39650872817955113,__nan__,__nan__,__nan__,0.40404929891298536
158,BILI,Bilibili Inc. American Depositary Shares,"Bilibili Inc. provides online entertainment services for the young generations in the People's Republic of China. Its platform offers a range of content, including video services, mobile games, and value-added service, as well as ACG-related comic and audio content. The company's video services include professional user generated videos, occupationally generated videos, and live broadcasting. Bilibili Inc. was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.",Mr. Rui  Chen,Electronic Gaming & Multimedia,18.22,USD,7440282450,https://images.financialmodelingprep.com/symbol/BILI.png,5140106,-91.1,0.07,9823227,1190163000,-1346800000,"[{'period': '2024', 'revenue': 26.83, 'unit': 'B', 'net_profit': -1.35}, {'period': '2023', 'revenue': 22.53, 'unit': 'B', 'net_profit': -4.82}, {'period': '2022', 'revenue': 21.9, 'unit': 'B', 'net_profit': -7.51}, {'period': '2021', 'revenue': 19.38, 'unit': 'B', 'net_profit': -6.81}]","[{'period': ""Q4 '24"", 'revenue': 7730.0, 'unit': 'M', 'net_profit': 89.96}, {'period': ""Q3 '24"", 'revenue': 7310.0, 'unit': 'M', 'net_profit': -79.52}, {'period': ""Q2 '24"", 'revenue': 6130.0, 'unit': 'M', 'net_profit': -608.7}, {'period': ""Q1 '24"", 'revenue': 5660.0, 'unit': 'M', 'net_profit': -748.54}, {'period': ""Q4 '23"", 'revenue': 6.35, 'unit': 'B', 'net_profit': -1.3}, {'period': ""Q3 '23"", 'revenue': 5.81, 'unit': 'B', 'net_profit': -1.35}]",-3.14,-3.17,32698500000,19756055000,16544392000,18594587000,2113360000,3911592000,14762803000,10249382000,4259743000,1.7133580477045305,0.7207153982491004,0.7309340188517566,__nan__,__nan__,__nan__,0.5686678899643715
159,BIMI,BOQI International Medical Inc. Common Stock,"BIMI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes generic drugs, Chinese herbal medicine, biochemical drugs, raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, health foods, sundry products, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BOQI International Medical Inc. and changed its name to BIMI International Medical Inc. in June 2021. BIMI International Medical Inc. was incorporated in 2000 and is based in Chongqing, the People's Republic of China.",Mr. Tiewei  Song,Medical - Pharmaceuticals,0.0003,USD,4188,https://images.financialmodelingprep.com/symbol/BIMI.png,1838,,0,2,-17967485,-22352754,"[{'period': '2022', 'revenue': 11.83, 'unit': 'M', 'net_profit': -22.35}, {'period': '2021', 'revenue': 27.08, 'unit': 'M', 'net_profit': -34.92}, {'period': '2020', 'revenue': 12.84, 'unit': 'M', 'net_profit': -3.79}, {'period': '2019', 'revenue': 0.15797999999999998, 'unit': 'M', 'net_profit': -3.9}]","[{'period': ""Q3 '23"", 'revenue': 2.52, 'unit': 'M', 'net_profit': -3.13}, {'period': ""Q2 '23"", 'revenue': 5.56, 'unit': 'M', 'net_profit': 1.05}, {'period': ""Q1 '23"", 'revenue': 3200.0, 'unit': 'K', 'net_profit': -884.21}, {'period': ""Q4 '22"", 'revenue': -5.43, 'unit': 'M', 'net_profit': -11.03}, {'period': ""Q3 '22"", 'revenue': 7.31, 'unit': 'M', 'net_profit': -3.71}, {'period': ""Q2 '22"", 'revenue': 2.83, 'unit': 'M', 'net_profit': -6.54}]",-8.4,-8.4,35714490,23235675,2336636,30497257,4175182,1800000,25362347,2336636,-10255206,0.43810519061142184,0.359918755491743,0.9974202345743848,__nan__,__nan__,__nan__,0.8539183115872577
160,BIOC,Biocept Inc. Common Stock,"Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), gastric cancer, colorectal cancer, prostate cancer, pancreaticobiliary cancer, and ovarian cancer. It also provides cerebrospinal fluid tumor cell and ctDNA and ctRNA testing services to medical oncologists, neuro-oncologists, surgical oncologists, urologists, pulmonologists, pathologists, and other physicians; clinical trial and research services to pharmaceutical companies, biopharmaceutical companies and clinical research organizations; and RT-PCR testing services for COVID-19. The company has a collaboration with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers; and with Protean BioDiagnostics, Inc. to research the ability of its Target Selector molecular assay to determine EGFR status in NSCLC patients. Biocept, Inc. was incorporated in 1997 and is headquartered in San Diego, California.",Mr. Darrell  Taylor Esq.,Medical - Diagnostics & Research,0.4349,USD,450786,https://images.financialmodelingprep.com/symbol/BIOC.png,0,-0.009028440938343367,0,572521,-30328000,-32087000,"[{'period': '2022', 'revenue': 25.86, 'unit': 'M', 'net_profit': -32.09}, {'period': '2021', 'revenue': 61.25, 'unit': 'M', 'net_profit': -2.82}, {'period': '2020', 'revenue': 27.46, 'unit': 'M', 'net_profit': -17.04}, {'period': '2019', 'revenue': 5.53, 'unit': 'M', 'net_profit': -24.61}]","[{'period': ""Q2 '23"", 'revenue': 0.589, 'unit': 'M', 'net_profit': -3.63}, {'period': ""Q1 '23"", 'revenue': 0.673, 'unit': 'M', 'net_profit': -7.24}, {'period': ""Q4 '22"", 'revenue': -10.29, 'unit': 'M', 'net_profit': -18.52}, {'period': ""Q3 '22"", 'revenue': 5.59, 'unit': 'M', 'net_profit': -5.51}, {'period': ""Q2 '22"", 'revenue': 10.61, 'unit': 'M', 'net_profit': -5.41}, {'period': ""Q1 '22"", 'revenue': 19.95, 'unit': 'M', 'net_profit': -2.77}]",-56.78,-56.78,30873000,16343000,12897000,22013000,2151000,0,5506000,12897000,-14096000,-11.589456205894562,-10.362252124645892,-8.909249563699824,__nan__,__nan__,__nan__,0.7130178473099472
161,BIOL,Biolase Inc. Common Stock,"BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.",Mr. John R. Beaver,Medical - Devices,0.02,USD,731942,https://images.financialmodelingprep.com/symbol/BIOL.png,201374,0.0012360939431396787,0.0043,2672966,-15139000,-20632000,"[{'period': '2023', 'revenue': 49.16, 'unit': 'M', 'net_profit': -20.63}, {'period': '2022', 'revenue': 48.46, 'unit': 'M', 'net_profit': -28.63}, {'period': '2021', 'revenue': 39.19, 'unit': 'M', 'net_profit': -16.16}, {'period': '2020', 'revenue': 22.78, 'unit': 'M', 'net_profit': -16.83}]","[{'period': ""Q3 '24"", 'revenue': 10.85, 'unit': 'M', 'net_profit': -1.43}, {'period': ""Q2 '24"", 'revenue': 11.55, 'unit': 'M', 'net_profit': -2.8}, {'period': ""Q1 '24"", 'revenue': 10.13, 'unit': 'M', 'net_profit': -6.49}, {'period': ""Q4 '23"", 'revenue': 13.49, 'unit': 'M', 'net_profit': -5.33}, {'period': ""Q3 '23"", 'revenue': 10.92, 'unit': 'M', 'net_profit': -4.59}, {'period': ""Q2 '23"", 'revenue': 14.29, 'unit': 'M', 'net_profit': -4.87}]",-16.14,-16.14,35101000,24863000,6566000,35348000,5483000,0,19663000,6566000,-15402000,0.3905639869570468,0.2794579870084515,0.9609380672329921,"[0.01, 0.01]","['2005-06-24', '2004-08-12']",__nan__,1.007036836557363
162,BIOT,Biotech Acquisition Company Class A Ordinary Shares,"Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",Dr. Michael  Shleifer Ph.D.,Shell Companies,10.15,USD,0,https://images.financialmodelingprep.com/symbol/BIOT.png,103991,0,-0.08,44124,-6864581,-12158997,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.16}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.77}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 20.03}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.68}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.24}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.94}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.07}]",-0.42,-0.42,230.320701,0.29946300000000003,0.091407,27.469212,0,230.021238,0.31381200000000004,0.091407,-1465214,0,0,0,__nan__,__nan__,__nan__,0.11926505902741238
163,BIOTU,Biotech Acquisition Company Unit,"Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",Dr. Michael  Shleifer Ph.D.,Shell Companies,10.14,USD,0,https://images.financialmodelingprep.com/symbol/BIOTU.png,797,0,-0.05,1342,-6864581,-12158997,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.16}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.77}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 20.03}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.68}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.24}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.94}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.07}]",-0.42,-0.42,230.320701,0.29946300000000003,0.091407,27.469212,0,230.021238,0.31381200000000004,0.091407,-1465214,0,0,0,__nan__,__nan__,__nan__,0.11926505902741238
164,BIOTW,Biotech Acquisition Company Warrant,"Biotech Acquisition Company is a blank check company. The company was incorporated in 2020 and is based in New York, New York.",Mr. Michael  Shleifer Ph.D.,Shell Companies,0.0073,USD,0,https://images.financialmodelingprep.com/symbol/BIOTW.png,0,0,0,414459,-6864581,-12158997,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.16}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.77}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 20.03}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.68}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.24}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.94}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.07}]",-0.42,-0.42,230.320701,0.29946300000000003,0.091407,27.469212,0,230.021238,0.31381200000000004,0.091407,-1465214,0,0,0,__nan__,__nan__,__nan__,0.11926505902741238
165,BIOX,Bioceres Crop Solutions Corp. Ordinary Shares,"Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. The company also offers HB4, a drought tolerant seed technology program. It operates in Argentina, Uruguay, France, South Africa, and internationally. The company was founded in 2001 and is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC.",Dr. Federico  Trucco Ph.D.,Agricultural Inputs,4.45,USD,279063060,https://images.financialmodelingprep.com/symbol/BIOX.png,209888,222.5,-0.2,167939,55455336,3243361,"[{'period': '2024', 'revenue': 464.83, 'unit': 'M', 'net_profit': 3.24}, {'period': '2023', 'revenue': 419.45, 'unit': 'M', 'net_profit': 18.78}, {'period': '2022', 'revenue': 328.46, 'unit': 'M', 'net_profit': -7.2}, {'period': '2021', 'revenue': 206.7, 'unit': 'M', 'net_profit': -6.87}]","[{'period': ""Q2 '25"", 'revenue': 106800.0, 'unit': 'K', 'net_profit': 100.0}, {'period': ""Q1 '25"", 'revenue': 92.6, 'unit': 'M', 'net_profit': -5.5}, {'period': ""Q4 '24"", 'revenue': 124.31, 'unit': 'M', 'net_profit': -1.53}, {'period': ""Q3 '24"", 'revenue': 84.0, 'unit': 'M', 'net_profit': 9.5}, {'period': ""Q2 '24"", 'revenue': 140300.0, 'unit': 'K', 'net_profit': 108.45}, {'period': ""Q1 '24"", 'revenue': 116.18, 'unit': 'M', 'net_profit': -4.59}]",0.0516,0.0511,850628347,408668037,56168798,501063986,216033262,40420906,329505846,44473270,18934175,-0.09217614789664848,-0.8272959310274466,-0.828,__nan__,__nan__,__nan__,0.5890515967016087
166,BIVI,BioVie Inc. Class A Common Stock,"BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease and Phase I clinical trial for the treatment of Parkinson's disease. The company is also developing NE3107, which is in pre-clinical stage for the treatment of multiple myeloma and prostate cancer. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is based in Carson City, Nevada.",Mr. Cuong Viet  Do M.B.A.,Biotechnology,1.0,USD,18562400,https://images.financialmodelingprep.com/symbol/BIVI.png,449067,-0.75,-0.04,200189,-31950208,-32120533,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -32.12}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -50.26}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -26.08}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -183.85}]","[{'period': ""Q3 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.79}, {'period': ""Q2 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.16}, {'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.15}, {'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.94}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.95}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.4}]",-3.555,-3.555,25208345,24048190,23843798,9702130,0,0,9352236,23843798,-27945024,0.3006996919137094,0.3608593624610279,0.5404007756948933,__nan__,__nan__,__nan__,0.38487770617230127
167,BJRI,BJ's Restaurants Inc. Common Stock,"BJ's Restaurants, Inc. owns and operates casual dining restaurants in the United States. The company's restaurants offer pizzas, craft and other beers, appetizers, entrées, pastas, sandwiches, specialty salads, and desserts. As of April 19, 2022, it operated 213 restaurants in 29 states. The company was founded in 1978 and is based in Huntington Beach, California.",Mr. Carl Bradford Richmond CPA,Restaurants,41.57,USD,919353806,https://images.financialmodelingprep.com/symbol/BJRI.png,454011,43.3,-0.52,295418,86494000,16687000,"[{'period': '2024', 'revenue': 1360.0, 'unit': 'M', 'net_profit': 16.69}, {'period': '2023', 'revenue': 1330.0, 'unit': 'M', 'net_profit': 19.66}, {'period': '2022', 'revenue': 1280.0, 'unit': 'M', 'net_profit': 4.08}, {'period': '2021', 'revenue': 1090.0, 'unit': 'M', 'net_profit': -3.61}]","[{'period': ""Q1 '25"", 'revenue': 347.97, 'unit': 'M', 'net_profit': 13.49}, {'period': ""Q4 '24"", 'revenue': 344.34, 'unit': 'M', 'net_profit': -5.27}, {'period': ""Q3 '24"", 'revenue': 325.7, 'unit': 'M', 'net_profit': -2.93}, {'period': ""Q2 '24"", 'revenue': 349.93, 'unit': 'M', 'net_profit': 17.16}, {'period': ""Q1 '24"", 'revenue': 337.33, 'unit': 'M', 'net_profit': 7.72}, {'period': ""Q4 '23"", 'revenue': 323.63, 'unit': 'M', 'net_profit': 8.05}]",0.72,0.7,1041064000,79565000,26096000,671047000,20402000,4266000,196309000,26096000,24572000,0.005662329810364273,-0.1512207527975585,-0.14285714285714285,"[0.13, 0.11]","['2020-03-09', '2017-11-10']",__nan__,0.6445780470749156
168,BKCC,BlackRock Capital Investment Corporation Common Stock,"BlackRock Capital Investment Corporation, formerly known as BlackRock Kelso Capital Corporation, is a Business Development Company specializing in investments in middle market companies. The fund invests in all industries. It prefers to invest between $10 million and $50 million and can invest more or less in companies with EBITDA or operating cash flow between $10 million and $50 million. The fund invests in the form of senior and junior secured, unsecured, and subordinated debt securities and loans including cash flow, asset backed, and junior lien facilities and equity securities. It's equity investments can be structured in the form of warrants, preferred stock, common equity co-investments, and direct investments in common stock. The fund's debt investments are principally structured to provide for current cash interest and to a lesser extent non-cash interest, particularly with subordinated debt investments, through a pay-in-kind (PIK) feature. It can also make non-control investments.",Mr. James Edward Keenan C.F.A.,Asset Management,3.68,USD,267064607,https://images.financialmodelingprep.com/symbol/BKCC.png,226764,10.222222222222221,0.01,143336,47947890,26236270,"[{'period': '2023', 'revenue': 32.94, 'unit': 'M', 'net_profit': 26.24}, {'period': '2022', 'revenue': 10.37, 'unit': 'M', 'net_profit': 3.49}, {'period': '2021', 'revenue': 73.9, 'unit': 'M', 'net_profit': 66.49}, {'period': '2020', 'revenue': -101.37, 'unit': 'M', 'net_profit': -103.85}]","[{'period': ""Q4 '23"", 'revenue': 6.98, 'unit': 'M', 'net_profit': 5.39}, {'period': ""Q3 '23"", 'revenue': 12.7, 'unit': 'M', 'net_profit': 10.83}, {'period': ""Q2 '23"", 'revenue': 3.27, 'unit': 'M', 'net_profit': 1.5}, {'period': ""Q1 '23"", 'revenue': 9.99, 'unit': 'M', 'net_profit': 8.52}, {'period': ""Q4 '22"", 'revenue': -3.55, 'unit': 'M', 'net_profit': -5.1}, {'period': ""Q3 '22"", 'revenue': 7.19, 'unit': 'M', 'net_profit': 5.61}]",0.36,0.36,627285472,17581928000000,9359280,311555613,8222648000000,604527268,11355040,9359280,28789624,1.8836709622123848,6.5240753019235,6.199999999999999,"[0.1, 0.42]","['2024-03-14', '2007-09-12']",__nan__,0.4966727700653651
169,BKEP,Blueknight Energy Partners L.P. Common Units,"Blueknight Energy Partners, L.P. provides integrated terminalling services for companies engaged in the production, distribution, and handling of liquid asphalt in the United States. As of March 1, 2022, it had 54 terminals located in 26 states. Blueknight Energy Partners G.P., L.L.C. operates as a general partner of Blueknight Energy Partners, L.P. The company was formerly known as SemGroup Energy Partners, L.P. and changed its name to Blueknight Energy Partners, L.P. in December 2009. Blueknight Energy Partners, L.P. was incorporated in 2007 and is headquartered in Tulsa, Oklahoma.",Mr. Mark Hurley,Oil & Gas Midstream,4.63,USD,0,https://images.financialmodelingprep.com/symbol/BKEP.png,0,0,-0.0050001144,2143538,-4956000,-4970000,"[{'period': '2021', 'revenue': 5.29, 'unit': 'M', 'net_profit': -4.97}, {'period': '2020', 'revenue': 110.25, 'unit': 'M', 'net_profit': -13.48}, {'period': '2019', 'revenue': 371.07, 'unit': 'M', 'net_profit': 18.41}, {'period': '2018', 'revenue': 384.83, 'unit': 'M', 'net_profit': -42.05}]","[{'period': ""Q2 '22"", 'revenue': 29.51, 'unit': 'M', 'net_profit': 6.34}, {'period': ""Q1 '22"", 'revenue': 28.46, 'unit': 'M', 'net_profit': 6.64}, {'period': ""Q4 '21"", 'revenue': 30.24, 'unit': 'M', 'net_profit': -30.8}, {'period': ""Q3 '21"", 'revenue': 30.34, 'unit': 'M', 'net_profit': 12.6}, {'period': ""Q2 '21"", 'revenue': 27.76, 'unit': 'M', 'net_profit': 7.28}, {'period': ""Q1 '21"", 'revenue': 27.07, 'unit': 'M', 'net_profit': 81.65}]",-0.12,-0.12,136898000,7644000,1172000,136898000,2989000,0,-89691000,1172000,40900000,-1.1493490838958533,0.6313056379821959,0.6363636363636364,"[0.043, 0.11]","['2022-08-04', '2012-02-01']",__nan__,1.0
170,BKEPP,Blueknight Energy Partners L.P. Series A Preferred Units,"Blueknight Energy Partners, L.P. provides integrated terminalling services for companies engaged in the production, distribution, and handling of liquid asphalt in the United States. As of March 1, 2022, it had 54 terminals located in 26 states. Blueknight Energy Partners G.P., L.L.C. operates as a general partner of Blueknight Energy Partners, L.P. The company was formerly known as SemGroup Energy Partners, L.P. and changed its name to Blueknight Energy Partners, L.P. in December 2009. Blueknight Energy Partners, L.P. was incorporated in 2007 and is headquartered in Tulsa, Oklahoma.",Mr. Mark A. Hurley,Oil & Gas Midstream,8.735,USD,0,https://images.financialmodelingprep.com/symbol/BKEPP.png,0,35.221774193548384,-0.0050001144,19523,-4956000,-4970000,"[{'period': '2021', 'revenue': 5.29, 'unit': 'M', 'net_profit': -4.97}, {'period': '2020', 'revenue': 110.25, 'unit': 'M', 'net_profit': -13.48}, {'period': '2019', 'revenue': 371.07, 'unit': 'M', 'net_profit': 18.41}, {'period': '2018', 'revenue': 384.83, 'unit': 'M', 'net_profit': -42.05}]","[{'period': ""Q2 '22"", 'revenue': 29.51, 'unit': 'M', 'net_profit': 6.34}, {'period': ""Q1 '22"", 'revenue': 28.46, 'unit': 'M', 'net_profit': 6.64}, {'period': ""Q4 '21"", 'revenue': 30.24, 'unit': 'M', 'net_profit': -30.8}, {'period': ""Q3 '21"", 'revenue': 30.34, 'unit': 'M', 'net_profit': 12.6}, {'period': ""Q2 '21"", 'revenue': 27.76, 'unit': 'M', 'net_profit': 7.28}, {'period': ""Q1 '21"", 'revenue': 27.07, 'unit': 'M', 'net_profit': 81.65}]",-0.12,-0.12,136898000,7644000,1172000,136898000,2989000,0,-89691000,1172000,40900000,-1.1493490838958533,0.6313056379821959,0.6363636363636364,"[0.179, 0.179]","['2022-08-04', '2012-05-02']",__nan__,1.0
171,BKNG,Booking Holdings Inc. Common Stock,"Booking Holdings Inc. provides travel and restaurant online reservation and related services worldwide. The company operates Booking.com, which offers online accommodation reservations; Rentalcars.com that provides online rental car reservation services; Priceline, which offer online travel reservation services, and consumers hotel, flight, and rental car reservation services, as well as vacation packages, cruises, and hotel distribution services. It also operates Agoda that provides online accommodation reservation services, as well as flight, ground transportation and activities reservation services. In addition, the company operates KAYAK, an online price comparison service that allows consumers to search and compare travel itineraries and prices, comprising airline ticket, accommodation reservation, and rental car reservation information; and OpenTable for booking online restaurant reservations. Further, it offers travel-related insurance products, and restaurant management services to consumers, travel service providers, and restaurants. The company was formerly known as The Priceline Group Inc. and changed its name to Booking Holdings Inc. in February 2018. The company was founded in 1997 and is headquartered in Norwalk, Connecticut.",Mr. Glenn D. Fogel,Travel Services,5293.31,USD,172245895393,https://images.financialmodelingprep.com/symbol/BKNG.png,286473,33.03,-17.37,126295,9338000000,5882000000,"[{'period': '2024', 'revenue': 23.74, 'unit': 'B', 'net_profit': 5.88}, {'period': '2023', 'revenue': 21.36, 'unit': 'B', 'net_profit': 4.29}, {'period': '2022', 'revenue': 17.09, 'unit': 'B', 'net_profit': 3.06}, {'period': '2021', 'revenue': 10.96, 'unit': 'B', 'net_profit': 1.17}]","[{'period': ""Q1 '25"", 'revenue': 4760.0, 'unit': 'M', 'net_profit': 333.0}, {'period': ""Q4 '24"", 'revenue': 5.47, 'unit': 'B', 'net_profit': 1.07}, {'period': ""Q3 '24"", 'revenue': 7.99, 'unit': 'B', 'net_profit': 2.52}, {'period': ""Q2 '24"", 'revenue': 5.86, 'unit': 'B', 'net_profit': 1.52}, {'period': ""Q1 '24"", 'revenue': 4420.0, 'unit': 'M', 'net_profit': 776.0}, {'period': ""Q4 '23"", 'revenue': 4780.0, 'unit': 'M', 'net_profit': 222.0}]",174.96,172.69,27708000000,20491000000,16164000000,31728000000,3199000000,536000000,15647000000,16164000000,7894000000,0.32585545932131194,0.3714152483096293,0.4743406084098762,"[9.6, 8.75]","['2025-06-06', '2024-03-07']",__nan__,1.1450844521437853
172,BKSC,Bank of South Carolina Corp. Common Stock,"Bank of South Carolina Corporation operates as a bank holding company for The Bank of South Carolina that provides a range of financial products and services primarily in Charleston, Berkeley, and Dorchester counties of South Carolina. Its deposits include non-interest-bearing demand accounts, NOW accounts, money market accounts, time deposits, and savings accounts, as well as certificates of deposit. The company offers secured and unsecured commercial loans, commercial real estate construction loans, consumer construction loans, home equity lines of credit, and mortgage originations, as well as paycheck protection program loans. It operates five banking house locations. The company was founded in 1986 and is headquartered in Charleston, South Carolina.",Mr. Eugene H. Walpole IV,Banks - Regional,14.4,USD,79883136,https://images.financialmodelingprep.com/symbol/BKSC.png,1829,14.85,-0.04,102,8741741,6749736,"[{'period': '2024', 'revenue': 22.35, 'unit': 'M', 'net_profit': 6.75}, {'period': '2023', 'revenue': 26.08, 'unit': 'M', 'net_profit': 5.49}, {'period': '2022', 'revenue': 20.96, 'unit': 'M', 'net_profit': 6.66}, {'period': '2021', 'revenue': 21.25, 'unit': 'M', 'net_profit': 6.74}]","[{'period': ""Q1 '25"", 'revenue': 7.22, 'unit': 'M', 'net_profit': 1.79}, {'period': ""Q4 '24"", 'revenue': 5.87, 'unit': 'M', 'net_profit': 1.82}, {'period': ""Q3 '24"", 'revenue': 7.33, 'unit': 'M', 'net_profit': 1.8}, {'period': ""Q2 '24"", 'revenue': 7.17, 'unit': 'M', 'net_profit': 1.75}, {'period': ""Q1 '24"", 'revenue': 7.02, 'unit': 'M', 'net_profit': 1.38}, {'period': ""Q4 '23"", 'revenue': 6.9, 'unit': 'M', 'net_profit': 1.36}]",1.23,1.23,557160417,11007122,11007122,504859405,0,0,433312532,11007122,5204771,0.19962045200765355,0.22865085582974856,0.25510204081632654,"[0.19, 0.4921]","['2025-04-08', '1989-06-26']",__nan__,0.9061293473042971
173,BKYI,BIO-key International Inc. Common Stock,"BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.",Mr. Michael W. DePasquale,Security & Protection Services,0.85,USD,4948114,https://images.financialmodelingprep.com/symbol/BKYI.png,279927,-0.44,0,286883,-3546401,-4300692,"[{'period': '2024', 'revenue': 6.93, 'unit': 'M', 'net_profit': -4.3}, {'period': '2023', 'revenue': 7.75, 'unit': 'M', 'net_profit': -8.52}, {'period': '2022', 'revenue': 7.02, 'unit': 'M', 'net_profit': -10.74}, {'period': '2021', 'revenue': 5.11, 'unit': 'M', 'net_profit': -4.57}]","[{'period': ""Q1 '25"", 'revenue': 1610.0, 'unit': 'K', 'net_profit': -736.54}, {'period': ""Q4 '24"", 'revenue': 1.46, 'unit': 'M', 'net_profit': -1.57}, {'period': ""Q3 '24"", 'revenue': 2140.0, 'unit': 'K', 'net_profit': -738.96}, {'period': ""Q2 '24"", 'revenue': 1.14, 'unit': 'M', 'net_profit': -1.67}, {'period': ""Q1 '24"", 'revenue': 2180.0, 'unit': 'K', 'net_profit': -510.29}, {'period': ""Q4 '23"", 'revenue': 0.9251, 'unit': 'M', 'net_profit': -6.17}]",-0.033,-0.033,8615560,1886958,437604,4843529,792399,5000000,4553536,437604,-2927119,0.5480816796513716,0.4953327551324908,0.9978303747534517,"[0.1111, 0.1111]","['1997-07-25', '1997-07-25']",__nan__,0.5621838858994657
174,BL,BlackLine Inc. Common Stock,"BlackLine, Inc. provides cloud-based solutions to automate and streamline accounting and finance operations worldwide. It offers financial close management solutions, such as account reconciliations that provides a centralized workspace for users to collaborate on account reconciliations; transaction matching that analyzes and reconciles high volumes of individual transactions; and task management to create and manage processes and task lists. The company's financial close management solutions also include journal entry that allows users to generate, review, and post manual journal entries; variance analysis that monitors and identifies anomalous fluctuations in balance sheet and income statement account balances; consolidation integrity manager that manages the automated system-to-system tie-out process that occurs during the consolidation phase of the financial close; and compliance, an integrated solution that facilitates compliance-related initiatives, consolidates project management, and provides visibility over control self-assessments and testing. In addition, it offers accounts receivable automation solutions, which include cash application, credit and risk management, collections management, disputes and deductions, team and task management, and AR intelligence solutions. Further, the company provides intercompany workflow that stores permissions by entity and transaction type thereby ensuring both the initiator and the approver of the intercompany transaction are authorized to conduct business; intercompany processing, which records an organization's intercompany transactions; and netting and settlement that generates a real-time settlement matrix, which shows the balance of transactions. The company sells its solutions primarily through direct sales force to multinational corporations, large domestic enterprises, and mid-market companies across various industries. BlackLine, Inc. was incorporated in 2001 and is headquartered in Woodland Hills, California.",Mr. Owen M. Ryan CPA,Software - Application,53.94,USD,3361546194,https://images.financialmodelingprep.com/symbol/BL.png,742149,39.09,-1.49,589163,183801000,161174000,"[{'period': '2024', 'revenue': 653.34, 'unit': 'M', 'net_profit': 161.17}, {'period': '2023', 'revenue': 590.0, 'unit': 'M', 'net_profit': 52.83}, {'period': '2022', 'revenue': 522.94, 'unit': 'M', 'net_profit': -33.89}, {'period': '2021', 'revenue': 425.71, 'unit': 'M', 'net_profit': -100.99}]","[{'period': ""Q1 '25"", 'revenue': 166.93, 'unit': 'M', 'net_profit': 6.05}, {'period': ""Q4 '24"", 'revenue': 169.46, 'unit': 'M', 'net_profit': 56.42}, {'period': ""Q3 '24"", 'revenue': 165.91, 'unit': 'M', 'net_profit': 17.24}, {'period': ""Q2 '24"", 'revenue': 160.51, 'unit': 'M', 'net_profit': 76.69}, {'period': ""Q1 '24"", 'revenue': 157.46, 'unit': 'M', 'net_profit': 10.83}, {'period': ""Q4 '23"", 'revenue': 155.73, 'unit': 'M', 'net_profit': 22.07}]",2.59,1.45,1825036000,1092404000,885915000,1341884000,178141000,0,422243000,885915000,188710000,0.5776097368375878,2.0506312342664623,1.9770114942528734,__nan__,__nan__,__nan__,0.7352644002638852
175,BLBD,Blue Bird Corporation Common Stock,"Blue Bird Corporation designs, engineers, manufactures, and sells school buses and related parts in the United States, Canada, and internationally. It operates through two segments, Bus and Parts. The company offers Type C, Type D, and specialty buses; and alternative fuel applications through its propane powered, gasoline powered, compressed natural gas powered, and electric powered school buses. Blue Bird Corporation sells its products through a network of dealers, as well as directly to fleet operators, the United States government, and state governments; and maintains a parts distribution center. Blue Bird Corporation was formerly known as Hennessy Capital Acquisition Corp. The company was founded in 1927 and is headquartered in Macon, Georgia.",Mr. John  Wyskiel,Auto - Manufacturers,39.2,USD,1237367600,https://images.financialmodelingprep.com/symbol/BLBD.png,509583,12.17,-1.62,344217,152335000,105547000,"[{'period': '2024', 'revenue': 1350.0, 'unit': 'M', 'net_profit': 105.55}, {'period': '2023', 'revenue': 1130.0, 'unit': 'M', 'net_profit': 23.81}, {'period': '2022', 'revenue': 800.64, 'unit': 'M', 'net_profit': -41.6}, {'period': '2021', 'revenue': 684000.0, 'unit': 'K', 'net_profit': -787.0}]","[{'period': ""Q2 '25"", 'revenue': 358.85, 'unit': 'M', 'net_profit': 26.05}, {'period': ""Q1 '25"", 'revenue': 313.87, 'unit': 'M', 'net_profit': 28.72}, {'period': ""Q4 '24"", 'revenue': 350.21, 'unit': 'M', 'net_profit': 24.66}, {'period': ""Q3 '24"", 'revenue': 333.37, 'unit': 'M', 'net_profit': 28.71}, {'period': ""Q2 '24"", 'revenue': 345.92, 'unit': 'M', 'net_profit': 26.02}, {'period': ""Q1 '24"", 'revenue': 317.66, 'unit': 'M', 'net_profit': 26.15}]",3.27,3.16,524894000,323379000,127687000,387730000,59099000,32089000,235973000,127687000,95849000,1.5006976706009816,3.432513018646061,3.4189189189189193,__nan__,__nan__,__nan__,0.7386824768429435
176,BLCM,Bellicum Pharmaceuticals Inc. Common Stock,"Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem cell antigen; and BPX-603, a dual-switch GoCAR-T product candidate that is in Phase 1/2 clinical trials to treat solid tumors that express the human epidermal growth factor receptor 2 antigens. Its clinical product candidates also include Rivo-cel, an allogeneic T cell product candidate intended to enhance outcomes in the treatment of leukemias, lymphomas, and inherited blood disorders. It has collaboration and license agreements with Adaptimmune Therapeutics plc; Agensys, Inc.; BioVec Pharma, Inc.; ARIAD Pharmaceuticals, Inc.; and Baylor College of Medicine. Bellicum Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in Houston, Texas.",Mr. David M. Maggio,Biotechnology,0.07475,USD,778326,https://images.financialmodelingprep.com/symbol/BLCM.png,28581,-0.11156716417910448,-0.0053,6059,-26981000,-24973000,"[{'period': '2022', 'revenue': 1.5, 'unit': 'M', 'net_profit': -24.97}, {'period': '2021', 'revenue': 6.2, 'unit': 'M', 'net_profit': -9.58}, {'period': '2020', 'revenue': 0.5, 'unit': 'M', 'net_profit': -8.62}, {'period': '2019', 'revenue': 7.14, 'unit': 'M', 'net_profit': -126.09}]","[{'period': ""Q3 '23"", 'revenue': 1000.0, 'unit': 'K', 'net_profit': -763.0}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.35}, {'period': ""Q1 '23"", 'revenue': 0.008, 'unit': 'M', 'net_profit': -7.49}, {'period': ""Q4 '22"", 'revenue': 0.5, 'unit': 'M', 'net_profit': -6.2}, {'period': ""Q3 '22"", 'revenue': 1.0, 'unit': 'M', 'net_profit': -7.26}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.47}]",-0.81,-0.81,23823000,23801000,21837000,21808000,0,0,3772000,21837000,-25804000,-0.1080947882869933,-1.60732929630403,0.024096385542168565,__nan__,__nan__,__nan__,0.9154178734836083
177,BLCT,BlueCity Holdings Limited American Depositary Shares,"BlueCity Holdings Limited operates a platform for LGBTQ community primarily under BlueCity brand in the People's Republic of China, India, South Korea, Thailand, and Vietnam. The company operates Blued, Finka, and LESDO mobile applications that offer mobile-based social and entertainment services, including live streaming, advertising, membership, merchandise sales, and other services. It also offers online health services. BlueCity Holdings Limited was founded in 2000 and is based in Beijing, China.",Mr. Baoli  Ma,Internet Content & Information,1.54,USD,0,https://images.financialmodelingprep.com/symbol/BLCT.png,104877,-1.289782244556114,0,167054,240150069000,-309623944,"[{'period': '2021', 'revenue': 1080.0, 'unit': 'M', 'net_profit': -309.62}, {'period': '2020', 'revenue': 1030.0, 'unit': 'M', 'net_profit': -221.85}, {'period': '2019', 'revenue': 758.89, 'unit': 'M', 'net_profit': -52.93}, {'period': '2018', 'revenue': 501.29, 'unit': 'M', 'net_profit': -144.56}]","[{'period': ""Q4 '21"", 'revenue': 243.58, 'unit': 'M', 'net_profit': -148.7}, {'period': ""Q3 '21"", 'revenue': 270.0, 'unit': 'M', 'net_profit': -73.83}, {'period': ""Q2 '21"", 'revenue': 291.88, 'unit': 'M', 'net_profit': -35.01}, {'period': ""Q1 '21"", 'revenue': 271.13, 'unit': 'M', 'net_profit': -52.08}, {'period': ""Q4 '20"", 'revenue': 278.79, 'unit': 'M', 'net_profit': -73.08}, {'period': ""Q3 '20"", 'revenue': 297.62, 'unit': 'M', 'net_profit': -137.81}]",-9.85,-9.85,610162588,469842783,349785624,164216062,12878562,0,152312966,349785624,-217906243,0.7166759079298974,-0.39562743711075105,-0.5836012861736335,__nan__,__nan__,__nan__,0.2691349244113276
178,BLDE,Blade Air Mobility Inc. Class A Common Stock,"Blade Air Mobility, Inc. provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.",Mr. Robert S. Wiesenthal,"Airlines, Airports & Air Services",3.37,USD,273028301,https://images.financialmodelingprep.com/symbol/BLDE.png,651862,-10.21,-0.115,598846,-68117000,-56076000,"[{'period': '2023', 'revenue': 225.18, 'unit': 'M', 'net_profit': -56.08}, {'period': '2022', 'revenue': 146.12, 'unit': 'M', 'net_profit': -27.26}, {'period': '2021', 'revenue': 50.53, 'unit': 'M', 'net_profit': -40.05}, {'period': '2020', 'revenue': 23.43, 'unit': 'M', 'net_profit': -10.16}]","[{'period': ""Q3 '24"", 'revenue': 74.88, 'unit': 'M', 'net_profit': -1.95}, {'period': ""Q2 '24"", 'revenue': 67.94, 'unit': 'M', 'net_profit': -11.33}, {'period': ""Q1 '24"", 'revenue': 51.51, 'unit': 'M', 'net_profit': -4.23}, {'period': ""Q4 '23"", 'revenue': 47.48, 'unit': 'M', 'net_profit': -33.94}, {'period': ""Q3 '23"", 'revenue': 71440.0, 'unit': 'K', 'net_profit': 289.0}, {'period': ""Q2 '23"", 'revenue': 60.99, 'unit': 'M', 'net_profit': -12.23}]",-0.76,-0.76,294938000,206261000,166137000,60638000,21005000,0,35491000,27873000,-34458000,0.02504759042180142,-1.0570799706529714,-1,__nan__,__nan__,__nan__,0.20559575232760782
179,BLDEW,Blade Air Mobility Inc. Warrants,"Blade Air Mobility, Inc. provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.",Mr. Robert S. Wiesenthal,"Airlines, Airports & Air Services",0.1776,USD,270280144,https://images.financialmodelingprep.com/symbol/BLDEW.png,58561.72131,,-0.0024,76369,-68117000,-56076000,"[{'period': '2023', 'revenue': 225.18, 'unit': 'M', 'net_profit': -56.08}, {'period': '2022', 'revenue': 146.12, 'unit': 'M', 'net_profit': -27.26}, {'period': '2021', 'revenue': 50.53, 'unit': 'M', 'net_profit': -40.05}, {'period': '2020', 'revenue': 23.43, 'unit': 'M', 'net_profit': -10.16}]","[{'period': ""Q3 '24"", 'revenue': 74.88, 'unit': 'M', 'net_profit': -1.95}, {'period': ""Q2 '24"", 'revenue': 67.94, 'unit': 'M', 'net_profit': -11.33}, {'period': ""Q1 '24"", 'revenue': 51.51, 'unit': 'M', 'net_profit': -4.23}, {'period': ""Q4 '23"", 'revenue': 47.48, 'unit': 'M', 'net_profit': -33.94}, {'period': ""Q3 '23"", 'revenue': 71440.0, 'unit': 'K', 'net_profit': 289.0}, {'period': ""Q2 '23"", 'revenue': 60.99, 'unit': 'M', 'net_profit': -12.23}]",-0.76,-0.76,294938000,206261000,166137000,60638000,21005000,0,35491000,27873000,-34458000,0.02504759042180142,-1.0570799706529714,-1,__nan__,__nan__,__nan__,0.20559575232760782
180,BLDP,Ballard Power Systems Inc. Common Shares,"Ballard Power Systems Inc. engages in the design, development, manufacture, sale, and service of proton exchange membrane (PEM) fuel cell products. The company offers its products for power product markets, consisting of heavy-duty motives, such as bus, truck, rail, and marine applications; material handling; and backup power. It also provides technology solutions, including engineering and technology transfer, as well as licenses and sells intellectual property portfolio and fundamental knowledge for various PEM fuel cell applications; and hydrogen fuel cell powertrain and vehicle systems integration solutions. It operates in China, Germany, the United States, the United Kingdom, Canada, Denmark, Norway, Belgium, Japan, France, Spain, Taiwan, Poland, India, Ukraine, Sweden, and internationally. The company has a strategic alliance with Linamar Corporation for the co-development and sale of fuel cell powertrains and components for class 1 and 2 vehicles in North America and Europe. Ballard Power Systems Inc. was founded in 1979 and is headquartered in Burnaby, Canada.","Mr. R. Randall MacEwen BA, LLB",Industrial - Machinery,1.31,USD,392781230,https://images.financialmodelingprep.com/symbol/BLDP.png,8655065,-1.3,-0.08,8930925,-290132107,-324245000,"[{'period': '2024', 'revenue': 69.73, 'unit': 'M', 'net_profit': -324.25}, {'period': '2023', 'revenue': 102.37, 'unit': 'M', 'net_profit': -177.72}, {'period': '2022', 'revenue': 83.8, 'unit': 'M', 'net_profit': -173.49}, {'period': '2021', 'revenue': 104.5, 'unit': 'M', 'net_profit': -114.4}]","[{'period': ""Q1 '25"", 'revenue': 15.39, 'unit': 'M', 'net_profit': -21.04}, {'period': ""Q4 '24"", 'revenue': 24.52, 'unit': 'M', 'net_profit': -46.47}, {'period': ""Q3 '24"", 'revenue': 14.76, 'unit': 'M', 'net_profit': -205.02}, {'period': ""Q2 '24"", 'revenue': 16.0, 'unit': 'M', 'net_profit': -31.46}, {'period': ""Q1 '24"", 'revenue': 14.39, 'unit': 'M', 'net_profit': -41.11}, {'period': ""Q4 '23"", 'revenue': 47.42, 'unit': 'M', 'net_profit': -52.66}]",-1.08,-1.08,777307000,698878000,606052000,104317000,31983000,45753000,75586000,603948000,-135716000,-1.3729219826246088,-0.824512142969682,-0.7704918032786887,__nan__,__nan__,__nan__,0.1342030883550515
181,BLDR,Builders FirstSource Inc. Common Stock,"Builders FirstSource, Inc., together with its subsidiaries, manufactures and supplies building materials, manufactured components, and construction services to professional homebuilders, sub-contractors, remodelers, and consumers in the United States. It offers lumber and lumber sheet goods comprising dimensional lumber, plywood, and oriented strand board products that are used in on-site house framing; manufactured products, such as wood floor and roof trusses, steel roof trusses, wall panels, stairs, and engineered wood products; and windows, and interior and exterior door units, as well as interior and exterior trims and custom products under the Synboard brand name. The company also offers gypsum, roofing, and insulation products, including wallboards, ceilings, joint treatments, and finishes; and siding, metal, and concrete products, such as vinyl, composite, and wood siding products, as well as exterior trims, other exteriors, metal studs, and cement products. In addition, it provides other building products and services, such as cabinets and hardware, as well as turn-key framing, shell construction, design assistance, and professional installation services. The company was formerly known as BSL Holdings, Inc. and changed its name to Builders FirstSource, Inc. in October 1999. Builders FirstSource, Inc. was founded in 1998 and is based in Dallas, Texas.",Mr. Peter M. Jackson CPA,Construction,108.38,USD,11977615700,https://images.financialmodelingprep.com/symbol/BLDR.png,1855462,13.88,-6.24,2821335,1595300000,1077898000,"[{'period': '2024', 'revenue': 16.4, 'unit': 'B', 'net_profit': 1.08}, {'period': '2023', 'revenue': 17.1, 'unit': 'B', 'net_profit': 1.54}, {'period': '2022', 'revenue': 22.73, 'unit': 'B', 'net_profit': 2.75}, {'period': '2021', 'revenue': 19.89, 'unit': 'B', 'net_profit': 1.73}]","[{'period': ""Q1 '25"", 'revenue': 3660.0, 'unit': 'M', 'net_profit': 96.3}, {'period': ""Q4 '24"", 'revenue': 3820.0, 'unit': 'M', 'net_profit': 190.2}, {'period': ""Q3 '24"", 'revenue': 4230.0, 'unit': 'M', 'net_profit': 284.78}, {'period': ""Q2 '24"", 'revenue': 4460.0, 'unit': 'M', 'net_profit': 344.09}, {'period': ""Q1 '24"", 'revenue': 3890.0, 'unit': 'M', 'net_profit': 258.78}, {'period': ""Q4 '23"", 'revenue': 4150.0, 'unit': 'M', 'net_profit': 350.69}]",9.13,9.06,10583086000,3141239000,153624000,6286616000,1658584000,0,1777276000,153624000,1492123000,-0.41662272351946944,-0.30031839174842834,-0.24295190713101159,__nan__,__nan__,__nan__,0.5940248430372767
182,BLFS,BioLife Solutions Inc. Common Stock,"BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.",Mr. Roderick  de Greef,Medical - Instruments & Supplies,22.09,USD,1050626908,https://images.financialmodelingprep.com/symbol/BLFS.png,545444,-116.26,-0.72,401677,1532000,-20184000,"[{'period': '2024', 'revenue': 82.25, 'unit': 'M', 'net_profit': -20.18}, {'period': '2023', 'revenue': 143.27, 'unit': 'M', 'net_profit': -66.43}, {'period': '2022', 'revenue': 161.76, 'unit': 'M', 'net_profit': -139.81}, {'period': '2021', 'revenue': 119.16, 'unit': 'M', 'net_profit': -8.38}]","[{'period': ""Q1 '25"", 'revenue': 23940.0, 'unit': 'K', 'net_profit': -448.0}, {'period': ""Q4 '24"", 'revenue': -3.42, 'unit': 'M', 'net_profit': 12.46}, {'period': ""Q3 '24"", 'revenue': 30.57, 'unit': 'M', 'net_profit': -1.7}, {'period': ""Q2 '24"", 'revenue': 28.33, 'unit': 'M', 'net_profit': -20.72}, {'period': ""Q1 '24"", 'revenue': 31.73, 'unit': 'M', 'net_profit': -10.22}, {'period': ""Q4 '23"", 'revenue': 32.73, 'unit': 'M', 'net_profit': -13.38}]",-0.44,-0.44,399487000,148761000,104584000,50578000,9168000,995000,32734000,95386000,5204000,1.0338653344533357,0.6961476508046427,0.7105263157894737,__nan__,__nan__,__nan__,0.12660737395709998
183,BLI,Berkeley Lights Inc. Common Stock,"Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.","Dr. Siddhartha Chandrakant Kadia B.E., M.S., Ph.D.",Biotechnology,1.2,USD,86608685,https://images.financialmodelingprep.com/symbol/BLI.png,815455,-0.9022556390977443,-0.075,2288364,-93517000,-98040000,"[{'period': '2022', 'revenue': 78.59, 'unit': 'M', 'net_profit': -98.04}, {'period': '2021', 'revenue': 85.39, 'unit': 'M', 'net_profit': -71.72}, {'period': '2020', 'revenue': 64.3, 'unit': 'M', 'net_profit': -41.58}, {'period': '2019', 'revenue': 56.69, 'unit': 'M', 'net_profit': -18.3}]","[{'period': ""Q2 '23"", 'revenue': 14.06, 'unit': 'M', 'net_profit': -50.24}, {'period': ""Q1 '23"", 'revenue': 18.52, 'unit': 'M', 'net_profit': -23.42}, {'period': ""Q4 '22"", 'revenue': 17.84, 'unit': 'M', 'net_profit': -29.3}, {'period': ""Q3 '22"", 'revenue': 21.4, 'unit': 'M', 'net_profit': -21.57}, {'period': ""Q2 '22"", 'revenue': 19.15, 'unit': 'M', 'net_profit': -25.75}, {'period': ""Q1 '22"", 'revenue': 20.21, 'unit': 'M', 'net_profit': -21.43}]",-1.42,-1.42,226094000,176952000,132774000,84039000,18534000,0,45490000,86522000,-55615000,-0.32445331973714026,-0.3669064748201439,-0.31481481481481466,__nan__,__nan__,__nan__,0.3716993816731094
184,BLIN,Bridgeline Digital Inc. Common Stock,"Bridgeline Digital, Inc. operates as a digital engagement company in the United States. The company's Bridgeline's Unbound platform enables companies and developers to create websites, web applications, and online stores. It offers Bridgeline Unbound Experience Manager, a marketing automation engine and content management system; Bridgeline Unbound Content Manager that enables non-technical users to create, edit, and publish content via a browser-based interface; and Bridgeline Unbound Commerce, an online B2B and B2C commerce solution that allows users to manage domestic and international commerce initiatives. The company also provides Bridgeline Unbound Marketing, an online marketing management solution that helps marketers drive to their sites through personalized and targeted marketing automation flows; and Bridgeline Unbound Insights to manage, measure, and optimize web properties by recording detailed events and mining data for statistical analysis. In addition, it offers Bridgeline Unbound Social, a social media management solution that empowers customers to set up customized watch lists; and Bridgeline Unbound Franchises, a web content management and e-commerce platform to multi-unit organizations and franchises. Further, the company provides digital strategy, web design and development, usability engineering, information architecture, and search engine optimization services; application monitoring, emergency response, version control, load balancing, managed firewall security, and virus protection services; and shared, dedicated, and Software as a Service hosting services. Further, it offers OrchestraCMS by Bridgeline and Celebros Search by Bridgeline digital solutions. It serves vertical markets, such as financial services, retail brand names, health services and life sciences, technology, credit unions and regional banks, and associations and foundations through its direct sales force. The company was formerly known as Bridgeline Software, Inc. Bridgeline Digital, Inc. was founded in 2000 and is based in Burlington, Massachusetts.",Mr. Roger E. Kahn Ph.D.,Software - Infrastructure,1.55,USD,18470730,https://images.financialmodelingprep.com/symbol/BLIN.png,68113,-6.74,-0.06,24988,-979000,-1961000,"[{'period': '2024', 'revenue': 15.36, 'unit': 'M', 'net_profit': -1.96}, {'period': '2023', 'revenue': 15.88, 'unit': 'M', 'net_profit': -9.44}, {'period': '2022', 'revenue': 16.82, 'unit': 'M', 'net_profit': 2.15}, {'period': '2021', 'revenue': 13.26, 'unit': 'M', 'net_profit': -6.69}]","[{'period': ""Q2 '25"", 'revenue': 3880.0, 'unit': 'K', 'net_profit': -730.0}, {'period': ""Q1 '25"", 'revenue': 3790.0, 'unit': 'K', 'net_profit': -634.0}, {'period': ""Q4 '24"", 'revenue': 3860.0, 'unit': 'K', 'net_profit': -432.0}, {'period': ""Q3 '24"", 'revenue': 3940.0, 'unit': 'K', 'net_profit': -305.0}, {'period': ""Q2 '24"", 'revenue': 3800.0, 'unit': 'K', 'net_profit': -602.0}, {'period': ""Q1 '24"", 'revenue': 3750.0, 'unit': 'K', 'net_profit': -622.0}]",-0.19,-0.19,15602000,2947000,1390000,5596000,1288000,0,4728000,1390000,-794000,-0.1125,0.792156862745098,0.7912087912087912,__nan__,__nan__,__nan__,0.3586719651326753
185,BLKB,Blackbaud Inc. Common Stock,"Blackbaud, Inc. provides cloud software solutions to higher education institutions, K12 schools, healthcare organizations, faith communities, arts and cultural organizations, foundations, companies, and individual change agents in the United States and internationally. The company offers fundraising and relationship management solutions, such as Blackbaud Raiser's Edge NXT and Blackbaud CRM, Blackbaud eTapestry, Blackbaud TeamRaiser, JustGiving, and Blackbaud Guided Fundraising and Blackbaud Volunteer Network Fundraising; marketing and engagement solutions, including Blackbaud Luminate Online, Blackbaud Online Express, and Blackbaud School Website System; and financial management solutions comprising Blackbaud Financial Edge NXT, Blackbaud Tuition Management, and Blackbaud Financial Aid Management. It also provides grant and award management solutions, consisting of Blackbaud Grantmaking and Blackbaud Award Management; organizational and program management, such as Blackbaud Student Information System, Blackbaud Learning Management System, Blackbaud Enrollment Management System, Blackbaud Altru, and Blackbaud Church Management; social responsibility solutions, which includes YourCause GrantsConnect and YourCause CSRconnect; Blackbaud Merchant Services and Blackbaud Purchase Cards payment services; and Blackbaud's Intelligence for Good solutions, as well as donor acquisition, prospect research, data enrichment, and benchmarking and performance management solutions and services. It sells its solutions and related services through its direct sales force. Blackbaud, Inc. was founded in 1981 and is headquartered in Charleston, South Carolina.",Mr. Michael P. Gianoni,Software - Application,62.12,USD,3013919524,https://images.financialmodelingprep.com/symbol/BLKB.png,364847,-11.09,-1.64,208389,-115158000,-283172000,"[{'period': '2024', 'revenue': 1160.0, 'unit': 'M', 'net_profit': -283.17}, {'period': '2023', 'revenue': 1110.0, 'unit': 'M', 'net_profit': 1.82}, {'period': '2022', 'revenue': 1060.0, 'unit': 'M', 'net_profit': -45.41}, {'period': '2021', 'revenue': 927.74, 'unit': 'M', 'net_profit': 5.7}]","[{'period': ""Q1 '25"", 'revenue': 270.66, 'unit': 'M', 'net_profit': 4.87}, {'period': ""Q4 '24"", 'revenue': 302.23, 'unit': 'M', 'net_profit': -334.54}, {'period': ""Q3 '24"", 'revenue': 286.73, 'unit': 'M', 'net_profit': 20.54}, {'period': ""Q2 '24"", 'revenue': 287.16, 'unit': 'M', 'net_profit': 21.8}, {'period': ""Q1 '24"", 'revenue': 279.25, 'unit': 'M', 'net_profit': 5.25}, {'period': ""Q4 '23"", 'revenue': 295.01, 'unit': 'M', 'net_profit': 5.4}]",-5.6,-5.6,2495715000,976308000,67628000,2353722000,83539000,0,1252097000,67628000,288525000,-1.6893500864994941,-156.589010989011,-162.84971098265896,"[0.12, 0.05]","['2020-02-27', '2005-02-10']",__nan__,0.9431052824541264
186,BLMN,Bloomin' Brands Inc. Common Stock,"Bloomin' Brands, Inc., through its subsidiaries, owns and operates casual, upscale casual, and fine dining restaurants in the United States and internationally. The company operates through two segments, U.S. and International. Its restaurant portfolio has four concepts, including Outback Steakhouse, a casual steakhouse restaurant; Carrabba's Italian Grill, a casual Italian restaurant; Bonefish Grill; and Fleming's Prime Steakhouse & Wine Bar, a contemporary steakhouse. As of December 26, 2021, the company owned and operated 1,013 full-service restaurants and franchised 157 restaurants across 47 states; and 156 full-service restaurants and franchised 172 restaurants across 17 countries and Guam. The company was founded in 1988 and is based in Tampa, Florida.",Mr. Michael  Spanos,Restaurants,7.62,USD,648167868,https://images.financialmodelingprep.com/symbol/BLMN.png,3188360,8.56,-0.39,2882539,179365999,-128018000,"[{'period': '2024', 'revenue': 3950.0, 'unit': 'M', 'net_profit': -128.02}, {'period': '2023', 'revenue': 4670.0, 'unit': 'M', 'net_profit': 247.39}, {'period': '2022', 'revenue': 4420.0, 'unit': 'M', 'net_profit': 101.91}, {'period': '2021', 'revenue': 4120.0, 'unit': 'M', 'net_profit': 215.56}]","[{'period': ""Q1 '25"", 'revenue': 1050.0, 'unit': 'M', 'net_profit': 42.15}, {'period': ""Q4 '24"", 'revenue': 597.51, 'unit': 'M', 'net_profit': -79.46}, {'period': ""Q3 '24"", 'revenue': 1040.0, 'unit': 'M', 'net_profit': 6.91}, {'period': ""Q2 '24"", 'revenue': 1120.0, 'unit': 'M', 'net_profit': 28.4}, {'period': ""Q1 '24"", 'revenue': 1200.0, 'unit': 'M', 'net_profit': -83.87}, {'period': ""Q4 '23"", 'revenue': 1190.0, 'unit': 'M', 'net_profit': 43.27}]",-1.49,-1.49,3384805000,320519000,70056000,3245359000,114601000,0,952336000,70056000,7395000,-0.6526035482215314,-1.5174828001584568,-1.5246478873239437,"[0.15, 0.06]","['2025-05-20', '2015-03-02']",__nan__,0.958802353459062
187,BLNK,Blink Charging Co. Common Stock,"Blink Charging Co., through its subsidiaries, owns, operates, and provides electric vehicle (EV) charging equipment and networked EV charging services in the United States and internationally. The company offers residential and commercial EV charging equipment that enable EV drivers to recharge at various location types. It also provides Blink Network, a cloud-based system that operates, maintains, and manages various Blink charging stations and associated charging data, back-end operations, and payment processing, as well as offers property owners, managers, parking companies, and state and municipal entities with cloud-based services that enable the remote monitoring and management of EV charging stations; and provides EV drivers with station information, including station location, availability, and applicable fees. In addition, the company provides EV charging hardware, software services, and service plans. It has strategic partnerships across transit/destination locations, including airports, auto dealers, healthcare/medicals, hotels, mixed-use, municipal locations, multifamily residential and condos, parks and recreation areas, parking lots, religious institutions, restaurants, retailers, schools and universities, stadiums, supermarkets, transportation hubs, and workplace locations. The company offers its services through direct sales force and resellers, as well as sells residential Level 2 chargers through various internet channels. As of March 10, 2022, it deployed approximately 30,000 charging ports. Blink Charging Co. was founded in 2009 and is headquartered in Miami Beach, Florida.",Mr. Michael C. Battaglia,Engineering & Construction,0.7163,USD,73576187,https://images.financialmodelingprep.com/symbol/BLNK.png,3564680,-0.36,-0.0235,1488035,-183580000,-198132000,"[{'period': '2024', 'revenue': 126.2, 'unit': 'M', 'net_profit': -198.13}, {'period': '2023', 'revenue': 140.6, 'unit': 'M', 'net_profit': -203.69}, {'period': '2022', 'revenue': 61.14, 'unit': 'M', 'net_profit': -91.56}, {'period': '2021', 'revenue': 20.94, 'unit': 'M', 'net_profit': -53.89}]","[{'period': ""Q1 '25"", 'revenue': 20.75, 'unit': 'M', 'net_profit': -20.71}, {'period': ""Q4 '24"", 'revenue': 30.09, 'unit': 'M', 'net_profit': -73.51}, {'period': ""Q3 '24"", 'revenue': 24.2, 'unit': 'M', 'net_profit': -87.39}, {'period': ""Q2 '24"", 'revenue': 33.26, 'unit': 'M', 'net_profit': -20.06}, {'period': ""Q1 '24"", 'revenue': 37.57, 'unit': 'M', 'net_profit': -17.17}, {'period': ""Q4 '23"", 'revenue': 42.71, 'unit': 'M', 'net_profit': -19.69}]",-1.96,-1.96,217988000,141152000,55404000,99286000,43201000,0,59244000,41774000,-55779000,-0.9714558790365017,0.027300889083080912,0.3894080996884735,__nan__,__nan__,__nan__,0.45546543846450266
188,BLNKW,Blink Charging Co. Warrant,"Blink Charging Co., through its subsidiaries, owns, operates, manufactures, and provides electric vehicle (EV) charging equipment and networked EV charging services in the United States and internationally. The company offers residential and commercial EV charging equipment that enable EV drivers to recharge at various location types. It also provides Blink Network, a cloud-based system that operates, maintains, and manages various Blink charging stations and associated charging data, back-end operations, and payment processing, as well as offers fleets, property owners, managers, parking companies, and state and municipal entities with cloud-based services that enable the remote monitoring and management of EV charging stations; and EV drivers with station information, including station location, availability, and applicable fees. In addition, the company offers EV charging hardware, software services, and service plans. It has strategic partnerships across transit/destination locations, including airports, auto dealers, healthcare/medicals, hotels, mixed-use and municipal locations, multifamily residential and condos, parks and recreation areas, parking lots, religious institutions, restaurants, retailers, schools and universities, stadiums, supermarkets, transportation hubs, and workplace locations. Blink Charging Co. was founded in 2009 and is headquartered in Bowie, Maryland.",None,Electrical Equipment & Parts,10.0499,USD,0,https://images.financialmodelingprep.com/symbol/BLNKW.png,0,0,0,997,-183580000,-198132000,"[{'period': '2024', 'revenue': 126.2, 'unit': 'M', 'net_profit': -198.13}, {'period': '2023', 'revenue': 140.6, 'unit': 'M', 'net_profit': -203.69}, {'period': '2022', 'revenue': 61.14, 'unit': 'M', 'net_profit': -91.56}, {'period': '2021', 'revenue': 20.94, 'unit': 'M', 'net_profit': -53.89}]","[{'period': ""Q1 '25"", 'revenue': 20.75, 'unit': 'M', 'net_profit': -20.71}, {'period': ""Q4 '24"", 'revenue': 30.09, 'unit': 'M', 'net_profit': -73.51}, {'period': ""Q3 '24"", 'revenue': 24.2, 'unit': 'M', 'net_profit': -87.39}, {'period': ""Q2 '24"", 'revenue': 33.26, 'unit': 'M', 'net_profit': -20.06}, {'period': ""Q1 '24"", 'revenue': 37.57, 'unit': 'M', 'net_profit': -17.17}, {'period': ""Q4 '23"", 'revenue': 42.71, 'unit': 'M', 'net_profit': -19.69}]",-1.96,-1.96,217988000,141152000,55404000,99286000,43201000,0,59244000,41774000,-55779000,-0.9714558790365017,0.027300889083080912,0.3894080996884735,__nan__,__nan__,__nan__,0.45546543846450266
189,BLPH,Bellerophon Therapeutics Inc. Common Stock,"Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated with fibrotic interstitial lung disease; which has completed Phase 2a clinical trial for pulmonary hypertension associated with chronic obstructive pulmonary disease; and that has completed Phase 2 dose escalation stage for pulmonary hypertension associated with sarcoidosis, as well as for chronic thromboembolic pulmonary hypertension and pulmonary hypertension associated with pulmonary edema from high altitude sickness. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics, Inc. in January 2014. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey.",Mr. Craig R. Jalbert CIRA,Biotechnology,0.012,USD,146791,https://images.financialmodelingprep.com/symbol/BLPH.png,13687,-0.01348314606741573,-0.007,1565,-22183000,-19831000,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -19.83}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.76}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -24.73}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.27}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.92}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.14}, {'period': ""Q1 '23"", 'revenue': 5.64, 'unit': 'M', 'net_profit': 2.82}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.43}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.07}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.11}]",-2.08,-2.08,7935000,7563000,7329000,5401000,0,0,5401000,6924000,-17770000,-0.10029264421407669,-0.11686190583464744,-0.11229946524064169,"[0.018965, 0.018965]","['2024-12-19', '2024-12-19']",__nan__,0.6806553245116572
190,BLRX,BioLineRx Ltd. American Depositary Shares,"BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in patients with acute respiratory distress syndrome secondary to COVID-19 and other respiratory viral infections, as well as for the treatment of solid tumors and acute myeloid leukemia. It is also developing AGI-134, an immuno-oncology agent, which is in Phase 1/2a clinical trials for the treatment of solid tumors; and BL-5010, a customized, proprietary, pen-like applicator for the non-surgical removal of skin lesions. The company has collaboration agreement with MSD for the cancer immunotherapy field; MD Anderson Cancer Center to investigate the combination of Motixafortide with KEYTRUDA (pembrolizumab) in pancreatic cancer; and licensing arrangement with Perrigo Company plc for over-the-counter sale of BL-5010. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.","Mr. Philip A. Serlin CPA, CPA, M.B.A., MBA",Biotechnology,3.63,USD,13507230,https://images.financialmodelingprep.com/symbol/BLRX.png,26783,-0.6,-0.01,28810,3918000,-9221000,"[{'period': '2024', 'revenue': 28.94, 'unit': 'M', 'net_profit': -9.22}, {'period': '2023', 'revenue': 4.8, 'unit': 'M', 'net_profit': -60.61}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -20.75}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -28.14}]","[{'period': ""Q4 '24"", 'revenue': 11.75, 'unit': 'M', 'net_profit': -3.19}, {'period': ""Q3 '24"", 'revenue': 4.94, 'unit': 'M', 'net_profit': -5.82}, {'period': ""Q2 '24"", 'revenue': 5390.0, 'unit': 'K', 'net_profit': 484.0}, {'period': ""Q1 '24"", 'revenue': 6860.0, 'unit': 'K', 'net_profit': -696.0}, {'period': ""Q4 '23"", 'revenue': 4.8, 'unit': 'M', 'net_profit': -13.88}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.02}]",-0.12,-0.12,38906000,27104000,19562000,25445000,3863000,0,15406000,10436000,-43927000,1.068633290123673,0.8478734285808559,0.8775834658187599,__nan__,__nan__,__nan__,0.6540122346167686
191,BLSA,BCLS Acquisition Corp. Class A Ordinary Shares,"BCLS Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Boston, Massachusetts.",Mr. Jeffrey Lawrence Schwartz M.B.A.,Shell Companies,10.035,USD,0,https://images.financialmodelingprep.com/symbol/BLSA.png,29954,-218.15217391304347,0,4694,-847038,-837545,"[{'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -837.54}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -166.75}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -55.75}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -233.65}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -627.45}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -164.3}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -242.92}]",-0.0442,-0.0442,144595871,835474,639686,5448349,0,143760397,417099,639686,-329114,-4.079596768873723,-4.0226682578424375,-4.0227272727272725,__nan__,__nan__,__nan__,0.037679838036315715
192,BLTS,Bright Lights Acquisition Corp. Class A Common Stock,"Bright Lights Acquisition Corp. is a blank check company. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It intends to focus for a target business operating in the consumer products, media, entertainment, and sports sectors. The company was incorporated in 2020 and is based in Los Angeles, California.",,Shell Companies,10.01,USD,0,https://images.financialmodelingprep.com/symbol/BLTS.png,106688,18.537037037037038,-0.04,1200,-1341378,4494420,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.49}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.4}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.34}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.93}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.93}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.89}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.17}]",0.16,0.16,230701499,687074,87074,28025185,0,230014425,5976435,87074,-2004860,0,0,0,__nan__,__nan__,__nan__,0.12147812268874768
193,BLTSU,Bright Lights Acquisition Corp. Unit,"Bright Lights Acquisition Corp. is a blank check company. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It intends to focus for a target business operating in the consumer products, media, entertainment, and sports sectors. The company was incorporated in 2020 and is based in Los Angeles, California.",,Shell Companies,10.03,USD,0,https://images.financialmodelingprep.com/symbol/BLTSU.png,1898,-44.776785714285715,-0.01,300,-1341378,4494420,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.49}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.4}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.34}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.93}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.93}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.89}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.17}]",0.16,0.16,230701499,687074,87074,28025185,0,230014425,5976435,87074,-2004860,0,0,0,__nan__,__nan__,__nan__,0.12147812268874768
194,BLTSW,Bright Lights Acquisition Corp. Warrant,"Bright Lights Acquisition Corp. is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in Los Angeles, California.",Mr. Michael  Mahan,Shell Companies,0.0095,USD,0,https://images.financialmodelingprep.com/symbol/BLTSW.png,0,0,0,1060,-1341378,4494420,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.49}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.4}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.34}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.93}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.93}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.89}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.17}]",0.16,0.16,230701499,687074,87074,28025185,0,230014425,5976435,87074,-2004860,0,0,0,__nan__,__nan__,__nan__,0.12147812268874768
195,BLU,BELLUS Health Inc. Common Shares,"BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. The company was incorporated in 1993 and is based in Laval, Canada.",Mr. Roberto Francesco Bellini,Biotechnology,14.745,USD,1869842940,https://images.financialmodelingprep.com/symbol/BLU.png,5381551,-20.198630136986303,0.005,2839350,-72763000,-76080000,"[{'period': '2022', 'revenue': 0.016, 'unit': 'M', 'net_profit': -76.08}, {'period': '2021', 'revenue': 0.016, 'unit': 'M', 'net_profit': -71.22}, {'period': '2020', 'revenue': 0.015, 'unit': 'M', 'net_profit': -31.8}, {'period': '2019', 'revenue': 0.02679, 'unit': 'M', 'net_profit': -26.41}]","[{'period': ""Q3 '23"", 'revenue': 1650.0, 'unit': 'M', 'net_profit': -42.7}, {'period': ""Q2 '23"", 'revenue': 1520.0, 'unit': 'M', 'net_profit': -22.19}, {'period': ""Q1 '23"", 'revenue': 0.003, 'unit': 'M', 'net_profit': -25.06}, {'period': ""Q4 '22"", 'revenue': 0.004, 'unit': 'M', 'net_profit': -18.25}, {'period': ""Q3 '22"", 'revenue': 0.004, 'unit': 'M', 'net_profit': -24.71}, {'period': ""Q2 '22"", 'revenue': 0.004, 'unit': 'M', 'net_profit': -18.78}]",-0.66,-0.66,407820000,355893000,337057000,16808000,1643000,23493740,15876000,87250000,-97982032,0.001303906228554174,-0.06817926541615187,0.26666666666666666,__nan__,__nan__,__nan__,0.04121426119366387
196,BLUE,bluebird bio Inc. Common Stock,"bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clinical study program includes HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. It has strategic collaboration and license agreements with Orchard Therapeutics Limited, Forty Seven, Inc., and Magenta Therapeutics, Inc. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts.",Mr. Andrew  Obenshain,Biotechnology,4.97,USD,48668526,https://images.financialmodelingprep.com/symbol/BLUE.png,555559,-0.24,-0.01,781488,-156822000,-240715000,"[{'period': '2024', 'revenue': 83.81, 'unit': 'M', 'net_profit': -240.72}, {'period': '2023', 'revenue': 29.5, 'unit': 'M', 'net_profit': -211.91}, {'period': '2022', 'revenue': 3.6, 'unit': 'M', 'net_profit': -266.58}, {'period': '2021', 'revenue': 3.66, 'unit': 'M', 'net_profit': -562.64}]","[{'period': ""Q1 '25"", 'revenue': 38.71, 'unit': 'M', 'net_profit': -29.07}, {'period': ""Q4 '24"", 'revenue': 38.52, 'unit': 'M', 'net_profit': -28.71}, {'period': ""Q3 '24"", 'revenue': 10.61, 'unit': 'M', 'net_profit': -60.81}, {'period': ""Q2 '24"", 'revenue': 16.1, 'unit': 'M', 'net_profit': -81.39}, {'period': ""Q1 '24"", 'revenue': 18.57, 'unit': 'M', 'net_profit': -69.8}, {'period': ""Q4 '23"", 'revenue': 7.83, 'unit': 'M', 'net_profit': -88.51}]",-24.84,-24.84,460232000,154668000,62305000,491766000,3094000,0,321462000,62305000,-262619000,0.061850551264948164,-0.1359142667037888,-11.870466321243525,__nan__,__nan__,__nan__,1.0685176172017592
197,BLUW,Blue Water Acquisition Corp. Class A Common Stock,"Blue Water Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded in 2020 and is based in Greenwich, Connecticut.",Mr. Joseph  Hernandez,Shell Companies,9.63,USD,0,https://images.financialmodelingprep.com/symbol/BLUW.png,717768,0,0.6999998,5919992,,,[],"[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",,,59473560,823512,655371,19131980,0,0,420845,655371,29526000,,,,__nan__,__nan__,__nan__,0.32168883113773583
198,BLUWU,Blue Water Acquisition Corp. Unit,"Blue Water Acquisition Corp. is a blank check company. The company intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or similar business combination. The company was founded in 2020 and is based in Greenwich, Connecticut.",,Shell Companies,10.35,USD,0,https://images.financialmodelingprep.com/symbol/BLUWU.png,4373,0,0.75,7616,,,[],"[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",,,59473560,823512,655371,19131980,0,0,420845,655371,29526000,,,,__nan__,__nan__,__nan__,0.32168883113773583
199,BLUWW,Blue Water Acquisition Corp. Warrant,"Blue Water Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded in 2020 and is based in Greenwich, Connecticut.",Mr. Joseph  Hernandez,Shell Companies,0.8801,USD,0,https://images.financialmodelingprep.com/symbol/BLUWW.png,0,0,0.0201,277090,,,[],"[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",,,59473560,823512,655371,19131980,0,0,420845,655371,29526000,,,,__nan__,__nan__,__nan__,0.32168883113773583
200,BMBL,Bumble Inc. Class A Common Stock,"Bumble Inc. provides online dating and social networking platforms in North America, Europe, internationally. It owns and operates websites and applications that offers subscription and in-app purchases dating products. The company operates two apps, Bumble and Badoo with approximately 40 million users on monthly basis, as well as Fruitz, an online dating app. Bumble Inc. was founded in 2014 in and is headquartered in Austin, Texas.",Ms. Whitney Wolfe Herd,Software - Application,5.69,USD,587725790,https://images.financialmodelingprep.com/symbol/BMBL.png,3596686,-1.22,0.04,2229434,-634685000,-557008000,"[{'period': '2024', 'revenue': 1070.0, 'unit': 'M', 'net_profit': -557.01}, {'period': '2023', 'revenue': 1050.0, 'unit': 'M', 'net_profit': -4.21}, {'period': '2022', 'revenue': 903.5, 'unit': 'M', 'net_profit': -79.75}, {'period': '2021', 'revenue': 760.91, 'unit': 'M', 'net_profit': 309.81}]","[{'period': ""Q1 '25"", 'revenue': 247.1, 'unit': 'M', 'net_profit': 13.44}, {'period': ""Q4 '24"", 'revenue': 261.65, 'unit': 'M', 'net_profit': 9.4}, {'period': ""Q3 '24"", 'revenue': 273.61, 'unit': 'M', 'net_profit': -613.2}, {'period': ""Q2 '24"", 'revenue': 268.62, 'unit': 'M', 'net_profit': 27.39}, {'period': ""Q1 '24"", 'revenue': 267.77, 'unit': 'M', 'net_profit': 24.62}, {'period': ""Q4 '23"", 'revenue': 273.64, 'unit': 'M', 'net_profit': -26.03}]",-4.61,-4.61,2524887000,342242000,204319000,1175833000,99687000,0,138570000,204319000,96687000,-6.228004711658059,-131.2117256112034,-152.66666666666669,__nan__,__nan__,__nan__,0.4656972767494149
201,BMEA,Biomea Fusion Inc. Common Stock,"Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.",Dr. Michael J. M. Hitchcock Ph.D.,Biotechnology,1.45,USD,54479690,https://images.financialmodelingprep.com/symbol/BMEA.png,723239,-0.41,-0.12,729285,-136678000,-138426000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -138.43}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -117.25}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -80.02}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -41.22}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q4 '24"", 'revenue': 1.22, 'unit': 'M', 'net_profit': -29.3}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -32.79}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -37.28}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -39.06}, {'period': ""Q4 '23"", 'revenue': 6.14, 'unit': 'M', 'net_profit': -34.88}]",-3.83,-3.83,79938000,68332000,58279000,28365000,0,0,21673000,58279000,-120256000,-0.09675814476007061,-0.1805552002046821,-0.11337209302325585,__nan__,__nan__,__nan__,0.35483749906177287
202,BMRA,Biomerica Inc. Common Stock,"Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.",Mr. Zackary S. Irani,Medical - Devices,3.51,USD,8935625,https://images.financialmodelingprep.com/symbol/BMRA.png,41409,-1.62,-0.13,11552,-5993000,-5978000,"[{'period': '2024', 'revenue': 5.42, 'unit': 'M', 'net_profit': -5.98}, {'period': '2023', 'revenue': 5.34, 'unit': 'M', 'net_profit': -7.14}, {'period': '2022', 'revenue': 18.87, 'unit': 'M', 'net_profit': -4.53}, {'period': '2021', 'revenue': 7.2, 'unit': 'M', 'net_profit': -6.47}]","[{'period': ""Q3 '25"", 'revenue': 1.12, 'unit': 'M', 'net_profit': -1.16}, {'period': ""Q2 '25"", 'revenue': 1640.0, 'unit': 'K', 'net_profit': -950.0}, {'period': ""Q1 '25"", 'revenue': 1.81, 'unit': 'M', 'net_profit': -1.32}, {'period': ""Q4 '24"", 'revenue': 1.12, 'unit': 'M', 'net_profit': -1.42}, {'period': ""Q3 '24"", 'revenue': 1.02, 'unit': 'M', 'net_profit': -1.92}, {'period': ""Q2 '24"", 'revenue': 1.57, 'unit': 'M', 'net_profit': -1.51}]",-0.36,-0.36,9254000,7731000,4170000,2663000,947000,165000,2204000,4170000,-5476000,0.11056693380825171,0.1627450980392157,0.28,__nan__,__nan__,__nan__,0.2877674519126864
203,BMRC,Bank of Marin Bancorp Common Stock,"Bank of Marin Bancorp operates as the holding company for Bank of Marin that provides a range of financial services primarily to small to medium-sized businesses, professionals, not-for-profit organizations, and individuals in California, the United States. It offers personal and business checking and savings accounts; and individual retirement, health savings, and demand deposit marketplace accounts, as well as time certificates of deposit, certificate of deposit account registry and insured cash sweep services. The company also provides commercial real estate, commercial and industrial, and consumer loans, as well as construction financing and home equity lines of credit. In addition, it offers merchant and payroll, and cash management services; credit cards; fraud detection tools; and mobile deposit, remote deposit capture, automated clearing house, wire transfer, and image lockbox services. Further, the company provides wealth management and trust services comprising customized investment portfolio management, financial planning, trust administration, estate settlement, and custody services, as well as 401(k) plan services; and automated teller machines, and telephone and digital banking services. It operates through 12 branch offices in Marin, southern Sonoma counties, and north of San Francisco, California; and a loan production office in San Francisco. The company was incorporated in 1989 and is headquartered in Novato, California.",Mr. Timothy D. Myers,Banks - Regional,20.93,USD,339402973,https://images.financialmodelingprep.com/symbol/BMRC.png,79098,-52.32,-0.49,73278,-11394000,-8409000,"[{'period': '2024', 'revenue': 116.39, 'unit': 'M', 'net_profit': -8.41}, {'period': '2023', 'revenue': 104.97, 'unit': 'M', 'net_profit': 19.89}, {'period': '2022', 'revenue': 138.4, 'unit': 'M', 'net_profit': 46.59}, {'period': '2021', 'revenue': 118.46, 'unit': 'M', 'net_profit': 33.23}]","[{'period': ""Q1 '25"", 'revenue': 35.24, 'unit': 'M', 'net_profit': 4.88}, {'period': ""Q4 '24"", 'revenue': 39.23, 'unit': 'M', 'net_profit': 6.0}, {'period': ""Q3 '24"", 'revenue': 27.39, 'unit': 'M', 'net_profit': 4.57}, {'period': ""Q2 '24"", 'revenue': 34.33, 'unit': 'M', 'net_profit': -21.9}, {'period': ""Q1 '24"", 'revenue': 25.1, 'unit': 'M', 'net_profit': 2.92}, {'period': ""Q4 '23"", 'revenue': 19370.0, 'unit': 'K', 'net_profit': 610.0}]",-0.52,-0.52,3701335000,1562849000,273038000,3265928000,164298000,40608000,3220169000,137304000,27845000,-1.3864468864468864,-1.422669012314652,-1.4193548387096775,"[0.25, 0.4]","['2025-05-08', '2004-05-25']",__nan__,0.8823648764567379
204,BMRN,BioMarin Pharmaceutical Inc. Common Stock,"BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme, which is delivered through subcutaneous injection to reduce blood Phe concentrations; Brineura, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; Voxzogo, a once daily injection analog of c-type natriuretic peptide for the treatment of achondroplasia; and Aldurazyme, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase. In addition, it develops valoctocogene roxaparvovec, an adeno associated virus vector, which is in Phase III clinical trial for the treatment of patients with severe hemophilia A; BMN 307, an AAV5 mediated gene therapy, which is in Phase 1/2 clinical trial to normalize blood Phe concentration levels in patients with PKU; and BMN 255 that is in Phase 1/2 clinical trial for treating primary hyperoxaluria. The company serves specialty pharmacies, hospitals, and non-U.S. government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. BioMarin Pharmaceutical Inc. has license and collaboration agreements with Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners, Inc., and Asubio Pharma Co., Ltd. The company was incorporated in 1996 and is headquartered in San Rafael, California.",Mr. Alexander  Hardy,Biotechnology,58.48,USD,11215060480,https://images.financialmodelingprep.com/symbol/BMRN.png,1775926,21.66,-1.45,2110733,650855000,426859000,"[{'period': '2024', 'revenue': 2850.0, 'unit': 'M', 'net_profit': 426.86}, {'period': '2023', 'revenue': 2420.0, 'unit': 'M', 'net_profit': 167.65}, {'period': '2022', 'revenue': 2100.0, 'unit': 'M', 'net_profit': 141.56}, {'period': '2021', 'revenue': 1850.0, 'unit': 'M', 'net_profit': -64.08}]","[{'period': ""Q1 '25"", 'revenue': 745.14, 'unit': 'M', 'net_profit': 185.69}, {'period': ""Q4 '24"", 'revenue': 738.22, 'unit': 'M', 'net_profit': 124.94}, {'period': ""Q3 '24"", 'revenue': 745.74, 'unit': 'M', 'net_profit': 106.08}, {'period': ""Q2 '24"", 'revenue': 708.66, 'unit': 'M', 'net_profit': 107.17}, {'period': ""Q1 '24"", 'revenue': 648.83, 'unit': 'M', 'net_profit': 88.66}, {'period': ""Q4 '23"", 'revenue': 646.21, 'unit': 'M', 'net_profit': 20.38}]",2.13,2.06,6988940000,3232427000,1137706000,1330950000,660535000,521238000,606988000,942842000,475423000,1.0976105761173633,1.546207760446181,1.3932584269662918,__nan__,__nan__,__nan__,0.19043660412022423
205,BMTC,Bryn Mawr Bank Corporation Common Stock,"Bryn Mawr Bank Corporation operates as a bank holding company for The Bryn Mawr Trust Company that provides commercial and retail banking services to individual and business customers. It operates in two segments, Wealth Management and Banking. The company accepts deposit products, including interest-bearing demand accounts, wholesale time deposits, retail time deposits, savings accounts, noninterest-bearing deposits, money market accounts, and wholesale non-maturity deposits. It also provides commercial mortgages, home equity lines and loans, and residential mortgages, as well as construction, commercial and industrial, and consumer loans; and leasing services. In addition, the company offers wealth management services comprising trust administration and other related fiduciary, custody, investment management and advisory, employee benefits and IRA administration, estate settlement, financial planning, and brokerage services, as well as estate administration, retirement planning, and tax planning and preparation services. Further, it provides insurance and related products and services that include casualty, property, and allied insurance lines, as well as life insurance, annuities, medical insurance, and accident and health insurance for groups and individuals. Additionally, the company offers a small-ticket equipment financing service. It provides its services through 41 banking locations, seven wealth management offices, and two insurance and risk management locations in the Montgomery, Chester, Delaware, Philadelphia, and Dauphin Counties in Pennsylvania; New Castle County in Delaware; and Mercer and Camden Counties in New Jersey. Bryn Mawr Bank Corporation was founded in 1889 and is headquartered in Bryn Mawr, Pennsylvania.",Mr. Francis Leto,Banks - Regional,45.01,USD,0,https://images.financialmodelingprep.com/symbol/BMTC.png,89506,12.46124031007752,-0.7200012,743295,78519000,32573000,"[{'period': '2020', 'revenue': 222.45, 'unit': 'M', 'net_profit': 32.57}, {'period': '2019', 'revenue': 229.01, 'unit': 'M', 'net_profit': 59.21}, {'period': '2018', 'revenue': 224.38, 'unit': 'M', 'net_profit': 63.79}, {'period': '2017', 'revenue': 173.97, 'unit': 'M', 'net_profit': 23.02}]","[{'period': ""Q3 '21"", 'revenue': 57.28, 'unit': 'M', 'net_profit': 18.38}, {'period': ""Q2 '21"", 'revenue': 55.99, 'unit': 'M', 'net_profit': 21.34}, {'period': ""Q1 '21"", 'revenue': 54.31, 'unit': 'M', 'net_profit': 17.08}, {'period': ""Q4 '20"", 'revenue': 54.45, 'unit': 'M', 'net_profit': 15.54}, {'period': ""Q3 '20"", 'revenue': 55.94, 'unit': 'M', 'net_profit': 13.16}, {'period': ""Q2 '20"", 'revenue': 57.7, 'unit': 'M', 'net_profit': 15.04}]",1.63,1.63,5432022000,3922469000,1271277000,4809700000,167837000,1216088000,39602000,96313000,69928000,-0.42437704809870463,-0.4498361652535216,-0.4436860068259386,"[0.28, 5.76]","['2021-10-29', '1985-10-16']",__nan__,0.8854345582547346
206,BNFT,Benefitfocus Inc. Common Stock,"Benefitfocus, Inc. provides cloud-based benefits management technology solutions for employers and health plans in the United States. Its products for employers comprise Benefitplace, a cloud-based benefits management portal that streamlines online enrollment, employee communication, and benefit administration; Health Insights, a data analytics solution; ACA Management and Reporting, a solution for employers to manage ACA compliance; Billing & Payments, an application that synchronizes enrollment and billing information to streamline the monthly billing process, automate adjustments, and enhance accuracy of payments; and COBRA Administration, a solution that simplifies management of Consolidated Omnibus Budget Reconciliation Act, benefits. The company's products for health plans include Enrollment that provides platform for carriers to automate enrollment across all segments of their commercial group business; Billing & Payments, an electronic invoice presentment and payment solution; Exchange, a solution that bridges the integration gap between health plan and employer systems; and Quoting that gives health plans and brokers tools to organize and proactively manage accounts, track leads, generate quotes, and create proposals for multiple products. Its products for brokers consist of Health Insights that support strategic decisions for their clients with on-demand health plan analytics; Benefit Catalog, which allows brokers to offer products to their clients; and benefit catalog consultative support for brokers through benefit advisors. The company also provides implementation services to its customers in order to help ensure seamless deployment and effective utilization of its solutions; and employers with expanded support services. The company was incorporated in 2000 and is headquartered in Charleston, South Carolina.",Mr. Matthew C. Levin,Software - Application,10.5,USD,0,https://images.financialmodelingprep.com/symbol/BNFT.png,597401,0,0,381982,-5710000,-32166000,"[{'period': '2021', 'revenue': 263.1, 'unit': 'M', 'net_profit': -32.17}, {'period': '2020', 'revenue': 268.14, 'unit': 'M', 'net_profit': -24.3}, {'period': '2019', 'revenue': 295.69, 'unit': 'M', 'net_profit': -45.52}, {'period': '2018', 'revenue': 258.72, 'unit': 'M', 'net_profit': -52.63}]","[{'period': ""Q3 '22"", 'revenue': 56.19, 'unit': 'M', 'net_profit': -6.99}, {'period': ""Q2 '22"", 'revenue': 56.59, 'unit': 'M', 'net_profit': -12.16}, {'period': ""Q1 '22"", 'revenue': 61.23, 'unit': 'M', 'net_profit': -2.28}, {'period': ""Q4 '21"", 'revenue': 75.1, 'unit': 'M', 'net_profit': 3.0}, {'period': ""Q3 '21"", 'revenue': 62.03, 'unit': 'M', 'net_profit': -18.05}, {'period': ""Q2 '21"", 'revenue': 60.9, 'unit': 'M', 'net_profit': -15.02}]",-0.97,-0.97,260841000,112156000,68050000,257965000,16491000,0,72236000,31001000,21726000,-1.239815203695926,-0.3238671440918632,-0.2933333333333333,__nan__,__nan__,__nan__,0.9889741260001303
207,BNGO,Bionano Genomics Inc. Common Stock,"Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.","Dr. Robert Erik Holmlin M.B.A., Ph.D.",Medical - Diagnostics & Research,3.62,USD,12177680,https://images.financialmodelingprep.com/symbol/BNGO.png,149824,-0.07,-0.15,102362,-97469000,-112017000,"[{'period': '2024', 'revenue': 30.78, 'unit': 'M', 'net_profit': -112.02}, {'period': '2023', 'revenue': 36.12, 'unit': 'M', 'net_profit': -232.49}, {'period': '2022', 'revenue': 27.8, 'unit': 'M', 'net_profit': -132.6}, {'period': '2021', 'revenue': 17.98, 'unit': 'M', 'net_profit': -72.44}]","[{'period': ""Q1 '25"", 'revenue': 6.46, 'unit': 'M', 'net_profit': -3.1}, {'period': ""Q4 '24"", 'revenue': 8.16, 'unit': 'M', 'net_profit': -20.12}, {'period': ""Q3 '24"", 'revenue': 6.07, 'unit': 'M', 'net_profit': -44.25}, {'period': ""Q2 '24"", 'revenue': 7.77, 'unit': 'M', 'net_profit': -16.22}, {'period': ""Q1 '24"", 'revenue': 8.77, 'unit': 'M', 'net_profit': -31.42}, {'period': ""Q4 '23"", 'revenue': 10.72, 'unit': 'M', 'net_profit': -43.89}]",-60.05,-60.05,76670000,39489000,9475000,41295000,4774000,0,37344000,9173000,-69025000,0.5436930020037078,0.5181919455639524,0.8529915785350568,__nan__,__nan__,__nan__,0.5386070170862136
208,BNGOW,Bionano Genomics Inc. Warrant,,None,,0.0036,USD,0,https://images.financialmodelingprep.com/symbol/BNGOW.png,0,0,-0.0015,63789,-97469000,-112017000,"[{'period': '2024', 'revenue': 30.78, 'unit': 'M', 'net_profit': -112.02}, {'period': '2023', 'revenue': 36.12, 'unit': 'M', 'net_profit': -232.49}, {'period': '2022', 'revenue': 27.8, 'unit': 'M', 'net_profit': -132.6}, {'period': '2021', 'revenue': 17.98, 'unit': 'M', 'net_profit': -72.44}]","[{'period': ""Q1 '25"", 'revenue': 6.46, 'unit': 'M', 'net_profit': -3.1}, {'period': ""Q4 '24"", 'revenue': 8.16, 'unit': 'M', 'net_profit': -20.12}, {'period': ""Q3 '24"", 'revenue': 6.07, 'unit': 'M', 'net_profit': -44.25}, {'period': ""Q2 '24"", 'revenue': 7.77, 'unit': 'M', 'net_profit': -16.22}, {'period': ""Q1 '24"", 'revenue': 8.77, 'unit': 'M', 'net_profit': -31.42}, {'period': ""Q4 '23"", 'revenue': 10.72, 'unit': 'M', 'net_profit': -43.89}]",-60.05,-60.05,76670000,39489000,9475000,41295000,4774000,0,37344000,9173000,-69025000,0.5436930020037078,0.5181919455639524,0.8529915785350568,__nan__,__nan__,__nan__,0.5386070170862136
209,BNR,Burning Rock Biotech Limited American Depositary Shares,"Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and prognosis prediction tests applicable to a range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC; ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and OncoScreen ParpMatch and OncoCompass ParpMatch to target critical genes associated with homologous recombination deficiency. In addition, the company has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; and licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China. It has collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. The company was incorporated in 2014 and is headquartered in Guangzhou, China.",Mr. Yusheng  Han,Medical - Diagnostics & Research,3.1,USD,3337646,https://images.financialmodelingprep.com/symbol/BNR.png,31037,-0.66,0.19,47176,-270232000,-346626000,"[{'period': '2024', 'revenue': 515.82, 'unit': 'M', 'net_profit': -346.63}, {'period': '2023', 'revenue': 537.43, 'unit': 'M', 'net_profit': -653.69}, {'period': '2022', 'revenue': 563.24, 'unit': 'M', 'net_profit': -971.23}, {'period': '2021', 'revenue': 507.86, 'unit': 'M', 'net_profit': -796.7}]","[{'period': ""Q4 '24"", 'revenue': 126.02, 'unit': 'M', 'net_profit': -81.29}, {'period': ""Q3 '24"", 'revenue': 128.64, 'unit': 'M', 'net_profit': -35.74}, {'period': ""Q2 '24"", 'revenue': 135.53, 'unit': 'M', 'net_profit': -108.04}, {'period': ""Q1 '24"", 'revenue': 125.62, 'unit': 'M', 'net_profit': -121.55}, {'period': ""Q4 '23"", 'revenue': 121.08, 'unit': 'M', 'net_profit': -162.21}, {'period': ""Q3 '23"", 'revenue': 127.57, 'unit': 'M', 'net_profit': -174.98}]",-335.6,-335.6,885305000,776618000,519849000,304478000,173447000,0,266299000,519849000,-98238000,0.4782168792877403,0.4697386677762667,-4.251956181533647,__nan__,__nan__,__nan__,0.34392441023150216
210,BNSO,Bonso Electronics International Inc. Common Stock,"Bonso Electronics International Inc., together with its subsidiaries, designs, develops, produces, and sells electronic sensor-based and wireless products. It operates in four segments: Scales, Pet Electronic Products, Rental and Management, and Others. The Scales segment provides sensor-based scales products that include bathroom, kitchen, office, jewelry, laboratory, postal, and industrial scales for consumer, commercial, and industrial applications. The Pet Electronic Products segment develops and produces pet-related electronic products for use in consumer applications. The Rental and Management segment offers leasing of factories and machineries to third parties. The Others segment sells cordless leaf blowers, food vacuum sealers, and hydroponics growing systems, as well as scrap materials; and provides tooling and molding charges for scales. It serves private label original equipment, original brand manufacturers, and original design manufacturers primarily in the United States, Germany, and the People's Republic of China. The company also sells its pet electronic products through online platforms. The company was formerly known as Golden Virtue Limited and changed its name to Bonso Electronics International Inc. in September 1988. Bonso Electronics International Inc. was incorporated in 1988 and is based in Tsim Sha Tsui, Hong Kong.",Mr. Chun Bong  So,"Hardware, Equipment & Parts",1.12,USD,5440053,https://images.financialmodelingprep.com/symbol/BNSO.png,35383,-2.4347826086956523,-0.07,22990,-1042000,-2760000,"[{'period': '2022', 'revenue': 14.8, 'unit': 'M', 'net_profit': -2.76}, {'period': '2021', 'revenue': 15.59, 'unit': 'M', 'net_profit': 1.77}, {'period': '2020', 'revenue': 13100.0, 'unit': 'K', 'net_profit': 217.0}, {'period': '2019', 'revenue': 9990.0, 'unit': 'K', 'net_profit': -479.0}]","[{'period': ""Q4 '22"", 'revenue': -2.66, 'unit': 'M', 'net_profit': -2.78}, {'period': ""Q4 '20"", 'revenue': 8690.0, 'unit': 'K', 'net_profit': 986.0}, {'period': ""Q2 '20"", 'revenue': 4410.0, 'unit': 'K', 'net_profit': -588.0}, {'period': ""Q4 '19"", 'revenue': 4360.0, 'unit': 'K', 'net_profit': -375.0}, {'period': ""Q2 '19"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q4 '18"", 'revenue': 5310.0, 'unit': 'K', 'net_profit': -684.0}]",-0.57,-0.57,23750000,11522000,7135000,8407000,2260000,0,4648000,6740000,-3187000,-1.4926713947990544,-2.5584415584415585,-2.583333333333333,"[0.05, 0.1]","['2006-09-27', '2001-01-29']",__nan__,0.35397894736842106
211,BNTC,Benitec Biopharma Inc. Common Stock,"Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.","Dr. Jerel A. Banks M.D., Ph.D.",Biotechnology,13.665,USD,349826733,https://images.financialmodelingprep.com/symbol/BNTC.png,46773,-2.72,-0.265,28742,-22490000,-21751000,"[{'period': '2024', 'revenue': 0.216, 'unit': 'M', 'net_profit': -21.75}, {'period': '2023', 'revenue': 0.075, 'unit': 'M', 'net_profit': -19.56}, {'period': '2022', 'revenue': 0.073, 'unit': 'M', 'net_profit': -18.56}, {'period': '2021', 'revenue': 0.059000000000000004, 'unit': 'M', 'net_profit': -13.78}]","[{'period': ""Q3 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.35}, {'period': ""Q2 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.36}, {'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.06}, {'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.72}, {'period': ""Q3 '24"", 'revenue': 0.006, 'unit': 'M', 'net_profit': -4.28}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.8}]",-2.68,-2.68,52210000,51674000,50866000,4962000,229000,0,4924000,50866000,-19582000,-0.20267379679144384,-0.11190062365811267,0.8101983002832861,"[0.003, 0.003]","['2018-06-01', '2018-06-01']",__nan__,0.0950392645087148
212,BNTX,BioNTech SE American Depositary Share,"BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, a preclinical stage product for non-small cell lung cancer. It also develops neoantigen specific immunotherapies, such as Autogene cevumeran (BNT122), which is in Phase II clinical trial for first-line melanoma, as well as in Phase 1a/1b clinical trial to treat multiple solid tumors; mRNA intratumoral immunotherapy comprising SAR441000 that is in Phase I clinical trial for solid tumors; and BNT141 and BNT142 that are in Phase I clinical trial to treat multiple solid tumors. In addition, the company develops RiboCytokines, which include BNT151, BNT152, and BNT153 to treat solid tumors; chimeric antigen receptor T cell immunotherapies, such as BNT211 to treat multiple solid tumors, and BNT221 for other cancers; and checkpoint immunomodulators consisting of GEN1046 and GEN1042, which are in Phase I/II clinical trial to treat solid tumors. Further, it develops BNT321, an IgG1 monoclonal antibody in Phase II clinical trial for pancreatic cancer; BNT411, a small molecule immunomodulator product candidate for solid tumors; prophylactic vaccine for COVID-19 and Influenza; and infectious disease immunotherapies and rare disease protein replacement therapies. The company has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; and Regeneron Pharmaceuticals, Inc. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.",Dr. Ugur  Sahin M.D.,Biotechnology,99.09,USD,23820504914,https://images.financialmodelingprep.com/symbol/BNTX.png,1135242,-27.83,-2.63,767865,-367100000,-665300000,"[{'period': '2024', 'revenue': 2750.0, 'unit': 'M', 'net_profit': -665.3}, {'period': '2023', 'revenue': 3820.0, 'unit': 'M', 'net_profit': 930.3}, {'period': '2022', 'revenue': 17.31, 'unit': 'B', 'net_profit': 9.43}, {'period': '2021', 'revenue': 18.98, 'unit': 'B', 'net_profit': 10.29}]","[{'period': ""Q1 '25"", 'revenue': 182.8, 'unit': 'M', 'net_profit': -415.8}, {'period': ""Q4 '24"", 'revenue': 1190.0, 'unit': 'M', 'net_profit': 259.5}, {'period': ""Q3 '24"", 'revenue': 1240.0, 'unit': 'M', 'net_profit': 195.46}, {'period': ""Q2 '24"", 'revenue': 128.7, 'unit': 'M', 'net_profit': -807.8}, {'period': ""Q1 '24"", 'revenue': 187.6, 'unit': 'M', 'net_profit': -315.1}, {'period': ""Q4 '23"", 'revenue': 1480.0, 'unit': 'M', 'net_profit': 457.9}]",-2.77,-2.77,22529700000,18803500000,16783600000,3118600000,1523900000,1254000000,2523200000,9761900000,-244600000,-1.266516625526354,-1.7151456519402344,-1.7157622739018088,"[2.111, 2.111]","['2022-06-02', '2022-06-02']",__nan__,0.13842172776379624
213,BOCH,Bank of Commerce Holdings (CA) Common Stock,"Bank of Commerce Holdings operates as the bank holding company for Merchants Bank of Commerce that provides a range of financial services and products for small to medium-sized businesses, and retail customers in California. The company accepts various deposit products, such as checking, interest bearing checking, money market, and savings accounts, as well as certificates of deposit. Its loan products include commercial loans, commercial real estate loans, residential real estate loans, consumer loans, construction loans, term loans, and small business administration loans. In addition, it provides sweep arrangements, safe deposit boxes, collection, electronic banking, payroll processing, and ATM and point of sale services. The company operates ten full service offices and one limited service office in northern California. Bank of Commerce Holdings is headquartered in Sacramento, California.",Mr. Randall Eslick,Banks - Regional,15.17,USD,0,https://images.financialmodelingprep.com/symbol/BOCH.png,107447,0,-0.23999977,431040,25909000,14164000,"[{'period': '2020', 'revenue': 59.51, 'unit': 'M', 'net_profit': 14.16}, {'period': '2019', 'revenue': 57.72, 'unit': 'M', 'net_profit': 14.96}, {'period': '2018', 'revenue': 51.56, 'unit': 'M', 'net_profit': 15.73}, {'period': '2017', 'revenue': 46.19, 'unit': 'M', 'net_profit': 7.34}]","[{'period': ""Q2 '21"", 'revenue': 15.1, 'unit': 'M', 'net_profit': 4.14}, {'period': ""Q1 '21"", 'revenue': 15.27, 'unit': 'M', 'net_profit': 4.92}, {'period': ""Q4 '20"", 'revenue': 15.57, 'unit': 'M', 'net_profit': 5.07}, {'period': ""Q3 '20"", 'revenue': 15.32, 'unit': 'M', 'net_profit': 4.33}, {'period': ""Q2 '20"", 'revenue': 14.74, 'unit': 'M', 'net_profit': 3.85}, {'period': ""Q1 '20"", 'revenue': 13880.0, 'unit': 'K', 'net_profit': 916.0}]",0.85,0.85,35590000,19875000,553866000,1586252000,7279000,455632000,15000000,106986000,21640000,-0.09342524231078764,-0.0532718401176392,0.024096385542168697,"[0.3, 1]","['2021-10-12', '1997-10-20']",__nan__,44.57016015734757
214,BOKF,BOK Financial Corporation Common Stock,"BOK Financial Corporation operates as the financial holding company for BOKF, NA that provides various financial products and services in Oklahoma, Texas, New Mexico, Northwest Arkansas, Colorado, Arizona, and Kansas/Missouri. It operates through three segments: Commercial Banking, Consumer Banking, and Wealth Management. The Commercial Banking segment offers lending, treasury, cash management, and customer commodity risk management products for small businesses, middle market, and larger commercial customers, as well as operates TransFund electronic funds transfer network. The Consumer Banking segment provides lending and deposit services to small business customers through consumer branch network; and engages in the mortgage loan origination and servicing activities. The Wealth Management segment offers fiduciary, private bank, insurance, and investment advisory services; and brokerage and trading services primarily related to providing liquidity to the mortgage markets through trading of U.S. government agency mortgage-backed securities and related derivative contracts, as well as underwrites state and municipal securities. The company also provides commercial loans, such as loans for working capital, facilities acquisition or expansion, purchases of equipment, and other needs of commercial customers; and service, healthcare, manufacturing, wholesale/retail, energy, and other sector loans. In addition, it offers commercial real estate loans for the construction of buildings or other enhancements to real estate and property held by borrowers for investment purposes; and residential mortgage and personal loans. Further, the company provides automated teller machine (ATM), call center, and Internet and mobile banking services. As of December 31, 2021, it operated 2,593 TransFund ATM locations. The company was founded in 1910 and is headquartered in Tulsa, Oklahoma.",Mr. Stacy C. Kymes,Banks - Regional,93.535,USD,6010727369,https://images.financialmodelingprep.com/symbol/BOKF.png,193213,10.74,-3.345,134341,2570931000,523569000,"[{'period': '2024', 'revenue': 2640.0, 'unit': 'M', 'net_profit': 523.57}, {'period': '2023', 'revenue': 1970.0, 'unit': 'M', 'net_profit': 530.75}, {'period': '2022', 'revenue': 1820.0, 'unit': 'M', 'net_profit': 520.27}, {'period': '2021', 'revenue': 1830.0, 'unit': 'M', 'net_profit': 618.12}]","[{'period': ""Q1 '25"", 'revenue': 618.57, 'unit': 'M', 'net_profit': 119.78}, {'period': ""Q4 '24"", 'revenue': 432.67, 'unit': 'M', 'net_profit': 134.82}, {'period': ""Q3 '24"", 'revenue': 680.31, 'unit': 'M', 'net_profit': 138.62}, {'period': ""Q2 '24"", 'revenue': 932.67, 'unit': 'M', 'net_profit': 163.71}, {'period': ""Q1 '24"", 'revenue': 814.35, 'unit': 'M', 'net_profit': 83.7}, {'period': ""Q4 '23"", 'revenue': 453.02, 'unit': 'M', 'net_profit': 82.58}]",8.14,8.14,49685892000,276046000,276046000,44134935000,285916000,19767915000,38077589000,1434701000,1430454000,2.357051826123291,-0.013522475911264521,0.0149625935162096,"[0.57, 0.1]","['2025-05-15', '2005-05-11']",__nan__,0.888279010870933
215,BOKFL,BOK Financial Corporation 5.375% Subordinated Notes due 2056,"BOK Financial Corporation operates as the financial holding company for BOKF, NA that provides various financial products and services in Oklahoma, Texas, New Mexico, Northwest Arkansas, Colorado, Arizona, and Kansas/Missouri. It operates through three segments: Commercial Banking, Consumer Banking, and Wealth Management. The Commercial Banking segment offers lending, treasury, and cash management services, as well as customer risk management products for small businesses, middle market, and larger commercial customers. This segment also operates TransFund electronic funds transfer network. The Consumer Banking segment provides lending and deposit services to small business customers through the retail branch network; and mortgage banking services. The Wealth Management segment offers fiduciary, private banking, and investment advisory services; insurance services; and brokerage and trading services, as well as underwrites state and municipal securities. The company also provides commercial loans, such as loans for working capital, facilities acquisition or expansion, purchases of equipment, and other needs of commercial customers; and service, healthcare, manufacturing, wholesale/retail, energy, and other sector loans. In addition, it offers commercial real estate loans for the construction of buildings or other enhancements to real estate and property held by borrowers for investment purposes; and residential mortgage, personal, and home equity loans. Further, the company provides automated teller machine (ATM), call center, and Internet and mobile banking services. As of December 31, 2019, it operated 2,463 TransFund ATM locations. BOK Financial Corporation was founded in 1910 and is headquartered in Tulsa, Oklahoma.",Mr. Steven Glen Bradshaw,Banks - Regional,25.19,USD,0,https://images.financialmodelingprep.com/symbol/BOKFL.png,14082,0,-0.01000023,7673,2570931000,523569000,"[{'period': '2024', 'revenue': 2640.0, 'unit': 'M', 'net_profit': 523.57}, {'period': '2023', 'revenue': 1970.0, 'unit': 'M', 'net_profit': 530.75}, {'period': '2022', 'revenue': 1820.0, 'unit': 'M', 'net_profit': 520.27}, {'period': '2021', 'revenue': 1830.0, 'unit': 'M', 'net_profit': 618.12}]","[{'period': ""Q1 '25"", 'revenue': 618.57, 'unit': 'M', 'net_profit': 119.78}, {'period': ""Q4 '24"", 'revenue': 432.67, 'unit': 'M', 'net_profit': 134.82}, {'period': ""Q3 '24"", 'revenue': 680.31, 'unit': 'M', 'net_profit': 138.62}, {'period': ""Q2 '24"", 'revenue': 932.67, 'unit': 'M', 'net_profit': 163.71}, {'period': ""Q1 '24"", 'revenue': 814.35, 'unit': 'M', 'net_profit': 83.7}, {'period': ""Q4 '23"", 'revenue': 453.02, 'unit': 'M', 'net_profit': 82.58}]",8.14,8.14,49685892000,276046000,276046000,44134935000,285916000,19767915000,38077589000,1434701000,1430454000,2.357051826123291,-0.013522475911264521,0.0149625935162096,"[0.336, 0.336]","['2021-03-12', '2017-09-14']",__nan__,0.888279010870933
216,BOLT,Bolt Biotherapeutics Inc. Common Stock,"Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; BDC-2034, a carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; and BDC-3042, a Dectin-2 agonist antibody program developed to repolarize critical cells in the tumor microenvironment by targeting cell-surface receptors on macrophages. It is also developing programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood city, California.",Mr. William P. Quinn,Biotechnology,0.317,USD,12153685,https://images.financialmodelingprep.com/symbol/BOLT.png,129788,-0.19,-0.0127,10355452,-66455000,-63118000,"[{'period': '2024', 'revenue': 7.69, 'unit': 'M', 'net_profit': -63.12}, {'period': '2023', 'revenue': 7.88, 'unit': 'M', 'net_profit': -69.2}, {'period': '2022', 'revenue': 5.73, 'unit': 'M', 'net_profit': -85.88}, {'period': '2021', 'revenue': 1.26, 'unit': 'M', 'net_profit': -104.39}]","[{'period': ""Q1 '25"", 'revenue': 1.22, 'unit': 'M', 'net_profit': -11.04}, {'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.94}, {'period': ""Q3 '24"", 'revenue': 1.14, 'unit': 'M', 'net_profit': -15.18}, {'period': ""Q2 '24"", 'revenue': 1.27, 'unit': 'M', 'net_profit': -21.2}, {'period': ""Q1 '24"", 'revenue': 5.27, 'unit': 'M', 'net_profit': -10.81}, {'period': ""Q4 '23"", 'revenue': 2.09, 'unit': 'M', 'net_profit': -17.9}]",-1.65,-1.65,99632000,50814000,47323000,42434000,1165000,22880000,15856000,7205000,-61330000,0.10609076968604557,0.08785062936254462,0.098360655737705,"[0.09, 0.05]","['2014-08-29', '2012-03-06']",__nan__,0.4259073390075478
217,BOMN,Boston Omaha Corporation Class A Common Stock,"Boston Omaha Corporation, together with its subsidiaries, engages in the outdoor billboard advertising business in the southeast United States. It is also involved in the surety insurance and related brokerage, broadband, and investment businesses. The company provides high-speed internet service to approximately 7,000 subscribers in communities in southern Arizona; and 10,000 subscribers in Salt Lake City, Park City, Ogden, Provo, and surrounding communities. As of March 26, 2021, it operated approximately 3,200 billboards containing approximately 6,000 advertising faces of which 60 are digital displays. The company was formerly known as REO Plus, Inc. and changed its name to Boston Omaha Corporation in March 2015. Boston Omaha Corporation was incorporated in 2009 and is headquartered in Omaha, Nebraska.",Mr. Adam Peterson,Advertising Agencies,25.76,USD,765030784,https://images.financialmodelingprep.com/symbol/BOMN.png,119377,8.65010073875084,0,86968,32586280,-1292450,"[{'period': '2024', 'revenue': 108.27, 'unit': 'M', 'net_profit': -1.29}, {'period': '2023', 'revenue': 96.25, 'unit': 'M', 'net_profit': -7.0}, {'period': '2022', 'revenue': 81.23, 'unit': 'M', 'net_profit': 7.14}, {'period': '2021', 'revenue': 56.97, 'unit': 'M', 'net_profit': 52.75}]","[{'period': ""Q1 '25"", 'revenue': 27730.0, 'unit': 'K', 'net_profit': -669.28}, {'period': ""Q4 '24"", 'revenue': 27.93, 'unit': 'M', 'net_profit': 5.35}, {'period': ""Q3 '24"", 'revenue': 27.7, 'unit': 'M', 'net_profit': -1.6}, {'period': ""Q2 '24"", 'revenue': 27.09, 'unit': 'M', 'net_profit': -2.24}, {'period': ""Q1 '24"", 'revenue': 25.55, 'unit': 'M', 'net_profit': -2.81}, {'period': ""Q4 '23"", 'revenue': 24.67, 'unit': 'M', 'net_profit': -3.58}]",-0.04,-0.04,728345729,117447401,89547001,165626276,12517200,146516198,54911524,28289712,-10959611,0.886736890936069,0.815469968699355,0.8260869565217391,__nan__,__nan__,__nan__,0.22740062775874395
218,BOOM,DMC Global Inc. Common Stock,"DMC Global Inc. provides a suite of technical products for the energy, industrial, and infrastructure markets worldwide. The company operates through three segments: Arcadia, DynaEnergetics, and NobelClad. The Arcadia segment manufactures, assembles, and sells architectural building materials, including storefronts and entrances, windows, curtain walls, and interior partitions; architectural components, architectural framing systems, and sun control products; sliding and glazing systems; and engineered steel, aluminum, and wood door and window systems. It sells its products through a national in-house sales force for buildings, such as office towers, hotels, education and athletic facilities, health care facilities, government buildings, retail centers, luxury homes, mixed use, and multi-family residential buildings. The DynaEnergetics segment designs, manufactures, markets, and sells perforating systems, including initiation systems, shaped charges, detonating cords, gun hardware, and control panels; and associated hardware for the oil and gas industry. It sells its products through direct selling, distributors, and independent sales representatives. The NobelClad segment produces and sells explosion-welded clad metal plates for use in the construction of heavy, corrosion resistant pressure vessels, and heat exchangers for oil and gas, chemical and petrochemical, alternative energy, hydrometallurgy, aluminum production, shipbuilding, power generation, and industrial refrigeration industries. It sells its products through direct sales personnel, program managers, and independent sales representatives. The company was formerly known as Dynamic Materials Corporation and changed its name to DMC Global Inc. in November 2016. DMC Global Inc. was founded in 1965 and is headquartered in Broomfield, Colorado.",Mr. James  O'Leary,Oil & Gas Equipment & Services,6.48,USD,132779736,https://images.financialmodelingprep.com/symbol/BOOM.png,220106,-0.79,-0.44,154870,-97280000,-161212000,"[{'period': '2024', 'revenue': 642.85, 'unit': 'M', 'net_profit': -161.21}, {'period': '2023', 'revenue': 719.19, 'unit': 'M', 'net_profit': 26.26}, {'period': '2022', 'revenue': 654.09, 'unit': 'M', 'net_profit': 14.18}, {'period': '2021', 'revenue': 260.12, 'unit': 'M', 'net_profit': -1.01}]","[{'period': ""Q1 '25"", 'revenue': 159290.0, 'unit': 'K', 'net_profit': 758.0}, {'period': ""Q4 '24"", 'revenue': 152370.0, 'unit': 'K', 'net_profit': -763.0}, {'period': ""Q3 '24"", 'revenue': 152.43, 'unit': 'M', 'net_profit': -163.01}, {'period': ""Q2 '24"", 'revenue': 171.18, 'unit': 'M', 'net_profit': 4.8}, {'period': ""Q1 '24"", 'revenue': 166870.0, 'unit': 'K', 'net_profit': 256.0}, {'period': ""Q4 '23"", 'revenue': 174040.0, 'unit': 'K', 'net_profit': 183.0}]",-8.2,-8.2,671337000,289022000,14289000,233286000,103361000,0,114102000,14289000,29312000,-2.014368834852245,-7.139304619368597,-8.592592592592592,"[0.125, 0.2]","['2020-03-30', '2005-06-22']",__nan__,0.3474946263947913
219,BOSC,B.O.S. Better Online Solutions Common Stock,"B.O.S. Better Online Solutions Ltd. provides intelligent robotics, radio frequency identification (RFID), and supply chain solutions for enterprises worldwide. The Intelligent Robotics Division provides custom-made machines for industrial automation and assembly of products and packing that offer technological solutions. The RFID Division provides hardware products, such as thermal and barcode printers; RFID and barcode scanners and readers; wireless, mobile, and forklift terminals; wireless infrastructure; active and passive RFID tags; ribbons, labels, and tags; and RFID systems for libraries. It also develops Warehouse Management System, a data collection solution for logistics management in logistic centers and warehouses; RFID-based systems for tracking inventory in a produce packing house; automatic systems for industrial packing lines; automatic systems to track the production line; and automatic systems to identify and track vehicles for transportation-related settings. In addition, this segment provides maintenance and repair services for data collection equipment, as well as warehouse and on-site service plans; on-site inventory count services in various fields; and asset tagging and counting services for corporate and governmental entities. The Supply Chain Division offers electro-mechanical components, electronics components, communications products, and components consolidation services to aerospace, defense, and other industries. This segment also provides inventory and quality control management of components entering production lines; and inventory management services for ongoing projects. The company markets its products through direct sales and sales agents, as well as through distributors. B.O.S. Better Online Solutions Ltd. was incorporated in 1990 and is headquartered in Rishon LeZion, Israel.",Mr. Eyal  Cohen,Communication Equipment,3.96,USD,23457298,https://images.financialmodelingprep.com/symbol/BOSC.png,36063,10.15,-0.09,23804,2057000,2300000,"[{'period': '2024', 'revenue': 39.95, 'unit': 'M', 'net_profit': 2.3}, {'period': '2023', 'revenue': 44.18, 'unit': 'M', 'net_profit': 2.0}, {'period': '2022', 'revenue': 41.51, 'unit': 'M', 'net_profit': 1.28}, {'period': '2021', 'revenue': 33630.0, 'unit': 'K', 'net_profit': 451.0}]","[{'period': ""Q4 '24"", 'revenue': 10390.0, 'unit': 'K', 'net_profit': 485.0}, {'period': ""Q3 '24"", 'revenue': 9830.0, 'unit': 'K', 'net_profit': 574.0}, {'period': ""Q2 '24"", 'revenue': 8450.0, 'unit': 'K', 'net_profit': 501.0}, {'period': ""Q1 '24"", 'revenue': 11290.0, 'unit': 'K', 'net_profit': 741.0}, {'period': ""Q4 '23"", 'revenue': 10890.0, 'unit': 'K', 'net_profit': 427.0}, {'period': ""Q3 '23"", 'revenue': 9810.0, 'unit': 'K', 'net_profit': 313.0}]",0.4,0.39,34343000,24360000,3368000,13012000,12034000,0,10665000,3368000,775000,-0.3050675675675676,0.14713216957605985,0.142857142857143,__nan__,__nan__,__nan__,0.37888361529278164
220,BOTJ,Bank of the James Financial Group Inc. Common Stock,"Bank of the James Financial Group, Inc. operates as the bank holding company for Bank of the James that provides general retail and commercial banking services to individuals, businesses, associations and organizations, and governmental authorities in Virginia, the Unites States. It offers checking, savings, individual retirement, and health care saving accounts, as well as other time deposits, including money market accounts and certificates of deposit. The company also offers loans to small- and medium-sized businesses for the purchases of equipment, facilities upgrades, inventory acquisition, and various working capital purposes; commercial and residential construction and development loans; commercial real estate mortgage loans; residential mortgage loans; and secured and unsecured consumer loans, such as lines of credit and overdraft lines of credit, as well as personal, automobile, installment, demand, and home equity loans for personal, family, or household purposes. In addition, it provides other banking services, including safe deposit boxes, traveler's checks, direct deposit of payroll and social security checks, automatic drafts for various accounts, treasury management, and credit card merchant services. Further, the company offers securities brokerage and investment services; and telephone and internet banking services comprising online bill pay, as well as acts as an agent for insurance and annuity products. It operates through a network of 16 full-service offices, 2 limited-service offices, and 1 residential mortgage loan production office. The company was founded in 1998 and is headquartered in Lynchburg, Virginia.",Mr. Robert R. Chapman III,Banks - Regional,14.25,USD,64742595,https://images.financialmodelingprep.com/symbol/BOTJ.png,4485,9.76,0,366,0,7944000,"[{'period': '2024', 'revenue': 45.03, 'unit': 'M', 'net_profit': 7.94}, {'period': '2023', 'revenue': 39.36, 'unit': 'M', 'net_profit': 8.7}, {'period': '2022', 'revenue': 42.02, 'unit': 'M', 'net_profit': 8.96}, {'period': '2021', 'revenue': 37.19, 'unit': 'M', 'net_profit': 7.59}]","[{'period': ""Q1 '25"", 'revenue': 14520.0, 'unit': 'K', 'net_profit': 842.0}, {'period': ""Q4 '24"", 'revenue': 11.3, 'unit': 'M', 'net_profit': 1.62}, {'period': ""Q3 '24"", 'revenue': 11.14, 'unit': 'M', 'net_profit': 1.99}, {'period': ""Q2 '24"", 'revenue': 10.94, 'unit': 'M', 'net_profit': 2.15}, {'period': ""Q1 '24"", 'revenue': 10.81, 'unit': 'M', 'net_profit': 2.19}, {'period': ""Q4 '23"", 'revenue': 10.47, 'unit': 'M', 'net_profit': 2.11}]",1.75,1.75,979244000,91760000,88695000,914379000,3065000,0,722000,23287000,5959000,-1,-0.08731617647058823,-0.08376963350785337,"[0.1, 0.05]","['2025-06-06', '2014-06-17']",__nan__,0.9337601251577747
221,BOWX,BowX Acquisition Corp. Class A Common Stock,"Bowx Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It primarily focuses on businesses in the technology, media, and telecommunications industries. The company was founded in 2020 and is based in Menlo Park, California.",Mr. Vivek Y. RanadivÃ©,Shell Companies,10.38,USD,0,https://images.financialmodelingprep.com/symbol/BOWX.png,903658,0,1.0100002,3408386,-792000000,-2034000000,"[{'period': '2022', 'revenue': 3.25, 'unit': 'B', 'net_profit': -2.03}, {'period': '2021', 'revenue': 2.57, 'unit': 'B', 'net_profit': -4.44}, {'period': '2020', 'revenue': 3.42, 'unit': 'B', 'net_profit': -3.13}, {'period': '2019', 'revenue': 3.46, 'unit': 'B', 'net_profit': -3.26}]","[{'period': ""Q3 '23"", 'revenue': 794.0, 'unit': 'M', 'net_profit': -788.0}, {'period': ""Q2 '23"", 'revenue': 844.0, 'unit': 'M', 'net_profit': -349.0}, {'period': ""Q1 '23"", 'revenue': 849.0, 'unit': 'M', 'net_profit': -264.0}, {'period': ""Q4 '22"", 'revenue': 848.0, 'unit': 'M', 'net_profit': -454.0}, {'period': ""Q3 '22"", 'revenue': 817.0, 'unit': 'M', 'net_profit': -568.0}, {'period': ""Q2 '22"", 'revenue': 815.0, 'unit': 'M', 'net_profit': -577.0}]",-106.79,-106.79,17863000000,689000000,287000000,21318000000,173000000,63000000,2230000000,287000000,-1071000000,0.5818373812038015,0.5417886911466546,0.8414708371064235,__nan__,__nan__,__nan__,1.193416559368527
222,BOWXU,BowX Acquisition Corp. Unit,"Bowx Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It primarily focuses on businesses in the technology, media, and telecommunications industries. The company was founded in 2020 and is based in Menlo Park, California.",Mr. Vivek Y. RanadivÃ©,Shell Companies,11.18,USD,0,https://images.financialmodelingprep.com/symbol/BOWXU.png,965,0,1.06,3270,-792000000,-2034000000,"[{'period': '2022', 'revenue': 3.25, 'unit': 'B', 'net_profit': -2.03}, {'period': '2021', 'revenue': 2.57, 'unit': 'B', 'net_profit': -4.44}, {'period': '2020', 'revenue': 3.42, 'unit': 'B', 'net_profit': -3.13}, {'period': '2019', 'revenue': 3.46, 'unit': 'B', 'net_profit': -3.26}]","[{'period': ""Q3 '23"", 'revenue': 794.0, 'unit': 'M', 'net_profit': -788.0}, {'period': ""Q2 '23"", 'revenue': 844.0, 'unit': 'M', 'net_profit': -349.0}, {'period': ""Q1 '23"", 'revenue': 849.0, 'unit': 'M', 'net_profit': -264.0}, {'period': ""Q4 '22"", 'revenue': 848.0, 'unit': 'M', 'net_profit': -454.0}, {'period': ""Q3 '22"", 'revenue': 817.0, 'unit': 'M', 'net_profit': -568.0}, {'period': ""Q2 '22"", 'revenue': 815.0, 'unit': 'M', 'net_profit': -577.0}]",-106.79,-106.79,17863000000,689000000,287000000,21318000000,173000000,63000000,2230000000,287000000,-1071000000,0.5818373812038015,0.5417886911466546,0.8414708371064235,__nan__,__nan__,__nan__,1.193416559368527
223,BOWXW,BowX Acquisition Corp. Warrant,,,,,,,,,,,,-136972,90079,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': 90.08}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.18}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.91}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 90.08}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -61.02}]",-0.02,-0.02,484520512,1293461,484148100,17116262,0,0,211262,921049,-599792,0,0,0,__nan__,__nan__,__nan__,0.03532618656194271
224,BOXL,Boxlight Corporation Class A Common Stock,"Boxlight Corporation develops, sells, and services interactive classroom technology products and solutions for the K-12 education market worldwide. The company provides interactive and non-interactive projectors, interactive flat panel displays, interactive touch projectors, touchboards, and MimioTeach that could turn any whiteboard interactive; and accessory document cameras, teacher pads for remote control, and assessment systems under the Mimio and Clevertouch brands. It also offers MimioStudio Interactive Instructional software that enables the creation, editing, and presentation of interactive instructional lessons and activities; MimioMobile, a software accessory for MimioStudio; Oktopus Instructional and Whiteboarding software that enables the creation, editing, and presentation of interactive instructional lessons and activities; Notes+, a software accessory for use with Oktopus software; and GameZones and MimioInteract, which are multi-student interactive gaming software. In addition, the company provides MimioClarity, a classroom audio solution; Mimio MyBot system that bridges the gap between learning about robotics in the classroom and the application of robotics; Robo3D printers; MyStemKits, which offers standards-driven lesson plans for grades K-12 math and science teachers; MimioView document camera; MimioVote, a student assessment system; and MimioPad, a wireless pen tablet, as well as peripherals and accessories, such as amplified speaker systems, mobile carts, installation accessories, and wall-mount accessories for interactive and standard projectors, and LED flat panels. Further, it offers classroom training, professional development, and educator certification services. The company was formerly known as Logical Choice Corporation. Boxlight Corporation was founded in 1985 and is headquartered in Lawrenceville, Georgia.",Mr. Dale W. Strang,Communication Equipment,1.72,USD,3836254,https://images.financialmodelingprep.com/symbol/BOXL.png,38406,-0.14,0.04,9213,537000,-28335000,"[{'period': '2024', 'revenue': 135.89, 'unit': 'M', 'net_profit': -28.34}, {'period': '2023', 'revenue': 176.72, 'unit': 'M', 'net_profit': -39.16}, {'period': '2022', 'revenue': 221.78, 'unit': 'M', 'net_profit': -3.74}, {'period': '2021', 'revenue': 185.18, 'unit': 'M', 'net_profit': -13.8}]","[{'period': ""Q1 '25"", 'revenue': 22.42, 'unit': 'M', 'net_profit': -3.56}, {'period': ""Q4 '24"", 'revenue': 24.0, 'unit': 'M', 'net_profit': -16.71}, {'period': ""Q3 '24"", 'revenue': 36.29, 'unit': 'M', 'net_profit': -3.06}, {'period': ""Q2 '24"", 'revenue': 38.51, 'unit': 'M', 'net_profit': -1.48}, {'period': ""Q1 '24"", 'revenue': 37.09, 'unit': 'M', 'net_profit': -7.09}, {'period': ""Q4 '23"", 'revenue': 38.81, 'unit': 'M', 'net_profit': -17.67}]",-75.55,-75.55,115305000,78382000,8007000,128201000,18325000,0,77040000,8007000,-945000,1.030526974020806,0.2763561140055164,-2.5303738317757003,__nan__,__nan__,__nan__,1.1118425046615499
225,BPFH,Boston Private Financial Holdings Inc. Common Stock,"Boston Private Financial Holdings, Inc. operates as the bank holding company for Boston Private Bank & Trust Company that provides a range of banking products and services in the United States. It operates in two segments, Private Banking; and Wealth Management and Trust. The company offers deposit products, such as checking, savings and NOW, and money market accounts; and certificates of deposit. Its loan products include loans to individuals, such as residential mortgage loans, mortgage loans on investment or vacation properties, unsecured and secured personal lines of credits, home equity loans, and overdraft protection; and loans to businesses consisting of commercial and mortgage loans, revolving lines of credit, working capital loans, equipment financing, community lending programs, and construction and land loans. In addition, the company provides wealth management solutions comprising planning-based financial strategies, wealth management, family office, financial planning, tax planning, and trust services to individuals, families, institutions, and nonprofit institutions. It operates offices in Boston, Miami, New York, Los Angeles, San Francisco, and Florida. Boston Private Financial Holdings, Inc. was founded in 1987 and is headquartered in Boston, Massachusetts.",Mr. Anthony DeChellis,Banks - Regional,14.75,USD,0,https://images.financialmodelingprep.com/symbol/BPFH.png,885418,0,0.01000023,1370858,116068000,45153000,"[{'period': '2020', 'revenue': 327.31, 'unit': 'M', 'net_profit': 45.15}, {'period': '2019', 'revenue': 329.62, 'unit': 'M', 'net_profit': 80.03}, {'period': '2018', 'revenue': 366.42, 'unit': 'M', 'net_profit': 80.38}, {'period': '2017', 'revenue': 379.92, 'unit': 'M', 'net_profit': 40.59}]","[{'period': ""Q1 '21"", 'revenue': 64.89, 'unit': 'M', 'net_profit': 10.65}, {'period': ""Q4 '20"", 'revenue': 86.06, 'unit': 'M', 'net_profit': 24.97}, {'period': ""Q3 '20"", 'revenue': 80.87, 'unit': 'M', 'net_profit': 22.68}, {'period': ""Q2 '20"", 'revenue': 81.6, 'unit': 'M', 'net_profit': -3.3}, {'period': ""Q1 '20"", 'revenue': 78780.0, 'unit': 'K', 'net_profit': 800.0}, {'period': ""Q4 '19"", 'revenue': 82.92, 'unit': 'M', 'net_profit': 21.24}]",0.55,0.55,1122251000,1055588000,2299281000,9180725000,28991000,1320368000,6774000,1055588000,49662000,-0.4395963595104169,-0.43578497525865945,-0.4210526315789473,"[0.06, 0.03]","['2021-05-06', '2000-01-27']",__nan__,8.180634278784336
226,BPMC,Blueprint Medicines Corporation Common Stock,"Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally available and potent inhibitor for the treatment of hepatocellular carcinoma. It is also developing GAVRETO for the treatment of RET fusion-positive non-small cell lung cancer, altered solid tumors, medullary thyroid carcinoma, and other solid tumors; BLU-701 and BLU-945 for the treatment of epidermal growth factor receptor driven non-small-cell lung carcinoma (NSCLC); and BLU-451 to treat NSCLC in patients with epidermal growth factor receptor gene (EGFR) exon 20 insertion mutations. In addition, the company is developing BLU-782, for the treatment of fibrodysplasia ossificans progressive; BLU- 222 to treat patients with cyclin E aberrant cancers; and BLU-852 for the treatment of advanced cancers. It has collaboration and license agreements with Clementia Pharmaceuticals, Inc.; Proteovant Therapeutics; CStone Pharmaceuticals; Genentech, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and Zai Lab (Shanghai) Co., Ltd. The company was formerly known as Hoyle Pharmaceuticals, Inc. and changed its name to Blueprint Medicines Corporation in June 2011. Blueprint Medicines Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.",Ms. Kathryn  Haviland M.B.A.,Biotechnology,101.51,USD,6555739122,https://images.financialmodelingprep.com/symbol/BPMC.png,993032,-40.44,-1.49,489733,19234000,-67089000,"[{'period': '2024', 'revenue': 508.82, 'unit': 'M', 'net_profit': -67.09}, {'period': '2023', 'revenue': 249.38, 'unit': 'M', 'net_profit': -506.98}, {'period': '2022', 'revenue': 204.04, 'unit': 'M', 'net_profit': -557.52}, {'period': '2021', 'revenue': 180.08, 'unit': 'M', 'net_profit': -644.09}]","[{'period': ""Q1 '25"", 'revenue': 149410.0, 'unit': 'K', 'net_profit': 496.0}, {'period': ""Q4 '24"", 'revenue': 146.37, 'unit': 'M', 'net_profit': -49.96}, {'period': ""Q3 '24"", 'revenue': 128.18, 'unit': 'M', 'net_profit': -56.28}, {'period': ""Q2 '24"", 'revenue': 138.16, 'unit': 'M', 'net_profit': -49.99}, {'period': ""Q1 '24"", 'revenue': 96.12, 'unit': 'M', 'net_profit': 89.14}, {'period': ""Q4 '23"", 'revenue': 71.96, 'unit': 'M', 'net_profit': -110.92}]",-1.07,-1.07,1179813000,742678000,615487000,881148000,77609000,277149000,260796000,102014000,-197216000,1.0408924282883603,0.8676703801303394,0.8721624850657108,__nan__,__nan__,__nan__,0.7468539505836942
227,BPOP,Popular Inc. Common Stock,"Popular, Inc., through its subsidiaries, provides various retail, mortgage, and commercial banking products and services in Puerto Rico, the United States, and British Virgin Islands. The company provides savings, NOW, money market, and other interest-bearing demand accounts; non-interest bearing demand deposits; and certificates of deposit. It also offers commercial and industrial, commercial multi-family, commercial real estate, and residential mortgage loans; consumer loans, including personal loans, credit cards, automobile loans, home equity lines of credit, and other loans to individual borrowers; construction loans; and lease financing comprising automobile loans/leases. In addition, the company provides investment banking, auto and equipment leasing and financing, broker-dealer, and insurance services; debit cards; and online banking services. As of December 31, 2021, it operated 169 branches; and 616 ATMs in Puerto Rico, 23 ATMs in the Virgin Islands, and 91 ATMs in the United States Mainland. Popular, Inc. was founded in 1893 and is headquartered in Hato Rey, Puerto Rico.",Mr. Ignacio  Alvarez Esq.,Banks - Regional,102.74,USD,7038799592,https://images.financialmodelingprep.com/symbol/BPOP.png,678262,10.6,-2.41,511113,0,614212000,"[{'period': '2024', 'revenue': 2680.0, 'unit': 'M', 'net_profit': 614.21}, {'period': '2023', 'revenue': 2640.0, 'unit': 'M', 'net_profit': 541.34}, {'period': '2022', 'revenue': 2.94, 'unit': 'B', 'net_profit': 1.1}, {'period': '2021', 'revenue': 2790.0, 'unit': 'M', 'net_profit': 934.89}]","[{'period': ""Q1 '25"", 'revenue': 1070.0, 'unit': 'M', 'net_profit': 177.5}, {'period': ""Q4 '24"", 'revenue': 689.36, 'unit': 'M', 'net_profit': 177.82}, {'period': ""Q3 '24"", 'revenue': 702.24, 'unit': 'M', 'net_profit': 155.32}, {'period': ""Q2 '24"", 'revenue': 695.52, 'unit': 'M', 'net_profit': 177.79}, {'period': ""Q1 '24"", 'revenue': 641.96, 'unit': 'M', 'net_profit': 103.28}, {'period': ""Q4 '23"", 'revenue': 673.46, 'unit': 'M', 'net_profit': 94.59}]",8.56,8.56,73045383000,715441000,419638000,67432317000,295803000,0,49356226000,6800586000,461310000,-1,0.1346099138806891,0.13678618857901728,"[0.7, 0.66]","['2025-05-29', '1986-12-08']",__nan__,0.9231564574040224
228,BPOPM,Popular Inc. Popular Capital Trust II - 6.125% Cumulative Monthly Income Trust Preferred Securities,Popular Capital Trust II is a statutory trust. It is engaged in issuing capital securities.,None,Banks,25.47,USD,2472453818,https://images.financialmodelingprep.com/symbol/BPOPM.png,2411,,-0.12,1179,113951000,934889000,"[{'period': '2021', 'revenue': 2120.0, 'unit': 'M', 'net_profit': 934.89}, {'period': '2020', 'revenue': 2090.0, 'unit': 'M', 'net_profit': 506.62}, {'period': '2019', 'revenue': 2260.0, 'unit': 'M', 'net_profit': 409.39}, {'period': '2018', 'revenue': 19.24, 'unit': 'M', 'net_profit': 618.16}]","[{'period': ""Q3 '22"", 'revenue': 651.24, 'unit': 'M', 'net_profit': 422.39}, {'period': ""Q2 '22"", 'revenue': 571.76, 'unit': 'M', 'net_profit': 211.42}, {'period': ""Q1 '22"", 'revenue': 529.72, 'unit': 'M', 'net_profit': 211.69}, {'period': ""Q4 '21"", 'revenue': 1980.0, 'unit': 'M', 'net_profit': 189.07}, {'period': ""Q3 '21"", 'revenue': 530.16, 'unit': 'M', 'net_profit': 248.11}, {'period': ""Q2 '21"", 'revenue': 529.76, 'unit': 'M', 'net_profit': 218.08}]",9.63,9.63,75097899000,17544242000,17544242000,69128502000,0,0,75000000,7523000,784849000,0.30649285132826565,0.8453383390377835,0.6377551020408165,"[0.1276, 0.128]","['2025-05-15', '2008-12-11']",__nan__,0.9205117975404346
229,BPOPN,Popular Inc. 6.70% Cumulative Monthly Income Trust Preferred Securities,,None,Banks,25.23,USD,0,https://images.financialmodelingprep.com/symbol/BPOPN.png,11440,0,0.1099987,11833,1412922000,671135000,"[{'period': '2019', 'revenue': 285.21, 'unit': 'M', 'net_profit': 671.13}, {'period': '2018', 'revenue': 19.24, 'unit': 'M', 'net_profit': 618.16}, {'period': '2017', 'revenue': 1500.0, 'unit': 'M', 'net_profit': 107.68}, {'period': '2016', 'revenue': 1420.0, 'unit': 'M', 'net_profit': 216.69}]","[{'period': ""Q1 '20"", 'revenue': 581.87, 'unit': 'M', 'net_profit': 573.6}, {'period': ""Q4 '19"", 'revenue': 75.56, 'unit': 'M', 'net_profit': 166.78}, {'period': ""Q3 '19"", 'revenue': 71.31, 'unit': 'M', 'net_profit': 165.32}, {'period': ""Q2 '19"", 'revenue': 74.03, 'unit': 'M', 'net_profit': 171.11}, {'period': ""Q1 '19"", 'revenue': 64.31, 'unit': 'M', 'net_profit': 167.93}, {'period': ""Q4 '18"", 'revenue': -1240.0, 'unit': 'M', 'net_profit': 106.4}]",6.92,6.92,52115324000,571682000,390811000,46098545000,180871000,3262286000,262971000,388311000,629702000,0.20301101416106423,0.08570139025944823,0.13442622950819677,"[0.13958, 0.1396]","['2021-09-14', '2003-12-11']",__nan__,0.8845487557556008
230,BPRN,The Bank of Princeton Common Stock,"The Bank of Princeton provides various banking products and services. It accepts various deposit products, including checking, savings, attorney trust, and money market accounts, as well as certificates of deposit. The company also offers various loan products comprising commercial real estate and multi-family, commercial and industrial, construction, residential first-lien mortgage, paycheck protection program, home equity, and consumer loans. In addition, it provides debit and credit cards, and money orders, direct deposit, automated teller machines, cashier's checks, safe deposit boxes, wire transfers, night depository, remote deposit capture, debit cards, bank-by-mail, online, and automated telephone banking services, as well as payroll-related services and merchant credit card processing services. Further, the company offers full on-line statements, on-line bill payment, account inquiries, transaction histories and details, and account-to-account transfer services. The company operates 21 branches in Princeton, including parts of Mercer, Somerset, Hunterdon, Ocean, Burlington, Camden, Gloucester, and Middlesex Counties in central New Jersey, as well as in additional areas in portions of Philadelphia, Montgomery, and Bucks counties in Pennsylvania. The Bank of Princeton was incorporated in 2007 and is headquartered in Princeton, New Jersey.",Mr. Edward J. Dietzler,Banks - Regional,31.46,USD,217990430,https://images.financialmodelingprep.com/symbol/BPRN.png,9850,19.18,-0.58,36503,0,10242000,"[{'period': '2024', 'revenue': 74.69, 'unit': 'M', 'net_profit': 10.24}, {'period': '2023', 'revenue': 69.33, 'unit': 'M', 'net_profit': 25.77}, {'period': '2022', 'revenue': 72.94, 'unit': 'M', 'net_profit': 26.49}, {'period': '2021', 'revenue': 67.27, 'unit': 'M', 'net_profit': 22.49}]","[{'period': ""Q1 '25"", 'revenue': 35.46, 'unit': 'M', 'net_profit': 5.38}, {'period': ""Q4 '24"", 'revenue': 20.03, 'unit': 'M', 'net_profit': 5.23}, {'period': ""Q3 '24"", 'revenue': 14.56, 'unit': 'M', 'net_profit': -4.46}, {'period': ""Q2 '24"", 'revenue': 31.5, 'unit': 'M', 'net_profit': 5.13}, {'period': ""Q1 '24"", 'revenue': 30.05, 'unit': 'M', 'net_profit': 4.34}, {'period': ""Q4 '23"", 'revenue': 29.33, 'unit': 'M', 'net_profit': 5.28}]",1.56,1.56,2340233000,2090936000,264086000,2078193000,1826850000,194108000,38342000,16915000,13205000,-1,-0.602483989908791,-0.6195121951219512,"[0.3, 0.03]","['2025-05-06', '2018-11-02']",__nan__,0.8880282433415818
231,BPTH,Bio-Path Holdings Inc. Common Stock,"Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 that is in preclinical stage for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and prexigebersen-A for various solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.",Mr. Peter H. Nielsen MBA,Biotechnology,0.17,USD,1412362,https://images.financialmodelingprep.com/symbol/BPTH.png,52754,-0.04,0.003,3086,0,-9894000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.89}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.08}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.84}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.44}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.85}, {'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.75}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.12}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.87}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.16}, {'period': ""Q4 '23"", 'revenue': 0.274, 'unit': 'M', 'net_profit': -3.37}]",-4.12,-4.12,3883000,3776000,1173000,3729000,0,0,3295000,1173000,-10575000,1,0.38462495335240704,0.877526753864447,__nan__,__nan__,__nan__,0.9603399433427762
232,BPTS,Biophytis SA American Depositary Share,"Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases. The company's lead drug candidate is Sarconeos (BIO101), an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD), as well as in Phase 2/3 clinical study for the treatment of severe respiratory failure in patients suffering from COVID-19. It also develops Macuneos (BIO201), an orally administered small molecule for the treatment of retinal diseases, including dry age-related macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is headquartered in Paris, France.",Mr. Stanislas  Veillet Ph.D.,Biotechnology,8.22,USD,2608625,https://images.financialmodelingprep.com/symbol/BPTS.png,9044,-0.06402367785653089,-1.28,17954,-13804000,-17026000,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.03}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -24.22}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -31.16}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -25.52}]","[{'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.81}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.26}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.76}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.82}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.2}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.96}]",-12.55,-12.54,11960000,8850000,5567000,15849000,0,134000,12365000,5567000,-13093000,0.40084205043621685,0.2969111331351173,0.7761327149482697,__nan__,__nan__,__nan__,1.3251672240802677
233,BPY,Brookfield Property Partners L.P. Limited Partnership Units,"Brookfield Property Partners, through Brookfield Property Partners L.P. and its subsidiary Brookfield Property REIT Inc., is one of the world's premier real estate companies, with approximately $88 billion in total assets. We own and operate iconic properties in the world's major markets, and our global portfolio includes office, retail, multifamily, logistics, hospitality, self-storage, triple net lease, manufactured housing and student housing. Brookfield Property Partners is the flagship listed real estate company of Brookfield Asset Management Inc., a leading global alternative asset manager with over $540 billion in assets under management. More information is available at www.brookfield.com.",Mr. Brian Kingston,Real Estate - Services,18.59,USD,0,https://images.financialmodelingprep.com/symbol/BPY.png,4292488,-11.280339805825243,-0.04999924,5400819,14495000000,-47000000,"[{'period': '2022', 'revenue': 8070.0, 'unit': 'M', 'net_profit': -47.0}, {'period': '2021', 'revenue': 7720.0, 'unit': 'M', 'net_profit': 530.0}, {'period': '2020', 'revenue': 7.25, 'unit': 'B', 'net_profit': -1.1}, {'period': '2019', 'revenue': 9120.0, 'unit': 'M', 'net_profit': 884.0}]","[{'period': ""Q2 '23"", 'revenue': 2420.0, 'unit': 'M', 'net_profit': -191.0}, {'period': ""Q1 '23"", 'revenue': 2400.0, 'unit': 'M', 'net_profit': -83.0}, {'period': ""Q4 '22"", 'revenue': 1960.0, 'unit': 'M', 'net_profit': -428.0}, {'period': ""Q3 '22"", 'revenue': 1880.0, 'unit': 'M', 'net_profit': -14.0}, {'period': ""Q2 '21"", 'revenue': 1660.0, 'unit': 'M', 'net_profit': 319.0}, {'period': ""Q1 '21"", 'revenue': 1450.0, 'unit': 'M', 'net_profit': 124.0}]",-0.16,-0.16,112516000000,4020000000,4020000000,41262000000,0,0,0,4020000000,-53000000,0.04853877314814815,-1.088679245283019,-1.0903954802259888,"[0.3325, 0.1277]","['2021-02-25', '2013-05-29']",__nan__,0.3667211774325429
234,BPYPN,Brookfield Property Partners L.P. 5.750% Class A Cumulative Redeemable Perpetual Preferred Units Series 3,"Brookfield Property Partners, through Brookfield Property Partners L.P. and its subsidiary Brookfield Property REIT Inc., is one of the world's premier real estate companies, with approximately $88 billion in total assets. We own and operate iconic properties in the world's major markets, and our global portfolio includes office, retail, multifamily, logistics, hospitality, self-storage, triple net lease, manufactured housing and student housing. Brookfield Property Partners is the flagship listed real estate company of Brookfield Asset Management Inc., a leading global alternative asset manager with over $540 billion in assets under management. More information is available at www.brookfield.com. As of July 26, 2021, Brookfield Property Partners L.P. operates as a subsidiary of Brookfield Asset Management Inc.",Mr. Brian William Kingston,Real Estate - Services,13.2009,USD,4850891886,https://images.financialmodelingprep.com/symbol/BPYPN.png,13275,6.01,-0.3291,20665,3474000000,-510000000,"[{'period': '2024', 'revenue': 9110.0, 'unit': 'M', 'net_profit': -510.0}, {'period': '2023', 'revenue': 9480.0, 'unit': 'M', 'net_profit': -442.0}, {'period': '2022', 'revenue': 7370.0, 'unit': 'M', 'net_profit': 996.0}, {'period': '2021', 'revenue': 7.1, 'unit': 'B', 'net_profit': 3.5}]","[{'period': ""Q4 '24"", 'revenue': 1900.0, 'unit': 'M', 'net_profit': -49.0}, {'period': ""Q3 '24"", 'revenue': 2470.0, 'unit': 'M', 'net_profit': -150.0}, {'period': ""Q2 '24"", 'revenue': 2420.0, 'unit': 'M', 'net_profit': -173.0}, {'period': ""Q1 '24"", 'revenue': 2320.0, 'unit': 'M', 'net_profit': -138.0}, {'period': ""Q4 '23"", 'revenue': 2480.0, 'unit': 'M', 'net_profit': -105.0}, {'period': ""Q3 '23"", 'revenue': 2430.0, 'unit': 'M', 'net_profit': -63.0}]",-1.49,-1.49,102591000000,8109000000,2208000000,64342000000,1450000000,23018000000,21670000000,2208000000,615000000,0.15993322203672788,-0.15384615384615385,-0.07971014492753631,"[0.35938, 0.527]","['2025-06-02', '2020-05-29']",__nan__,0.6271700246610327
235,BPYPO,Brookfield Property Partners L.P. 6.375% Class A Cumulative Redeemable Perpetual Preferred Units Series 2,"Brookfield Property Partners, through Brookfield Property Partners L.P. and its subsidiary Brookfield Property REIT Inc., is one of the world's premier real estate companies, with approximately $88 billion in total assets. We own and operate iconic properties in the world's major markets, and our global portfolio includes office, retail, multifamily, logistics, hospitality, self-storage, triple net lease, manufactured housing and student housing. Brookfield Property Partners is the flagship listed real estate company of Brookfield Asset Management Inc., a leading global alternative asset manager with over $540 billion in assets under management. More information is available at www.brookfield.com. As of July 26, 2021, Brookfield Property Partners L.P. operates as a subsidiary of Brookfield Asset Management Inc.",Mr. Brian William Kingston,Real Estate - Services,14.7391,USD,5416129249,https://images.financialmodelingprep.com/symbol/BPYPO.png,19270,6.71,-0.1309,4698,3474000000,-510000000,"[{'period': '2024', 'revenue': 9110.0, 'unit': 'M', 'net_profit': -510.0}, {'period': '2023', 'revenue': 9480.0, 'unit': 'M', 'net_profit': -442.0}, {'period': '2022', 'revenue': 7370.0, 'unit': 'M', 'net_profit': 996.0}, {'period': '2021', 'revenue': 7.1, 'unit': 'B', 'net_profit': 3.5}]","[{'period': ""Q4 '24"", 'revenue': 1900.0, 'unit': 'M', 'net_profit': -49.0}, {'period': ""Q3 '24"", 'revenue': 2470.0, 'unit': 'M', 'net_profit': -150.0}, {'period': ""Q2 '24"", 'revenue': 2420.0, 'unit': 'M', 'net_profit': -173.0}, {'period': ""Q1 '24"", 'revenue': 2320.0, 'unit': 'M', 'net_profit': -138.0}, {'period': ""Q4 '23"", 'revenue': 2480.0, 'unit': 'M', 'net_profit': -105.0}, {'period': ""Q3 '23"", 'revenue': 2430.0, 'unit': 'M', 'net_profit': -63.0}]",-1.49,-1.49,102591000000,8109000000,2208000000,64342000000,1450000000,23018000000,21670000000,2208000000,615000000,0.15993322203672788,-0.15384615384615385,-0.07971014492753631,"[0.39844, 0.58]","['2025-06-02', '2019-11-29']",__nan__,0.6271700246610327
236,BPYPP,Brookfield Property Partners L.P. 6.50% Class A Cumulative Redeemable Perpetual Preferred Units,"Brookfield Property Partners, through Brookfield Property Partners L.P. and its subsidiary Brookfield Property REIT Inc., is one of the world's premier real estate companies, with approximately $88 billion in total assets. We own and operate iconic properties in the world's major markets, and our global portfolio includes office, retail, multifamily, logistics, hospitality, self-storage, triple net lease, manufactured housing and student housing. Brookfield Property Partners is the flagship listed real estate company of Brookfield Asset Management Inc., a leading global alternative asset manager with over $540 billion in assets under management. More information is available at www.brookfield.com. As of July 26, 2021, Brookfield Property Partners L.P. operates as a subsidiary of Brookfield Asset Management Inc.",Mr. Brian William Kingston,Real Estate - Services,14.785,USD,5432995973,https://images.financialmodelingprep.com/symbol/BPYPP.png,19288,6.73,-0.565,17048,3474000000,-510000000,"[{'period': '2024', 'revenue': 9110.0, 'unit': 'M', 'net_profit': -510.0}, {'period': '2023', 'revenue': 9480.0, 'unit': 'M', 'net_profit': -442.0}, {'period': '2022', 'revenue': 7370.0, 'unit': 'M', 'net_profit': 996.0}, {'period': '2021', 'revenue': 7.1, 'unit': 'B', 'net_profit': 3.5}]","[{'period': ""Q4 '24"", 'revenue': 1900.0, 'unit': 'M', 'net_profit': -49.0}, {'period': ""Q3 '24"", 'revenue': 2470.0, 'unit': 'M', 'net_profit': -150.0}, {'period': ""Q2 '24"", 'revenue': 2420.0, 'unit': 'M', 'net_profit': -173.0}, {'period': ""Q1 '24"", 'revenue': 2320.0, 'unit': 'M', 'net_profit': -138.0}, {'period': ""Q4 '23"", 'revenue': 2480.0, 'unit': 'M', 'net_profit': -105.0}, {'period': ""Q3 '23"", 'revenue': 2430.0, 'unit': 'M', 'net_profit': -63.0}]",-1.49,-1.49,102591000000,8109000000,2208000000,64342000000,1450000000,23018000000,21670000000,2208000000,615000000,0.15993322203672788,-0.15384615384615385,-0.07971014492753631,"[0.40625, 0.447]","['2025-06-02', '2019-05-30']",__nan__,0.6271700246610327
237,BPYU,Brookfield Property REIT Inc. Class A Common Stock,"Brookfield Property REIT Inc. (?BPYU?) is a subsidiary of Brookfield Property Partners L.P., (NASDAQ: BPY; TSX: BPY.UN) (?BPY?) one of the world's premier real estate companies, with approximately $88 billion in total assets. BPYU was created as a public security that is intended to offer economic equivalence to an investment in BPY in the form of a U.S. REIT stock.",,REIT - Retail,18.52,USD,0,https://images.financialmodelingprep.com/symbol/BPYU.png,680367,-0.778543803598453,-0.15999985,9009668,589440000,-711461000,"[{'period': '2020', 'revenue': 1530.0, 'unit': 'M', 'net_profit': -711.46}, {'period': '2019', 'revenue': 1560.0, 'unit': 'M', 'net_profit': 432.88}, {'period': '2018', 'revenue': 2.06, 'unit': 'B', 'net_profit': 4.09}, {'period': '2017', 'revenue': 2330.0, 'unit': 'M', 'net_profit': 657.33}]","[{'period': ""Q2 '21"", 'revenue': 470550000.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q1 '21"", 'revenue': 368.4, 'unit': 'M', 'net_profit': -229.12}, {'period': ""Q4 '20"", 'revenue': 384.47, 'unit': 'M', 'net_profit': -249.96}, {'period': ""Q3 '20"", 'revenue': 366.98, 'unit': 'M', 'net_profit': -170.62}, {'period': ""Q2 '20"", 'revenue': 374.46, 'unit': 'M', 'net_profit': -209.05}, {'period': ""Q1 '20"", 'revenue': 403.63, 'unit': 'M', 'net_profit': -81.83}]",-17.04,-17.04,21879964000,1298891000,204541000,17790368000,641451000,4342995000,800644000,204541000,-8430000,-0.634374866249458,-2.643552485677324,-3.520710059171597,"[0.3325, 0.315]","['2021-02-25', '2018-08-30']",__nan__,0.813089454808975
238,BPYUP,Brookfield Property REIT Inc. 6.375% Series A Preferred Stock,"Brookfield Property REIT Inc. (?BPYU?) is a subsidiary of Brookfield Property Partners L.P., (NASDAQ: BPY; TSX: BPY.UN) (?BPY?) one of the world's premier real estate companies, with approximately $88 billion in total assets. BPYU was created as a public security that is intended to offer economic equivalence to an investment in BPY in the form of a U.S. REIT stock.",Mr. Brian William Kingston,REIT - Retail,25.2,USD,0,https://images.financialmodelingprep.com/symbol/BPYUP.png,35433,-0.9692680487711066,0,28091,589440000,-711461000,"[{'period': '2020', 'revenue': 1530.0, 'unit': 'M', 'net_profit': -711.46}, {'period': '2019', 'revenue': 1560.0, 'unit': 'M', 'net_profit': 432.88}, {'period': '2018', 'revenue': 2.06, 'unit': 'B', 'net_profit': 4.09}, {'period': '2017', 'revenue': 2330.0, 'unit': 'M', 'net_profit': 657.33}]","[{'period': ""Q2 '21"", 'revenue': 470550000.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q1 '21"", 'revenue': 368.4, 'unit': 'M', 'net_profit': -229.12}, {'period': ""Q4 '20"", 'revenue': 384.47, 'unit': 'M', 'net_profit': -249.96}, {'period': ""Q3 '20"", 'revenue': 366.98, 'unit': 'M', 'net_profit': -170.62}, {'period': ""Q2 '20"", 'revenue': 374.46, 'unit': 'M', 'net_profit': -209.05}, {'period': ""Q1 '20"", 'revenue': 403.63, 'unit': 'M', 'net_profit': -81.83}]",-17.04,-17.04,21879964000,1298891000,204541000,17790368000,641451000,4342995000,800644000,204541000,-8430000,-0.634374866249458,-2.643552485677324,-3.520710059171597,"[0.3984, 0.398]","['2021-06-14', '2018-09-14']",__nan__,0.813089454808975
239,BREZ,Breeze Holdings Acquisition Corp. Common Stock,"Breeze Holdings Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on businesses in the energy industry in North America. The company was incorporated in 2020 and is based in Irving, Texas.","Dr. J. Douglas Ramsey Jr., Jr.",Shell Companies,11.39,USD,48968799,https://images.financialmodelingprep.com/symbol/BREZ.png,2258,-2.0485611510791366,-0.03,46403,-2225820,-2304638,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.3}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.55}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.79}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.7}]","[{'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.19}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 17.1}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -22.02}, {'period': ""Q4 '23"", 'revenue': 3130.0, 'unit': 'K', 'net_profit': 692.04}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.08}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.51}]",-0.56,-0.56,10779618,247573,101674,20657555,0,0,17780305,101674,-1609475,-0.0752031626861771,0.0959051998912562,0.034482758620689495,__nan__,__nan__,__nan__,1.9163531583401192
240,BREZR,Breeze Holdings Acquisition Corp. Right,"Breeze Holdings Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on businesses in the energy industry in North America. The company was incorporated in 2020 and is based in Irving, Texas.","Dr. J. Douglas Ramsey Jr., Jr.",Shell Companies,0.175,USD,785225,https://images.financialmodelingprep.com/symbol/BREZR.png,0,0.4654255319148936,-0.025,165006,-2225820,-2304638,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.3}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.55}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.79}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.7}]","[{'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.19}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 17.1}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -22.02}, {'period': ""Q4 '23"", 'revenue': 3130.0, 'unit': 'K', 'net_profit': 692.04}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.08}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.51}]",-0.56,-0.56,10779618,247573,101674,20657555,0,0,17780305,101674,-1609475,-0.0752031626861771,0.0959051998912562,0.034482758620689495,"[0.285, 0.285]","['2022-03-15', '2022-03-15']",__nan__,1.9163531583401192
241,BREZW,Breeze Holdings Acquisition Corp. Warrant,"Breeze Holdings Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in North Richland Hills, Texas.","Dr. J. Douglas Ramsey Jr., Jr.",Shell Companies,0.3488,USD,1565066,https://images.financialmodelingprep.com/symbol/BREZW.png,0,0,-0.1022,13144,-2225820,-2304638,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.3}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.55}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.79}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.7}]","[{'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.19}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 17.1}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -22.02}, {'period': ""Q4 '23"", 'revenue': 3130.0, 'unit': 'K', 'net_profit': 692.04}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.08}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.51}]",-0.56,-0.56,10779618,247573,101674,20657555,0,0,17780305,101674,-1609475,-0.0752031626861771,0.0959051998912562,0.034482758620689495,__nan__,__nan__,__nan__,1.9163531583401192
242,BRID,Bridgford Foods Corporation Common Stock,"Bridgford Foods Corporation, together with its subsidiaries, manufactures, markets, and distributes frozen, refrigerated, and snack food products in the United States. It operates in two segments, Frozen Food Products and Snack Food Products. The company primarily offers biscuits, bread dough items, roll dough items, and dry sausage and beef jerky products. It provides approximately 130 frozen food products to food service and retail customers through wholesalers, cooperatives, and distributors; and 170 snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. The company was founded in 1932 and is headquartered in Dallas, Texas. Bridgford Foods Corporation is a subsidiary of Bridgford Industries Incorporated.",Mr. Michael W. Bridgford,Packaged Foods,7.8601,USD,71344791,https://images.financialmodelingprep.com/symbol/BRID.png,2909,-12.48,0.004,2405,2277000,-3381000,"[{'period': '2024', 'revenue': 223.65, 'unit': 'M', 'net_profit': -3.38}, {'period': '2023', 'revenue': 251.64, 'unit': 'M', 'net_profit': 3.47}, {'period': '2022', 'revenue': 265.9, 'unit': 'M', 'net_profit': 45.07}, {'period': '2021', 'revenue': 240.43, 'unit': 'M', 'net_profit': -5.5}]","[{'period': ""Q1 '25"", 'revenue': 52.55, 'unit': 'M', 'net_profit': -1.11}, {'period': ""Q4 '24"", 'revenue': 72230.0, 'unit': 'K', 'net_profit': -651.0}, {'period': ""Q3 '24"", 'revenue': 49.26, 'unit': 'M', 'net_profit': -1.77}, {'period': ""Q2 '24"", 'revenue': 47.31, 'unit': 'M', 'net_profit': -2.19}, {'period': ""Q1 '24"", 'revenue': 54.84, 'unit': 'M', 'net_profit': 1.24}, {'period': ""Q4 '23"", 'revenue': 80.31, 'unit': 'M', 'net_profit': 1.71}]",-0.37,-0.37,157354000,77989000,10230000,29218000,33812000,0,16453000,10230000,-4399000,-0.8042469050894085,-1.9732297063903281,-1.9736842105263157,"[0.05, 0.05]","['2012-11-23', '1987-12-02']",__nan__,0.18568323652401592
243,BRIVU,B. Riley Principal 250 Merger Corp. Units,"B. Riley Principal 250 Merger Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York. B. Riley Principal 250 Merger Corp. is a subsidiary of B. Riley Financial, Inc.",Mr. Daniel  Shribman,Shell Companies,10.16,USD,225032824,https://images.financialmodelingprep.com/symbol/BRIVU.png,1336,125.4320987654321,0,0,-5765524,5439084,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.44}, {'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': 166.25}]","[{'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.62}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.17}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.18}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.27}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.25}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.31}]",0.3,1.26,175601511,1164265,442978,993420,558497,174437246,812920,442978,-607166,-3.405626157183651,31.7155075968097,6.317073170731708,__nan__,__nan__,__nan__,0.005657240614518402
244,BRKL,Brookline Bancorp Inc. Common Stock,"Brookline Bancorp, Inc. operates as a bank holding company for the Brookline Bank that provide commercial, business, and retail banking services to corporate, municipal, and retail customers in the United States. Its deposit products include demand checking, NOW, money market, and savings accounts. The company's loan portfolio primarily comprises first mortgage loans secured by commercial, multi-family, and residential real estate properties; loans to business entities comprising commercial lines of credit; loans to condominium associations; loans and leases used to finance equipment for small businesses; financing for construction and development projects; and home equity and other consumer loans. It also provides term loans, letters of credit, foreign exchange, cash management, investment advisory, and online and mobile banking services, as well as invests in debt and equity securities. As of December 31, 2021, the company operated 50 full-service banking offices in greater Boston, Massachusetts, and greater Providence, Rhode Island. Brookline Bancorp, Inc. was founded in 1871 and is headquartered in Boston, Massachusetts.",Mr. Paul A. Perrault,Banks - Regional,10.56,USD,940944576,https://images.financialmodelingprep.com/symbol/BRKL.png,550767,12.88,-0.38,570006,0,68715000,"[{'period': '2024', 'revenue': 628.52, 'unit': 'M', 'net_profit': 68.72}, {'period': '2023', 'revenue': 333.44, 'unit': 'M', 'net_profit': 75.0}, {'period': '2022', 'revenue': 328.02, 'unit': 'M', 'net_profit': 109.74}, {'period': '2021', 'revenue': 309.36, 'unit': 'M', 'net_profit': 115.44}]","[{'period': ""Q1 '25"", 'revenue': 159.32, 'unit': 'M', 'net_profit': 19.1}, {'period': ""Q4 '24"", 'revenue': 91.68, 'unit': 'M', 'net_profit': 17.54}, {'period': ""Q3 '24"", 'revenue': 89.53, 'unit': 'M', 'net_profit': 20.14}, {'period': ""Q2 '24"", 'revenue': 80.83, 'unit': 'M', 'net_profit': 16.37}, {'period': ""Q1 '24"", 'revenue': 80.49, 'unit': 'M', 'net_profit': 14.66}, {'period': ""Q4 '23"", 'revenue': 87.81, 'unit': 'M', 'net_profit': 22.89}]",0.77,0.77,11905326000,543670000,543670000,10683387000,0,1310907000,7572498000,543670000,99969000,-1,-0.08378778383711782,-0.09411764705882349,"[0.135, 0.1095]","['2025-05-09', '1998-07-29']",__nan__,0.8973619873995891
245,BRKR,Bruker Corporation Common Stock,"Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.",Dr. Frank H. Laukien Ph.D.,Medical - Devices,36.45,USD,5523341400,https://images.financialmodelingprep.com/symbol/BRKR.png,2464932,70.1,-1.74,2463964,438600000,113100000,"[{'period': '2024', 'revenue': 3370.0, 'unit': 'M', 'net_profit': 113.1}, {'period': '2023', 'revenue': 2960.0, 'unit': 'M', 'net_profit': 427.2}, {'period': '2022', 'revenue': 2530.0, 'unit': 'M', 'net_profit': 296.6}, {'period': '2021', 'revenue': 2420.0, 'unit': 'M', 'net_profit': 277.1}]","[{'period': ""Q1 '25"", 'revenue': 801.4, 'unit': 'M', 'net_profit': 17.4}, {'period': ""Q4 '24"", 'revenue': 979.6, 'unit': 'M', 'net_profit': 13.7}, {'period': ""Q3 '24"", 'revenue': 864.4, 'unit': 'M', 'net_profit': 40.9}, {'period': ""Q2 '24"", 'revenue': 800.7, 'unit': 'M', 'net_profit': 7.6}, {'period': ""Q1 '24"", 'revenue': 721.7, 'unit': 'M', 'net_profit': 50.9}, {'period': ""Q4 '23"", 'revenue': 854.5, 'unit': 'M', 'net_profit': 205.5}]",0.76,0.76,5806700000,2053200000,183400000,3991500000,565500000,0,1281300000,183400000,136000000,-0.267779632721202,-0.735252808988764,-0.7397260273972603,"[0.05, 0.04]","['2025-06-16', '2016-03-02']",__nan__,0.6873955947440026
246,BRKS,Brooks Automation Inc.,"Brooks Automation, Inc. provides automation and cryogenic solutions worldwide. The company operates in two segments, Brooks Semiconductor Solutions Group and Brooks Life Science Systems. The Brooks Semiconductor Solutions Group segment offers wafer automation and contamination controls solutions and services. Its products include atmospheric and vacuum robots, robotic modules, and tool automation systems that offer precision handling and clean wafer environments; and automated cleaning and inspection systems for wafer carriers, reticle pod cleaners, and stockers. This segment also offers repair, diagnostic, and installation services, as well as spare parts and productivity enhancement upgrade services. The Brooks Life Science Systems segment provides automated cold storage systems; consumables, including various formats of racks, tubes, caps, plates, and foils; and instruments used for labeling, bar coding, capping, de-capping, auditing, sealing, peeling, and piercing tubes and plates. It also provides sample management services, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery, and business continuity, as well as project management and consulting. In addition, this segment offers sample intelligence software solutions and customer technology integration; laboratory work flow scheduling for life science tools and instrument work cells, sample inventory and logistics, environmental and temperature monitoring, and clinical trial and consent management, as well as planning, data management, virtualization, and visualization services; and gene sequencing analysis and synthesis services. The company serves the semiconductor capital equipment and life sciences sample management markets in approximately 50 countries. Brooks Automation, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.",Dr. Stephen Schwartz,Semiconductors,113.1,USD,7815594540,https://images.financialmodelingprep.com/symbol/BRKS.png,620741,0,-3.1800003,999754,153943000,110747000,"[{'period': '2021', 'revenue': 513.7, 'unit': 'M', 'net_profit': 110.75}, {'period': '2020', 'revenue': 897.27, 'unit': 'M', 'net_profit': 64.85}, {'period': '2019', 'revenue': 780.85, 'unit': 'M', 'net_profit': 437.42}, {'period': '2018', 'revenue': 631.56, 'unit': 'M', 'net_profit': 116.58}]","[{'period': ""Q3 '21"", 'revenue': 136.94, 'unit': 'M', 'net_profit': 21.8}, {'period': ""Q2 '21"", 'revenue': 315.35, 'unit': 'M', 'net_profit': 39.17}, {'period': ""Q1 '21"", 'revenue': 286.59, 'unit': 'M', 'net_profit': 23.75}, {'period': ""Q4 '20"", 'revenue': 249.5, 'unit': 'M', 'net_profit': 26.03}, {'period': ""Q3 '20"", 'revenue': 246.2, 'unit': 'M', 'net_profit': 28.97}, {'period': ""Q2 '20"", 'revenue': 220.35, 'unit': 'M', 'net_profit': 13.7}]",1.49,1.49,1819512000,777366000,227508000,494178000,119877000,3598000,345088000,227427000,97052000,0.07479578300635342,0.7076619431637704,0.6931818181818181,"[0.1, 0.08]","['2021-12-02', '2011-09-07']",__nan__,0.27159919802672366
247,BRLI,Brilliant Acquisition Corporation Ordinary Shares,"Brilliant Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2019 and is based in Shanghai, China.",Dr. Peng  Jiang,Shell Companies,4.7,USD,8529090,https://images.financialmodelingprep.com/symbol/BRLI.png,36586,-18.8,-3.98,370983,-14178010,-8518520,"[{'period': '2024', 'revenue': 5.91, 'unit': 'M', 'net_profit': -8.52}, {'period': '2022', 'revenue': 0.0, 'unit': 'K', 'net_profit': -732.83}, {'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -594.49}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -314.68}]","[{'period': ""Q3 '24"", 'revenue': 5.91, 'unit': 'M', 'net_profit': -8.19}, {'period': ""Q2 '24"", 'revenue': 0.17521, 'unit': 'M', 'net_profit': -1.62}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -126.06}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -122.36}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -80.23}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 321.6}]",-4.93,-4.93,984999,965709,3678,8082712,0,0,7070071,3678,-3818443,0,0,0,__nan__,__nan__,__nan__,8.205807315540422
248,BRLIR,Brilliant Acquisition Corporation Rights,,Dr. Peng  Jiang,Shell Companies,0.4501,USD,816898,https://images.financialmodelingprep.com/symbol/BRLIR.png,0,0,0.1501,1136776,-14178010,-8518520,"[{'period': '2024', 'revenue': 5.91, 'unit': 'M', 'net_profit': -8.52}, {'period': '2022', 'revenue': 0.0, 'unit': 'K', 'net_profit': -732.83}, {'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -594.49}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -314.68}]","[{'period': ""Q3 '24"", 'revenue': 5.91, 'unit': 'M', 'net_profit': -8.19}, {'period': ""Q2 '24"", 'revenue': 0.17521, 'unit': 'M', 'net_profit': -1.62}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -126.06}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -122.36}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -80.23}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 321.6}]",-4.93,-4.93,984999,965709,3678,8082712,0,0,7070071,3678,-3818443,0,0,0,__nan__,__nan__,__nan__,8.205807315540422
249,BRLIW,Brilliant Acquisition Corporation Warrants,,,Shell Companies,0.16,USD,8529090,https://images.financialmodelingprep.com/symbol/BRLIW.png,0,0,-0.0399,76470,-14178010,-8518520,"[{'period': '2024', 'revenue': 5.91, 'unit': 'M', 'net_profit': -8.52}, {'period': '2022', 'revenue': 0.0, 'unit': 'K', 'net_profit': -732.83}, {'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -594.49}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -314.68}]","[{'period': ""Q3 '24"", 'revenue': 5.91, 'unit': 'M', 'net_profit': -8.19}, {'period': ""Q2 '24"", 'revenue': 0.17521, 'unit': 'M', 'net_profit': -1.62}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -126.06}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -122.36}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -80.23}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 321.6}]",-4.93,-4.93,984999,965709,3678,8082712,0,0,7070071,3678,-3818443,0,0,0,__nan__,__nan__,__nan__,8.205807315540422
250,BROG,Brooge Energy Limited Ordinary Shares,"Brooge Energy Limited, through its subsidiaries, provides oil storage and related services at the Port of Fujairah in the emirate of Fujairah in the United Arab Emirates. The company operates phase I facility that comprises 14 storage tanks with an aggregate geometric capacity of 399,324 cbm for the storage, heating, and blending of fuel oil and clean petroleum products, including aviation fuel, gas oil, gasoline, marine gas oil, and naphtha. It also provides ancillary services that comprise blending and circulation, heating, throughput, and intertank transfer. The company was formerly known as Brooge Holdings Limited and changed its name to Brooge Energy Limited in April 2020. Brooge Energy Limited was incorporated in 2019 and is headquartered in Fujairah, the United Arab Emirates.",Ms. Ines  Bezaznia,Oil & Gas Midstream,1.76,USD,157674704,https://images.financialmodelingprep.com/symbol/BROG.png,13967,35.2,0.196,29048,42193728,4438910,"[{'period': '2024', 'revenue': 76.47, 'unit': 'M', 'net_profit': 4.44}, {'period': '2023', 'revenue': 105.7, 'unit': 'M', 'net_profit': -48.33}, {'period': '2022', 'revenue': 81.54, 'unit': 'M', 'net_profit': 27.23}, {'period': '2021', 'revenue': 41.76, 'unit': 'M', 'net_profit': 12.8}]","[{'period': ""Q2 '24"", 'revenue': 15.12, 'unit': 'M', 'net_profit': -1.76}, {'period': ""Q1 '24"", 'revenue': 15.12, 'unit': 'M', 'net_profit': -1.76}, {'period': ""Q4 '23"", 'revenue': 21.39, 'unit': 'M', 'net_profit': -42.85}, {'period': ""Q3 '23"", 'revenue': 21.39, 'unit': 'M', 'net_profit': -42.85}, {'period': ""Q2 '23"", 'revenue': 31.46, 'unit': 'M', 'net_profit': 18.68}, {'period': ""Q1 '23"", 'revenue': 31.46, 'unit': 'M', 'net_profit': 18.68}]",0.05,0.05,485636610,27250306,13447206,424431203,6246540,0,336520437,13447206,40078649,4.042839671229273,1.0918492817701964,1.090909090909091,__nan__,__nan__,__nan__,0.8739687129436143
251,BROGW,Brooge Holdings Limited Warrant expiring 12/20/2024,"Brooge Energy Limited, through its subsidiaries, provides oil storage and related services at the Port of Fujairah in the United Arab Emirates. It operates phase I and phase II facilities comprising 22 tanks with a capacity of approximately 1,001,388 cubic meters for offering storage, heating, and blending of fuel oil and clean petroleum products, including aviation fuel, gas oil, gasoline, marine gas oil, and naphtha. The company was formerly known as Brooge Holdings Limited and changed its name to Brooge Energy Limited in April 2020. Brooge Energy Limited was incorporated in 2019 and is headquartered in Dubai, the United Arab Emirates.",Mr. Saif  Alhazaimeh,Oil & Gas Midstream,0.0007,USD,61450,https://images.financialmodelingprep.com/symbol/BROGW.png,0,0,-0.0004,249364,42193728,4438910,"[{'period': '2024', 'revenue': 76.47, 'unit': 'M', 'net_profit': 4.44}, {'period': '2023', 'revenue': 105.7, 'unit': 'M', 'net_profit': -48.33}, {'period': '2022', 'revenue': 81.54, 'unit': 'M', 'net_profit': 27.23}, {'period': '2021', 'revenue': 41.76, 'unit': 'M', 'net_profit': 12.8}]","[{'period': ""Q2 '24"", 'revenue': 15.12, 'unit': 'M', 'net_profit': -1.76}, {'period': ""Q1 '24"", 'revenue': 15.12, 'unit': 'M', 'net_profit': -1.76}, {'period': ""Q4 '23"", 'revenue': 21.39, 'unit': 'M', 'net_profit': -42.85}, {'period': ""Q3 '23"", 'revenue': 21.39, 'unit': 'M', 'net_profit': -42.85}, {'period': ""Q2 '23"", 'revenue': 31.46, 'unit': 'M', 'net_profit': 18.68}, {'period': ""Q1 '23"", 'revenue': 31.46, 'unit': 'M', 'net_profit': 18.68}]",0.05,0.05,485636610,27250306,13447206,424431203,6246540,0,336520437,13447206,40078649,4.042839671229273,1.0918492817701964,1.090909090909091,__nan__,__nan__,__nan__,0.8739687129436143
252,BRP,BRP Group Inc. (Insurance Company) Class A Common Stock,"BRP Group, Inc. markets and sells insurance products and services in the United States. The company operates through four segments: Middle Market, Specialty, MainStreet, and Medicare. The Middle Market segment provides commercial risk management, employee benefits solutions, and private risk management for mid-to-large size businesses and high net worth individuals, as well as its families. The Specialty segment delivers specialty insurers, professionals, individuals, and industry businesses the access to specialty markets, as well as capabilities and programs requiring underwriting and placement. This segment also operates as a managing general agent of the Future platform, which delivers proprietary, technology-enabled insurance solutions. The MainStreet segment offers personal insurance, commercial insurance, and life and health solutions to individuals and businesses in its communities. The Medicare segment provides consultation for government assistance programs and solutions, including Medicare and Medicare Advantage to seniors and Medicare-eligible individuals through a network of primarily independent contractor agents. The company was founded in 2011 and is headquartered in Tampa, Florida.",Mr. Trevor Lowry Baldwin,Insurance - Brokers,32.66,USD,2160187922,https://images.financialmodelingprep.com/symbol/BRP.png,359205,-35.11827956989247,0.15,694652,60648000,-24518000,"[{'period': '2024', 'revenue': 1390.0, 'unit': 'M', 'net_profit': -24.52}, {'period': '2023', 'revenue': 1220.0, 'unit': 'M', 'net_profit': -90.14}, {'period': '2022', 'revenue': 980.72, 'unit': 'M', 'net_profit': -76.75}, {'period': '2021', 'revenue': 567.29, 'unit': 'M', 'net_profit': -58.12}]","[{'period': ""Q1 '25"", 'revenue': 413.4, 'unit': 'M', 'net_profit': 13.94}, {'period': ""Q4 '24"", 'revenue': 417.75, 'unit': 'M', 'net_profit': 14.32}, {'period': ""Q3 '24"", 'revenue': 338.94, 'unit': 'M', 'net_profit': -8.38}, {'period': ""Q2 '24"", 'revenue': 339.84, 'unit': 'M', 'net_profit': -17.56}, {'period': ""Q1 '24"", 'revenue': 380.37, 'unit': 'M', 'net_profit': 21.58}, {'period': ""Q4 '23"", 'revenue': 284.65, 'unit': 'M', 'net_profit': -34.48}]",-0.39,-0.39,3534731000,1026490000,148120000,2525934000,702096000,0,1056434000,148120000,61102000,-0.47814414538445654,0.7280039049932883,0.7399999999999999,"[0.5, 0.5]","['2008-12-30', '2008-12-30']",__nan__,0.7146043079374357
253,BRPA,Big Rock Partners Acquisition Corp. Common Stock,,,,,,,,,,,,-416571,-398730,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -398.73}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'B', 'net_profit': -16.01}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -398.73}]",-0.15,-0.15,6050405,82458,5968413,3281546,0,0,1809889,466,-598617,0,0,0,__nan__,__nan__,__nan__,0.5423679902419756
254,BRPAR,Big Rock Partners Acquisition Corp. Right,,,,,,,,,,,,-416571,-398730,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -398.73}, {'period': '2019', 'revenue': 0.0, 'unit': 'K', 'net_profit': 408.43}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'B', 'net_profit': -16.01}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -398.73}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -211.16}, {'period': ""Q4 '19"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 408.43}]",2.74,2.74,6050.405,82.458,5968.4130000000005,3281.546,0,5967.947,2419.398,0.466,-598617,-2.2848365775196546,-1.9762576910929004,25.90909090909091,__nan__,__nan__,__nan__,0.5423679902419756
255,BRPAU,Big Rock Partners Acquisition Corp. Unit,,,,,,,,,,,,-416571,-434412,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -434.41}, {'period': '2019', 'revenue': 0.0, 'unit': 'K', 'net_profit': 408.43}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'B', 'net_profit': -16.01}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -893.72}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -432.35}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -125.78}, {'period': ""Q2 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -149.5}, {'period': ""Q1 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 273.22}]",2.74,2.74,6050405,82458,5968413,3281546,0,0,609509,466,-598617,-1.8456010864071226,-2.063622140553881,0,__nan__,__nan__,__nan__,0.5423679902419756
256,BRPAW,Big Rock Partners Acquisition Corp. Warrant,,,,,,,,,,,,-416571,-398730,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -398.73}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'B', 'net_profit': -16.01}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -398.73}]",2.74,2.74,6050405,82458,5968413,3281546,0,0,1809889,466,-598617,0,0,0,__nan__,__nan__,__nan__,0.5423679902419756
257,BRPM,B. Riley Principal 150 Merger Corp. Class A Common Stock,"B. Riley Principal 150 Merger Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York. B. Riley Principal 150 Merger Corp. is a subsidiary of B. Riley Financial, Inc.",,Shell Companies,13.02,USD,944038536,https://images.financialmodelingprep.com/symbol/BRPM.png,0,-72.73743016759776,1.9700003,743455,-6867161,-10288632,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.29}, {'period': '2019', 'revenue': 0.0, 'unit': 'K', 'net_profit': 8.85}]","[{'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.61}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.99}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.3}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.82}, {'period': ""Q4 '19"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.85}, {'period': ""Q3 '19"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 466.8}]",-3.47,-3.47,173171973,655773,43324,11412401,0,0,2813168,43324,-1246.42,0,0,0,__nan__,__nan__,__nan__,0.06590212493565573
258,BRPMU,B. Riley Principal 150 Merger Corp. Unit,"As of July 19, 2022, B. Riley Principal 150 Merger Corp. was acquired by FaZe Holdings Inc., in a reverse merger transaction. B. Riley Principal 150 Merger Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York. B. Riley Principal 150 Merger Corp. is a subsidiary of B. Riley Financial, Inc.",Mr. Daniel  Shribman,Shell Companies,13.45,USD,0,https://images.financialmodelingprep.com/symbol/BRPMU.png,0,-75.13966480446928,2.41,1784,-6867161,-10288632,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.29}, {'period': '2019', 'revenue': 0.0, 'unit': 'K', 'net_profit': 8.85}]","[{'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.61}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.99}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.3}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.82}, {'period': ""Q4 '19"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.85}, {'period': ""Q3 '19"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 466.8}]",-3.47,-3.47,173171973,655773,43324,11412401,0,0,2813168,43324,-1246.42,0,0,0,__nan__,__nan__,__nan__,0.06590212493565573
259,BRPMW,B. Riley Principal 150 Merger Corp. Warrant,,,,,,,,,,,,-6867161,-10288632,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.29}]","[{'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.61}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.99}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.82}]",-0.58,-0.58,173171973,655773,43324,11412401,0,0,2813168,43324,-1246420,0,0,0,__nan__,__nan__,__nan__,0.06590212493565573
260,BRQS,Borqs Technologies Inc. Ordinary Shares,"Borqs Technologies, Inc. provides Android-based smart connected devices and cloud service solutions in the United States, India, China, and internationally. The company offers commercial grade Android platform software and service solutions to address vertical market segment needs through the targeted BorqsWare software platform solutions. Its BorqsWare software platform consists of BorqsWare Client software that has been used in Android phones, tablets, watches, and various Internet-of-things devices; and BorqsWare Server software platform, which includes back-end server software that allows customers to develop their own mobile end-to-end services for their devices. In addition, it provides IVI solutions, machine to machine solutions, smart appliance solution, mobile operator services, and google mobile services (GMS). The company primarily serves mobile chipset manufacturers, mobile device original equipment manufacturers, and mobile operators, as well as product solutions of mobile connected devices for enterprise and consumer applications. Borqs Technologies, Inc. was founded in 2007 and is headquartered in Kwun Tong, Hong Kong.",Mr. Sek Yuen  Chan,Software - Application,0.43,USD,6284579,https://images.financialmodelingprep.com/symbol/BRQS.png,113330,-0.028666666666666667,-0.1365,889356,-3952000,-28945000,"[{'period': '2022', 'revenue': 52.54, 'unit': 'M', 'net_profit': -28.95}, {'period': '2021', 'revenue': 29.56, 'unit': 'M', 'net_profit': -56.6}, {'period': '2020', 'revenue': 26.75, 'unit': 'M', 'net_profit': -36.09}, {'period': '2019', 'revenue': 98.96, 'unit': 'M', 'net_profit': -31.58}]","[{'period': ""Q4 '21"", 'revenue': -11.45, 'unit': 'M', 'net_profit': 16.61}, {'period': ""Q4 '20"", 'revenue': -14.26, 'unit': 'M', 'net_profit': 37.57}, {'period': ""Q4 '19"", 'revenue': 57.94, 'unit': 'M', 'net_profit': 42.08}, {'period': ""Q2 '19"", 'revenue': 27.19, 'unit': 'M', 'net_profit': -1.21}, {'period': ""Q4 '18"", 'revenue': -14.47, 'unit': 'M', 'net_profit': -70.24}, {'period': ""Q3 '18"", 'revenue': 28.29, 'unit': 'M', 'net_profit': -2.51}]",-1.26,-1.26,30143000,27991000,12741000,41295000,3482000,0,37940000,11305000,-6241000,0.8250088558271342,0.4886223101657185,0.8359375,__nan__,__nan__,__nan__,1.369969810569618
261,BRY,Berry Corporation (bry) Common Stock,"Berry Corporation, an independent upstream energy company, engages in the development and production of conventional oil reserves located in the western United States. It operates in two segments, Development and Production, and Well Servicing and Abandonment. The company's properties are located in the San Joaquin and Ventura basins, California; and Uinta basin, Utah. As of December 31, 2021, it had a total of 3,417 net productive wells. The company was formerly known as Berry Petroleum Corporation and changed its name to Berry Corporation in February 2020. Berry Corporation was founded in 1909 and is headquartered in Dallas, Texas.",Mr. Fernando  Araujo,Oil & Gas Exploration & Production,2.61,USD,202526082,https://images.financialmodelingprep.com/symbol/BRY.png,1067642,-5.55,-0.03,1221152,161046000,19251000,"[{'period': '2024', 'revenue': 776.5, 'unit': 'M', 'net_profit': 19.25}, {'period': '2023', 'revenue': 863.45, 'unit': 'M', 'net_profit': 37.4}, {'period': '2022', 'revenue': 1060.0, 'unit': 'M', 'net_profit': 250.17}, {'period': '2021', 'revenue': 701.35, 'unit': 'M', 'net_profit': -15.54}]","[{'period': ""Q1 '25"", 'revenue': 177.18, 'unit': 'M', 'net_profit': -96.68}, {'period': ""Q4 '24"", 'revenue': 186.18, 'unit': 'M', 'net_profit': -1.76}, {'period': ""Q3 '24"", 'revenue': 184.35, 'unit': 'M', 'net_profit': 69.86}, {'period': ""Q2 '24"", 'revenue': 203.66, 'unit': 'M', 'net_profit': -8.77}, {'period': ""Q1 '24"", 'revenue': 202.31, 'unit': 'M', 'net_profit': -40.08}, {'period': ""Q4 '23"", 'revenue': 336.4, 'unit': 'M', 'net_profit': 62.55}]",-0.02,-0.02,1517686000,149643000,15336000,787050000,77630000,0,187880000,15336000,107868000,-0.3593498263578103,-0.4852673796791444,-1.0408163265306123,"[0.03, 0.09]","['2025-05-19', '2018-09-13']",__nan__,0.5185855308673862
262,BSBK,Bogota Financial Corp. Common Stock,"Bogota Financial Corp. operates as the bank holding company for Bogota Savings Bank that provides banking products and services in the United States. It offers deposit accounts, including demand accounts, savings accounts, money market accounts, and certificate of deposit accounts. The company also provides one-to four-family residential real estate loans, and commercial real estate and multi-family loans, as well as consumer loans, such as home equity loans and lines of credit, commercial and industrial loans, and construction loans; and buys, sells, and holds investment securities. It operates through various offices located in Bogota, Hasbrouck Heights, Newark, Oak Ridge, Parsippany, and Teaneck, as well as through a loan production office in Spring Lake, New Jersey. The company was founded in 1893 and is based in Teaneck, New Jersey. Bogota Financial Corp. operates as a subsidiary of Bogota Financial, MHC.",Mr. Kevin  Pace,Banks - Regional,6.94,USD,90282460,https://images.financialmodelingprep.com/symbol/BSBK.png,3611,-86.75,-0.034,254,0,-2170420,"[{'period': '2024', 'revenue': 11.9, 'unit': 'M', 'net_profit': -2.17}, {'period': '2023', 'revenue': 16110.0, 'unit': 'K', 'net_profit': 642.53}, {'period': '2022', 'revenue': 31.47, 'unit': 'M', 'net_profit': 6.88}, {'period': '2021', 'revenue': 27.61, 'unit': 'M', 'net_profit': 7.52}]","[{'period': ""Q1 '25"", 'revenue': 11810.0, 'unit': 'K', 'net_profit': 730.95}, {'period': ""Q4 '24"", 'revenue': 11010.0, 'unit': 'K', 'net_profit': -930.0}, {'period': ""Q3 '24"", 'revenue': 10950.0, 'unit': 'K', 'net_profit': -366.96}, {'period': ""Q2 '24"", 'revenue': 10780.0, 'unit': 'K', 'net_profit': -432.48}, {'period': ""Q1 '24"", 'revenue': 10360.0, 'unit': 'K', 'net_profit': -440.98}, {'period': ""Q4 '23"", 'revenue': 9.85, 'unit': 'M', 'net_profit': -1.18}]",-0.17,-0.17,971489884,52232208,52232208,834200724,0,0,0,52232208,-3154693,0,-4.3779015929093354,-4.413654618473895,__nan__,__nan__,__nan__,0.8586818429495865
263,BSET,Bassett Furniture Industries Incorporated Common Stock,"Bassett Furniture Industries, Incorporated engages in the manufacture, marketing, and retail of home furnishings in the United States and internationally. It operates through three segments: Wholesale, Retail company-owned Stores, and Logistical Services. The company engages in the design, manufacture, sourcing, sale, and distribution of furniture products to a network of company-owned retail stores and licensee-owned stores, and independent furniture retailers; and wood and upholstery operations. As of November 27, 2021, it operated a network of 63 company-owned stores and 34 licensee-owned stores. It also provides shipping, and warehousing services to customers in the furniture industry. In addition, the company owns and leases retail store properties; and distributes its products through other multi-line furniture stores, Bassett galleries or design centers, mass merchants, and specialty stores, as well as sells its products online. Bassett Furniture Industries, Incorporated was incorporated in 1902 and is based in Bassett, Virginia.",Mr. Robert H. Spilman Jr.,"Furnishings, Fixtures & Appliances",17.07,USD,148579328,https://images.financialmodelingprep.com/symbol/BSET.png,24406,-22.46,0.02,12674,-4423000,-9695000,"[{'period': '2024', 'revenue': 329.92, 'unit': 'M', 'net_profit': -9.7}, {'period': '2023', 'revenue': 390.14, 'unit': 'M', 'net_profit': -3.17}, {'period': '2022', 'revenue': 485.6, 'unit': 'M', 'net_profit': 25.36}, {'period': '2021', 'revenue': 486.53, 'unit': 'M', 'net_profit': 18.04}]","[{'period': ""Q1 '25"", 'revenue': 82.16, 'unit': 'M', 'net_profit': 1.85}, {'period': ""Q4 '24"", 'revenue': 84.34, 'unit': 'M', 'net_profit': 3.2}, {'period': ""Q3 '24"", 'revenue': 75.62, 'unit': 'M', 'net_profit': -4.5}, {'period': ""Q2 '24"", 'revenue': 83.41, 'unit': 'M', 'net_profit': -7.2}, {'period': ""Q1 '24"", 'revenue': 86.55, 'unit': 'M', 'net_profit': -1.19}, {'period': ""Q4 '23"", 'revenue': 94.7, 'unit': 'M', 'net_profit': -4.1}]",-1.11,-1.11,341170000,141539000,59911000,173843000,17421000,0,73403000,39551000,-1161000,-1.5762866449511401,-2.0573951434878586,-2.083333333333334,"[0.2, 0.2001]","['2025-05-16', '1986-02-10']",__nan__,0.5095494914558725
264,BSGM,BioSig Technologies Inc. Common Stock,"BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.",Mr. Anthony  Amato,Medical - Devices,3.3,USD,90072180,https://images.financialmodelingprep.com/symbol/BSGM.png,419580,-4.4,0.24,506506,-12421000,-10330000,"[{'period': '2024', 'revenue': 0.04, 'unit': 'M', 'net_profit': -10.33}, {'period': '2023', 'revenue': 0.018000000000000002, 'unit': 'M', 'net_profit': -29.04}, {'period': '2022', 'revenue': 0.28600000000000003, 'unit': 'M', 'net_profit': -27.27}, {'period': '2021', 'revenue': 0.441, 'unit': 'M', 'net_profit': -31.36}]","[{'period': ""Q4 '24"", 'revenue': 0.013000000000000001, 'unit': 'M', 'net_profit': -1.1}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.91}, {'period': ""Q2 '24"", 'revenue': 0.013000000000000001, 'unit': 'M', 'net_profit': -3.92}, {'period': ""Q1 '24"", 'revenue': 0.014, 'unit': 'M', 'net_profit': -3.4}, {'period': ""Q4 '23"", 'revenue': 0.012, 'unit': 'M', 'net_profit': -6.05}, {'period': ""Q3 '23"", 'revenue': 0.001, 'unit': 'M', 'net_profit': -4.57}]",-0.0736,-0.0736,842000,344000,142000,2264000,109000,0,2264000,142000,-4758000,0.5587723349081738,0.6442959953169657,0.8160000000000001,__nan__,__nan__,__nan__,2.688836104513064
265,BSKYU,Big Sky Growth Partners Inc. Unit,"Big Sky Growth Partners, Inc. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on pursuing opportunities in internet retail and direct-to-consumer companies. The company was incorporated in 2021 and is based in Seattle, Washington.",,Shell Companies,10.14,USD,0,https://images.financialmodelingprep.com/symbol/BSKYU.png,34178,42.25,0.09,2439,5132991,10963259,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.96}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.66}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.11}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'T', 'net_profit': 7.09}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.58}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.72}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 588.02}]",0.29,0.29,301455581,1440975,1004964,20369003,0,300014606,341003,1004964,-929097,0,0,0,__nan__,__nan__,__nan__,0.06756883694914907
266,BSPE,Bespoke Capital Acquisition Corp. Class A Restricted Voting Shares,,,,,,,,,0,,,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
267,BSQR,BSQUARE Corporation Common Stock,"BSQUARE Corporation develops and deploys technologies for the makers and operators of connected devices in North America, Europe, and Asia. The company operates through two segments, Partner Solutions and Edge to Cloud. It offers software that connect devices to create intelligent systems; and embedded operating system software and services for makers of connected and intelligent devices, such as point-of-sale terminals, kiosks, tablets and handheld data collection devices, smart vending machines, ATMs, essential equipment in buildings and facilities environments, digital signs, and in-vehicle telematics and entertainment devices. The company also resells Windows IoT, Windows Embedded, and Windows Server IoT software, as well as system utility software for Adobe and McAfee; and provides license compliance services, technical support, and manufacturing support. In addition, it provides operating system configuration and device hardening, fleet transition, 24/7 IoT operations, data engineering, and software utilities and professional services, as well as device management solutions. The company serves original equipment manufacturers, original design manufacturers, silicon vendors, and peripheral vendors. BSQUARE Corporation was incorporated in 1994 and is headquartered in Seattle, Washington.",Mr. Ralph C. Derrickson,Software - Application,1.89,USD,37555245,https://images.financialmodelingprep.com/symbol/BSQR.png,170701,-14.538461538461538,0.01,22363,-3626000,-3031000,"[{'period': '2022', 'revenue': 36.49, 'unit': 'M', 'net_profit': -3.03}, {'period': '2021', 'revenue': 40.37, 'unit': 'M', 'net_profit': -1.76}, {'period': '2020', 'revenue': 47.14, 'unit': 'M', 'net_profit': -1.26}, {'period': '2019', 'revenue': 59.28, 'unit': 'M', 'net_profit': -9.18}]","[{'period': ""Q3 '23"", 'revenue': 9.29, 'unit': 'M', 'net_profit': -1.13}, {'period': ""Q2 '23"", 'revenue': 6530.0, 'unit': 'K', 'net_profit': -260.0}, {'period': ""Q1 '23"", 'revenue': 8140.000000000001, 'unit': 'K', 'net_profit': 306.0}, {'period': ""Q4 '22"", 'revenue': 7.96, 'unit': 'M', 'net_profit': -1.21}, {'period': ""Q3 '22"", 'revenue': 8.41, 'unit': 'M', 'net_profit': -1.1}, {'period': ""Q2 '22"", 'revenue': 10390.0, 'unit': 'K', 'net_profit': -625.0}]",-0.15,-0.15,42171000,40037000,35421000,6772000,3985000,0,5712000,35414000,-4243000,0.0683453237410072,-0.7250996015936255,-0.3636363636363636,__nan__,__nan__,__nan__,0.16058428778070238
268,BSRR,Sierra Bancorp Common Stock,"Sierra Bancorp operates as the bank holding company for Bank of the Sierra that provides retail and commercial banking services to individuals and businesses in California. The company accepts various deposit products, such as checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. Its loan products include agricultural, commercial, consumer, real estate, construction, and mortgage loans. The company also offers automated teller machines; electronic point-of-sale payment alternatives; online and automated telephone banking services; and remote deposit capture and automated payroll services for business customers. As of December 31, 2021, it operated 35 full-service branches, an online branch, a loan production office, an agricultural credit center, and an SBA center. Sierra Bancorp was founded in 1977 and is headquartered in Porterville, California.",Mr. Kevin J. McPhaill,Banks - Regional,27.51,USD,380155188,https://images.financialmodelingprep.com/symbol/BSRR.png,39496,9.72,-1.21,24076,0,40560000,"[{'period': '2024', 'revenue': 138.82, 'unit': 'M', 'net_profit': 40.56}, {'period': '2023', 'revenue': 139.12, 'unit': 'M', 'net_profit': 34.84}, {'period': '2022', 'revenue': 130.09, 'unit': 'M', 'net_profit': 33.66}, {'period': '2021', 'revenue': 127.56, 'unit': 'M', 'net_profit': 43.01}]","[{'period': ""Q1 '25"", 'revenue': 48.09, 'unit': 'M', 'net_profit': 9.1}, {'period': ""Q4 '24"", 'revenue': 50.62, 'unit': 'M', 'net_profit': 10.36}, {'period': ""Q3 '24"", 'revenue': 37.22, 'unit': 'M', 'net_profit': 10.6}, {'period': ""Q2 '24"", 'revenue': 51.12, 'unit': 'M', 'net_profit': 10.26}, {'period': ""Q1 '24"", 'revenue': 45.75, 'unit': 'M', 'net_profit': 9.33}, {'period': ""Q4 '23"", 'revenue': 64.99, 'unit': 'M', 'net_profit': 6.29}]",2.84,2.82,3614271000,130119000,114120000,3256969000,15999000,991288000,12535000,0,55997000,-1,0.1640454597635174,0.1983122362869197,"[0.25, 0.39]","['2025-05-05', '1994-04-28']",__nan__,0.9011413366623587
269,BSVN,Bank7 Corp. Common stock,"Bank7 Corp. operates as a bank holding company for Bank7 that provides banking and financial services to individual and corporate customers. It offers commercial deposit services, including commercial checking, money market, and other deposit accounts; and retail deposit services, such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. The company also provides commercial real estate, hospitality, energy, and commercial and industrial lending services; consumer lending services to individuals for personal and household purposes comprising secured and unsecured term loans, and home improvement loans. As of March 8, 2022, it operated through a network of twelve full-service branches in Oklahoma, the Dallas/Fort Worth, Texas metropolitan area, and Kansas. The company was formerly known as Haines Financial Corp.Bank7 Corp. was founded in 1901 and is headquartered in Oklahoma City, Oklahoma.",Mr. Thomas L. Travis,Banks - Regional,37.54,USD,354724470,https://images.financialmodelingprep.com/symbol/BSVN.png,29619,7.97,-1.67,17976,0,45698000,"[{'period': '2024', 'revenue': 131.54, 'unit': 'M', 'net_profit': 45.7}, {'period': '2023', 'revenue': 130.79, 'unit': 'M', 'net_profit': 28.27}, {'period': '2022', 'revenue': 72.37, 'unit': 'M', 'net_profit': 29.64}, {'period': '2021', 'revenue': 55.49, 'unit': 'M', 'net_profit': 23.16}]","[{'period': ""Q1 '25"", 'revenue': 32.2, 'unit': 'M', 'net_profit': 10.34}, {'period': ""Q4 '24"", 'revenue': 24.14, 'unit': 'M', 'net_profit': 11.11}, {'period': ""Q3 '24"", 'revenue': 33.49, 'unit': 'M', 'net_profit': 11.78}, {'period': ""Q2 '24"", 'revenue': 35.6, 'unit': 'M', 'net_profit': 11.52}, {'period': ""Q1 '24"", 'revenue': 35.3, 'unit': 'M', 'net_profit': 11.29}, {'period': ""Q4 '23"", 'revenue': 39.17, 'unit': 'M', 'net_profit': 1.07}]",4.92,4.84,1739808000,294137000,294137000,1526595000,0,5790000,77000,240915000,50849000,-1,0.6161980548187445,0.5922330097087379,"[0.24, 0.1]","['2025-03-20', '2019-09-30']",__nan__,0.8774502703746621
270,BSY,Bentley Systems Incorporated Class B Common Stock,"Bentley Systems, Incorporated, together with its subsidiaries, provides infrastructure engineering software solutions in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company offers open modeling and open simulation applications for infrastructure design integration, which include MicroStation, OpenRoads, OpenRail, OpenPlant, OpenBuildings, OpenBridge, OpenSite, OpenFlows, STAAD and RAM, SACS, MOSES, AutoPIPE, SITEOPS, CUBE, DYNAMEQ, EMME, and LEGION; and geoprofessional applications for modeling and simulation of near and deep subsurface conditions, including Leapfrog, AGS Workbench, GeoStudio, Imago, MX Deposit, Oasis montaj, PLAXIS, and OpenGround. It also provides project delivery systems that support collaboration, work-sharing, and 4D construction modeling for infrastructure project delivery enterprises, such as ProjectWise, ProjectWise Design Review Service, and SYNCHRO; and asset and network performance systems, such as AssetWise ALIM, AssetWise Asset Reliability, AssetWise Enterprise Interoperability, AssetWise 4D Analytics, AssetWise Linear, and Seequent Central. In addition, it offers industry solutions comprising AssetWise Linear SUPERLOAD, AssetWise Linear Analytics, AssetWise Inspections, ContextCapture, OpenCities, OpenUtilities, OpenTower, OpenWindPower, Power Line, SPIDA, OrbitGT, sensemetrics, PlantSight, and WaterSight. The company serves civil, structural, geotechnical, geoscience subsurface engineers, architects, geospatial professionals, city and regional planners, contractors, fabricators, and operations and maintenance engineers. Bentley Systems, Incorporated was incorporated in 1984 and is headquartered in Exton, Pennsylvania.",Mr. Nicholas H. Cumins,Software - Application,47.31,USD,13807139640,https://images.financialmodelingprep.com/symbol/BSY.png,1547021,60.65,-0.75,967662,378192000,234787000,"[{'period': '2024', 'revenue': 1350.0, 'unit': 'M', 'net_profit': 234.79}, {'period': '2023', 'revenue': 1230.0, 'unit': 'M', 'net_profit': 326.79}, {'period': '2022', 'revenue': 1100.0, 'unit': 'M', 'net_profit': 174.78}, {'period': '2021', 'revenue': 965.05, 'unit': 'M', 'net_profit': 93.19}]","[{'period': ""Q1 '25"", 'revenue': 370.54, 'unit': 'M', 'net_profit': 91.37}, {'period': ""Q4 '24"", 'revenue': 349.82, 'unit': 'M', 'net_profit': 50.09}, {'period': ""Q3 '24"", 'revenue': 335.17, 'unit': 'M', 'net_profit': 42.34}, {'period': ""Q2 '24"", 'revenue': 330.34, 'unit': 'M', 'net_profit': 72.05}, {'period': ""Q1 '24"", 'revenue': 337.76, 'unit': 'M', 'net_profit': 70.31}, {'period': ""Q4 '23"", 'revenue': 310.64, 'unit': 'M', 'net_profit': 179.59}]",0.75,0.72,3399807000,442073000,64009000,2358687000,314467000,25764000,814334000,64009000,421246000,0.31114077207093205,-0.28152894698993536,-0.2990654205607477,"[0.07, 0.03]","['2025-03-19', '2020-12-04']",__nan__,0.6937708522866151
271,BTAI,BioXcel Therapeutics Inc. Common Stock,"BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. Its commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. The company also continues to conduct clinical trials evaluating BXCL501 for the treatment of agitation in Alzheimer's disease patients, and for adjunctive treatment of patients with major depressive disorder, as well as in the community for agitation associated with bipolar disorders and schizophrenia. In addition, it is developing BXCL502 as a potential therapy for chronic agitation in dementia; and BXCL701, an investigational, orally administered, systemic innate immunity activator for the treatment of aggressive forms of prostate cancer and advanced solid tumors that are refractory or treatment naïve to checkpoint inhibitors. The company was incorporated in 2017 and is headquartered in New Haven, Connecticut.",Dr. Vimal D. Mehta Ph.D.,Biotechnology,1.39,USD,8417910,https://images.financialmodelingprep.com/symbol/BTAI.png,4591647,-0.12,-0.03,92079,-44161000,-59599000,"[{'period': '2024', 'revenue': 2.27, 'unit': 'M', 'net_profit': -59.6}, {'period': '2023', 'revenue': 1.38, 'unit': 'M', 'net_profit': -179.05}, {'period': '2022', 'revenue': 0.375, 'unit': 'M', 'net_profit': -171.85}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -106.63}]","[{'period': ""Q1 '25"", 'revenue': 0.168, 'unit': 'M', 'net_profit': -7.25}, {'period': ""Q4 '24"", 'revenue': 0.366, 'unit': 'M', 'net_profit': -10.86}, {'period': ""Q3 '24"", 'revenue': 0.214, 'unit': 'M', 'net_profit': -13.65}, {'period': ""Q2 '24"", 'revenue': 1.1, 'unit': 'M', 'net_profit': -8.3}, {'period': ""Q1 '24"", 'revenue': 0.582, 'unit': 'M', 'net_profit': -26.79}, {'period': ""Q4 '23"", 'revenue': 0.376, 'unit': 'M', 'net_profit': -22.26}]",-23.51,-23.51,38338000,37394000,29854000,131439000,131000,0,22233000,29854000,-72027000,0.7330387314790746,0.6671432480885547,-2.822764227642276,__nan__,__nan__,__nan__,3.4284261046481297
272,BTAQ,Burgundy Technology Acquisition Corporation Class A Ordinary shares,"Burgundy Technology Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses on public and private opportunities in the technology sector, primarily companies in enterprise software or technology-enabled services. The company was incorporated in 2020 and is based in George Town, the Cayman Islands.",Mr. Leo  Apotheker,Shell Companies,10.04,USD,0,https://images.financialmodelingprep.com/symbol/BTAQ.png,159077,-101.41414141414141,0,28012,-336288,-336288,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -336.29}]","[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.03}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.87}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -336.29}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -143.58}]",-0.0078,-0.0078,347848218,1111451,347711582,12164352,0,0,89352,974815,,0,0,0,__nan__,__nan__,__nan__,0.03497028695429453
273,BTAQU,Burgundy Technology Acquisition Corporation Unit,"Burgundy Technology Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses on public and private opportunities in the technology sector, primarily companies in enterprise software or technology-enabled services. The company was incorporated in 2020 and is based in George Town, the Cayman Islands.",Mr. Leo  Apotheker,Shell Companies,10.03,USD,0,https://images.financialmodelingprep.com/symbol/BTAQU.png,1124,-101.31313131313131,0,4,-336288,-336288,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -336.29}]","[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.03}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.87}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -336.29}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -143.58}]",-0.0078,-0.0078,347848218,1111451,347711582,12164352,0,0,89352,974815,,0,0,0,__nan__,__nan__,__nan__,0.03497028695429453
274,BTAQW,Burgundy Technology Acquisition Corporation Warrant,,,,,,,,,,,,-336288,-336288,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -336.29}]","[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.03}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.87}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 14.49}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -336.29}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -121.02}]",-0.04,-0.04,347848218,1111451,347711582,12164352,0,0,89352,974815,-439484,0,0,0,__nan__,__nan__,__nan__,0.03497028695429453
275,BTBT,Bit Digital Inc. Ordinary Shares,"Bit Digital, Inc., together with its subsidiaries, engages in the bitcoin mining business. It is also involved in the treasury management activities. The company was formerly known as Golden Bull Limited and changed its name to Bit Digital, Inc. in September 2020. Bit Digital, Inc. was incorporated in 2017 and is headquartered in New York, New York.",Mr. Samir  Tabar,Financial - Capital Markets,2.42,USD,502830020,https://images.financialmodelingprep.com/symbol/BTBT.png,14993259,-4.32,-0.05,24198778,59874320,28305810,"[{'period': '2024', 'revenue': 163.76, 'unit': 'M', 'net_profit': 28.31}, {'period': '2023', 'revenue': 44.92, 'unit': 'M', 'net_profit': -13.89}, {'period': '2022', 'revenue': 32.3, 'unit': 'M', 'net_profit': -105.3}, {'period': '2021', 'revenue': 96.08, 'unit': 'M', 'net_profit': 4.86}]","[{'period': ""Q1 '25"", 'revenue': 25.11, 'unit': 'M', 'net_profit': -57.71}, {'period': ""Q4 '24"", 'revenue': 26.1, 'unit': 'M', 'net_profit': 28.97}, {'period': ""Q3 '24"", 'revenue': 22.71, 'unit': 'M', 'net_profit': -38.8}, {'period': ""Q2 '24"", 'revenue': 28.95, 'unit': 'M', 'net_profit': -11.95}, {'period': ""Q1 '24"", 'revenue': 30.29, 'unit': 'M', 'net_profit': 50.08}, {'period': ""Q4 '23"", 'revenue': 16.05, 'unit': 'M', 'net_profit': -2.02}]",0.2,0.2,538247664,296856935,98159267,74768515,27099987,37579844,55026604,95201335,-106989802,5.864253492918947,3.0373740371334894,2.25,__nan__,__nan__,__nan__,0.13891098838099183
276,BTNB,Bridgetown 2 Holdings Limited Class A Ordinary Shares,"Bridgetown 2 Holdings Limited does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Central, Hong Kong.",,Shell Companies,8.33,USD,0,https://images.financialmodelingprep.com/symbol/BTNB.png,131465,0,0,162786,,,[],"[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.86}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.91}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",,,67500,25000,25000,52500,0,0,52500,25000,,,,,__nan__,__nan__,__nan__,0.7777777777777778
277,BTRS,BTRS Holdings Inc. Class 1 Common Stock,"BTRS Holdings Inc. provides cloud-based software and integrated payment processing solutions that automates business-to-business (B2B) commerce worldwide. The company operates in two segments, Print, and Software and Payments. The company offers solutions that span credit decisioning and monitoring, online ordering, invoicing, cash application, and collections. Its products include credit Application, a B2B credit application module, which provides a digital process that delivers credit-related information in real-time to streamline prospect evaluation and new customer onboarding during initial sales activity; Credit Management, a credit management module, which provides ongoing risk assessment for its customers' customers; order/E-commerce module that offers B2B wholesale distributors with e-commerce capabilities; and invoicing module, which enables its customers to optimize invoice delivery across various distribution channels. The company's products also comprise integrated B2B payments, an integrated payment capabilities that enable customers to facilitate payments at every possible touchpoint across solution set; cash application module, which enables revenue reconciliation through line item reconciliation within accounting and ERP systems; collections module that enables customers to shift from a reactive recovery-centric model to a strategic customer touchpoint-centric operation, preventing payment delays, and driving positive customer experiences; and business payments network, which makes accepting electronic payments through connecting suppliers and their underlying systems, AP portals, payment card issuers, banks, and payment processors. It serves customers across various industry verticals comprising technology, healthcare, industrial, wholesale distribution, consumer packaged goods, and others. The company was incorporated in 2001 and is headquartered in Lawrenceville, New Jersey. As of December 16, 2022, BTRS Holdings Inc. was taken private.",Mr. Flint A. Lane,Software - Application,9.49,USD,0,https://images.financialmodelingprep.com/symbol/BTRS.png,1623187,-22.488151658767773,0,1,-64265000,-61200000,"[{'period': '2021', 'revenue': 166.41, 'unit': 'M', 'net_profit': -61.2}, {'period': '2020', 'revenue': 145.69, 'unit': 'M', 'net_profit': -4.45}, {'period': '2019', 'revenue': 136.47, 'unit': 'M', 'net_profit': -22.8}, {'period': '2018', 'revenue': 120.52, 'unit': 'M', 'net_profit': -18.23}]","[{'period': ""Q3 '22"", 'revenue': 51.36, 'unit': 'M', 'net_profit': -21.21}, {'period': ""Q2 '22"", 'revenue': 49.28, 'unit': 'M', 'net_profit': -15.8}, {'period': ""Q1 '22"", 'revenue': 45.63, 'unit': 'M', 'net_profit': -29.03}, {'period': ""Q4 '21"", 'revenue': 42.88, 'unit': 'M', 'net_profit': -16.48}, {'period': ""Q3 '21"", 'revenue': 41.36, 'unit': 'M', 'net_profit': -11.19}, {'period': ""Q2 '21"", 'revenue': 40.23, 'unit': 'M', 'net_profit': -10.74}]",-0.39,-0.39,470649,299663,187672,161015,34394,45117,88825,187672,-11193000,-12.014304971048137,-12.743667133771693,-11.703583061889251,__nan__,__nan__,__nan__,0.34211269969765157
278,BTRSW,BTRS Holdings Inc. Warrants,,,,,,,,,,,,-4450315,-4447670,"[{'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.45}, {'period': '2019', 'revenue': 136.47, 'unit': 'M', 'net_profit': -22.8}, {'period': '2018', 'revenue': 120.52, 'unit': 'M', 'net_profit': -18.23}]","[{'period': ""Q3 '21"", 'revenue': 41.36, 'unit': 'M', 'net_profit': -11.19}, {'period': ""Q2 '21"", 'revenue': 40.23, 'unit': 'M', 'net_profit': -10.74}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.45}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': -225.89}, {'period': ""Q2 '20"", 'revenue': 34.59, 'unit': 'M', 'net_profit': -2.9}]",0.02,0.02,253568166,1275211,253310357,12741227,0,252292955,4770852,1017402,-1071206,0.7082717141920681,0.80495241854142,0,__nan__,__nan__,__nan__,0.05024773890583726
279,BTWN,Bridgetown Holdings Limited Class A Ordinary Shares,"Bridgetown Holdings Limited does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the technology, financial services, or media sectors. The company was incorporated in 2020 and is based in Central, Hong Kong.",Mr. Daniel  Wong,Shell Companies,6.15,USD,184302591,https://images.financialmodelingprep.com/symbol/BTWN.png,74873,-87.85714285714286,-0.26,159230,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
280,BTWNU,Bridgetown Holdings Limited Units,"Bridgetown Holdings Limited does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the technology, financial services, or media sectors. The company was incorporated in 2020 and is based in Central, Hong Kong.",Mr. Daniel  Wong,Shell Companies,6.14,USD,179469744,https://images.financialmodelingprep.com/symbol/BTWNU.png,1715,8.175765645805592,0.0205,2000,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
281,BTWNW,Bridgetown Holdings Limited Warrants,"As of October 12, 2023, Bridgetown Holdings Limited was acquired by MoneyHero Limited, in a reverse merger transaction. Bridgetown Holdings Limited does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company focuses its search on target companies operating in the technology, financial services, and media sectors in Southeast Asia. Bridgetown Holdings Limited was incorporated in 2020 and is based in Central, Hong Kong.",,Shell Companies,0.1901,USD,2869186,https://images.financialmodelingprep.com/symbol/BTWNW.png,62660,0,-0.0299,64930,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
282,BUSE,First Busey Corporation Class A Common Stock,"First Busey Corporation operates as the bank holding company for Busey Bank that provides retail and commercial banking products and services to individual, corporate, institutional, and governmental customers in the United States. The company operates through three segments: Banking, FirsTech, and Wealth Management. It offers customary types of demand and savings deposits; and commercial, agricultural, real estate construction, commercial and residential real estate, and consumer loans, as well as home equity lines of credit. The company also provides money transfer, safe deposit, IRA, and other fiduciary services through banking center, ATM and technology-based networks. In addition, it offers investment management, trust, estate advisory, and financial planning services, as well as business succession and employee retirement planning services; investment strategy consulting and fiduciary services; and security brokerage services. Further, the company provides asset management, philanthropic advisory, tax preparation, and professional farm management services; and commercial depository services, such as cash management services. Additionally, it offers payment technology solutions through its payment platform, such as walk-in payment processing for customers at retail pay agents; online bill payment solutions; customer service payments accepted over the telephone; mobile bill pay; direct debit services; electronic concentration of payments delivered to automated clearing house network; money management and credit card networks; and lockbox remittance processing to make payments by mail, as well as provides tools related to billing, reconciliation, bill reminders, and treasury services. The company has 46 banking centers in Illinois; 8 in Missouri; 3 in southwest Florida; and 1 in Indianapolis, Indiana. First Busey Corporation was founded in 1868 and is headquartered in Champaign, Illinois.",Mr. Van A. Dukeman CFA,Banks - Regional,21.86,USD,1956264516,https://images.financialmodelingprep.com/symbol/BUSE.png,583421,20.24,-0.64,564292,0,113691000,"[{'period': '2024', 'revenue': 461.44, 'unit': 'M', 'net_profit': 113.69}, {'period': '2023', 'revenue': 439.44, 'unit': 'M', 'net_profit': 122.56}, {'period': '2022', 'revenue': 445.62, 'unit': 'M', 'net_profit': 128.31}, {'period': '2021', 'revenue': 403.5, 'unit': 'M', 'net_profit': 123.45}]","[{'period': ""Q1 '25"", 'revenue': 124.95, 'unit': 'M', 'net_profit': -29.99}, {'period': ""Q4 '24"", 'revenue': 131.32, 'unit': 'M', 'net_profit': 28.11}, {'period': ""Q3 '24"", 'revenue': 118.49, 'unit': 'M', 'net_profit': 32.0}, {'period': ""Q2 '24"", 'revenue': 116.23, 'unit': 'M', 'net_profit': 27.36}, {'period': ""Q1 '24"", 'revenue': 110.77, 'unit': 'M', 'net_profit': 26.23}, {'period': ""Q4 '23"", 'revenue': 108.65, 'unit': 'M', 'net_profit': 25.75}]",2.01,1.98,12046722000,1939665000,1939665000,10663453000,0,2652713000,11040000,697659000,171837000,0,-0.07240239872720597,-0.09049773755656117,"[0.25, 0.1]","['2025-04-17', '1998-10-16']",__nan__,0.8851746558109335
283,BVS,Bioventus Inc. Class A Common Stock,"Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.",Mr. Robert E. Claypoole,Medical - Devices,6.5,USD,431324400,https://images.financialmodelingprep.com/symbol/BVS.png,419791,-13.54,-0.49,299311,-49555000,-33542000,"[{'period': '2024', 'revenue': 573.28, 'unit': 'M', 'net_profit': -33.54}, {'period': '2023', 'revenue': 512.35, 'unit': 'M', 'net_profit': -156.23}, {'period': '2022', 'revenue': 512.12, 'unit': 'M', 'net_profit': -158.7}, {'period': '2021', 'revenue': 430.9, 'unit': 'M', 'net_profit': 19.38}]","[{'period': ""Q1 '25"", 'revenue': 123.88, 'unit': 'M', 'net_profit': -2.64}, {'period': ""Q4 '24"", 'revenue': 153640.0, 'unit': 'K', 'net_profit': -156.0}, {'period': ""Q3 '24"", 'revenue': 138.96, 'unit': 'M', 'net_profit': -4.82}, {'period': ""Q2 '24"", 'revenue': 151.22, 'unit': 'M', 'net_profit': -23.99}, {'period': ""Q1 '24"", 'revenue': 129.46, 'unit': 'M', 'net_profit': -4.57}, {'period': ""Q4 '23"", 'revenue': 135.42, 'unit': 'M', 'net_profit': -6.1}]",-0.75,-0.75,727956000,275610000,41582000,542352000,127393000,0,210398000,41582000,37789000,-1.14802774165583,0.7853037188760161,0.6987951807228916,__nan__,__nan__,__nan__,0.7450340405189325
284,BVXV,BiondVax Pharmaceuticals Ltd. American Depositary Shares,"BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.","Mr. Amir  Reichman M.B.A., M.Sc.",Biotechnology,1.36,USD,4966625,https://images.financialmodelingprep.com/symbol/BVXV.png,38939,-0.5787234042553191,0.01,22668,-10499000,-531000,"[{'period': '2022', 'revenue': 0.0, 'unit': 'K', 'net_profit': -531.0}, {'period': '2021', 'revenue': 2.75, 'unit': 'M', 'net_profit': -50.81}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.82}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -124.11}]","[{'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.76}, {'period': ""Q1 '23"", 'revenue': 2.02, 'unit': 'M', 'net_profit': -3.84}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.6}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.79}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.07}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.42}]",0,0,27067000,14370000,14075000,28827000,110000,0,2338000,14075000,-8101000,0.6763962520034521,0.989549301318638,1,__nan__,__nan__,__nan__,1.0650238297557912
285,BWAC,Better World Acquisition Corp. Common Stock,"Better World Acquisition Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities in the healthy living industries. Better World Acquisition Corp. was incorporated in 2020 and is based in New York, New York.",Ms. Rosemary L. Ripley,Shell Companies,10.85,USD,0,https://images.financialmodelingprep.com/symbol/BWAC.png,6527,-29.324324324324323,-0.02,193,-4350522,3250075,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.25}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.1}]","[{'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -607.37}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -157.18}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 844.15}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 915.7}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.85}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -107.03}]",0.41,0.41,44743088,46464,2369,3861285,0,44696624,3332727,2369,-1334539,0.3201626350897442,0.5474904331587646,-0.3166666666666667,__nan__,__nan__,__nan__,0.08629902790795307
286,BWACU,Better World Acquisition Corp. Unit,"Better World Acquisition Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities in the healthy living industries. Better World Acquisition Corp. was incorporated in 2020 and is based in New York, New York.",Ms. Rosemary L. Ripley,Shell Companies,10.02,USD,0,https://images.financialmodelingprep.com/symbol/BWACU.png,91,55.35911602209945,-0.92,198,-4350522,3250075,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.25}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.1}]","[{'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -607.37}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -157.18}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 844.15}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 915.7}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.85}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -107.03}]",0.41,0.41,44743088,46464,2369,3861285,0,44696624,3332727,2369,-1334539,0.3201626350897442,0.5474904331587646,-0.3166666666666667,__nan__,__nan__,__nan__,0.08629902790795307
287,BWACW,Better World Acquisition Corp. Warrants,,Ms. Rosemary L. Ripley,Shell Companies,0.0035,USD,0,https://images.financialmodelingprep.com/symbol/BWACW.png,0,0,0.0015,300,-4350522,3250075,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.25}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.1}]","[{'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -607.37}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -157.18}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 844.15}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 915.7}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.85}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -107.03}]",0.41,0.41,44743088,46464,2369,3861285,0,44696624,3332727,2369,-1334539,0.3201626350897442,0.5474904331587646,-0.3166666666666667,__nan__,__nan__,__nan__,0.08629902790795307
288,BWAY,BrainsWay Ltd. American Depositary Shares,"Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.",Mr. Hadar  Levy,Medical - Devices,10.4,USD,196268800,https://images.financialmodelingprep.com/symbol/BWAY.png,46588,47.27,-0.29,78672,5467000,2921000,"[{'period': '2024', 'revenue': 41.02, 'unit': 'M', 'net_profit': 2.92}, {'period': '2023', 'revenue': 31.79, 'unit': 'M', 'net_profit': -4.2}, {'period': '2022', 'revenue': 27.18, 'unit': 'M', 'net_profit': -13.35}, {'period': '2021', 'revenue': 29.66, 'unit': 'M', 'net_profit': -6.46}]","[{'period': ""Q4 '24"", 'revenue': 11.41, 'unit': 'M', 'net_profit': 1.55}, {'period': ""Q3 '24"", 'revenue': 10500.0, 'unit': 'K', 'net_profit': 662.0}, {'period': ""Q2 '24"", 'revenue': 10010.0, 'unit': 'K', 'net_profit': 600.0}, {'period': ""Q1 '24"", 'revenue': 9100.0, 'unit': 'K', 'net_profit': 111.0}, {'period': ""Q4 '23"", 'revenue': 9030.0, 'unit': 'K', 'net_profit': 127.0}, {'period': ""Q3 '23"", 'revenue': 8300.0, 'unit': 'K', 'net_profit': -230.0}]",0.18,0.18,94316000,79527000,69345000,31674000,4596000,0,15346000,69345000,6504000,3.3656425789701427,1.6959733142720992,1.3599999999999999,__nan__,__nan__,__nan__,0.33582849145426014
289,BWB,Bridgewater Bancshares Inc. Common Stock,"Bridgewater Bancshares, Inc. operates as the bank holding company for Bridgewater Bank that provides banking products and services to commercial real estate investors, small business entrepreneurs, and high net worth individuals in the United States. The company offers savings and money market accounts, demand deposits, time and brokered deposits, and interest and noninterest bearing transaction, as well as certificates of deposit. It also provides commercial loans to sole proprietorships, partnerships, corporations, and other business enterprises to finance accounts receivable or inventory, capital assets, or other business-related purposes; paycheck protection program loans; construction and land development loans; 1-4 family mortgage loans; multifamily lending products; owner and non-owner occupied commercial real estate loans; and consumer and other loans. In addition, the company online, mobile, and direct banking services. It operates through seven full-service offices located in Bloomington, Greenwood, Minneapolis, St. Louis Park, Orono, and St. Paul, Minnesota. The company was incorporated in 2005 and is headquartered in Saint Louis Park, Minnesota.",Mr. Gerald John Baack,Banks - Regional,14.96,USD,410500904,https://images.financialmodelingprep.com/symbol/BWB.png,83537,13.6,-0.55,45063,0,32825000,"[{'period': '2024', 'revenue': 107.74, 'unit': 'M', 'net_profit': 32.83}, {'period': '2023', 'revenue': 111.84, 'unit': 'M', 'net_profit': 39.96}, {'period': '2022', 'revenue': 136.03, 'unit': 'M', 'net_profit': 53.39}, {'period': '2021', 'revenue': 114.82, 'unit': 'M', 'net_profit': 45.69}]","[{'period': ""Q1 '25"", 'revenue': 31.84, 'unit': 'M', 'net_profit': 9.63}, {'period': ""Q4 '24"", 'revenue': 29.07, 'unit': 'M', 'net_profit': 8.2}, {'period': ""Q3 '24"", 'revenue': 0.0009599999999999999, 'unit': 'M', 'net_profit': 8.68}, {'period': ""Q2 '24"", 'revenue': 62.11, 'unit': 'M', 'net_profit': 8.12}, {'period': ""Q1 '24"", 'revenue': 59.73, 'unit': 'M', 'net_profit': 7.83}, {'period': ""Q4 '23"", 'revenue': 59.96, 'unit': 'M', 'net_profit': 8.87}]",1.05,1.03,5066242000,998007000,998007000,4608307000,62002000,385693000,17758000,234137000,42296000,-1,-0.17855355355355354,-0.18604651162790697,__nan__,__nan__,__nan__,0.9096105160393049
290,BWEN,Broadwind Inc. Common Stock,"Broadwind, Inc. manufactures and sells structures, equipment, and components for clean tech and other specialized applications primarily in the United States. It operates through three segments: Heavy Fabrications, Gearing, and Industrial Solutions. The Heavy Fabrications segment provides fabrications to various industrial markets. It offers steel towers and adapters primarily to wind turbine manufacturers. The Gearing segment provides gearing, and gearboxes and systems for onshore and offshore oil and gas fracking and drilling, surface and underground mining, wind energy, steel, material handling, and other infrastructure markets. This segment also offers heat treat services for aftermarket and original equipment manufacturer applications. The Industrial Solutions segment provides supply chain solutions for offering instrumentation and controls, valve assemblies, sensor devices, fuel system components, electrical junction boxes and wiring, energy storage services, and electromechanical devices; light fabrication, inventory management, and kitting and assembly services; packaging solutions; and fabricating services for panels and sub-assemblies to combined cycle natural gas turbine market. The company sells its products to the energy, mining, and infrastructure sector customers through its direct sales force and independent sales agents. The company was formerly known as Broadwind Energy, Inc. and changed its name to Broadwind, Inc. in May 2020. Broadwind, Inc. is headquartered in Cicero, Illinois.",Mr. Eric B. Blashford,Industrial - Machinery,1.8,USD,40836780,https://images.financialmodelingprep.com/symbol/BWEN.png,107440,-45,0.02,54159,10988000,1152000,"[{'period': '2024', 'revenue': 143.14, 'unit': 'M', 'net_profit': 1.15}, {'period': '2023', 'revenue': 203.48, 'unit': 'M', 'net_profit': 7.65}, {'period': '2022', 'revenue': 176.76, 'unit': 'M', 'net_profit': -9.73}, {'period': '2021', 'revenue': 145.62, 'unit': 'M', 'net_profit': 2.85}]","[{'period': ""Q1 '25"", 'revenue': 36840.0, 'unit': 'K', 'net_profit': -370.0}, {'period': ""Q4 '24"", 'revenue': 33560.0, 'unit': 'K', 'net_profit': -914.0}, {'period': ""Q3 '24"", 'revenue': 35500.0, 'unit': 'K', 'net_profit': 74.0}, {'period': ""Q2 '24"", 'revenue': 36450.0, 'unit': 'K', 'net_profit': 482.0}, {'period': ""Q1 '24"", 'revenue': 37.62, 'unit': 'M', 'net_profit': 1.51}, {'period': ""Q4 '23"", 'revenue': 46.6, 'unit': 'M', 'net_profit': 1.07}]",0.0526,0.0524,128290000,66868000,7721000,68890000,13454000,0,43557000,7721000,10188000,-0.3711800389149594,-0.849392077395738,-0.8538888888888889,__nan__,__nan__,__nan__,0.5369865149271182
291,BWFG,Bankwell Financial Group Inc. Common Stock,"Bankwell Financial Group, Inc. operates as the bank holding company for Bankwell Bank that provides various banking services for individual and commercial customers. It offers various traditional depository products, including checking, savings, money market, and certificates of deposit. The company also provides first mortgage loans secured by one-to-four family owner occupied residential properties for personal use; home equity loans and home equity lines of credit secured by owner occupied one-to-four family residential properties; loans secured by commercial real estate, multi-family dwellings, and investor-owned one-to-four family dwellings; commercial construction loans for commercial development projects, including apartment buildings and condominiums, as well as office buildings, retail, and other income producing properties; land loans; commercial business loans secured by assignments of corporate assets and personal guarantees of the business owners; loans secured by savings or certificate accounts and automobiles; and unsecured personal loans and overdraft lines of credit. It operates branches in New Canaan, Stamford, Fairfield, Wilton, Westport, Darien, Norwalk, and Hamden, Connecticut. The company was formerly known as BNC Financial Group, Inc. and changed its name to Bankwell Financial Group, Inc. in September 2013. Bankwell Financial Group, Inc. was founded in 2002 and is headquartered in New Canaan, Connecticut.",Mr. Christopher R. Gruseke,Banks - Regional,34.23,USD,269506140,https://images.financialmodelingprep.com/symbol/BWFG.png,14150,21.13,-1.36,15558,0,9314000,"[{'period': '2024', 'revenue': 87.0, 'unit': 'M', 'net_profit': 9.31}, {'period': '2023', 'revenue': 99.31, 'unit': 'M', 'net_profit': 36.66}, {'period': '2022', 'revenue': 97.78, 'unit': 'M', 'net_profit': 37.43}, {'period': '2021', 'revenue': 73.54, 'unit': 'M', 'net_profit': 26.59}]","[{'period': ""Q1 '25"", 'revenue': 49.98, 'unit': 'M', 'net_profit': 6.89}, {'period': ""Q4 '24"", 'revenue': 47.84, 'unit': 'M', 'net_profit': 2.96}, {'period': ""Q3 '24"", 'revenue': 21.87, 'unit': 'M', 'net_profit': 1.93}, {'period': ""Q2 '24"", 'revenue': 48.55, 'unit': 'M', 'net_profit': 1.12}, {'period': ""Q1 '24"", 'revenue': 49.23, 'unit': 'M', 'net_profit': 3.76}, {'period': ""Q4 '23"", 'revenue': 50.52, 'unit': 'M', 'net_profit': 8.52}]",1.24,1.23,3268476000,2983164000,295670000,2997956000,2687494000,175695000,2781298000,293552000,29323000,-1,-0.7459564138232005,-0.7367303609341825,"[0.2, 0.05]","['2025-05-09', '2015-12-09']",__nan__,0.9172335975543342
292,BWMN,Bowman Consulting Group Ltd. Common Stock,"Bowman Consulting Group Ltd. provides a range of real estate, energy, infrastructure, and environmental management solutions in the United States. It offers civil and site engineering services, such as conceptual land planning, environmental consulting and permitting, planning/zoning and entitlements, roadway and highway designs, erosion and sediment designs, stormwater management designs, construction administration, traffic studies, floodplain studies, and utility relocation designs; and commissioning and energy efficiency services comprise construction observation, direct systems functional performance testing, system development readiness checklist, post occupancy review, review of construction documents, deferred/seasonal functional testing, final commissioning report, and commissioning review of submittals. The company also provides construction management services, including constructability review, value engineering, budgeting and cost estimating, interagency and utility coordination, onsite observation and report evaluation, public communication and outreach, and resident engineer services, as well as bid solicitation, documentation, and preparation services; and environmental consulting services consisting of wetlands and waters of the U.S. delineations, natural resources inventories, wildlife and vegetation surveys, threatened and endangered species surveys, endangered species conservation and management, wetland creation and enhancement design, NEPA documentation, section 404/401 permitting and compliance, NPDES permitting, and phase I environmental site assessment. In addition, it offers landscape architecture, land procurement and right-of-way acquisition, structural engineering, surveying and geospatial engineering, and transportation and water resources engineering services, as well as mechanical, electrical, and plumbing engineering services. Bowman Consulting Group Ltd. was incorporated in 1995 and is headquartered in Reston, Virginia.",Mr. Gary P. Bowman,Engineering & Construction,25.45,USD,438582395,https://images.financialmodelingprep.com/symbol/BWMN.png,113165,149.71,-0.93,101284,25968000,2804000,"[{'period': '2024', 'revenue': 426.56, 'unit': 'M', 'net_profit': 2.8}, {'period': '2023', 'revenue': 346.26, 'unit': 'M', 'net_profit': -6.62}, {'period': '2022', 'revenue': 261.71, 'unit': 'M', 'net_profit': 5.0}, {'period': '2021', 'revenue': 149970.0, 'unit': 'K', 'net_profit': 299.0}]","[{'period': ""Q1 '25"", 'revenue': 112.93, 'unit': 'M', 'net_profit': -1.74}, {'period': ""Q4 '24"", 'revenue': 113.22, 'unit': 'M', 'net_profit': 5.9}, {'period': ""Q3 '24"", 'revenue': 113930.0, 'unit': 'K', 'net_profit': 771.0}, {'period': ""Q2 '24"", 'revenue': 104.5, 'unit': 'M', 'net_profit': -2.08}, {'period': ""Q1 '24"", 'revenue': 94.91, 'unit': 'M', 'net_profit': -1.56}, {'period': ""Q4 '23"", 'revenue': 92.97, 'unit': 'M', 'net_profit': -7.71}]",0.18,0.17,505881000,176621000,6698000,259766000,150363000,0,134979000,6698000,23675000,0.47077480743090167,1.4233091787439613,1.3396226415094339,__nan__,__nan__,__nan__,0.513492303525928
293,BWMX,Betterware de Mexico S.A.B. de C.V. Ordinary Shares,"Betterware de México, S.A.P.I. de C.V. operates as a direct-to-consumer company in Mexico. It focuses on the home organization segment with a product portfolio, including home solutions, kitchen and food preservation, technology and mobility, bedroom, bathroom, laundry and cleaning, and other categories. The company sells its products through twelve catalogues. Betterware de México, S.A.P.I. de C.V. was incorporated in 1995 and is based in Zapopan, Mexico. Betterware de México, S.A.P.I. de C.V. is a subsidiary of Campalier, S.A. de C.V.",Mr. Andres Campos Chevallier,Specialty Retail,9.23,USD,344431295,https://images.financialmodelingprep.com/symbol/BWMX.png,24455,-46.15,-0.14,31877,2212673000,711728000,"[{'period': '2024', 'revenue': 14100.0, 'unit': 'M', 'net_profit': 711.73}, {'period': '2023', 'revenue': 13.01, 'unit': 'B', 'net_profit': 1.05}, {'period': '2022', 'revenue': 11500.0, 'unit': 'M', 'net_profit': 872.56}, {'period': '2021', 'revenue': 10.04, 'unit': 'B', 'net_profit': 1.75}]","[{'period': ""Q1 '25"", 'revenue': 3500.0, 'unit': 'M', 'net_profit': 151.39}, {'period': ""Q4 '24"", 'revenue': 3780.0, 'unit': 'M', 'net_profit': 225.31}, {'period': ""Q3 '24"", 'revenue': 3330.0, 'unit': 'M', 'net_profit': -115.61}, {'period': ""Q2 '24"", 'revenue': 3390.0, 'unit': 'M', 'net_profit': 300.77}, {'period': ""Q1 '24"", 'revenue': 3600.0, 'unit': 'M', 'net_profit': 294.15}, {'period': ""Q4 '23"", 'revenue': 3400.0, 'unit': 'M', 'net_profit': 406.1}]",19.07,19.07,10453767000,4628738000,296558000,9291119000,1231608000,0,4264488000,296558000,1601425000,-0.15756412101497116,-0.32181567490359336,-0.3232789212207239,"[0.27, 0.131]","['2025-05-12', '2020-05-28']",__nan__,0.8887819099086482
294,BXRX,Baudax Bio Inc. Common Stock,"Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMBA, which is in phase I clinical trial; BX3000, an NMBA reversal agent; and Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.",Dr. Geraldine A. Henwood Ph.D.,Biotechnology,0.0218,USD,0,https://images.financialmodelingprep.com/symbol/BXRX.png,424847,-0.00023159460320832891,0.0015,310872,-35578000,-58795000,"[{'period': '2022', 'revenue': 1.27, 'unit': 'M', 'net_profit': -58.8}, {'period': '2021', 'revenue': 1.08, 'unit': 'M', 'net_profit': -19.77}, {'period': '2020', 'revenue': 0.493, 'unit': 'M', 'net_profit': -76.1}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -18.0}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.93}, {'period': ""Q2 '23"", 'revenue': 0.03, 'unit': 'M', 'net_profit': -7.38}, {'period': ""Q1 '23"", 'revenue': -0.014, 'unit': 'M', 'net_profit': 11.4}, {'period': ""Q4 '22"", 'revenue': 0.31, 'unit': 'M', 'net_profit': -9.25}, {'period': ""Q3 '22"", 'revenue': 0.23800000000000002, 'unit': 'M', 'net_profit': -29.2}, {'period': ""Q2 '22"", 'revenue': 0.3, 'unit': 'M', 'net_profit': -7.53}]",-177.3,-177.3,10032000,6347000,5259000,34274000,335000,0,21460000,5259000,-27813000,0.2627849150435143,-1.974100864990642,0.5090818473806623,__nan__,__nan__,__nan__,3.416467304625199
295,BYFC,Broadway Financial Corporation Common Stock,"Broadway Financial Corporation operates as the holding company for City First Bank, National Association that provides various banking products and services in the United States. It accepts various deposit accounts, including savings accounts, checking accounts, NOW accounts, money market accounts, and fixed-term certificates of deposit. The company also offers mortgage loans, which are secured by multi-family residential properties; single family residential properties; and commercial real estate, including charter schools, community facilities, and churches, as well as commercial business, construction, and consumer loans. In addition, it invests in securities issued by federal government agencies, residential mortgage-backed securities, and other investments. The company operates through three branch offices. Broadway Financial Corporation was founded in 1946 and is headquartered in Los Angeles, California.",Mr. Brian E. Argrett,Banks - Regional,6.26,USD,57787181,https://images.financialmodelingprep.com/symbol/BYFC.png,6150,-78.25,-0.08,1730,0,1926000,"[{'period': '2024', 'revenue': 32.66, 'unit': 'M', 'net_profit': 1.93}, {'period': '2023', 'revenue': 52.59, 'unit': 'M', 'net_profit': 4.51}, {'period': '2022', 'revenue': 33.06, 'unit': 'M', 'net_profit': 5.64}, {'period': '2021', 'revenue': 27.97, 'unit': 'M', 'net_profit': -4.05}]","[{'period': ""Q1 '25"", 'revenue': 14.37, 'unit': 'M', 'net_profit': -1.2}, {'period': ""Q4 '24"", 'revenue': 9.05, 'unit': 'M', 'net_profit': 1.3}, {'period': ""Q3 '24"", 'revenue': 16580.0, 'unit': 'K', 'net_profit': 522.0}, {'period': ""Q2 '24"", 'revenue': 15760.0, 'unit': 'K', 'net_profit': 269.0}, {'period': ""Q1 '24"", 'revenue': 15100.0, 'unit': 'K', 'net_profit': -164.0}, {'period': ""Q4 '23"", 'revenue': 17.09, 'unit': 'M', 'net_profit': 2.61}]",0.21,0.21,1303711000,151324000,146323000,1018335000,5001000,0,10794000,61365000,1255000,-1,-0.5733274257864421,-0.5961538461538463,"[0.01, 0.05]","['2010-04-08', '1996-04-11']",__nan__,0.7811048614301789
296,BYND,Beyond Meat Inc. Common Stock,"Beyond Meat, Inc. manufactures, markets, and sells plant-based meat products in the United States and internationally. The company sells a range of plant-based meat products across the platforms of beef, pork, and poultry. It sells its products through grocery, mass merchandiser, club store, convenience store and natural retailer channels, and direct-to-consumer, as well as various food-away-from-home channels, including restaurants, foodservice outlets, and schools. The company was formerly known as Savage River, Inc. and changed its name to Beyond Meat, Inc. in September 2018. Beyond Meat, Inc. was founded in 2009 and is headquartered in El Segundo, California.",Mr. Ethan  Brown,Packaged Foods,2.96,USD,226355344,https://images.financialmodelingprep.com/symbol/BYND.png,2553257,-1.3,-0.01,2725765,-133013000,-160278000,"[{'period': '2024', 'revenue': 326.45, 'unit': 'M', 'net_profit': -160.28}, {'period': '2023', 'revenue': 343.38, 'unit': 'M', 'net_profit': -338.14}, {'period': '2022', 'revenue': 418.93, 'unit': 'M', 'net_profit': -347.19}, {'period': '2021', 'revenue': 464.7, 'unit': 'M', 'net_profit': -179.13}]","[{'period': ""Q1 '25"", 'revenue': 68.73, 'unit': 'M', 'net_profit': -52.92}, {'period': ""Q4 '24"", 'revenue': 76.66, 'unit': 'M', 'net_profit': -44.86}, {'period': ""Q3 '24"", 'revenue': 81.01, 'unit': 'M', 'net_profit': -26.58}, {'period': ""Q2 '24"", 'revenue': 93.19, 'unit': 'M', 'net_profit': -34.48}, {'period': ""Q1 '24"", 'revenue': 75.6, 'unit': 'M', 'net_profit': -54.36}, {'period': ""Q4 '23"", 'revenue': 73.68, 'unit': 'M', 'net_profit': -155.11}]",-2.43,-2.43,678146000,286456000,131913000,1279354000,26862000,1601000,61453000,131913000,-109828000,0.5286369370774094,0.5260066717138261,0.5380228136882129,__nan__,__nan__,__nan__,1.886546554871665
297,BYRN,Byrna Technologies Inc. Common Stock,"Byrna Technologies Inc., a less-lethal defense technology company, develops and manufactures less-lethal munitions. It offers a Byrna line of handheld personal security devices, including the Byrna SD and Byrna SD .68 caliber handheld personal security devices that are designed to be used by civilians and private security professionals, as well as Byrna HD magazines, shoulder-fired launchers, and projectiles. The company also offers accessories and related safety products, including the Byrna Banshee, Byrna Shield, compressed carbon dioxide canisters, sighting systems, holsters, and Byrna-branded apparels. It operates in the United States and South Africa. The company was formerly known as Security Devices International, Inc. and changed its name to Byrna Technologies Inc. in March 2020. Byrna Technologies Inc. was incorporated in 2005 and is headquartered in Andover, Massachusetts.",Mr. Bryan Scott Ganz J.D.,Aerospace & Defense,23.85,USD,540612720,https://images.financialmodelingprep.com/symbol/BYRN.png,581970,38.47,-1.05,273344,8162000,12792000,"[{'period': '2024', 'revenue': 85.76, 'unit': 'M', 'net_profit': 12.79}, {'period': '2023', 'revenue': 42.64, 'unit': 'M', 'net_profit': -8.19}, {'period': '2022', 'revenue': 48.04, 'unit': 'M', 'net_profit': -7.88}, {'period': '2021', 'revenue': 42.16, 'unit': 'M', 'net_profit': -3.28}]","[{'period': ""Q1 '25"", 'revenue': 26.19, 'unit': 'M', 'net_profit': 1.66}, {'period': ""Q4 '24"", 'revenue': 27.98, 'unit': 'M', 'net_profit': 9.67}, {'period': ""Q3 '24"", 'revenue': 20.85, 'unit': 'M', 'net_profit': 1.02}, {'period': ""Q2 '24"", 'revenue': 20.27, 'unit': 'M', 'net_profit': 2.08}, {'period': ""Q1 '24"", 'revenue': 16650.0, 'unit': 'K', 'net_profit': 17.0}, {'period': ""Q4 '23"", 'revenue': 15640.0, 'unit': 'K', 'net_profit': -829.0}]",0.57,0.55,71922000,50958000,25733000,17553000,2630000,0,15438000,16829000,9392000,2.2503063725490198,2.5615234375,2.5405405405405403,__nan__,__nan__,__nan__,0.24405606073246017
298,BYSI,BeyondSpring Inc. Ordinary Shares,"BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of NSCLC; nivolumab and ipilimumab, a CTLA-4 antibody for the treatment of SCLC; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.",Dr. Lan  Huang Ph.D.,Biotechnology,1.68,USD,67731384,https://images.financialmodelingprep.com/symbol/BYSI.png,20677,-7.64,-0.04,2328,-8484000,-11123000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.12}, {'period': '2023', 'revenue': 1.75, 'unit': 'M', 'net_profit': -21.03}, {'period': '2022', 'revenue': 1.35, 'unit': 'M', 'net_profit': -36.28}, {'period': '2021', 'revenue': 1.35, 'unit': 'M', 'net_profit': -68.21}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.48}, {'period': ""Q4 '24"", 'revenue': -1.44, 'unit': 'M', 'net_profit': 2.99}, {'period': ""Q2 '24"", 'revenue': 0.5, 'unit': 'M', 'net_profit': -3.63}, {'period': ""Q1 '24"", 'revenue': 0.5, 'unit': 'M', 'net_profit': -3.63}, {'period': ""Q4 '23"", 'revenue': 0.438, 'unit': 'M', 'net_profit': -4.15}, {'period': ""Q3 '23"", 'revenue': 0.438, 'unit': 'M', 'net_profit': -4.15}]",-0.28,-0.28,34315000,28577000,2922000,48600000,0,0,11010000,2922000,-16667000,0.6061281337047354,0.4709883001997527,0.48148148148148145,__nan__,__nan__,__nan__,1.4162902520763514
299,BYTS,BYTE Acquisition Corp. Class A Ordinary Shares,"BYTE Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus its search for targets in the Israeli technology industry, including cybersecurity, automotive technology, fintech, enterprise software, cloud computing, semiconductors, medical technology, artificial intelligence, and robotics. The company was incorporated in 2021 and is based in New York, New York.",Mr. Samuel  Gloor,Shell Companies,6.49,USD,71129751,https://images.financialmodelingprep.com/symbol/BYTS.png,13482,-108.16666666666667,-3.97,320028,-3505113000,-57464890000,"[{'period': '2024', 'revenue': 23.05, 'unit': 'B', 'net_profit': -57.46}, {'period': '2023', 'revenue': 5.76, 'unit': 'B', 'net_profit': 16.37}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.63}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.02}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'B', 'net_profit': 23.71}, {'period': ""Q4 '24"", 'revenue': 23.05, 'unit': 'B', 'net_profit': -57.46}, {'period': ""Q3 '24"", 'revenue': 0.28545, 'unit': 'B', 'net_profit': 6.21}, {'period': ""Q2 '24"", 'revenue': 1.31, 'unit': 'B', 'net_profit': 18.46}, {'period': ""Q1 '24"", 'revenue': 7.79, 'unit': 'B', 'net_profit': -31.96}, {'period': ""Q4 '23"", 'revenue': 5.76, 'unit': 'B', 'net_profit': 16.37}]",-2337.31,-1898.27,13707454000,12659470000,11414830000,66730591000,1226757000,0,5654790000,11414830000,-6503968000,0.4721505519651405,-4.5101349729346785,-1948.7583333333332,__nan__,__nan__,__nan__,4.868197332633763
300,BYTSU,BYTE Acquisition Corp. Units,"BYTE Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus its search for targets in the Israeli technology industry, including cybersecurity, automotive technology, fintech, enterprise software, cloud computing, semiconductors, medical technology, artificial intelligence, and robotics. The company was incorporated in 2021 and is based in New York, New York.",Mr. Samuel  Gloor,Shell Companies,6.36,USD,59631360,https://images.financialmodelingprep.com/symbol/BYTSU.png,368,23.043478260869566,-3.69,14185,-3505113000,-57464890000,"[{'period': '2024', 'revenue': 23.05, 'unit': 'B', 'net_profit': -57.46}, {'period': '2023', 'revenue': 5.76, 'unit': 'B', 'net_profit': 16.37}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.63}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.02}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'B', 'net_profit': 23.71}, {'period': ""Q4 '24"", 'revenue': 23.05, 'unit': 'B', 'net_profit': -57.46}, {'period': ""Q3 '24"", 'revenue': 0.28545, 'unit': 'B', 'net_profit': 6.21}, {'period': ""Q2 '24"", 'revenue': 1.31, 'unit': 'B', 'net_profit': 18.46}, {'period': ""Q1 '24"", 'revenue': 7.79, 'unit': 'B', 'net_profit': -31.96}, {'period': ""Q4 '23"", 'revenue': 5.76, 'unit': 'B', 'net_profit': 16.37}]",-2337.31,-1898.27,13707454000,12659470000,11414830000,66730591000,1226757000,0,5654790000,11414830000,-6503968000,0.4721505519651405,-4.5101349729346785,-1948.7583333333332,__nan__,__nan__,__nan__,4.868197332633763
301,BYTSW,BYTE Acquisition Corp. Warrants,"BYTE Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded in 2021 and is based in New York, New York.",Mr. Samuel  Gloor,Shell Companies,0.12,USD,1125120,https://images.financialmodelingprep.com/symbol/BYTSW.png,0,0,0.045,141015,-3505113000,-57464890000,"[{'period': '2024', 'revenue': 23.05, 'unit': 'B', 'net_profit': -57.46}, {'period': '2023', 'revenue': 5.76, 'unit': 'B', 'net_profit': 16.37}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.63}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.02}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'B', 'net_profit': 23.71}, {'period': ""Q4 '24"", 'revenue': 23.05, 'unit': 'B', 'net_profit': -57.46}, {'period': ""Q3 '24"", 'revenue': 0.28545, 'unit': 'B', 'net_profit': 6.21}, {'period': ""Q2 '24"", 'revenue': 1.31, 'unit': 'B', 'net_profit': 18.46}, {'period': ""Q1 '24"", 'revenue': 7.79, 'unit': 'B', 'net_profit': -31.96}, {'period': ""Q4 '23"", 'revenue': 5.76, 'unit': 'B', 'net_profit': 16.37}]",-2337.31,-1898.27,13707454000,12659470000,11414830000,66730591000,1226757000,0,5654790000,11414830000,-6503968000,0.4721505519651405,-4.5101349729346785,-1948.7583333333332,__nan__,__nan__,__nan__,4.868197332633763
302,BZUN,Baozun Inc. American Depositary Shares,"Baozun Inc., through its subsidiaries, provides e-commerce solutions to brand partners in the People's Republic of China. The company offers IT infrastructure setup and integration, online store design and setup, online store operations, visual merchandising and marketing campaigns, customer services, and warehousing and order fulfilment. It serves brand partners in various categories, including apparel and accessories; appliances; electronics; home and furnishings; food and health products; beauty and cosmetics; fast moving consumer goods, and mother and baby products; and automobiles. The company was formerly known as Baozun Cayman Inc. and changed its name to Baozun Inc. in March 2015. Baozun Inc. was founded in 2007 and is headquartered in Shanghai, the People's Republic of China.",Mr. Wenbin  Qiu,Specialty Retail,3.08,USD,187083512,https://images.financialmodelingprep.com/symbol/BZUN.png,367713,-7.16,-0.14,458654,190851000,-185198000,"[{'period': '2024', 'revenue': 9420.0, 'unit': 'M', 'net_profit': -185.2}, {'period': '2023', 'revenue': 8810.0, 'unit': 'M', 'net_profit': -278.42}, {'period': '2022', 'revenue': 8400.0, 'unit': 'M', 'net_profit': -606.79}, {'period': '2021', 'revenue': 9400.0, 'unit': 'M', 'net_profit': -209.26}]","[{'period': ""Q4 '24"", 'revenue': 2990000.0, 'unit': 'K', 'net_profit': 129.0}, {'period': ""Q3 '24"", 'revenue': 2060.0, 'unit': 'M', 'net_profit': -88.07}, {'period': ""Q2 '24"", 'revenue': 2390.0, 'unit': 'M', 'net_profit': -30.62}, {'period': ""Q1 '24"", 'revenue': 1980.0, 'unit': 'M', 'net_profit': -66.64}, {'period': ""Q4 '23"", 'revenue': 2780.0, 'unit': 'M', 'net_profit': -48.41}, {'period': ""Q3 '23"", 'revenue': 1820.0, 'unit': 'M', 'net_profit': -126.43}]",-3.09,-3.09,10207001000,7214171000,2560941000,4426422000,2403836000,341687000,3747557000,1289323000,-106991000,1.5129829089089617,0.3348298625826982,0.33974358974358976,__nan__,__nan__,__nan__,0.4336652852292265
303,CAAS,China Automotive Systems Inc. Common Stock,"China Automotive Systems, Inc., through its subsidiaries, manufactures and sells automotive systems and components in the People's Republic of China. It produces rack and pinion power steering gears for cars and light-duty vehicles; integral power steering gears for heavy-duty vehicles; power steering parts for light duty vehicles; sensor modules; automobile steering systems and columns; and automobile electronic and hydraulic power steering systems and parts. The company also offers automotive motors and electromechanical integrated systems; polymer materials; and intelligent automotive technology research and development services. In addition, it provides after sales services, and research and development support services, as well as markets automotive parts in North America and Brazil. The company primarily sells its products to the original equipment manufacturing customers. China Automotive Systems, Inc. was incorporated in 1999 and is headquartered in Jingzhou, the People's Republic of China.",Mr. Qizhou  Wu,Auto - Parts,4.12,USD,124303284,https://images.financialmodelingprep.com/symbol/CAAS.png,48165,4.29,0.064,59846,66511000,29979000,"[{'period': '2024', 'revenue': 650.93, 'unit': 'M', 'net_profit': 29.98}, {'period': '2023', 'revenue': 576.35, 'unit': 'M', 'net_profit': 37.66}, {'period': '2022', 'revenue': 529.55, 'unit': 'M', 'net_profit': 21.18}, {'period': '2021', 'revenue': 497.99, 'unit': 'M', 'net_profit': 4.39}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.12}, {'period': ""Q4 '24"", 'revenue': 188.72, 'unit': 'M', 'net_profit': 9.07}, {'period': ""Q3 '24"", 'revenue': 164.22, 'unit': 'M', 'net_profit': 5.5}, {'period': ""Q2 '24"", 'revenue': 158.61, 'unit': 'M', 'net_profit': 7.14}, {'period': ""Q1 '24"", 'revenue': 139.39, 'unit': 'M', 'net_profit': 8.27}, {'period': ""Q4 '23"", 'revenue': 159.16, 'unit': 'M', 'net_profit': 10.88}]",0.99,0.99,850579000,602638000,84524000,460790000,345701000,64332000,456482000,56961000,-34684000,-0.02443639350514103,-0.20391417494290723,-0.20800000000000002,"[0.8, 0.18]","['2024-07-30', '2014-06-24']",__nan__,0.5417368639479696
304,CABA,Cabaletta Bio Inc. Common Stock,"Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company's lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and Hemophilia A with Factor VIII alloantibodies. Its product candidate pipeline also includes MuSK-CAART, a preclinical stage product to treat a subset of patients with myasthenia gravis; FVIII-CAART, a discovery stage product to treat a subset of patients with Hemophilia A; and DSG3/1-CAART, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. It has a collaboration with the University of Pennsylvania; and research agreement with The Regents of the University of California. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.",Dr. Steven A. Nichtberger M.D.,Biotechnology,1.795,USD,91083865,https://images.financialmodelingprep.com/symbol/CABA.png,1327980,-0.71,-0.085,1447491,-125141000,-115864000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -115.86}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -67.67}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -51.81}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -45.53}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -35.94}, {'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -32.59}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -30.63}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -27.6}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -25.05}, {'period': ""Q4 '23"", 'revenue': 4.01, 'unit': 'M', 'net_profit': -20.89}]",-2.37,-2.34,185046000,166675000,163962000,32711000,0,0,27086000,163962000,-90433000,-0.7087828058005844,-0.7120650166235686,-0.4363636363636365,__nan__,__nan__,__nan__,0.17677226203214336
305,CAC,Camden National Corporation Common Stock,"Camden National Corporation operates as the bank holding company for Camden National Bank that provides various commercial and consumer banking products and services for consumer, institutional, municipal, non-profit, and commercial customers. The company accepts checking, savings, time, and brokered deposits, as well as deposits with the certificate of deposit account registry system. It also offers non-owner-occupied commercial estate loans, owner-occupied commercial real estate loans, unsecured fully-guaranteed commercial loans backed by the U.S. small business administration, loans secured by one-to four-family properties, and consumer and home equity loans. In addition, the company provides brokerage and insurance services through its financial offerings consisting of college, retirement, estate planning, mutual funds, strategic asset management accounts, and variable and fixed annuities. Further, it offers a range of fiduciary and asset management, wealth management, investment management, financial planning, and trustee services. As of December 31, 2021, the company had 57 branches within Maine; one residential mortgage lending office in Braintree, Massachusetts; two locations in New Hampshire, including a branch in Portsmouth and a commercial loan production office in Manchester; and an online residential mortgage and small commercial digital loan platform, as well as 66 ATMs. Camden National Corporation was founded in 1875 and is headquartered in Camden, Maine.",Mr. Simon R. Griffiths,Banks - Regional,39.86,USD,673721692,https://images.financialmodelingprep.com/symbol/CAC.png,89906,12.69,-1.31,44633,69326000,53004000,"[{'period': '2024', 'revenue': 172.62, 'unit': 'M', 'net_profit': 53.0}, {'period': '2023', 'revenue': 161.2, 'unit': 'M', 'net_profit': 43.38}, {'period': '2022', 'revenue': 183.79, 'unit': 'M', 'net_profit': 61.44}, {'period': '2021', 'revenue': 182.86, 'unit': 'M', 'net_profit': 69.01}]","[{'period': ""Q1 '25"", 'revenue': 87.9, 'unit': 'M', 'net_profit': 7.33}, {'period': ""Q4 '24"", 'revenue': 63.49, 'unit': 'M', 'net_profit': 14.67}, {'period': ""Q3 '24"", 'revenue': 43.62, 'unit': 'M', 'net_profit': 13.07}, {'period': ""Q2 '24"", 'revenue': 72.94, 'unit': 'M', 'net_profit': 11.99}, {'period': ""Q1 '24"", 'revenue': 70.5, 'unit': 'M', 'net_profit': 13.27}, {'period': ""Q4 '23"", 'revenue': 59.8, 'unit': 'M', 'net_profit': 8.48}]",3.63,3.62,5805138000,656128000,792757000,5273907000,0,0,5133788000,214963000,55357000,0.1994325161334971,0.22176889565036997,0.21812080536912748,"[0.42, 0.35]","['2025-04-15', '1997-10-21']",__nan__,0.9084895139443714
306,CACC,Credit Acceptance Corporation Common Stock,"Credit Acceptance Corporation provides financing programs, and related products and services to independent and franchised automobile dealers in the United States. The company advances money to dealers in exchange for the right to service the underlying consumer loans; and buys the consumer loans from the dealers and keeps various amounts collected from the consumers. It is also involved in the business of reinsuring coverage under vehicle service contracts sold to consumers by dealers on vehicles financed by the company. The company was founded in 1972 and is headquartered in Southfield, Michigan.",Mr. Kenneth S. Booth,Financial - Credit Services,483.14,USD,5606114990,https://images.financialmodelingprep.com/symbol/CACC.png,100383,20.59,-12.9,94224,352900000,247900000,"[{'period': '2024', 'revenue': 2130.0, 'unit': 'M', 'net_profit': 247.9}, {'period': '2023', 'revenue': 1900.0, 'unit': 'M', 'net_profit': 286.1}, {'period': '2022', 'revenue': 1180.0, 'unit': 'M', 'net_profit': 535.8}, {'period': '2021', 'revenue': 1800.0, 'unit': 'M', 'net_profit': 958.3}]","[{'period': ""Q1 '25"", 'revenue': 562.3, 'unit': 'M', 'net_profit': 106.3}, {'period': ""Q4 '24"", 'revenue': 557.7, 'unit': 'M', 'net_profit': 151.9}, {'period': ""Q3 '24"", 'revenue': 543.6, 'unit': 'M', 'net_profit': 78.8}, {'period': ""Q2 '24"", 'revenue': 538.2, 'unit': 'M', 'net_profit': -47.1}, {'period': ""Q1 '24"", 'revenue': 508.0, 'unit': 'M', 'net_profit': 64.3}, {'period': ""Q4 '23"", 'revenue': 491.6, 'unit': 'M', 'net_profit': 93.6}]",20.12,19.88,8854600000,8708900000,951400000,7105000000,7850300000,0,433000000,845000000,1136100000,-0.0561647499331372,-0.13351974833974134,-0.08918062471706649,__nan__,__nan__,__nan__,0.8024077880423734
307,CAHC,CA Healthcare Acquisition Corp. Class A Common Stock,"CA Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more operating businesses. CA Healthcare Acquisition Corp. was founded in 2020 and is based in Boston, Massachusetts.",Mr. Larry J. Neiterman,Shell Companies,9.94,USD,0,https://images.financialmodelingprep.com/symbol/CAHC.png,243436,0,-0.03000069,1383727,,,[],"[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.37}]",,,150698,9498,9498,127961,0,0,127961,9498,,,,,__nan__,__nan__,__nan__,0.8491220852300628
308,CAHCU,CA Healthcare Acquisition Corp. Unit,,,,,,,,,,,,,,[],"[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.37}]",,,150698,9498,9498,127961,0,0,127961,9498,,,,,__nan__,__nan__,__nan__,0.8491220852300628
309,CAHCW,CA Healthcare Acquisition Corp. Warrant,"CA Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more operating businesses. CA Healthcare Acquisition Corp. was founded in 2020 and is based in Boston, Massachusetts.",Mr. Larry J. Neiterman,Shell Companies,1.31,USD,0,https://images.financialmodelingprep.com/symbol/CAHCW.png,0,0,0.07999992,67091,,,[],"[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.37}]",,,150698,9498,9498,127961,0,0,127961,9498,,,,,__nan__,__nan__,__nan__,0.8491220852300628
310,CAKE,Cheesecake Factory Incorporated (The) Common Stock,"The Cheesecake Factory Incorporated operates restaurants. It operates two bakeries that produces cheesecakes and other baked products for its restaurants, international licensees, third-party bakery customers, external foodservice operators, retailers, and distributors. The company owns and operates 306 restaurants throughout the United States and Canada under brands, including 208 The Cheesecake Factory and 29 North Italia; and a collection of Fox Restaurant Concepts, as well as 29 The Cheesecake Factory restaurants under licensing agreements internationally. The Cheesecake Factory Incorporated was founded in 1972 and is headquartered in Calabasas, California.",Mr. David M. Overton,Restaurants,52.52,USD,2601210560,https://images.financialmodelingprep.com/symbol/CAKE.png,1512442,16.46,-1.12,925096,282904000,156783000,"[{'period': '2024', 'revenue': 3580.0, 'unit': 'M', 'net_profit': 156.78}, {'period': '2023', 'revenue': 3440.0, 'unit': 'M', 'net_profit': 101.35}, {'period': '2022', 'revenue': 3300.0, 'unit': 'M', 'net_profit': 43.12}, {'period': '2021', 'revenue': 2930.0, 'unit': 'M', 'net_profit': 72.37}]","[{'period': ""Q1 '25"", 'revenue': 927.2, 'unit': 'M', 'net_profit': 32.94}, {'period': ""Q4 '24"", 'revenue': 920.96, 'unit': 'M', 'net_profit': 41.15}, {'period': ""Q3 '24"", 'revenue': 865.47, 'unit': 'M', 'net_profit': 29.99}, {'period': ""Q2 '24"", 'revenue': 904.04, 'unit': 'M', 'net_profit': 52.44}, {'period': ""Q1 '24"", 'revenue': 891.22, 'unit': 'M', 'net_profit': 33.19}, {'period': ""Q4 '23"", 'revenue': 877.01, 'unit': 'M', 'net_profit': 12.68}]",3.28,3.2,3041760000,333313000,84176000,2598305000,112503000,0,711420000,84176000,107961000,0.39428886851780665,0.546930962694004,0.5619047619047618,"[0.27, 0.12]","['2025-05-14', '2012-08-06']",__nan__,0.8542110488664457
311,CALA,Calithera Biosciences Inc. Common Stock,"Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginase inhibitor that has completed Phase 1b clinical trial for the treatment of cystic fibrosis and chronic airway infection; and ATG-037, an orally-bioavailable small molecule inhibitor of CD73, as well as CB-668, an orally administered inhibitor of the enzyme IL4I1. The company has a license agreement with Mars, Inc. to develop and commercialize Symbioscience's portfolio of arginase inhibitors for use in human healthcare. It also has clinical trial collaboration with Pfizer to evaluate Pfizer's PARP inhibitor talazoparib and CDK4/6 inhibitor palbociclib, each in combination with telaglenasta. In addition, the company has a collaboration and license agreement with Incyte Corporation for the research, development, and commercialization of INCB001158, a small molecule arginase inhibitor for the treatment of hematology and oncology; and a license agreement with Antengene Corporation Ltd. for the development and commercialization of CB-708. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.",Ms. Stephanie  Wong CPA,Biotechnology,0.0006,USD,2923,https://images.financialmodelingprep.com/symbol/CALA.png,5240,,0.0005,200,-38265000,-18866000,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -18.87}, {'period': '2021', 'revenue': 9.75, 'unit': 'M', 'net_profit': -165.34}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -88.52}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -86.35}]","[{'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.94}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.8}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.22}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.84}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -120.02}, {'period': ""Q3 '21"", 'revenue': 6.75, 'unit': 'M', 'net_profit': -11.17}]",-7.94,-7.94,28676000,26624000,25451000,8284000,0,0,7390000,25451000,-43741000,0.6685090052238095,0.8858943497562569,0.8226490953763682,__nan__,__nan__,__nan__,0.28888268935695355
312,CALB,California BanCorp Common Stock,"California BanCorp operates as the bank holding company for California Bank of Commerce that provides commercial banking services in California. It accepts various deposit products, including commercial checking, savings, and money market accounts, as well as certificates of deposit. The company also offers asset-based lending loans; standby letters of credit; construction and development loans; real estate loans, such as commercial real estate loans and other loans; small business administration (SBA) loans, including SBA 7(a) and SBA 504 loans; consumer loans, such as secured and unsecured installment loans, and revolving lines of credit; and commercial and industrial loans, including term loans, working capital, accounts receivable and inventory financing, and other business loans to the dental and veterinary industries, contractors, and emerging companies. In addition, it provides foreign exchange, treasury and cash management, and online and mobile banking services. The company has a full-service branch in California located in Contra Costa County, California; and 4 loan production offices in Alameda, Contra Costa, Sacramento, and Santa Clara. California BanCorp was incorporated in 2007 and is headquartered in Oakland, California.",Mr. Steven E. Shelton,Banks - Regional,25.09,USD,212563484,https://images.financialmodelingprep.com/symbol/CALB.png,53288,24.359223300970875,0.26,122789,945000,21633000,"[{'period': '2023', 'revenue': 114.08, 'unit': 'M', 'net_profit': 21.63}, {'period': '2022', 'revenue': 78.35, 'unit': 'M', 'net_profit': 21.11}, {'period': '2021', 'revenue': 58.9, 'unit': 'M', 'net_profit': 13.37}, {'period': '2020', 'revenue': 48.93, 'unit': 'M', 'net_profit': 4.3}]","[{'period': ""Q2 '24"", 'revenue': 28.27, 'unit': 'M', 'net_profit': -5.86}, {'period': ""Q1 '24"", 'revenue': 29.09, 'unit': 'M', 'net_profit': 3.82}, {'period': ""Q4 '23"", 'revenue': 29.74, 'unit': 'M', 'net_profit': 5.34}, {'period': ""Q3 '23"", 'revenue': 19.87, 'unit': 'M', 'net_profit': 5.4}, {'period': ""Q2 '23"", 'revenue': 19.78, 'unit': 'M', 'net_profit': 5.44}, {'period': ""Q1 '23"", 'revenue': 19.86, 'unit': 'M', 'net_profit': 5.45}]",2.58,2.56,1990383000,220219000,-27520000,1793922000,0,5000000,993471000,27520000,28070000,-0.9770697854993691,0.024872086412734508,0.015748031496063006,__nan__,__nan__,__nan__,0.901294876413233
313,CALM,Cal-Maine Foods Inc. Common Stock,"Cal-Maine Foods, Inc., together with its subsidiaries, produces, grades, packages, markets, and distributes shell eggs. The company offers specialty shell eggs, such as nutritionally enhanced, cage free, organic, and brown eggs under the Egg-Land's Best, Land O' Lakes, Farmhouse Eggs, and 4-Grain brand names, as well as under private labels. It sells its products to various customers, including national and regional grocery store chains, club stores, independent supermarkets, foodservice distributors, and egg product consumers primarily in the southwestern, southeastern, mid-western, and mid-Atlantic regions of the United States. Cal-Maine Foods, Inc. was founded in 1957 and is headquartered in Ridgeland, Mississippi.",Mr. Sherman L. Miller,Agricultural Farm Products,96.77,USD,4692774057,https://images.financialmodelingprep.com/symbol/CALM.png,1110491,4.78,0.41,683265,440761000,277888000,"[{'period': '2024', 'revenue': 2330.0, 'unit': 'M', 'net_profit': 277.89}, {'period': '2023', 'revenue': 3150.0, 'unit': 'M', 'net_profit': 758.02}, {'period': '2022', 'revenue': 1780.0, 'unit': 'M', 'net_profit': 132.65}, {'period': '2021', 'revenue': 1350.0, 'unit': 'M', 'net_profit': 2.06}]","[{'period': ""Q3 '25"", 'revenue': 1420.0, 'unit': 'M', 'net_profit': 508.53}, {'period': ""Q2 '25"", 'revenue': 954.67, 'unit': 'M', 'net_profit': 219.06}, {'period': ""Q1 '25"", 'revenue': 785.87, 'unit': 'M', 'net_profit': 149.98}, {'period': ""Q4 '24"", 'revenue': 640.79, 'unit': 'M', 'net_profit': 113.24}, {'period': ""Q3 '24"", 'revenue': 703.08, 'unit': 'M', 'net_profit': 146.71}, {'period': ""Q2 '24"", 'revenue': 523.23, 'unit': 'M', 'net_profit': 17.01}]",5.7,5.69,2184761000,1241839000,812377000,387718000,162442000,11195000,227743000,237878000,304282000,-0.5885994248469478,-0.6334047470792481,-0.6341463414634145,"[3.456, 0.04]","['2025-04-30', '1998-02-05']",__nan__,0.17746472039733407
314,CALT,Calliditas Therapeutics AB American Depositary Shares,"Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment of the autoimmune renal disease immunoglobulin A nephropathy. The company's lead product candidate is Setanaxib, a NOX inhibitor that is in Phase 2b/3 clinical trial for the treatment of primary biliary cholangitis; and in Phase 2 clinical trial for the treatment of squamous cell carcinoma of the head and neck cancer and idiopathic pulmonary fibrosis, as well as for type 1 diabetic kidney disease. It also develops Budenofalk 3 mg oral capsules for the treatment of autoimmune hepatitis. The company was incorporated in 2004 and is headquartered in Stockholm, Sweden.",Ms. Renee  Aguiar-Lucander,Biotechnology,40.0001,USD,2147483289,https://images.financialmodelingprep.com/symbol/CALT.png,7730,-22.727329545454545,-0.0399,9795,-367803000,-466185000,"[{'period': '2023', 'revenue': 1210.0, 'unit': 'M', 'net_profit': -466.19}, {'period': '2022', 'revenue': 802.88, 'unit': 'M', 'net_profit': -412.27}, {'period': '2021', 'revenue': 229.35, 'unit': 'M', 'net_profit': -509.54}, {'period': '2020', 'revenue': 0.874, 'unit': 'M', 'net_profit': -436.51}]","[{'period': ""Q2 '24"", 'revenue': 559.78, 'unit': 'M', 'net_profit': -47.48}, {'period': ""Q1 '24"", 'revenue': 295.48, 'unit': 'M', 'net_profit': -246.16}, {'period': ""Q4 '23"", 'revenue': 451.56, 'unit': 'M', 'net_profit': -18.37}, {'period': ""Q3 '23"", 'revenue': 294.59, 'unit': 'M', 'net_profit': -168.36}, {'period': ""Q2 '23"", 'revenue': 269.38, 'unit': 'M', 'net_profit': -91.93}, {'period': ""Q1 '23"", 'revenue': 191.35, 'unit': 'M', 'net_profit': -187.53}]",-17.38,-17.38,1900549000,1275152000,973733000,1565743000,188189000,24201000,407144000,973733000,-447442000,0.05404599078743985,-0.13078143343650248,-0.11696658097686366,__nan__,__nan__,__nan__,0.8238372175618729
315,CAMP,CalAmp Corp. Common Stock,"CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.",Mr. Joshua  Mandel-Brehm,Biotechnology,1.98,USD,39918927,https://images.financialmodelingprep.com/symbol/CAMP.png,259675,-0.77,-0.25,268440,-8721000,-93261000,"[{'period': '2024', 'revenue': 186.23, 'unit': 'M', 'net_profit': -93.26}, {'period': '2023', 'revenue': 294.95, 'unit': 'M', 'net_profit': -32.49}, {'period': '2022', 'revenue': 295.84, 'unit': 'M', 'net_profit': -31.15}, {'period': '2021', 'revenue': 308.59, 'unit': 'M', 'net_profit': -21.16}]","[{'period': ""Q3 '24"", 'revenue': 53.62, 'unit': 'M', 'net_profit': -85.0}, {'period': ""Q2 '24"", 'revenue': 61.71, 'unit': 'M', 'net_profit': -4.22}, {'period': ""Q1 '24"", 'revenue': 70.89, 'unit': 'M', 'net_profit': -4.03}, {'period': ""Q4 '23"", 'revenue': 78.51, 'unit': 'M', 'net_profit': -8.09}, {'period': ""Q3 '23"", 'revenue': 78.89, 'unit': 'M', 'net_profit': -4.73}, {'period': ""Q2 '23"", 'revenue': 72.83, 'unit': 'M', 'net_profit': -7.49}]",-2.52,-2.52,380120000,174795000,41928000,365813000,82946000,0,106500000,41928000,-34032000,-32.59782608695652,-1.8704524469067405,-1.8,__nan__,__nan__,__nan__,0.9623618857202989
316,CAMT,Camtek Ltd. Ordinary Shares,"Camtek Ltd., together with its subsidiaries, develops, manufactures, and sells inspection and metrology equipment for the advanced interconnect packaging, memory, complementary metal oxide semiconductor image sensors, micro-electro mechanical systems, radio frequency, and other segments of the semiconductor industry. It provides inspection and metrology systems, including Eagle-i, a system that delivers 2D inspection and metrology capabilities; Eagle-AP, which addresses the advanced packaging market using software and hardware technologies that deliver superior 2D and 3D inspection and metrology capabilities on the same platform; and Golden Eagle, a panel inspection and metrology system to support fanout wafer level packaging applications. The company sells its products in the Asia Pacific, the United States, and Europe. Camtek Ltd. was incorporated in 1987 and is headquartered in Migdal HaEmek, Israel.",Mr. Rafi  Amit,Semiconductors,64.71,USD,2950420095,https://images.financialmodelingprep.com/symbol/CAMT.png,448131,24.79,-1.07,328982,142998000,118515000,"[{'period': '2024', 'revenue': 429.23, 'unit': 'M', 'net_profit': 118.52}, {'period': '2023', 'revenue': 315.38, 'unit': 'M', 'net_profit': 78.63}, {'period': '2022', 'revenue': 320.91, 'unit': 'M', 'net_profit': 79.95}, {'period': '2021', 'revenue': 269.66, 'unit': 'M', 'net_profit': 60.28}]","[{'period': ""Q1 '25"", 'revenue': 118.64, 'unit': 'M', 'net_profit': 34.31}, {'period': ""Q4 '24"", 'revenue': 117.29, 'unit': 'M', 'net_profit': 33.01}, {'period': ""Q3 '24"", 'revenue': 112.34, 'unit': 'M', 'net_profit': 32.74}, {'period': ""Q2 '24"", 'revenue': 102.59, 'unit': 'M', 'net_profit': 27.96}, {'period': ""Q1 '24"", 'revenue': 97.01, 'unit': 'M', 'net_profit': 24.8}, {'period': ""Q4 '23"", 'revenue': 88.69, 'unit': 'M', 'net_profit': 20.79}]",2.62,2.42,892042000,620059000,388037000,342807000,114197000,113115000,123910000,126224000,112137000,0.4913490118370965,0.5072108047614203,0.4719101123595506,"[1.33, 0.14]","['2024-04-03', '2017-11-21']",__nan__,0.384294685676235
317,CAN,Canaan Inc. American Depositary Shares,"Canaan Inc. engages in the research, design, and sale of integrated circuits (IC), and lease of final mining equipment by integrating IC products for bitcoin mining and related components in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts; and distribution of artificial intelligence products, as well as mining business. The company has operations in the United States, Australia, Kazakhstan, Canada, Indonesia, Mainland China, Malaysia, Thailand, Cyprus, and internationally. Canaan Inc. was founded in 2013 and is headquartered in Singapore.",Mr. Nangeng  Zhang,Computer Hardware,0.6836,USD,196081025,https://images.financialmodelingprep.com/symbol/CAN.png,19482645,-0.66,-0.079,50534439,-143332000,-249752000,"[{'period': '2024', 'revenue': 269.32, 'unit': 'M', 'net_profit': -249.75}, {'period': '2023', 'revenue': 211.48, 'unit': 'M', 'net_profit': -414.15}, {'period': '2022', 'revenue': 656.32, 'unit': 'M', 'net_profit': 70.4}, {'period': '2021', 'revenue': 771.14, 'unit': 'M', 'net_profit': 308.44}]","[{'period': ""Q4 '24"", 'revenue': 88.77, 'unit': 'M', 'net_profit': -92.9}, {'period': ""Q3 '24"", 'revenue': 73.61, 'unit': 'M', 'net_profit': -75.58}, {'period': ""Q2 '24"", 'revenue': 71.86, 'unit': 'M', 'net_profit': -41.88}, {'period': ""Q1 '24"", 'revenue': 35.03, 'unit': 'M', 'net_profit': -39.33}, {'period': ""Q4 '23"", 'revenue': 104.53, 'unit': 'M', 'net_profit': -223.86}, {'period': ""Q3 '23"", 'revenue': 33.3, 'unit': 'M', 'net_profit': -80.05}]",-0.92,-0.92,463011000,334021000,96488000,196757000,114659000,2782000,178569000,96488000,-218566000,0.5658105987628517,0.3969571631739961,0.618464730252303,"[0.38, 0.38]","['2021-11-15', '2021-11-15']",__nan__,0.42495102708143
318,CAPA,HighCape Capital Acquisition Corp. Class A Common Stock,,,,,,,,,0,,,-263139,-263139,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -263.14}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -35.7}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -263.14}]",-0.08,-0.08,116186042,1183890,1034163,4171558,0,0,146558,1034163,,0,0,0,__nan__,__nan__,__nan__,0.03590412349187349
319,CAPAU,HighCape Capital Acquisition Corp. Unit,,,,,,,,,,,,-263139,-263139,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -263.14}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -35.7}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -212.89}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -50.25}]",-0.08,-0.08,116186042,1183890,1034163,4171558,0,0,146558,1034163,-268460,0,0,0,__nan__,__nan__,__nan__,0.03590412349187349
320,CAPAW,HighCape Capital Acquisition Corp. Warrant,,,,,,,,,,,,-263139,-263139,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -263.14}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -35.7}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -263.14}]",-0.08,-0.08,116186042,1183890,1034163,4171558,0,0,146558,1034163,,0,0,0,__nan__,__nan__,__nan__,0.03590412349187349
321,CAPR,Capricor Therapeutics Inc. Common Stock,"Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Phase II clinical trial for the treatment of cytokine storm associated with SARS-CoV-2. The company also develops CAP-2003 that is in pre-clinical development for the treatment of trauma related injuries and conditions; and two vaccine candidates, which are in development stage for the potential prevention of COVID-19. It collaborates with Lonza Houston, Inc. for the clinical manufacturing of CAP-1002, its cell therapy candidate for the treatment of DMD and other indications. The company was founded in 2005 and is headquartered in San Diego, California.",Dr. Linda  Marbán Ph.D.,Biotechnology,11.12,USD,508270736,https://images.financialmodelingprep.com/symbol/CAPR.png,2060632,-8.12,0.11,3107503,-41139628,-40467186,"[{'period': '2024', 'revenue': 22.27, 'unit': 'M', 'net_profit': -40.47}, {'period': '2023', 'revenue': 25.18, 'unit': 'M', 'net_profit': -22.29}, {'period': '2022', 'revenue': 2.55, 'unit': 'M', 'net_profit': -29.02}, {'period': '2021', 'revenue': 0.2449, 'unit': 'M', 'net_profit': -20.02}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -24.39}, {'period': ""Q4 '24"", 'revenue': 11.13, 'unit': 'M', 'net_profit': -7.12}, {'period': ""Q3 '24"", 'revenue': 2.26, 'unit': 'M', 'net_profit': -12.56}, {'period': ""Q2 '24"", 'revenue': 3.97, 'unit': 'M', 'net_profit': -11.0}, {'period': ""Q1 '24"", 'revenue': 4.91, 'unit': 'M', 'net_profit': -9.79}, {'period': ""Q4 '23"", 'revenue': 12090.0, 'unit': 'K', 'net_profit': -762.09}]",-1.15,-1.15,170481086,163385267,151515877,25018750,10368489,0,21026176,11286996,-41534717,-0.7879816212602585,-0.8156863596712459,-0.38554216867469876,__nan__,__nan__,__nan__,0.1467538164321642
322,CAR,Avis Budget Group Inc. Common Stock,"Avis Budget Group, Inc., together with its subsidiaries, provides car and truck rentals, car sharing, and ancillary products and services to businesses and consumers. It operates the Avis brand, that offers vehicle rental and other mobility solutions to the premium commercial and leisure segments of the travel industry; the Budget Truck brand, a local, and one-way truck and cargo van rental businesses with a fleet of approximately 20,000 vehicles, which are rented through a network of approximately 465 dealer-operated and 385 company-operated locations that serve the consumer and light commercial sectors in the continental United States; and the Zipcar brand, a car sharing network. The company also operates various other car rental brands, such as Budget, Payless, Apex, Maggiore, MoriniRent, FranceCars, Amicoblue, Turiscar, and ACL Hire. In addition, it offers optional insurance products and coverages, such as supplemental liability, personal accident, personal effects protection, emergency sickness protection, and automobile towing protection and cargo insurance products; fuel service options, roadside assistance services, electronic toll collection services, curbside delivery, tablet rentals, access to satellite radio, portable navigation units, and child safety seat rentals; automobile towing equipment and other moving accessories, such as hand trucks, furniture pads, and moving supplies; and Business Intelligence solution, an online portal for corporate travel. Avis Budget Group, Inc. operates in approximately 10,400 locations worldwide. The company was formerly known as Cendant Corporation and changed its name to Avis Budget Group, Inc. in September 2006. Avis Budget Group, Inc. was founded in 1946 and is headquartered in Parsippany, New Jersey.",Mr. Joseph A. Ferraro,Rental & Leasing Services,108.97,USD,3834894034,https://images.financialmodelingprep.com/symbol/CAR.png,1645004,-1.75,-3.03,1085434,1740000000,-1821000000,"[{'period': '2024', 'revenue': 11.79, 'unit': 'B', 'net_profit': -1.82}, {'period': '2023', 'revenue': 12.01, 'unit': 'B', 'net_profit': 1.63}, {'period': '2022', 'revenue': 11.99, 'unit': 'B', 'net_profit': 2.76}, {'period': '2021', 'revenue': 9.31, 'unit': 'B', 'net_profit': 1.28}]","[{'period': ""Q1 '25"", 'revenue': 2430.0, 'unit': 'M', 'net_profit': -505.0}, {'period': ""Q4 '24"", 'revenue': 2.66, 'unit': 'B', 'net_profit': -1.96}, {'period': ""Q3 '24"", 'revenue': 3480.0, 'unit': 'M', 'net_profit': 237.0}, {'period': ""Q2 '24"", 'revenue': 3050.0, 'unit': 'M', 'net_profit': 14.0}, {'period': ""Q1 '24"", 'revenue': 2550.0, 'unit': 'M', 'net_profit': -114.0}, {'period': ""Q4 '23"", 'revenue': 2760.0, 'unit': 'M', 'net_profit': 259.0}]",-51.23,-51.23,29041000000,2034000000,534000000,31358000000,1025000000,1408000000,2720000000,534000000,-6544000000,-0.6925795053003534,-2.1158088235294117,-2.202299929593992,"[10, 5]","['2023-12-14', '1989-06-07']",__nan__,1.0797837540029613
323,CARA,Cara Therapeutics Inc. Common Stock,"Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. Its product candidate includes Oral KORSUVA (difelikefalin), which has completed Phase II clinical trial to treat pruritus atopic dermatitis and pruritus non-dialysis-dependent chronic kidney disease (NDD-CKD) associated pruritus; and in Phase II clinical trial to treat pruritus chronic liver disease (CLD) primary biliary cholangitis (PBC) and notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.",Mr. Christopher A. Posner,Biotechnology,5.32,USD,8110553,https://images.financialmodelingprep.com/symbol/CARA.png,7889,-0.1141875939042713,-0.14,236845,-62600000,-70867000,"[{'period': '2024', 'revenue': 7.14, 'unit': 'M', 'net_profit': -70.87}, {'period': '2023', 'revenue': 20.97, 'unit': 'M', 'net_profit': -118.51}, {'period': '2022', 'revenue': 41.87, 'unit': 'M', 'net_profit': -83.41}, {'period': '2021', 'revenue': 23.03, 'unit': 'M', 'net_profit': -88.19}]","[{'period': ""Q1 '25"", 'revenue': 2.57, 'unit': 'M', 'net_profit': -4.91}, {'period': ""Q4 '24"", 'revenue': 1.46, 'unit': 'M', 'net_profit': -7.68}, {'period': ""Q3 '24"", 'revenue': 2.56, 'unit': 'M', 'net_profit': -12.48}, {'period': ""Q2 '24"", 'revenue': 0.991, 'unit': 'M', 'net_profit': -20.02}, {'period': ""Q1 '24"", 'revenue': 2.13, 'unit': 'M', 'net_profit': -30.7}, {'period': ""Q4 '23"", 'revenue': 3.0, 'unit': 'M', 'net_profit': -32.34}]",-1.55,-1.55,43827000,43827000,37903000,48420000,4495000,0,3972000,37903000,-61963000,0.4679133021674458,0.40203184460776453,0.2922374429223744,__nan__,__nan__,__nan__,1.1047984119378464
324,CARE,Carter Bankshares Inc. Common Stock,"Carter Bankshares, Inc. operates as the bank holding company for Carter Bank & Trust that provides various banking products and services. It accepts various deposit products, including checking, savings, retirement, and money market accounts, as well as longer-term certificates of deposits. The company also offers commercial loans comprising secured and unsecured loans; consumer loans, such as secured and unsecured loans for financing automobiles, home improvements, education, overdraft protection, and personal investments, as well as residential mortgages; real estate construction and acquisition loans; home equity lines of credit; and credit cards, as well as originates and holds fixed and variable rate mortgage loans. In addition, it provides other banking services that include safe deposit boxes, direct deposit of payroll and social security checks, online banking, bill pay, online account opening, mobile deposit, mobile banking, debit cards, e-statements, and ATM services; title insurance and other financial institution-related products and services; and treasury and corporate cash management services. It operates through 69 branches in Virginia and North Carolina. Carter Bankshares, Inc. was founded in 1974 and is headquartered in Martinsville, Virginia.",Mr. Litz H. Van Dyke,Banks - Regional,15.86,USD,367301740,https://images.financialmodelingprep.com/symbol/CARE.png,65726,13.22,-0.13,65149,0,24523000,"[{'period': '2024', 'revenue': 132.4, 'unit': 'M', 'net_profit': 24.52}, {'period': '2023', 'revenue': 136.61, 'unit': 'M', 'net_profit': 23.38}, {'period': '2022', 'revenue': 0.073, 'unit': 'M', 'net_profit': 50.12}, {'period': '2021', 'revenue': 133.66, 'unit': 'M', 'net_profit': 31.59}]","[{'period': ""Q1 '25"", 'revenue': 62.91, 'unit': 'M', 'net_profit': 8.95}, {'period': ""Q4 '24"", 'revenue': 33.55, 'unit': 'M', 'net_profit': 8.28}, {'period': ""Q3 '24"", 'revenue': 33.33, 'unit': 'M', 'net_profit': 5.63}, {'period': ""Q2 '24"", 'revenue': 60.12, 'unit': 'M', 'net_profit': 4.8}, {'period': ""Q1 '24"", 'revenue': 59.09, 'unit': 'M', 'net_profit': 5.81}, {'period': ""Q4 '23"", 'revenue': 55.11, 'unit': 'M', 'net_profit': -1.89}]",1.06,1.06,4659189000,849571000,849571000,4274876000,0,601541000,3418870000,131171000,28805000,0,0.0487085186452275,0.06000000000000005,"[0.14, 0.1]","['2020-02-14', '2007-08-07']",__nan__,0.9175150439271728
325,CARG,CarGurus Inc. Class A Common Stock ,"CarGurus, Inc. operates an online automotive marketplace connecting buyers and sellers of new and used cars in the United States and internationally. The company provides consumers an online automotive marketplace where they can search for new and used car listings from its dealers, as well as sell their car in the United States marketplace. Its marketplace connects dealers to a large audience of informed and engaged consumers. The company operates online marketplaces under the CarGurus brand in Canada and the United Kingdom; and the Autolist and PistonHeads online marketplaces as independent brands in the United States and the United Kingdom. CarGurus, Inc. was founded in 2005 and is headquartered in Cambridge, Massachusetts.",Mr. Jason M. Trevisan,Internet Content & Information,31.56,USD,3119599453,https://images.financialmodelingprep.com/symbol/CARG.png,1330090,85.3,-0.91,690150,173273000,20972000,"[{'period': '2024', 'revenue': 894.38, 'unit': 'M', 'net_profit': 20.97}, {'period': '2023', 'revenue': 914.24, 'unit': 'M', 'net_profit': 31.1}, {'period': '2022', 'revenue': 1660.0, 'unit': 'M', 'net_profit': 84.39}, {'period': '2021', 'revenue': 951.37, 'unit': 'M', 'net_profit': 109.24}]","[{'period': ""Q1 '25"", 'revenue': 225.16, 'unit': 'M', 'net_profit': 39.05}, {'period': ""Q4 '24"", 'revenue': 228.54, 'unit': 'M', 'net_profit': 45.88}, {'period': ""Q3 '24"", 'revenue': 231.36, 'unit': 'M', 'net_profit': 22.51}, {'period': ""Q2 '24"", 'revenue': 218.69, 'unit': 'M', 'net_profit': -68.72}, {'period': ""Q1 '24"", 'revenue': 215.8, 'unit': 'M', 'net_profit': 21.3}, {'period': ""Q4 '23"", 'revenue': 223.12, 'unit': 'M', 'net_profit': -17.91}]",0.2,0.2,824536000,391206000,304193000,282847000,44248000,0,93051000,304193000,180321000,1.1365087976720385,-0.32574588477366256,0.05263157894736847,__nan__,__nan__,__nan__,0.3430377812490904
326,CARV,Carver Bancorp Inc. Common Stock,"Carver Bancorp, Inc. operates as the holding company for Carver Federal Savings Bank that provides consumer and commercial banking services for consumers, businesses, non-profit organizations, and governmental and quasi-governmental agencies primarily in New York. It accepts various deposit products, including demand, savings, and time deposits; passbook and statement accounts, and certificates of deposit; and individual retirement accounts. The company also provides lending products, such as one-to-four family residential, multifamily real estate, and commercial real estate lending; and construction, business and small business administration, and consumer and other loans. In addition, it offers other consumer and commercial banking products and services, including debit cards, online account opening and banking, online bill pay, and telephone banking, as well as check cashing, wire transfer, bill payment, reloadable prepaid card, and money order services. The company operates through one administrative office, seven branches, and four ATMs. Carver Bancorp, Inc. was founded in 1948 and is headquartered in New York, New York.",Mr. Donald  Felix,Banks - Regional,1.48,USD,7562400,https://images.financialmodelingprep.com/symbol/CARV.png,13637,-0.77,0.06,54572,0,-2977000,"[{'period': '2024', 'revenue': 29.2, 'unit': 'M', 'net_profit': -2.98}, {'period': '2023', 'revenue': 26.38, 'unit': 'M', 'net_profit': -3.34}, {'period': '2022', 'revenue': 27.82, 'unit': 'M', 'net_profit': -3.25}, {'period': '2021', 'revenue': 22.09, 'unit': 'M', 'net_profit': -3.9}]","[{'period': ""Q3 '25"", 'revenue': 3.79, 'unit': 'M', 'net_profit': -5.65}, {'period': ""Q2 '25"", 'revenue': 6.58, 'unit': 'M', 'net_profit': -2.11}, {'period': ""Q1 '25"", 'revenue': 6.21, 'unit': 'M', 'net_profit': -2.21}, {'period': ""Q4 '24"", 'revenue': 10660.0, 'unit': 'K', 'net_profit': 11.0}, {'period': ""Q3 '24"", 'revenue': 9610.0, 'unit': 'K', 'net_profit': 15.0}, {'period': ""Q2 '24"", 'revenue': 8.01, 'unit': 'M', 'net_profit': -1.59}]",-0.61,-0.61,756796000,62739000,59025000,714487000,0,0,458706000,59025000,-6931000,0,0.1094825007478313,0.21794871794871798,"[0.025, 0.05]","['2010-08-25', '1997-07-10']",__nan__,0.944094577666901
327,CASA,Casa Systems Inc. Common Stock,"Casa Systems, Inc., a communications technology company, provides solutions for next-generation physical, virtualized, and cloud native architectures for cable broadband, fixed-line broadband, and wireless networks in North America, Latin America, the Asia-Pacific, Europe, the Middle East, and Africa. It offers converged cable access platforms; wireless network core products, such as virtual evolved packet and 5G core products, as well as small cell solutions, axyom element management system, and fixed wireless access devices; and virtual, centralized, and distributed deployment, and bandwidth capacity expansion systems. The company also provides optical access solutions, virtualized broadband network gateway router and multiservice router, fiber extension, and residential broadband gateways; and machine-to-machine and industrial internet of things routers. The company was incorporated in 2003 and is headquartered in Andover, Massachusetts.",Mr. Michael  Glickman,Communication Equipment,0.035,USD,3468815,https://images.financialmodelingprep.com/symbol/CASA.png,1322293,-0.03211009174311927,-0.02,28327484,-52055000,-79205000,"[{'period': '2022', 'revenue': 286.54, 'unit': 'M', 'net_profit': -79.2}, {'period': '2021', 'revenue': 401.32, 'unit': 'M', 'net_profit': 3.21}, {'period': '2020', 'revenue': 393.25, 'unit': 'M', 'net_profit': 24.8}, {'period': '2019', 'revenue': 282.3, 'unit': 'M', 'net_profit': -48.21}]","[{'period': ""Q3 '23"", 'revenue': 62.09, 'unit': 'M', 'net_profit': -25.62}, {'period': ""Q2 '23"", 'revenue': 58.0, 'unit': 'M', 'net_profit': -51.14}, {'period': ""Q1 '23"", 'revenue': 45.3, 'unit': 'M', 'net_profit': -31.66}, {'period': ""Q4 '22"", 'revenue': 84.4, 'unit': 'M', 'net_profit': 1.24}, {'period': ""Q3 '22"", 'revenue': 66.9, 'unit': 'M', 'net_profit': -31.16}, {'period': ""Q2 '22"", 'revenue': 70.84, 'unit': 'M', 'net_profit': -16.7}]",-0.86,-0.86,398294000,291779000,126312000,348893000,74484000,3113000,323912000,126312000,-13053000,-2.4361980962891434,-25.697536638603054,-23.872340425531913,__nan__,__nan__,__nan__,0.8759685056767111
328,CASH,Meta Financial Group Inc. Common Stock,"Pathward Financial, Inc. operates as the holding company for Pathward, National Association that provides various banking products and services in the United States. It operates through three segments: Consumer, Commercial, and Corporate Services/Other. The company offers demand deposit accounts, savings accounts, money market savings accounts, and certificate accounts. It also provides commercial finance product comprising term lending, asset based lending, factoring, lease financing, insurance premium finance, government guaranteed lending, and other commercial finance products; consumer credit products; other consumer financing services; short-term taxpayer advance loans; and warehouse financing services. In addition, the company issues prepaid cards and consumer credit products; sponsors merchant acquiring and automated teller machines (ATMs) in various debit networks; and offers tax refund-transfer services, and other payment industry products and services. The company was formerly known as Meta Financial Group, Inc. and changed its name to Pathward Financial, Inc. in July 2022. Pathward Financial, Inc. was founded in 1954 and is headquartered in Sioux Falls, South Dakota.",Mr. Brett L. Pharr,Banks - Regional,78.17,USD,1864002735,https://images.financialmodelingprep.com/symbol/CASH.png,221822,10.58,-2.54,88639,0,168357000,"[{'period': '2024', 'revenue': 299.59, 'unit': 'M', 'net_profit': 168.36}, {'period': '2023', 'revenue': 577.38, 'unit': 'M', 'net_profit': 163.62}, {'period': '2022', 'revenue': 501.28, 'unit': 'M', 'net_profit': 156.39}, {'period': '2021', 'revenue': 508.27, 'unit': 'M', 'net_profit': 141.71}]","[{'period': ""Q2 '25"", 'revenue': 269.95, 'unit': 'M', 'net_profit': 74.0}, {'period': ""Q1 '25"", 'revenue': 57.38, 'unit': 'M', 'net_profit': 31.43}, {'period': ""Q4 '24"", 'revenue': 171.76, 'unit': 'M', 'net_profit': 33.6}, {'period': ""Q3 '24"", 'revenue': 179.81, 'unit': 'M', 'net_profit': 41.84}, {'period': ""Q2 '24"", 'revenue': 212.55, 'unit': 'M', 'net_profit': 65.27}, {'period': ""Q1 '24"", 'revenue': 127.99, 'unit': 'M', 'net_profit': 27.66}]",6.63,6.62,7549336000,189722000,1899558000,6709731000,0,724884000,377000000,158337000,176783000,-1,0.02898267273782966,0.1031613976705491,"[0.05, 0.075]","['2025-03-13', '1994-12-09']",__nan__,0.8887842586420845
329,CASI,CASI Pharmaceuticals Inc. Common Stock,"CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T investigative product for the treatment of patients with B-cell acute lymphoblastic leukemia (B-ALL) and B-cell non-Hodgkin lymphoma (B-NHL); BI-1206 that is in Phase I/II trial in combination with anti-PD1 therapy Keytruda for solid tumors, and in a Phase I/IIa trial in combination with MabThera (rituximab) in patients with relapsed/refractory NHL; and CB-5339, which is in Phase I clinical trial for acute myeloid leukemia and myelodysplastic syndrome. Its product pipeline also comprises CID-103 for the treatment of patients with multiple myeloma; Thiotepa, which has multiple indications including use as a conditioning treatment for various allogeneic haemopoietic stem cell transplants; and Octreotide long acting injectable formulations for the treatment of acromegaly and for the control of symptoms associated with various neuroendocrine tumors. The company has licensing agreements with Juventas Cell Therapy Ltd; BioInvent International AB; Black Belt Therapeutics Limited; and Cleave Therapeutics, Inc. It also has distribution agreements with China Resources Pharmaceutical Commercial Group International Trading Co., Ltd; Pharmathen Global BV; and Riemser Pharma GmbH. The company was formerly known as EntreMed, Inc. and changed its name to CASI Pharmaceuticals, Inc. in June 2014. CASI Pharmaceuticals, Inc. was incorporated in 1991 and is based in Rockville, Maryland.",Dr. Wei-Wu  He Ph.D.,Biotechnology,1.92,USD,29745984,https://images.financialmodelingprep.com/symbol/CASI.png,9290,-0.75,0.05,12824,-34867000,-39258000,"[{'period': '2024', 'revenue': 28.54, 'unit': 'M', 'net_profit': -39.26}, {'period': '2023', 'revenue': 33.88, 'unit': 'M', 'net_profit': -26.94}, {'period': '2022', 'revenue': 43.11, 'unit': 'M', 'net_profit': -39.41}, {'period': '2021', 'revenue': 30.17, 'unit': 'M', 'net_profit': -37.77}]","[{'period': ""Q4 '24"", 'revenue': 13.36, 'unit': 'M', 'net_profit': -14.37}, {'period': ""Q3 '24"", 'revenue': 7.79, 'unit': 'M', 'net_profit': -8.39}, {'period': ""Q2 '24"", 'revenue': 3.98, 'unit': 'M', 'net_profit': -6.96}, {'period': ""Q1 '24"", 'revenue': 3.41, 'unit': 'M', 'net_profit': -9.53}, {'period': ""Q4 '23"", 'revenue': 6.09, 'unit': 'M', 'net_profit': -5.46}, {'period': ""Q3 '23"", 'revenue': 8.84, 'unit': 'M', 'net_profit': -4.63}]",-2.56,-2.56,53674000,39576000,16091000,51823000,15345000,1716000,36452000,13468000,-29464000,-0.6187845303867403,-0.45734649936892124,-0.26732673267326734,__nan__,__nan__,__nan__,0.9655140291388754
330,CASS,Cass Information Systems Inc Common Stock,"Cass Information Systems, Inc. provides payment and information processing services to manufacturing, distribution, and retail enterprises in the United States. It operates through two segments, Information Services and Banking Services. The company's services include freight invoice rating, payment processing, auditing, and the generation of accounting and transportation information. It also processes and pays facility-related invoices, such as electricity, gas, waste, and telecommunications expenses; and provides telecom expense management solutions. In addition, the company, through its banking subsidiary, Cass Commercial Bank, provides a range of banking products and services, such as checking, savings, and time deposit accounts; commercial, industrial, and real estate loans; and cash management services to privately-owned businesses and faith-related ministries. Further, it provides B2B payment platform for clients that require an agile fintech partner. It operates through its banking facility near downtown St. Louis, Missouri; operating branch in the Bridgeton, Missouri; and leased facilities in Fenton, Missouri and Colorado Springs, Colorado. The company was formerly known as Cass Commercial Corporation and changed its name to Cass Information Systems, Inc. in January 2001. Cass Information Systems, Inc. was founded in 1906 and is headquartered in St. Louis, Missouri.",Mr. Martin H. Resch,Specialty Business Services,42.67,USD,570071200,https://images.financialmodelingprep.com/symbol/CASS.png,47160,28.26,-0.25,63578,30207000,19168000,"[{'period': '2024', 'revenue': 219.89, 'unit': 'M', 'net_profit': 19.17}, {'period': '2023', 'revenue': 213.23, 'unit': 'M', 'net_profit': 30.06}, {'period': '2022', 'revenue': 183.83, 'unit': 'M', 'net_profit': 34.9}, {'period': '2021', 'revenue': 146.6, 'unit': 'M', 'net_profit': 28.6}]","[{'period': ""Q1 '25"", 'revenue': 47.31, 'unit': 'M', 'net_profit': 8.97}, {'period': ""Q4 '24"", 'revenue': 50.37, 'unit': 'M', 'net_profit': 4.59}, {'period': ""Q3 '24"", 'revenue': 55.57, 'unit': 'M', 'net_profit': 2.94}, {'period': ""Q2 '24"", 'revenue': 54.3, 'unit': 'M', 'net_profit': 4.48}, {'period': ""Q1 '24"", 'revenue': 54.95, 'unit': 'M', 'net_profit': 7.15}, {'period': ""Q4 '23"", 'revenue': 50.52, 'unit': 'M', 'net_profit': 8.41}]",1.42,1.39,2395081000,405634000,349728000,2166051000,55906000,725642000,1149276000,19328000,29620000,-0.28825899483989537,-0.36232076915399714,-0.36036036036036045,"[0.31, 0.0638]","['2025-06-03', '1996-09-03']",__nan__,0.9043748416024343
331,CASY,Casey's General Stores Inc. Common Stock,"Casey's General Stores, Inc., together with its subsidiaries, operates convenience stores under the Casey's and Casey's General Store names. Its stores offer a selection of food, including freshly prepared foods, such as pizza, donuts, and sandwiches; beverages; tobacco and nicotine products; health and beauty aids; automotive products; and other nonfood items. The company's stores also provide motor fuel for sale on a self-service basis; and gasoline and diesel fuel. In addition, its stores offer various products, include soft drinks, energy, water, sports drinks, juices, coffee, and tea and dairy products; beer, wine, and spirits; snacks, candy, packaged bakery, and other food items; ice, ice cream, meals, and appetizers; health and beauty aids, electronic accessories, housewares, and pet supplies; and lotto/lottery and prepaid cards. Further, the company operates two stores that sells tobacco and nicotine products; one liquor store; and one grocery store. As of April 30, 2022, it operated 2,452 convenience stores. Casey's General Stores, Inc. was founded in 1959 and is headquartered in Ankeny, Iowa.",Mr. Darren M. Rebelez,Specialty Retail,450.43,USD,16719511170,https://images.financialmodelingprep.com/symbol/CASY.png,392691,31.37,-8.21,322384,1059398000,501972000,"[{'period': '2024', 'revenue': 14860.0, 'unit': 'M', 'net_profit': 501.97}, {'period': '2023', 'revenue': 15090.0, 'unit': 'M', 'net_profit': 446.69}, {'period': '2022', 'revenue': 12950.0, 'unit': 'M', 'net_profit': 339.79}, {'period': '2021', 'revenue': 8710.0, 'unit': 'M', 'net_profit': 312.9}]","[{'period': ""Q3 '25"", 'revenue': 3900.0, 'unit': 'M', 'net_profit': 87.1}, {'period': ""Q2 '25"", 'revenue': 3950.0, 'unit': 'M', 'net_profit': 180.92}, {'period': ""Q1 '25"", 'revenue': 4100.0, 'unit': 'M', 'net_profit': 180.2}, {'period': ""Q4 '24"", 'revenue': 3600.0, 'unit': 'M', 'net_profit': 87.02}, {'period': ""Q3 '24"", 'revenue': 3330.0, 'unit': 'M', 'net_profit': 86.93}, {'period': ""Q2 '24"", 'revenue': 4059.9999999999995, 'unit': 'M', 'net_profit': 158.78}]",13.51,13.43,6347433000,829854000,206482000,3332052000,168859000,0,953466000,206482000,370949000,0.11227090997665004,0.12375669086684084,0.12677231025854876,"[0.5, 0.025]","['2025-05-01', '1990-07-26']",__nan__,0.5249448083973474
332,CATB,Catabasis Pharmaceuticals Inc. Common Stock,"Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics in the United States. Its lead product candidate is edasalonexent, an oral small molecule that inhibits nuclear factor kappa-light-chain-enhancer of activated B cells, which is in Phase III clinical trial for the treatment of duchenne muscular dystrophy (DMD). The company is also developing CAT-5571 for the treatment of cystic fibrosis. Catabasis Pharmaceuticals, Inc. has a preclinical research collaboration with the Jain Foundation to study edasalonexent in dysferlinopathy; and an agreement with the Bill & Melinda Gates Medical Research Institute to study CAT-5571 in drug-sensitive and drug-resistant tuberculosis. The company was founded in 2008 and is based in Boston, Massachusetts.",Dr. Jill Milne,Biotechnology,8.54,USD,234861102,https://images.financialmodelingprep.com/symbol/CATB.png,528916,0,-0.64000034,98872,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
333,CATC,Cambridge Bancorp Common Stock,"Cambridge Bancorp operates as the bank holding company for Cambridge Trust Company that provides commercial and consumer banking, and investment management and trust services. The company accepts various deposits, such as checking, savings, money market, trust, and individual retirement accounts; and time and demand deposits, and certificates of deposit. Its loan products include residential and commercial real estate loans; home equity lines of credit and term loans; commercial and industrial loans; secured and unsecured loans, lines of credit, and personal installment loans; and construction loans. The company also offers cash management, online and mobile banking, and payments services. It serves commercial enterprises, non-profit organizations, and individuals. The company operates through a network of 19 banking offices in Eastern Massachusetts and New Hampshire; and two wealth management offices located in Massachusetts, as well as three wealth management offices located in New Hampshire. Cambridge Bancorp was founded in 1890 and is headquartered in Cambridge, Massachusetts.",Mr. Denis K. Sheahan,Banks - Regional,220,USD,0,https://images.financialmodelingprep.com/symbol/CATC.png,3,60.60606060606061,0,0,46409000,34109000,"[{'period': '2023', 'revenue': 161.63, 'unit': 'M', 'net_profit': 34.11}, {'period': '2022', 'revenue': 186.22, 'unit': 'M', 'net_profit': 52.91}, {'period': '2021', 'revenue': 172.31, 'unit': 'M', 'net_profit': 54.02}, {'period': '2020', 'revenue': 159.76, 'unit': 'M', 'net_profit': 31.96}]","[{'period': ""Q1 '24"", 'revenue': 37.51, 'unit': 'M', 'net_profit': 6.89}, {'period': ""Q4 '23"", 'revenue': 56.95, 'unit': 'M', 'net_profit': 8.03}, {'period': ""Q3 '23"", 'revenue': 55.7, 'unit': 'M', 'net_profit': 6.54}, {'period': ""Q2 '23"", 'revenue': 39.79, 'unit': 'M', 'net_profit': 7.12}, {'period': ""Q1 '23"", 'revenue': 44.96, 'unit': 'M', 'net_profit': 12.42}, {'period': ""Q4 '22"", 'revenue': 50.95, 'unit': 'M', 'net_profit': 11.32}]",4.36,4.35,5417666000,48769000,32504000,4897716000,15765000,1097170000,2678118000,32504000,31718000,-0.4770168696965258,-0.3553270710087131,-0.4068027210884353,"[0.67, 0.5]","['2024-05-08', '2001-02-28']",__nan__,0.9040269370610887
334,CATM,Cardtronics plc Class A Ordinary Shares (UK),"Cardtronics plc provides automated consumer financial services through its network of automated teller machines (ATMs) and multi-function financial services kiosks. The company offers cash dispensing and balance inquiries; and financial related services to cardholders, as well as ATM management and ATM equipment-related services to large retail merchants, smaller retailers, financial institutions, and operators of facilities, such as shopping malls, airports, train stations, and casinos. It also provides transaction processing, cash and cash delivery management, supply, and telecommunications, as well as routine and technical maintenance services for ATMs; and owns and operates electronic funds transfer transaction processing platforms that offer transaction processing services to its network of ATMS, as well as other ATMs under managed services arrangements. In addition, the company provides processing services for issuers of debit cards; and owns and operates Allpoint network, a surcharge-free ATM network, which offers surcharge-free ATM access to participating banks, credit unions, digital banks, financial technology companies, and stored-value debit card issuers. As of April 1, 2020, it provided services to approximately 285,000 ATMs in North America, Europe, the Asia-Pacific, and Africa. The company was founded in 1989 and is based in Houston, Texas.",Mr. Edward West,Business Equipment & Supplies,39.01,USD,0,https://images.financialmodelingprep.com/symbol/CATM.png,475200,0,0,460335,221777000,19144000,"[{'period': '2020', 'revenue': 1090.0, 'unit': 'M', 'net_profit': 19.14}, {'period': '2019', 'revenue': 1350.0, 'unit': 'M', 'net_profit': 48.27}, {'period': '2018', 'revenue': 1350.0, 'unit': 'M', 'net_profit': 3.68}, {'period': '2017', 'revenue': 1510.0, 'unit': 'M', 'net_profit': -145.35}]","[{'period': ""Q1 '21"", 'revenue': 267.83, 'unit': 'M', 'net_profit': 5.88}, {'period': ""Q4 '20"", 'revenue': 274.81, 'unit': 'M', 'net_profit': 9.58}, {'period': ""Q3 '20"", 'revenue': 279.4, 'unit': 'M', 'net_profit': 5.73}, {'period': ""Q2 '20"", 'revenue': 233.19, 'unit': 'M', 'net_profit': -1.92}, {'period': ""Q1 '20"", 'revenue': 306.6, 'unit': 'M', 'net_profit': 5.75}, {'period': ""Q4 '19"", 'revenue': 338.81, 'unit': 'M', 'net_profit': 12.62}]",0.42,0.42,1831445000,462013000,174242000,1452029000,89867000,0,475985000,174242000,191207000,-0.1826510943955303,-0.6034304180304098,-0.6000000000000001,__nan__,__nan__,__nan__,0.7928324355904763
335,CATY,Cathay General Bancorp Common Stock,"Cathay General Bancorp operates as the holding company for Cathay Bank that offers various commercial banking products and services to individuals, professionals, and small to medium-sized businesses in the United States. The company offers various deposit products, including passbook accounts, checking accounts, money market deposit accounts, certificates of deposit, individual retirement accounts, and public funds deposits. It also provides loan products, such as commercial mortgage loans, commercial loans, small business administration loans, residential mortgage loans, real estate construction loans, and home equity lines of credit, as well as installment loans to individuals for household, and other consumer expenditures. In addition, the company offers trade financing, letter of credit, wire transfer, forward currency spot and forward contract, traveler's check, safe deposit, night deposit, social security payment deposit, collection, bank-by-mail, drive-up and walk-up window, automatic teller machine, Internet banking, investment, and other customary bank services, as well as securities and insurance products. As of March 1, 2022, it operated 31 branches in Southern California, 16 branches in Northern California, 10 branches in New York, four branches in Washington, two branches in Illinois, and two branches in Texas, as well as one branch each in Maryland, Massachusetts, Nevada, and New Jersey, and Hong Kong; and a representative office each in Beijing, Taipei, and Shanghai. The company was founded in 1962 and is headquartered in Los Angeles, California.",Mr. Chang Ming Liu,Banks - Regional,43.69,USD,3063123376,https://images.financialmodelingprep.com/symbol/CATY.png,472734,11.06,-0.88,595469,0,285979000,"[{'period': '2024', 'revenue': 729.72, 'unit': 'M', 'net_profit': 285.98}, {'period': '2023', 'revenue': 784.06, 'unit': 'M', 'net_profit': 354.12}, {'period': '2022', 'revenue': 790.51, 'unit': 'M', 'net_profit': 360.64}, {'period': '2021', 'revenue': 652.36, 'unit': 'M', 'net_profit': 298.3}]","[{'period': ""Q1 '25"", 'revenue': 334.55, 'unit': 'M', 'net_profit': 69.51}, {'period': ""Q4 '24"", 'revenue': 186.49, 'unit': 'M', 'net_profit': 80.2}, {'period': ""Q3 '24"", 'revenue': 189.52, 'unit': 'M', 'net_profit': 67.51}, {'period': ""Q2 '24"", 'revenue': 344.59, 'unit': 'M', 'net_profit': 66.83}, {'period': ""Q1 '24"", 'revenue': 339.0, 'unit': 'M', 'net_profit': 71.44}, {'period': ""Q4 '23"", 'revenue': 356.17, 'unit': 'M', 'net_profit': 82.53}]",3.97,3.95,23054681000,1802074000,1704295000,20208977000,97779000,17740000,18428339000,157167000,325519000,0,-0.19243259423252873,-0.1864754098360655,"[0.34, 0.601]","['2025-05-29', '1991-01-07']",__nan__,0.8765671925801098
336,CBAN,Colony Bankcorp Inc. Common Stock,"Colony Bankcorp, Inc. operates as the bank holding company for Colony Bank that provides various banking products and services to commercial and consumer customers. The company offers various deposit products, including demand, savings, and time deposits. It also provides loans to small and medium-sized businesses; residential and commercial construction, and land development loans; commercial real estate loans; commercial loans; agri-business and production loans; residential mortgage loans; home equity loans; and consumer loans. In addition, the company offers internet banking services, electronic bill payment services, safe deposit box rentals, telephone banking, credit and debit card services, and remote depository products, as well as access to a network of ATMs. As of January 20, 2022, it operated 39 locations throughout Georgia. The company was founded in 1975 and is headquartered in Fitzgerald, Georgia.",Mr. T. Heath Fountain CPA,Banks - Regional,15.39,USD,268453926,https://images.financialmodelingprep.com/symbol/CBAN.png,71319,10.69,-0.34,39476,37697000,23868000,"[{'period': '2024', 'revenue': 176.62, 'unit': 'M', 'net_profit': 23.87}, {'period': '2023', 'revenue': 113.88, 'unit': 'M', 'net_profit': 21.75}, {'period': '2022', 'revenue': 112.33, 'unit': 'M', 'net_profit': 19.54}, {'period': '2021', 'revenue': 102.48, 'unit': 'M', 'net_profit': 18.66}]","[{'period': ""Q1 '25"", 'revenue': 44.57, 'unit': 'M', 'net_profit': 6.61}, {'period': ""Q4 '24"", 'revenue': 46.3, 'unit': 'M', 'net_profit': 7.43}, {'period': ""Q3 '24"", 'revenue': 28.62, 'unit': 'M', 'net_profit': 5.63}, {'period': ""Q2 '24"", 'revenue': 27.91, 'unit': 'M', 'net_profit': 5.47}, {'period': ""Q1 '24"", 'revenue': 27.14, 'unit': 'M', 'net_profit': 5.33}, {'period': ""Q4 '23"", 'revenue': 26.68, 'unit': 'M', 'net_profit': 5.6}]",1.36,1.36,3109782000,392094000,392094000,2831107000,0,0,2567943000,26045000,22321000,0.21161572333108347,0.09753069388881225,0.09677419354838718,"[0.115, 0.1719]","['2025-05-07', '1998-06-26']",__nan__,0.9103876091636005
337,CBAT,CBAK Energy Technology Inc. Common Stock,"CBAK Energy Technology, Inc., together with its subsidiaries, develops, manufactures, and sells lithium batteries in Mainland China, the United States, Korea, Europe, and internationally. Its products are used in various applications, including electric vehicles, such as electric cars, electric buses, and hybrid electric cars and buses; light electric vehicles that include electric bicycles, electric motors, and sight-seeing cars; and electric tools, energy storage, uninterruptible power supply, and other high power applications, as well as cordless power tools. The company was formerly known as China BAK Battery, Inc. and changed its name to CBAK Energy Technology, Inc. in January 2017. CBAK Energy Technology, Inc. was incorporated in 1999 and is based in Dalian, China.",Mr. Zhiguang  Hu,Electrical Equipment & Parts,0.856,USD,76988383,https://images.financialmodelingprep.com/symbol/CBAT.png,170986,6.58,0.0263,221260,20587199,11790032,"[{'period': '2024', 'revenue': 176.61, 'unit': 'M', 'net_profit': 11.79}, {'period': '2023', 'revenue': 204.44, 'unit': 'M', 'net_profit': -2.45}, {'period': '2022', 'revenue': 248.73, 'unit': 'M', 'net_profit': -11.33}, {'period': '2021', 'revenue': 52.67, 'unit': 'M', 'net_profit': 61.49}]","[{'period': ""Q4 '24"", 'revenue': 25.37, 'unit': 'M', 'net_profit': -4.51}, {'period': ""Q3 '24"", 'revenue': 44630.0, 'unit': 'K', 'net_profit': 17.65}, {'period': ""Q2 '24"", 'revenue': 47.79, 'unit': 'M', 'net_profit': 6.45}, {'period': ""Q1 '24"", 'revenue': 58.82, 'unit': 'M', 'net_profit': 9.84}, {'period': ""Q4 '23"", 'revenue': 56.18, 'unit': 'M', 'net_profit': -4.77}, {'period': ""Q3 '23"", 'revenue': 63.44, 'unit': 'M', 'net_profit': 6.33}]",0.13,0.13,302421384,141396860,10961450,182150979,44945097,18110812,171700980,6724360,22517588,1.027442344211613,5.814110900644615,5.744525547445256,__nan__,__nan__,__nan__,0.602308529214323
338,CBAY,CymaBay Therapeutics Inc. Common Stock,"CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of primary biliary cholangitis (PBC), as well as has completed Phase 2b clinical study to treat patients with nonalcoholic steatohepatitis. The company also develops MBX-2982, which is in Phase 2a clinical study for the disease/condition of hypoglycemia in type 1 diabetics. It has a license agreement with ABW Cyclops SPV LP to support development of seladelpar for the treatment of PBC; and holds a worldwide license from Janssen Pharmaceuticals, Inc. to research, develop, and commercialize compounds with activity against an undisclosed metabolic disease target. The company was formerly known as Metabolex, Inc. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Newark, California.",Mr. Sujal A. Shah,Biotechnology,32.48,USD,3728216800,https://images.financialmodelingprep.com/symbol/CBAY.png,3944615,-32.80808080808081,0.01,8354629,-85744000,-105370000,"[{'period': '2023', 'revenue': 31.07, 'unit': 'M', 'net_profit': -105.37}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -118.89}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -92.58}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -48.66}]","[{'period': ""Q4 '23"", 'revenue': 0.057, 'unit': 'M', 'net_profit': -41.9}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -33.88}, {'period': ""Q2 '23"", 'revenue': 31020.0, 'unit': 'K', 'net_profit': -808.0}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -35.08}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -36.38}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -27.65}]",-0.99,-0.99,434686000,403802000,394255000,142430000,0,22360000,36843000,206535000,-72976000,0.07204467484118138,0.11372601794921398,0.2666666666666667,__nan__,__nan__,__nan__,0.32766180645339393
339,CBFV,CB Financial Services Inc. Common Stock,"CB Financial Services, Inc. operates as the bank holding company for Community Bank that provides various banking products and services for individuals and businesses in southwestern Pennsylvania, West Virginia, and Ohio. The company's primary deposit products include demand deposits, NOW accounts, money market accounts, and savings accounts, as well as time deposit products. Its loan products comprise residential real estate loans, such as one- to four-family mortgage loans, home equity installment loans, and home equity lines of credit; commercial real estate loans that are secured primarily by improved properties, such as retail facilities, office buildings, and other non-residential buildings; construction loans to individuals to finance the construction of residential dwellings, as well as for the construction of commercial properties, including hotels, apartment buildings, housing developments, and owner-occupied properties used for businesses; commercial and industrial loans, and lines of credit; consumer loans consisting of indirect auto loans, secured and unsecured loans, and lines of credit; and other loans. In addition, the company conducts insurance agency activities by offering property and casualty, commercial liability, surety, and other insurance products. It operates through its main office and 13 branch offices in Greene, Allegheny, Washington, Fayette, and Westmoreland counties in southwestern Pennsylvania; Marshall and Ohio counties in West Virginia; and Belmont County in Ohio, as well as one loan production offices in Allegheny County. The company was founded in 1901 and is headquartered in Carmichaels, Pennsylvania.",Mr. John H. Montgomery,Banks - Regional,29.48,USD,148085115,https://images.financialmodelingprep.com/symbol/CBFV.png,17100,15.43,-0.07,10378,0,12594000,"[{'period': '2024', 'revenue': 49.14, 'unit': 'M', 'net_profit': 12.59}, {'period': '2023', 'revenue': 68.73, 'unit': 'M', 'net_profit': 22.55}, {'period': '2022', 'revenue': 0.538, 'unit': 'M', 'net_profit': 11.25}, {'period': '2021', 'revenue': 47.22, 'unit': 'M', 'net_profit': 11.57}]","[{'period': ""Q1 '25"", 'revenue': 18.63, 'unit': 'M', 'net_profit': 1.91}, {'period': ""Q4 '24"", 'revenue': 12.28, 'unit': 'M', 'net_profit': 2.53}, {'period': ""Q3 '24"", 'revenue': 12.14, 'unit': 'M', 'net_profit': 3.22}, {'period': ""Q2 '24"", 'revenue': 19.59, 'unit': 'M', 'net_profit': 2.65}, {'period': ""Q1 '24"", 'revenue': 19.65, 'unit': 'M', 'net_profit': 4.2}, {'period': ""Q4 '23"", 'revenue': 8.88, 'unit': 'M', 'net_profit': 12.96}]",2.45,2.38,1481564000,309086000,309086000,1334186000,0,262153000,20000000,49572000,3435000,0,-0.4415077605321508,-0.4444444444444444,"[0.25, 0.19]","['2025-05-16', '2003-12-05']",__nan__,0.900525390735736
340,CBIO,Catalyst Biosciences Inc. Common Stock,"Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD); and CB 4332 for patients with deficiencies in complement factor I (CFI), including dAMD. The company also develops ProTUNE C3b/C4b degrader and ImmunoTUNE C3a/C5a degrader platforms designed to target other disorders of the complement or inflammatory pathways. It has a strategic research collaboration with Mosaic Biosciences, Inc.; and license and collaboration agreement with Biogen International GmbH. Catalyst Biosciences, Inc. was founded in 2002 and is headquartered in South San Francisco, California.",Dr. Nassim  Usman Ph.D.,Biotechnology,0.5113,USD,19418203,https://images.financialmodelingprep.com/symbol/CBIO.png,437269,-0.02470048309178744,-0.0139,460710,16163000,28538000,"[{'period': '2024', 'revenue': 105.76, 'unit': 'M', 'net_profit': 28.54}, {'period': '2022', 'revenue': 0.794, 'unit': 'M', 'net_profit': -8.24}, {'period': '2021', 'revenue': 7.34, 'unit': 'M', 'net_profit': -87.89}, {'period': '2020', 'revenue': 20.95, 'unit': 'M', 'net_profit': -55.54}]","[{'period': ""Q1 '25"", 'revenue': 22.06, 'unit': 'M', 'net_profit': 5.54}, {'period': ""Q4 '24"", 'revenue': 105.76, 'unit': 'M', 'net_profit': 32.33}, {'period': ""Q3 '24"", 'revenue': 25.49, 'unit': 'M', 'net_profit': 5.0}, {'period': ""Q2 '24"", 'revenue': 25.23, 'unit': 'M', 'net_profit': 7.53}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.58}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.47}]",0.34,0.28,125406000,64786000,11813000,27004000,19589000,0,19516000,11813000,-5956000,0,0,0,"[0.016, 0.1443]","['2023-01-13', '2015-08-20']",__nan__,0.21533259971612204
341,CBLI,Cleveland BioLabs Inc. Common Stock,"Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. The company is headquartered in Buffalo, New York and currently employs 15 full-time employees. The firm is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product candidate is Entolimod, an immuno-stimulatory agent, which it is developing as a radiation countermeasure and an immunotherapy for oncology and other indications. Its other products include CBLB612, Mobilan and CBL0137. CBLB612 is a compound based upon a natural activator of another tissue-specific component of the innate immune system, the toll-like receptor 2 (TLR2)/ toll-like receptor 6 (TLR6) heterodimeric receptor. Mobilan is a recombinant non-replicating adenovirus that directs expression of TLR5 and its agonistic ligand. CBL0137 is a small molecule with a multi-targeted mechanism of action that may be useful for the treatment of various types of cancer.",Dr. Yakov Kogan,Biotechnology,3.17,USD,226388720,https://images.financialmodelingprep.com/symbol/CBLI.png,156953,0,-0.25,116255,-2387011,-2398457,"[{'period': '2020', 'revenue': 0.26294, 'unit': 'M', 'net_profit': -2.4}, {'period': '2019', 'revenue': 1.11, 'unit': 'M', 'net_profit': -2.65}, {'period': '2018', 'revenue': 1.14, 'unit': 'M', 'net_profit': -3.61}, {'period': '2017', 'revenue': 1.95, 'unit': 'M', 'net_profit': -9.71}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -659.51}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -538.1}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -694.7}, {'period': ""Q3 '20"", 'revenue': 43.65, 'unit': 'K', 'net_profit': -745.39}, {'period': ""Q2 '20"", 'revenue': 63.26, 'unit': 'K', 'net_profit': -369.84}, {'period': ""Q1 '20"", 'revenue': 156.04, 'unit': 'K', 'net_profit': -588.53}]",-0.19,-0.19,2318021,2314306,2271288,304611,11512,0,304611,1946418,-2372985,0.0934959488532036,0.09389165870478397,0.1739130434782609,__nan__,__nan__,__nan__,0.13140993977190024
342,CBMB,CBM Bancorp Inc. Common Stock,"CBM Bancorp, Inc. operates as a bank holding company for the Chesapeake Bank of Maryland. Its deposit products include savings, money market, certificate of deposit, and retirement, as well as small business and corporate checking accounts. The company's loan portfolio comprises one-to four-family residential real estate loans, nonresidential real estate loans, construction and land development loans, home equity loans and lines of credit, commercial loans, and consumer loans. It also invests in various investment securities; online and mobile banking services; and mortgages. The company operates through a main office located in Baltimore County, Maryland; and three branch offices situated in Arbutus, Bel Air, and Pasadena, Maryland. CBM Bancorp, Inc. was founded in 1913 and is based in Baltimore, Maryland.",Mr. Joseph M. Solomon,Banks - Regional,17.71,USD,0,https://images.financialmodelingprep.com/symbol/CBMB.png,5143,70.84,0,4514,2987288,942557,"[{'period': '2020', 'revenue': 8860.0, 'unit': 'K', 'net_profit': 942.56}, {'period': '2019', 'revenue': 8230.0, 'unit': 'K', 'net_profit': 907.71}, {'period': '2018', 'revenue': 7310.0, 'unit': 'K', 'net_profit': 673.12}, {'period': '2017', 'revenue': 6940000.0, 'unit': '', 'net_profit': 986.0}]","[{'period': ""Q2 '21"", 'revenue': 2080.0, 'unit': 'K', 'net_profit': 104.29}, {'period': ""Q1 '21"", 'revenue': 2009.9999999999998, 'unit': 'K', 'net_profit': 121.72}, {'period': ""Q4 '20"", 'revenue': 2330.0, 'unit': 'K', 'net_profit': 387.34}, {'period': ""Q3 '20"", 'revenue': 2190.0, 'unit': 'K', 'net_profit': 250.84}, {'period': ""Q2 '20"", 'revenue': 2200.0, 'unit': 'K', 'net_profit': 130.62}, {'period': ""Q1 '20"", 'revenue': 2140.0, 'unit': 'K', 'net_profit': 173.76}]",0.26,0.26,234803603,71234672,70629339,181240888,605333,16543524,1029677,54085815,-2456296,0.052444892893141165,0.03838658254316067,0.13043478260869565,"[0.5, 0.5]","['2022-02-28', '2020-04-03']",__nan__,0.7718829084577548
343,CBNK,Capital Bancorp Inc. Common Stock,"Capital Bancorp, Inc. operates as the bank holding company for Capital Bank, N.A. that provides various banking products and services to businesses, not-for-profit associations, and entrepreneurs in the United States. It operates through Commercial Banking, Capital Bank Home Loans, and OpenSky segments. The company offers a range of deposit products and services, including checking and savings, time, interest bearing demand, and money market accounts, as well as certificates of deposit; and credit cards. It originates residential mortgages and offers residential and commercial real estate, construction, and commercial business loans, as well as other consumer loans, such as term loans, car loans, and boat loans to small to medium-sized businesses, professionals, real estate investors, and small residential builders and individuals. It operates through four commercial bank branches, four mortgage offices, and one loan production office. The company was founded in 1974 and is headquartered in Rockville, Maryland.",Mr. Karl  Dicker,Banks - Regional,32.94,USD,545628042,https://images.financialmodelingprep.com/symbol/CBNK.png,58039,13.34,-0.69,105327,0,30972000,"[{'period': '2024', 'revenue': 183.72, 'unit': 'M', 'net_profit': 30.97}, {'period': '2023', 'revenue': 156.99, 'unit': 'M', 'net_profit': 35.87}, {'period': '2022', 'revenue': 169.98, 'unit': 'M', 'net_profit': 41.8}, {'period': '2021', 'revenue': 167.33, 'unit': 'M', 'net_profit': 39.98}]","[{'period': ""Q1 '25"", 'revenue': 70.17, 'unit': 'M', 'net_profit': 13.93}, {'period': ""Q4 '24"", 'revenue': 53.81, 'unit': 'M', 'net_profit': 7.53}, {'period': ""Q3 '24"", 'revenue': 44.99, 'unit': 'M', 'net_profit': 8.67}, {'period': ""Q2 '24"", 'revenue': 43.95, 'unit': 'M', 'net_profit': 8.21}, {'period': ""Q1 '24"", 'revenue': 40.98, 'unit': 'M', 'net_profit': 6.56}, {'period': ""Q4 '23"", 'revenue': 40.83, 'unit': 'M', 'net_profit': 9.03}]",2.12,2.12,3206911000,228909000,307957000,2851772000,0,223630000,2626932000,205274000,32769000,-1,-0.13657271890942543,-0.17187499999999997,"[0.1, 0.05]","['2025-05-12', '2021-07-29']",__nan__,0.889258230116146
344,CBRL,Cracker Barrel Old Country Store Inc Common Stock,"Cracker Barrel Old Country Store, Inc. develops and operates the Cracker Barrel Old Country Store concept in the United States. The company's Cracker Barrel stores consist of a restaurant with a gift shop. Its restaurants serve breakfast, lunch, and dinner, as well as dine-in, pick-up, and delivery services. The company's gift shops comprise various decorative and functional items, such as rocking chairs, seasonal gifts, apparel, toys, cookware, and various other gift items, as well as various candies, preserves, and other food items. As of September 15, 2021, it operated 664 Cracker Barrel stores in 45 states. The company was founded in 1969 and is headquartered in Lebanon, Tennessee.",Ms. Julie Felss Masino,Restaurants,54.75,USD,1218926625,https://images.financialmodelingprep.com/symbol/CBRL.png,1065855,34.22,-1.3,770078,156865000,40930000,"[{'period': '2024', 'revenue': 3470.0, 'unit': 'M', 'net_profit': 40.93}, {'period': '2023', 'revenue': 3440.0, 'unit': 'M', 'net_profit': 99.05}, {'period': '2022', 'revenue': 3270.0, 'unit': 'M', 'net_profit': 131.88}, {'period': '2021', 'revenue': 2820.0, 'unit': 'M', 'net_profit': 254.51}]","[{'period': ""Q2 '25"", 'revenue': 949.44, 'unit': 'M', 'net_profit': 22.21}, {'period': ""Q1 '25"", 'revenue': 845.09, 'unit': 'M', 'net_profit': 4.84}, {'period': ""Q4 '24"", 'revenue': 894.39, 'unit': 'M', 'net_profit': 18.14}, {'period': ""Q3 '24"", 'revenue': 817.13, 'unit': 'M', 'net_profit': -9.2}, {'period': ""Q2 '24"", 'revenue': 935.4, 'unit': 'M', 'net_profit': 26.53}, {'period': ""Q1 '24"", 'revenue': 823.84, 'unit': 'M', 'net_profit': 5.46}]",1.84,1.83,2161494000,278214000,12035000,1721345000,49086000,0,454207000,12035000,40685000,-0.3439383356824104,-0.5867743563856638,-0.5883668903803132,"[0.25, 0.0353]","['2025-04-11', '1985-03-08']",__nan__,0.7963681601706968
345,CBSH,Commerce Bancshares Inc. Common Stock,"Commerce Bancshares, Inc. operates as the bank holding company for Commerce Bank that provides retail, mortgage banking, corporate, investment, trust, and asset management products and services to individuals and businesses in the United States. It operates through three segments: Consumer, Commercial, and Wealth. The Consumer segment offers various banking products and services, including consumer deposits; consumer loans, such as automobile, motorcycle, marine, tractor/trailer, recreational vehicle, fixed rate and revolving home equity, and other consumer loans; patient health care financing; real estate loans; indirect and other consumer financing; personal mortgage banking; consumer installment lending; and consumer debit and credit bank cards. The Commercial segment provides corporate lending, leasing, international, merchant and commercial bank card, and securities safekeeping and bond accounting services; and business products, government deposits, and related commercial cash management services, as well as sells fixed income securities to correspondent banks, corporations, public institutions, municipalities, and individuals. The Wealth segment provides traditional trust and estate planning, advisory and discretionary investment portfolio management, and brokerage services, as well as private banking accounts. The company also offers private equity investment, securities brokerage, insurance agency, specialty lending, and leasing services, as well as online and mobile banking services. It operates through a network of 287 locations in Missouri, Kansas, Illinois, Oklahoma, and Colorado, as well as commercial offices. Commerce Bancshares, Inc. was founded in 1865 and is headquartered in Kansas City, Missouri.",Mr. John W. Kemper,Banks - Regional,63.19,USD,8431315320,https://images.financialmodelingprep.com/symbol/CBSH.png,631847,15.68,-1.8,671345,733566000,526331000,"[{'period': '2024', 'revenue': 1470.0, 'unit': 'M', 'net_profit': 526.33}, {'period': '2023', 'revenue': 1380.0, 'unit': 'M', 'net_profit': 477.06}, {'period': '2022', 'revenue': 1510.0, 'unit': 'M', 'net_profit': 488.4}, {'period': '2021', 'revenue': 1430.0, 'unit': 'M', 'net_profit': 530.76}]","[{'period': ""Q1 '25"", 'revenue': 515.72, 'unit': 'M', 'net_profit': 131.59}, {'period': ""Q4 '24"", 'revenue': 423.06, 'unit': 'M', 'net_profit': 136.11}, {'period': ""Q3 '24"", 'revenue': 534.97, 'unit': 'M', 'net_profit': 138.01}, {'period': ""Q2 '24"", 'revenue': 524.84, 'unit': 'M', 'net_profit': 139.55}, {'period': ""Q1 '24"", 'revenue': 499.87, 'unit': 'M', 'net_profit': 112.66}, {'period': ""Q4 '23"", 'revenue': 515.09, 'unit': 'M', 'net_profit': 109.22}]",3.88,3.95,31996627000,10210737000,10210737000,28664152000,0,9091188000,8150669000,748357000,531726000,0.0961196224368275,0.10328050978912506,0.06593406593406587,"[0.275, 0.4951]","['2025-06-06', '1985-02-25']",__nan__,0.8958491781024294
346,CBTX,CBTX Inc. Common Stock,"CBTX, Inc. operates as the bank holding company for CommunityBank of Texas, National Association that provides commercial banking products and services to small and mid-sized businesses, and professionals in the United States. The company offers demand, money market, savings, and time deposit accounts, as well as certificates of deposit; commercial and industrial, commercial real estate, construction and development, 1-4 family residential mortgage, multi-family residential, consumer, and agricultural loans; and treasury and online banking services. It operates through 34 banking locations, including 18 branches in Houston; 15 branches in Beaumont; and one branch in Dallas. The company was formerly known as CBFH, Inc. and changed its name to CBTX, Inc. in September 2017. CBTX, Inc. was incorporated in 2007 and is headquartered in Beaumont, Texas.",Mr. Robert Franklin,Banks - Regional,29.25,USD,1548933750,https://images.financialmodelingprep.com/symbol/CBTX.png,0,19.763513513513512,-0.42,5324146,0,115003000,"[{'period': '2024', 'revenue': 602.4, 'unit': 'M', 'net_profit': 115.0}, {'period': '2023', 'revenue': 590.82, 'unit': 'M', 'net_profit': 130.5}, {'period': '2022', 'revenue': 322.99, 'unit': 'M', 'net_profit': 51.43}, {'period': '2021', 'revenue': 142.43, 'unit': 'M', 'net_profit': 35.6}]","[{'period': ""Q1 '25"", 'revenue': 142.32, 'unit': 'M', 'net_profit': 24.7}, {'period': ""Q4 '24"", 'revenue': 103.63, 'unit': 'M', 'net_profit': 32.54}, {'period': ""Q3 '24"", 'revenue': 151.78, 'unit': 'M', 'net_profit': 33.89}, {'period': ""Q2 '24"", 'revenue': 152.18, 'unit': 'M', 'net_profit': 29.75}, {'period': ""Q3 '23"", 'revenue': 151.27, 'unit': 'M', 'net_profit': 30.91}, {'period': ""Q2 '23"", 'revenue': 146.96, 'unit': 'M', 'net_profit': 35.17}]",4.701,4.701,10905790000,2130867000,2092983000,9297930000,37884000,0,0,419967000,132619000,0,-0.1187306987900105,-0.5969253843269591,"[0.13, 0.05]","['2022-09-28', '2017-12-30']",__nan__,0.8525682229347897
347,CCAP,Crescent Capital BDC Inc. Common stock,"Crescent Capital BDC, Inc. is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.",Mr. Jason A. Breaux,Asset Management,15.45,USD,572600175,https://images.financialmodelingprep.com/symbol/CCAP.png,162457,11.53,-0.35,139082,74740000,73649000,"[{'period': '2024', 'revenue': 142.44, 'unit': 'M', 'net_profit': 73.65}, {'period': '2023', 'revenue': 147.33, 'unit': 'M', 'net_profit': 83.84}, {'period': '2022', 'revenue': 20.22, 'unit': 'M', 'net_profit': 15.54}, {'period': '2021', 'revenue': 93.99, 'unit': 'M', 'net_profit': 83.63}]","[{'period': ""Q1 '25"", 'revenue': 42.13, 'unit': 'M', 'net_profit': 16.62}, {'period': ""Q4 '24"", 'revenue': 26.51, 'unit': 'M', 'net_profit': 9.99}, {'period': ""Q3 '24"", 'revenue': 51.63, 'unit': 'M', 'net_profit': 15.27}, {'period': ""Q2 '24"", 'revenue': 45.4, 'unit': 'M', 'net_profit': 20.39}, {'period': ""Q1 '24"", 'revenue': 50.2, 'unit': 'M', 'net_profit': 28.0}, {'period': ""Q4 '23"", 'revenue': 33.03, 'unit': 'M', 'net_profit': 30.86}]",1.99,1.99,1656274000,22301000,10130000,915637000,12171000,1603672000,25974000,10130000,58907000,-0.11141230041255008,-0.12152152390949103,-0.14592274678111591,"[0.05, 0.41]","['2025-08-29', '2020-03-30']",__nan__,0.5528294231510004
348,CCB,Coastal Financial Corporation Common Stock,"Coastal Financial Corporation operates as the bank holding company for Coastal Community Bank that provides various banking products and services to small to medium-sized businesses, professionals, and individuals in the Puget Sound region in Washington. It accepts a range of deposit products, including demand and savings accounts, time deposits, and money market accounts. The company offers commercial and industrial loans, including term loans, small business administration loans, commercial lines of credit, working capital loans, equipment financing, borrowing base loans, and other loan products; owner-occupied and non-owner-occupied real estate loans, and multi-family residential loans; construction and land development loans; residential real estate loans; and consumer and other loans, including automobile, boat and recreational vehicle, and secured term loans, as well as overdraft protection. It also provides remote deposit capture, online and mobile banking, and direct and reciprocal deposit services, as well as debit cards. In addition, the company offers business accounts and cash management services, including business checking and savings accounts, and treasury services, as well as banking as a service (BaaS), a platform that allows broker dealers and digital financial service providers to offer their clients banking services. It operates 14 full-service banking locations. Coastal Financial Corporation was founded in 1997 and is headquartered in Everett, Washington.",Mr. Eric M. Sprink,Banks - Regional,88.41,USD,1328475183,https://images.financialmodelingprep.com/symbol/CCB.png,129390,26.08,-0.7,91127,61869000,45219000,"[{'period': '2024', 'revenue': 576.61, 'unit': 'M', 'net_profit': 45.22}, {'period': '2023', 'revenue': 330.37, 'unit': 'M', 'net_profit': 44.58}, {'period': '2022', 'revenue': 213.59, 'unit': 'M', 'net_profit': 40.62}, {'period': '2021', 'revenue': 101.81, 'unit': 'M', 'net_profit': 27.0}]","[{'period': ""Q1 '25"", 'revenue': 168.38, 'unit': 'M', 'net_profit': 9.73}, {'period': ""Q4 '24"", 'revenue': 137.95, 'unit': 'M', 'net_profit': 13.37}, {'period': ""Q3 '24"", 'revenue': 117.56, 'unit': 'M', 'net_profit': 13.46}, {'period': ""Q2 '24"", 'revenue': 136.54, 'unit': 'M', 'net_profit': 11.6}, {'period': ""Q1 '24"", 'revenue': 64.73, 'unit': 'M', 'net_profit': 6.8}, {'period': ""Q4 '23"", 'revenue': 88.24, 'unit': 'M', 'net_profit': 9.01}]",3.35,3.25,4121208000,487790000,452548000,3682504000,35242000,58121000,35531000,452513000,249886000,0.0404971325742924,0.014356535588505798,-0.0029761904761904127,__nan__,__nan__,__nan__,0.8935496582555406
349,CCBG,Capital City Bank Group Common Stock,"Capital City Bank Group, Inc. operates as the financial holding company for Capital City Bank that provides a range of banking and banking-related services to individual and corporate clients. The company offers financing for commercial business properties, equipment, inventories, and accounts receivable, as well as commercial leasing and letters of credit; treasury management services; and merchant credit card transaction processing services. It also provides commercial and residential real estate lending products, as well as fixed- and adjustable-rate residential mortgage loans; personal, automobile, boat/RV, and home equity loans; and credit card programs. In addition, the company offers institutional banking services, including customized checking and savings accounts, cash management systems, tax-exempt loans, lines of credit, and term loans to meet the needs of state and local governments, public schools and colleges, charities, membership, and not-for-profit associations. Further, it provides consumer banking services comprising checking accounts, savings programs, interactive/automated teller machines, debit/credit cards, night deposit services, safe deposit facilities, and online and mobile banking services. Additionally, the company provides asset management for individuals through agency, personal trust, IRA, and personal investment management accounts; and various retail securities products, such as the U.S. government bonds, tax-free municipal bonds, stocks, mutual funds, unit investment trusts, annuities, life insurance, and long-term health care. As of December 31, 2021, it operated through 57 banking offices and 86 ATMs/ITMs in Florida, Georgia, and Alabama. The company was founded in 1895 and is headquartered in Tallahassee, Florida.",Mr. William Godfrey Smith Jr.,Banks - Regional,38.25,USD,652349925,https://images.financialmodelingprep.com/symbol/CCBG.png,25196,11.35,-0.52,37065,73399000,52915000,"[{'period': '2024', 'revenue': 226.5, 'unit': 'M', 'net_profit': 52.91}, {'period': '2023', 'revenue': 223.61, 'unit': 'M', 'net_profit': 52.26}, {'period': '2022', 'revenue': 212.55, 'unit': 'M', 'net_profit': 33.41}, {'period': '2021', 'revenue': 203.84, 'unit': 'M', 'net_profit': 33.4}]","[{'period': ""Q1 '25"", 'revenue': 58.98, 'unit': 'M', 'net_profit': 16.86}, {'period': ""Q4 '24"", 'revenue': 57.48, 'unit': 'M', 'net_profit': 13.09}, {'period': ""Q3 '24"", 'revenue': 68.84, 'unit': 'M', 'net_profit': 13.12}, {'period': ""Q2 '24"", 'revenue': 68.18, 'unit': 'M', 'net_profit': 14.15}, {'period': ""Q1 '24"", 'revenue': 55.53, 'unit': 'M', 'net_profit': 12.56}, {'period': ""Q4 '23"", 'revenue': 62.84, 'unit': 'M', 'net_profit': 11.72}]",3.12,3.12,4324932000,402521000,496461000,3829615000,0,972899000,3176742000,70543000,54885000,24.13965952080706,0.012572237743503387,0.012987012987012998,"[0.24, 0.11]","['2025-03-10', '1994-07-05']",__nan__,0.8854740375108788
350,CCCC,C4 Therapeutics Inc. Common Stock,"C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting IKZF1 and IKZF3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma. The company is also developing CFT8634, an orally bioavailable BiDAC degrader of BRD9, a protein target for synovial sarcoma and SMARCB1-deleted solid tumors; CFT1946, an orally bioavailable BiDAC degrader targeting V600X mutant BRAF to treat melanoma, non-small cell lung cancer (NSCLC), colorectal cancer, and other solid malignancies; CFT8919, an orally bioavailable, allosteric, and mutant-selective BiDAC degrader of epidermal growth factor receptor, or EGFR, with an L858R mutation in NSCLC; and earlier stage programs comprising RET degraders for the treatment of various cancers. C4 Therapeutics, Inc. has strategic collaborations with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; Biogen MA, Inc.; and Calico Life Sciences LLC. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.",Mr. Andrew J. Hirsch M.B.A.,Biotechnology,1.36,USD,96569656,https://images.financialmodelingprep.com/symbol/CCCC.png,1148890,-0.92,-0.12,945206,-103367000,-105316000,"[{'period': '2024', 'revenue': 35.58, 'unit': 'M', 'net_profit': -105.32}, {'period': '2023', 'revenue': 20.76, 'unit': 'M', 'net_profit': -132.49}, {'period': '2022', 'revenue': 31.1, 'unit': 'M', 'net_profit': -126.5}, {'period': '2021', 'revenue': 45.78, 'unit': 'M', 'net_profit': -86.04}]","[{'period': ""Q3 '24"", 'revenue': 5.18, 'unit': 'M', 'net_profit': -34.57}, {'period': ""Q2 '24"", 'revenue': 15.36, 'unit': 'M', 'net_profit': -24.67}, {'period': ""Q1 '24"", 'revenue': 12.01, 'unit': 'M', 'net_profit': -17.72}, {'period': ""Q4 '23"", 'revenue': 3.04, 'unit': 'M', 'net_profit': -28.36}, {'period': ""Q3 '23"", 'revenue': 3.26, 'unit': 'M', 'net_profit': -34.75}, {'period': ""Q2 '23"", 'revenue': 11.07, 'unit': 'M', 'net_profit': -27.04}]",-1.52,-1.52,349602000,257767000,244904000,133616000,3102000,22359000,45177000,55499000,-65337000,0.15344422331965635,0.20512027050485687,0.4307116104868914,__nan__,__nan__,__nan__,0.3821946098706529
351,CCD,Calamos Dynamic Convertible & Income Fund Common Stock,"Calamos Dynamic Convertible and Income Fund is a closed ended fixed income mutual fund launched by Calamos Investments LLC. It is managed by Calamos Advisors LLC. The fund invests in the fixed income markets of the United States. It primarily invests in a portfolio of convertible securities, investment grade and below investment grade bonds, loans, equity-linked notes, and floating rate securities. The fund also invests through derivatives such as options. It employs fundamental analysis with a top-down global macroeconomic approach to create its portfolio. Calamos Dynamic Convertible and Income Fund was formed on March 11, 2014 and is domiciled in the United States.",Mr. John Peter Calamos Sr.,Asset Management - Income,21.48,USD,581139252,https://images.financialmodelingprep.com/symbol/CCD.png,67855,4.95,-0.43,116093,131182605,115378765,"[{'period': '2024', 'revenue': 115.87, 'unit': 'M', 'net_profit': 115.38}, {'period': '2023', 'revenue': -16.53, 'unit': 'M', 'net_profit': -17.07}, {'period': '2022', 'revenue': -232.16, 'unit': 'M', 'net_profit': -232.78}, {'period': '2021', 'revenue': 221.19, 'unit': 'M', 'net_profit': 220.62}]","[{'period': ""Q4 '24"", 'revenue': 50.76, 'unit': 'M', 'net_profit': 45.64}, {'period': ""Q2 '24"", 'revenue': 8.26, 'unit': 'M', 'net_profit': 69.74}, {'period': ""Q4 '23"", 'revenue': 38.35, 'unit': 'M', 'net_profit': -23.31}, {'period': ""Q2 '23"", 'revenue': 50.37, 'unit': 'M', 'net_profit': 6.24}, {'period': ""Q4 '22"", 'revenue': -2.24, 'unit': 'M', 'net_profit': -67.68}, {'period': ""Q2 '22"", 'revenue': 63.47, 'unit': 'M', 'net_profit': -165.1}]",4.31,4.31,824073068,0,0,307075585,4263323,800822422,0,0,56246270,16.69533574944338,7.7585192932075975,7.951612903225806,"[0.195, 0.167]","['2025-05-13', '2015-06-08']",__nan__,0.3726315018949266
352,CCLP,CSI Compressco LP Common Units,"CSI Compressco LP provides contract services for natural gas compression and treating in the United States, Latin America, Canada, Egypt, and internationally. The company offers natural gas compression services through low-, medium-, and high-horsepower compressor packages for oil and natural gas production, gathering, artificial lift, transmission, processing, and storage. It also provides treating services for natural gas producers and midstream companies, such as providing equipment for lease or sale, equipment installation services, and the operation of equipment for removal of contaminants from a natural gas stream, and natural gas cooling to reduce the temperature of produced gas and liquids; well monitoring and sand separation services; and operation, maintenance, overhaul, and reconfiguration services for compression equipment. In addition, the company sells engine parts, compressor package parts, and other parts manufactured by third-party suppliers. CSI Compressco GP LLC serves as the general partner of CSI Compressco LP. The company was formerly known as Compressco Partners, L.P. and changed its name to CSI Compressco LP in December 2014. CSI Compressco LP was incorporated in 2008 and is headquartered in The Woodlands, Texas.",Mr. John Earl Jackson,Oil & Gas Equipment & Services,2.42,USD,344842721,https://images.financialmodelingprep.com/symbol/CCLP.png,224392,-34.57142857142857,0.09,3018771,125601000,-9480000,"[{'period': '2023', 'revenue': 386.13, 'unit': 'M', 'net_profit': -9.48}, {'period': '2022', 'revenue': 353.4, 'unit': 'M', 'net_profit': -22.27}, {'period': '2021', 'revenue': 304.17, 'unit': 'M', 'net_profit': -49.66}, {'period': '2020', 'revenue': 301.59, 'unit': 'M', 'net_profit': -62.95}]","[{'period': ""Q4 '23"", 'revenue': 98.27, 'unit': 'M', 'net_profit': -3.33}, {'period': ""Q3 '23"", 'revenue': 99710.0, 'unit': 'K', 'net_profit': -947.0}, {'period': ""Q2 '23"", 'revenue': 96.78, 'unit': 'M', 'net_profit': -2.57}, {'period': ""Q1 '23"", 'revenue': 91.37, 'unit': 'M', 'net_profit': -2.61}, {'period': ""Q4 '22"", 'revenue': 93.97, 'unit': 'M', 'net_profit': -4.25}, {'period': ""Q3 '22"", 'revenue': 94.89, 'unit': 'M', 'net_profit': -4.53}]",-0.0668,-0.0668,687036000,120023000,7012000,725895000,59428000,0,70372000,7012000,4299000,2.7881831342743393,0.5742769894018322,0.5825,"[0.01, 0.047]","['2024-01-30', '2011-07-28']",__nan__,1.0565603549158995
353,CCMP,CMC Materials Inc. Common Stock,"CMC Materials, Inc., together with its subsidiaries, provides consumable materials to semiconductor manufacturers, and pipeline and adjacent industry customers in North America, Asia, Europe, the Middle East, Africa, and South America. The company operates in two segments, Electronic Materials and Performance Materials. The Electronic Materials segment develops, produces, and sells chemical mechanical planarization (CMP) slurries for polishing various materials used in IC devices, including tungsten, dielectric materials, copper, tantalum, and aluminum; and various materials that are used in the production of disk substrates and magnetic heads for hard disk drives; and CMP pads, which are used in conjunction with slurries in the CMP process. This segment also offers sulfuric, phosphoric, nitric, and hydrofluoric acids, as well as ammonium hydroxide, hydrogen peroxide, isopropyl alcohol, other specialty organic solvents, and various blends of chemicals; and develops and manufactures consumable products for cleaning advanced probe cards and test sockets. The Performance Materials segment provides pipeline and industrial materials comprising polymer-based drag-reducing agents for crude oil transmission, valve greases, cleaners and sealants, and related services and equipment; and routine and emergency maintenance services, as well as training services. This segment also offers precision polishing and metrology systems for advanced optics applications; and magneto-rheological polishing fluids, consumables, and spare and replacement parts, as well as optical polishing services and other customer support services; and engages in the wood treatment business. The company was formerly known as Cabot Microelectronics Corporation and changed its name to CMC Materials, Inc. in October 2020. CMC Materials, Inc. was incorporated in 1999 and is headquartered in Aurora, Illinois.",Mr. David Li,Semiconductors,173.69,USD,0,https://images.financialmodelingprep.com/symbol/CCMP.png,448476,0,0,0,115736000,-68577000,"[{'period': '2021', 'revenue': 1200.0, 'unit': 'M', 'net_profit': -68.58}, {'period': '2020', 'revenue': 1120.0, 'unit': 'M', 'net_profit': 142.83}, {'period': '2019', 'revenue': 1040.0, 'unit': 'M', 'net_profit': 39.22}, {'period': '2018', 'revenue': 590.12, 'unit': 'M', 'net_profit': 110.04}]","[{'period': ""Q2 '22"", 'revenue': 324.13, 'unit': 'M', 'net_profit': 34.57}, {'period': ""Q1 '22"", 'revenue': 317.05, 'unit': 'M', 'net_profit': 27.43}, {'period': ""Q4 '21"", 'revenue': 311.92, 'unit': 'M', 'net_profit': 16.06}, {'period': ""Q3 '21"", 'revenue': 309.52, 'unit': 'M', 'net_profit': 33.64}, {'period': ""Q2 '21"", 'revenue': 290.53, 'unit': 'M', 'net_profit': -149.81}, {'period': ""Q1 '21"", 'revenue': 287.86, 'unit': 'M', 'net_profit': 31.53}]",-2.35,-2.35,2150885000,534981000,185979000,1271948000,150099000,0,205858000,185979000,228510000,-0.66316059069716,-1.4801369479373792,-1.486542443064182,"[0.46, 15]","['2022-03-22', '2012-03-02']",__nan__,0.5913603005274572
